Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
NMR metabolomics,X23424.Total Lipids in VLDL,AGRP,Agouti-related protein,42296,0.272682200303297,0.00478881851619748,0.26329611601155,0.282068284595044,0
NMR metabolomics,X23424.Total Lipids in VLDL,CCL27,C-C motif chemokine 27,42145,0.25030110793894,0.00607039034938402,0.238403142854147,0.262199073023733,0
NMR metabolomics,X23424.Total Lipids in VLDL,CCN1,CCN family member 1,42047,0.360637097467922,0.00670862473198787,0.347488192993226,0.373786001942619,0
NMR metabolomics,X23424.Total Lipids in VLDL,LCAT,Phosphatidylcholine-sterol acyltransferase,39990,0.0843928360900819,0.00209737219945546,0.0802819865791492,0.0885036856010146,0
NMR metabolomics,X23424.Total Lipids in VLDL,LDLR,Low-density lipoprotein receptor,42170,0.400815789852509,0.00398973813545907,0.392995903107009,0.408635676598009,0
NMR metabolomics,X23424.Total Lipids in VLDL,MFGE8,Lactadherin,42137,0.233670730909685,0.00422605359338202,0.225387665866657,0.241953795952714,0
NMR metabolomics,X23424.Total Lipids in VLDL,NPY,Pro-neuropeptide Y,42262,0.335275765058117,0.00588771229400845,0.323735848961861,0.346815681154374,0
NMR metabolomics,X23424.Total Lipids in VLDL,PLA2G7,Platelet-activating factor acetylhydrolase,42137,0.169227949400818,0.00298470327063564,0.163377930990372,0.175077967811264,0
NMR metabolomics,X23424.Total Lipids in VLDL,GHR,Growth hormone receptor,39736,0.105033143185471,0.00275301328123503,0.0996372371542499,0.110429049216691,1.94251122570446e-299
NMR metabolomics,X23424.Total Lipids in VLDL,F7,Coagulation factor VII,42194,0.114206349829357,0.00304653694777329,0.108235137411722,0.120177562246993,9.05431133450092e-293
NMR metabolomics,X23424.Total Lipids in VLDL,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,42217,0.155799418935487,0.00421048970261914,0.147546859118354,0.164051978752621,1.12768230874438e-285
NMR metabolomics,X23424.Total Lipids in VLDL,CES1,Liver carboxylesterase 1,42163,0.306918158467095,0.00835845848043159,0.290535579845449,0.323300737088741,1.69293889489544e-281
NMR metabolomics,X23424.Total Lipids in VLDL,HHEX,Hematopoietically-expressed homeobox protein HHEX,39929,0.277033736921905,0.0075275859313081,0.262279668496541,0.291787805347269,3.5130855865409e-280
NMR metabolomics,X23424.Total Lipids in VLDL,PTH,Parathyroid hormone,39649,0.299005405049793,0.00813051100289681,0.283069603484116,0.314941206615471,2.03957855961625e-279
NMR metabolomics,X23424.Total Lipids in VLDL,SMOC1,SPARC-related modular calcium-binding protein 1,42262,0.114098529825323,0.00318703593516976,0.10785193939239,0.120345120258256,2.19680434656131e-268
NMR metabolomics,X23424.Total Lipids in VLDL,LPL,Lipoprotein lipase,42145,-0.168350172617903,0.00474204447583634,-0.177644579790542,-0.159055765445264,4.79489198274357e-264
NMR metabolomics,X23424.Total Lipids in VLDL,APCS,Serum amyloid P-component,39870,0.113882601388626,0.00319862022489695,0.107613305747828,0.120151897029424,3.32829198838533e-263
NMR metabolomics,X23424.Total Lipids in VLDL,PROC,Vitamin K-dependent protein C,42199,0.0888499537248374,0.00253605094443723,0.0838792938737404,0.0938206135759343,1.55680611789812e-257
NMR metabolomics,X23424.Total Lipids in VLDL,GCG,Pro-glucagon,41843,0.426050764826186,0.012278738858161,0.401984436664191,0.450117092988182,1.41694035143019e-252
NMR metabolomics,X23424.Total Lipids in VLDL,IGSF9,Protein turtle homolog A,39958,0.293554176186395,0.00846404204570238,0.276964653776818,0.310143698595971,1.28354352752818e-250
NMR metabolomics,X23424.Total Lipids in VLDL,TFPI,Tissue factor pathway inhibitor,42152,0.106084327330157,0.00308436616478488,0.100038969647179,0.112129685013136,1.27465501461213e-248
NMR metabolomics,X23424.Total Lipids in VLDL,RARRES2,Retinoic acid receptor responder protein 2,42230,0.163809095502947,0.00478525629882011,0.154429993157259,0.173188197848634,1.88027643783728e-246
NMR metabolomics,X23424.Total Lipids in VLDL,FURIN,Furin,42181,0.111658488893984,0.00327004772476757,0.10524919535344,0.118067782434528,3.08523036962079e-245
NMR metabolomics,X23424.Total Lipids in VLDL,SMAD1,Mothers against decapentaplegic homolog 1,41843,0.275018388969917,0.0083359190279596,0.258679987675116,0.291356790264718,1.79450409254321e-229
NMR metabolomics,X23424.Total Lipids in VLDL,DEFB4A_DEFB4B,Beta-defensin 4A,41921,0.468675152818739,0.014548235638994,0.440160610966311,0.497189694671168,2.49621842525514e-219
NMR metabolomics,X23424.Total Lipids in VLDL,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,42262,0.106645085980683,0.00332441296329046,0.100129236572633,0.113160935388732,9.20165399016084e-218
NMR metabolomics,X23424.Total Lipids in VLDL,BCHE,Cholinesterase,39806,0.0855970346649999,0.00266264921025935,0.0803782422128916,0.0908158271171082,5.69333522678759e-217
NMR metabolomics,X23424.Total Lipids in VLDL,CD4,T-cell surface glycoprotein CD4,42100,0.0920360591992654,0.00288851780812631,0.0863745642953378,0.0976975541031929,7.15698519678519e-215
NMR metabolomics,X23424.Total Lipids in VLDL,CCL23,C-C motif chemokine 23,42185,0.133756788310398,0.0042060323984587,0.125512964809419,0.142000611811377,3.98254266769347e-214
NMR metabolomics,X23424.Total Lipids in VLDL,DNAJB1,DnaJ homolog subfamily B member 1,42070,0.269884379779156,0.00849571110238613,0.253232786018479,0.286535973539833,1.2626100712362e-213
NMR metabolomics,X23424.Total Lipids in VLDL,ERBB3,Receptor tyrosine-protein kinase erbB-3,42084,0.0600591375197892,0.00193129640229981,0.0562737965712816,0.0638444784682969,4.11952534089597e-205
NMR metabolomics,X23424.Total Lipids in VLDL,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,41900,0.25259833636343,0.00814437472094752,0.236635361910372,0.268561310816487,5.64788233025798e-204
NMR metabolomics,X23424.Total Lipids in VLDL,NRP1,Neuropilin-1,42230,-0.0842893260421951,0.00272449889681696,-0.0896293438799563,-0.0789493082044338,3.6308440644973e-203
NMR metabolomics,X23424.Total Lipids in VLDL,VPS37A,Vacuolar protein sorting-associated protein 37A,42070,0.244128802511944,0.00797950429777728,0.2284889740883,0.259768630935587,8.44823054940197e-199
NMR metabolomics,X23424.Total Lipids in VLDL,SERPINA5,Plasma serine protease inhibitor,39835,0.0918315247310107,0.00300186557487427,0.0859478682042571,0.0977151812577642,1.73582409156954e-197
NMR metabolomics,X23424.Total Lipids in VLDL,SLC39A5,Zinc transporter ZIP5,42119,0.158404958188976,0.00530253009339296,0.148011999205926,0.168797917172026,6.03365877685303e-190
NMR metabolomics,X23424.Total Lipids in VLDL,LAMP2,Lysosome-associated membrane glycoprotein 2,41734,0.0612715173429634,0.00206131660290364,0.0572313368012723,0.0653116978846545,5.77060660513035e-188
NMR metabolomics,X23424.Total Lipids in VLDL,ERBB2,Receptor tyrosine-protein kinase erbB-2,42181,0.0721412618316071,0.00244120173261285,0.0673565064356859,0.0769260172275283,4.55756777430574e-186
NMR metabolomics,X23424.Total Lipids in VLDL,IGFBP2,Insulin-like growth factor-binding protein 2,42286,-0.178427384783997,0.00605062844213038,-0.190286616530573,-0.166568153037422,2.34096459049265e-185
NMR metabolomics,X23424.Total Lipids in VLDL,SERPINA4,Kallistatin,39802,0.0690452116309271,0.00233915141954323,0.0644604748486223,0.0736299484132318,1.78522636852158e-184
NMR metabolomics,X23424.Total Lipids in VLDL,C9,Complement component C9,39990,-0.169107905066189,0.00574134328309635,-0.180360937901058,-0.157854872231321,7.75139888565881e-184
NMR metabolomics,X23424.Total Lipids in VLDL,CDKN1A,Cyclin-dependent kinase inhibitor 1,42070,0.313368305365391,0.0106795040098077,0.292436477506168,0.334300133224614,1.63676326528323e-183
NMR metabolomics,X23424.Total Lipids in VLDL,VMO1,Vitelline membrane outer layer protein 1 homolog,42070,0.200648846647832,0.00687033621152896,0.187182987673235,0.214114705622429,7.30843982834357e-182
NMR metabolomics,X23424.Total Lipids in VLDL,TTR,Transthyretin,39862,0.0725397670453706,0.00248066275390418,0.0676776680477184,0.0774018660430228,3.02204088381597e-181
NMR metabolomics,X23424.Total Lipids in VLDL,PRAP1,Proline-rich acidic protein 1,39966,0.113604614047366,0.00390005622311923,0.105960503850052,0.12124872424468,5.71601737119833e-180
NMR metabolomics,X23424.Total Lipids in VLDL,SNCA,Alpha-synuclein,39736,0.341701237790011,0.011768378434285,0.318635216058813,0.36476725952121,9.6447166969885e-179
NMR metabolomics,X23424.Total Lipids in VLDL,CHMP6,Charged multivesicular body protein 6,39958,0.16507967203485,0.00571984732114569,0.153868771285405,0.176290572784296,8.10489121415005e-177
NMR metabolomics,X23424.Total Lipids in VLDL,GPR37,Prosaposin receptor GPR37,41900,0.186330343422634,0.00653208574924849,0.173527455354107,0.199133231491161,9.14021784988072e-174
NMR metabolomics,X23424.Total Lipids in VLDL,INHBC,Inhibin beta C chain,42137,0.112538459443507,0.00398670543941829,0.104724516782247,0.120352402104767,2.1468560042766e-170
NMR metabolomics,X23424.Total Lipids in VLDL,CXCL6,C-X-C motif chemokine 6,42296,0.21285218745699,0.00757473519040004,0.198005706483806,0.227698668430174,5.76046271700615e-169
NMR metabolomics,X23424.Total Lipids in VLDL,PLAT,Tissue-type plasminogen activator,42272,0.144203627906217,0.0051352673238239,0.134138503951522,0.154268751860911,9.78985632889898e-169
NMR metabolomics,X23424.Total Lipids in VLDL,CNTN3,Contactin-3,42137,0.0797482732905248,0.00284319429929126,0.074175612463914,0.0853209341171357,2.5585708358291e-168
NMR metabolomics,X23424.Total Lipids in VLDL,APOC1,Apolipoprotein C-I,39959,0.107205615809071,0.00386497132742443,0.099630272007319,0.114780959610823,6.57748748697229e-164
NMR metabolomics,X23424.Total Lipids in VLDL,AFM,Afamin,39979,0.0561864846893181,0.0020265449926581,0.0522144565037083,0.060158512874928,8.91339541089318e-164
NMR metabolomics,X23424.Total Lipids in VLDL,GUSB,Beta-glucuronidase,42211,0.168539541371823,0.00613013396170438,0.156524478806882,0.180554603936763,5.35009565010989e-162
NMR metabolomics,X23424.Total Lipids in VLDL,DSG2,Desmoglein-2,42137,-0.0744654745070077,0.00271777490032073,-0.0797923133116364,-0.0691386357023791,6.55437192973433e-161
NMR metabolomics,X23424.Total Lipids in VLDL,CFP,Properdin,39979,0.0651781508435792,0.00237431166470059,0.0605244999807661,0.0698318017063924,1.07082307031223e-160
NMR metabolomics,X23424.Total Lipids in VLDL,PLA2G10,Group 10 secretory phospholipase A2,42016,-0.159826208482593,0.00584722277080605,-0.171286765113373,-0.148365651851813,3.93964428164272e-160
NMR metabolomics,X23424.Total Lipids in VLDL,PAMR1,Inactive serine protease PAMR1,42137,0.0725776731756117,0.00265610188215371,0.0673717134865905,0.077783632864633,4.53989986522869e-160
NMR metabolomics,X23424.Total Lipids in VLDL,CRIP2,Cysteine-rich protein 2,42016,0.0983936739434636,0.00365954869375735,0.0912209585036992,0.105566389383228,3.89261940858801e-155
NMR metabolomics,X23424.Total Lipids in VLDL,PSRC1,Proline/serine-rich coiled-coil protein 1,41843,0.161428348304898,0.00602573854161964,0.149617900763324,0.173238795846473,5.19958812002719e-154
NMR metabolomics,X23424.Total Lipids in VLDL,SORT1,Sortilin,42129,0.101892134752603,0.00383284561931813,0.0943797573387396,0.109404512166467,7.98518559221456e-152
NMR metabolomics,X23424.Total Lipids in VLDL,CFH,Complement factor H,39418,0.0626199059290324,0.00235413351406458,0.0580058042414658,0.067234007616599,4.58618217458062e-151
NMR metabolomics,X23424.Total Lipids in VLDL,PROS1,Vitamin K-dependent protein S,39979,0.067775631382692,0.00255144175014733,0.0627748055524033,0.0727764572129808,6.73081103948054e-151
NMR metabolomics,X23424.Total Lipids in VLDL,GSTA3,Glutathione S-transferase A3,41843,0.204900842724318,0.00776155365785942,0.189688197554913,0.220113487893722,1.00418652653248e-149
NMR metabolomics,X23424.Total Lipids in VLDL,FLI1,Friend leukemia integration 1 transcription factor,41843,0.295005190680886,0.0112346580692767,0.272985260865104,0.317025120496668,3.43362972239338e-148
NMR metabolomics,X23424.Total Lipids in VLDL,PLTP,Phospholipid transfer protein,42267,-0.0998724901117786,0.00380923736462024,-0.107338595346434,-0.0924063848771229,7.19135989163327e-148
NMR metabolomics,X23424.Total Lipids in VLDL,IGFBP3,Insulin-like growth factor-binding protein 3,42217,0.0842596330441777,0.00324414544411867,0.0779011079737051,0.0906181581146503,3.35177326366248e-145
NMR metabolomics,X23424.Total Lipids in VLDL,APOM,Apolipoprotein M,42199,0.0737773590645629,0.00285741733677077,0.0681768210844922,0.0793778970446336,1.49482498180566e-143
NMR metabolomics,X23424.Total Lipids in VLDL,ADIPOQ,Adiponectin,39979,-0.178344950161319,0.00693383073862792,-0.19193525840903,-0.164754641913608,7.35106116146635e-142
NMR metabolomics,X23424.Total Lipids in VLDL,MEGF9,Multiple epidermal growth factor-like domains protein 9,42272,0.0507375497061054,0.00197908307504726,0.0468585468790127,0.054616552533198,1.27885017072583e-141
NMR metabolomics,X23424.Total Lipids in VLDL,ELN,Elastin,39958,0.0896929318512124,0.00349190086583788,0.0828488061541701,0.0965370575482546,1.75083984899774e-141
NMR metabolomics,X23424.Total Lipids in VLDL,IGFBP1,Insulin-like growth factor-binding protein 1,42287,-0.327698821080312,0.0127915288025849,-0.352770217533378,-0.302627424627245,1.99415253068353e-141
NMR metabolomics,X23424.Total Lipids in VLDL,ATRN,"Attractin, Isoform 2",39979,0.0429963218381867,0.00167742562903635,0.0397085676052755,0.0462840760710979,6.34245289690772e-141
NMR metabolomics,X23424.Total Lipids in VLDL,KDR,Vascular endothelial growth factor receptor 2,42181,0.0645624343273655,0.00252734512547123,0.0596088378814419,0.0695160307732891,1.25438415914364e-140
NMR metabolomics,X23424.Total Lipids in VLDL,ENO3,Beta-enolase,39638,0.160556614275796,0.00632827588302899,0.148153193545059,0.172960035006533,4.51613010573538e-138
NMR metabolomics,X23424.Total Lipids in VLDL,P4HB,Protein disulfide-isomerase,42073,0.0984406670210178,0.00389065951677263,0.0908149743681435,0.106066359673892,4.96975257406618e-138
NMR metabolomics,X23424.Total Lipids in VLDL,KLKB1,Plasma kallikrein,39759,0.0625893901750996,0.00246856051168222,0.0577510115722025,0.0674277687779968,6.13453482333778e-138
NMR metabolomics,X23424.Total Lipids in VLDL,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,39736,0.0561753558734169,0.00222037030330173,0.0518234300789456,0.0605272816678883,2.31432775098342e-137
NMR metabolomics,X23424.Total Lipids in VLDL,GH1,Somatotropin,42129,-0.451303133824352,0.0179035331505191,-0.486394058799369,-0.416212208849335,4.70702560243257e-137
NMR metabolomics,X23424.Total Lipids in VLDL,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,42249,0.131824977028068,0.00525268762950425,0.121529709274239,0.142120244781896,6.37639872604958e-136
NMR metabolomics,X23424.Total Lipids in VLDL,KYNU,Kynureninase,42296,0.115013033002782,0.00458604745057049,0.106024379999664,0.1240016860059,9.54433748205578e-136
NMR metabolomics,X23424.Total Lipids in VLDL,CXCL13,C-X-C motif chemokine 13,42249,0.145333050030869,0.00579534597636891,0.133974171917186,0.156691928144552,1.0094708675053e-135
NMR metabolomics,X23424.Total Lipids in VLDL,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,42016,0.184845157250218,0.00737566821204416,0.170388847554612,0.199301466945825,1.67122141524837e-135
NMR metabolomics,X23424.Total Lipids in VLDL,TMPRSS15,Enteropeptidase,42070,0.221970100136755,0.00886529209421136,0.204594127632101,0.239346072641409,2.84661144623662e-135
NMR metabolomics,X23424.Total Lipids in VLDL,CFI,Complement factor I,39979,0.0489725248549776,0.00195769670788964,0.0451354393075138,0.0528096104024413,1.7194673091155e-134
NMR metabolomics,X23424.Total Lipids in VLDL,LAT2,Linker for activation of T-cells family member 2,42070,0.317255099401926,0.0127283960240453,0.292307443194797,0.342202755609055,4.25700036770684e-134
NMR metabolomics,X23424.Total Lipids in VLDL,NCS1,Neuronal calcium sensor 1,42262,0.0709995994797434,0.00285265325489338,0.0654083991001523,0.0765907998593344,9.14240034951569e-134
NMR metabolomics,X23424.Total Lipids in VLDL,GRP,Gastrin-releasing peptide,39638,0.133990431618267,0.00538053782275357,0.12344457748567,0.144536285750864,3.16301063032383e-133
NMR metabolomics,X23424.Total Lipids in VLDL,ACY1,Aminoacylase-1,42145,0.157404250661424,0.00633789221389994,0.14498198192218,0.169826519400668,3.46545977173113e-133
NMR metabolomics,X23424.Total Lipids in VLDL,SMAD2,Mothers against decapentaplegic homolog 2,39919,0.177346952725105,0.00715382620308878,0.163325453367051,0.191368452083159,3.65879513892346e-132
NMR metabolomics,X23424.Total Lipids in VLDL,CPM,Carboxypeptidase M,42195,0.0844629627591349,0.00343202397713364,0.0777361957639529,0.0911897297543168,7.02475441083343e-131
NMR metabolomics,X23424.Total Lipids in VLDL,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,42217,-0.0957224624583464,0.00390036035120238,-0.103367168746703,-0.0880777561699897,3.47754962354854e-130
NMR metabolomics,X23424.Total Lipids in VLDL,NUMB,Protein numb homolog,39657,0.208065125242547,0.00845775101785945,0.191487933247543,0.224642317237552,3.78183446973136e-130
NMR metabolomics,X23424.Total Lipids in VLDL,SYAP1,Synapse-associated protein 1,39736,0.144455561218367,0.00590628657348167,0.132879239534343,0.156031882902391,9.94051742498136e-129
NMR metabolomics,X23424.Total Lipids in VLDL,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,42070,0.101289980617612,0.00418100699057941,0.0930952069160762,0.109484754319147,6.00872603433876e-127
NMR metabolomics,X23424.Total Lipids in VLDL,LATS1,Serine/threonine-protein kinase LATS1,39657,0.211465325082021,0.00875416315095634,0.194307165306147,0.228623484857896,1.12652764468884e-125
NMR metabolomics,X23424.Total Lipids in VLDL,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,41843,0.166219738692827,0.00689804769514869,0.152699565210335,0.179739912175318,1.34402468296461e-125
NMR metabolomics,X23424.Total Lipids in VLDL,ANGPTL2,Angiopoietin-related protein 2,42140,0.0963082819706539,0.00399782667067092,0.0884725416961389,0.104144022245169,1.36773831848847e-125
NMR metabolomics,X23424.Total Lipids in VLDL,FN1,Fibronectin,39979,0.0662410719411514,0.00275264663759082,0.0608458845314734,0.0716362593508294,7.51297541642442e-125
NMR metabolomics,X23424.Total Lipids in VLDL,GSTA1,Glutathione S-transferase A1,42119,0.205342286782034,0.00855081792602622,0.188582683647023,0.222101889917046,7.95679442492747e-125
NMR metabolomics,X23424.Total Lipids in VLDL,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,42129,0.299864955483954,0.0125181381460398,0.275329404717716,0.324400506250192,3.15108642258739e-124
NMR metabolomics,X23424.Total Lipids in VLDL,ERP44,Endoplasmic reticulum resident protein 44,42047,0.0627460796311686,0.00262704736987366,0.0575970667862162,0.0678950924761209,1.6234642207948e-123
NMR metabolomics,X23424.Total Lipids in VLDL,CKB,Creatine kinase B-type,39966,-0.138010343470303,0.00579665009149788,-0.149371777649639,-0.126648909290967,2.60523132296737e-122
NMR metabolomics,X23424.Total Lipids in VLDL,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,39930,0.337023931631731,0.0141589714132071,0.309272347661845,0.364775515601617,3.03434943865179e-122
NMR metabolomics,X23424.Total Lipids in VLDL,SOST,Sclerostin,42129,0.0929266164943964,0.00391317927037834,0.0852567851244549,0.100596447864338,3.65739103945527e-122
NMR metabolomics,X23424.Total Lipids in VLDL,CDHR2,Cadherin-related family member 2,42070,0.157441361416225,0.0066560994673438,0.144395406460231,0.170487316372219,3.1493865388812e-121
NMR metabolomics,X23424.Total Lipids in VLDL,SNAPIN,SNARE-associated protein Snapin,39934,0.139112907505359,0.00588897952172644,0.127570507642775,0.150655307367942,1.79025769782005e-120
NMR metabolomics,X23424.Total Lipids in VLDL,F10,Coagulation factor X,39990,0.0689972353234798,0.00292649249521083,0.0632613100328666,0.074733160614093,4.87062687594284e-120
NMR metabolomics,X23424.Total Lipids in VLDL,HEG1,Protein HEG homolog 1,39736,0.0656224778522574,0.00278581161954694,0.0601622870779454,0.0710826686265694,8.99464089644083e-120
NMR metabolomics,X23424.Total Lipids in VLDL,EEF1D,Elongation factor 1-delta,39958,0.216875971747213,0.00920908767058002,0.198826159912876,0.23492578358155,9.01479825598558e-120
NMR metabolomics,X23424.Total Lipids in VLDL,DTYMK,Thymidylate kinase,39958,0.159853014291115,0.00679285433674739,0.14653901979109,0.17316700879114,1.34180183859674e-119
NMR metabolomics,X23424.Total Lipids in VLDL,AGR3,Anterior gradient protein 3,41827,0.140446950550922,0.00598725839950765,0.128711924087887,0.152181977013957,2.95568021824139e-119
NMR metabolomics,X23424.Total Lipids in VLDL,MTSS1,Protein MTSS 1,39930,0.26407940249275,0.0112624317350306,0.24200503629209,0.28615376869341,9.12135600756487e-119
NMR metabolomics,X23424.Total Lipids in VLDL,NOMO1,Nodal modulator 1,42137,0.0548673254603899,0.00235491581891716,0.0502516904553123,0.0594829604654676,9.26689377623762e-118
NMR metabolomics,X23424.Total Lipids in VLDL,PTPRB,Receptor-type tyrosine-protein phosphatase beta,39958,0.0698888073169489,0.00300679832179647,0.0639954826062278,0.07578213202767,8.56394386700743e-117
NMR metabolomics,X23424.Total Lipids in VLDL,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,42070,0.0769303381414928,0.00331784094640665,0.0704273698865358,0.0834333063964499,1.17212468577345e-116
NMR metabolomics,X23424.Total Lipids in VLDL,SNAP29,Synaptosomal-associated protein 29,42181,0.213586937976995,0.00926057811149585,0.195436204878463,0.231737671075527,1.73489245153636e-115
NMR metabolomics,X23424.Total Lipids in VLDL,YES1,Tyrosine-protein kinase Yes,42070,0.266168058852098,0.0115506822649914,0.243528721612715,0.288807396091481,2.85727661686214e-115
NMR metabolomics,X23424.Total Lipids in VLDL,SKAP1,Src kinase-associated phosphoprotein 1,41997,0.168417629037893,0.00731992934912457,0.154070567513608,0.182764690562177,6.44013488998739e-115
NMR metabolomics,X23424.Total Lipids in VLDL,F13B,Coagulation factor XIII B chain,39925,0.0596840020657833,0.00259247826791279,0.0546027446606743,0.0647652594708924,1.17551634578388e-114
NMR metabolomics,X23424.Total Lipids in VLDL,SERPIND1,Heparin cofactor 2,39959,0.0678548588553247,0.00295301321577991,0.0620669529523961,0.0736427647582534,3.03073746559e-114
NMR metabolomics,X23424.Total Lipids in VLDL,MXRA8,Matrix remodeling-associated protein 8,39736,-0.0715657462271503,0.00311498541242059,-0.0776711176354947,-0.065460374818806,3.67660337168795e-114
NMR metabolomics,X23424.Total Lipids in VLDL,MYH9,Myosin-9,39966,0.263535206976646,0.01148777239312,0.24101917308613,0.286051240867161,6.91403543749609e-114
NMR metabolomics,X23424.Total Lipids in VLDL,F9,Coagulation factor IX,42199,0.0424437590526395,0.00185629250035779,0.0388054257519382,0.0460820923533408,1.42409608466972e-113
NMR metabolomics,X23424.Total Lipids in VLDL,CCL16,C-C motif chemokine 16,42310,0.118112548725992,0.00519627900747236,0.107927841871346,0.128297255580638,2.6482604413201e-112
NMR metabolomics,X23424.Total Lipids in VLDL,FGF21,Fibroblast growth factor 21,42247,0.274636558032776,0.0121577856235362,0.250807298210645,0.298465817854907,5.89952753294248e-111
NMR metabolomics,X23424.Total Lipids in VLDL,SARG,Specifically androgen-regulated gene protein,39915,0.251847809250193,0.0111307276482967,0.230031583059532,0.273664035440855,6.74039453270864e-111
NMR metabolomics,X23424.Total Lipids in VLDL,ASGR1,Asialoglycoprotein receptor 1,42016,0.0694214997181953,0.00307395251439226,0.0633965527899864,0.0754464466464041,7.20450526573738e-111
NMR metabolomics,X23424.Total Lipids in VLDL,FYB1,FYN-binding protein 1,42115,0.211595676135675,0.00937512648906978,0.193220428217099,0.229970924054252,9.42684615089123e-111
NMR metabolomics,X23424.Total Lipids in VLDL,NOTCH3,Neurogenic locus notch homolog protein 3,42310,-0.0764291075050775,0.00339366084781472,-0.0830806827667943,-0.0697775322433606,2.55449596556583e-110
NMR metabolomics,X23424.Total Lipids in VLDL,NOS3,"Nitric oxide synthase, endothelial",41839,0.115269926273714,0.0051222631762377,0.105230290448289,0.12530956209914,4.37532016877597e-110
NMR metabolomics,X23424.Total Lipids in VLDL,YTHDF3,YTH domain-containing family protein 3,41913,0.195198231883119,0.00867884950498777,0.178187686853343,0.212208776912895,5.58851967816214e-110
NMR metabolomics,X23424.Total Lipids in VLDL,NAA80,N-alpha-acetyltransferase 80,39649,0.280100055827403,0.0124596401521686,0.255679161129152,0.304520950525653,1.79283736730703e-109
NMR metabolomics,X23424.Total Lipids in VLDL,ADH1B,All-trans-retinol dehydrogenase,39736,0.173383121879024,0.00772432952069964,0.158243436018453,0.188522807739596,3.58949013079761e-109
NMR metabolomics,X23424.Total Lipids in VLDL,AP1G2,AP-1 complex subunit gamma-like 2,39919,0.179990490756378,0.00804189241098079,0.164228381630856,0.1957525998819,1.32406253167413e-108
NMR metabolomics,X23424.Total Lipids in VLDL,NPPC,C-type natriuretic peptide,42119,0.119033848792528,0.00533341574694819,0.108580353928509,0.129487343656546,2.19231154841045e-108
NMR metabolomics,X23424.Total Lipids in VLDL,UPB1,Beta-ureidopropionase,39958,0.204867727839285,0.00917238078081809,0.186889861508882,0.222845594169689,3.51393874642102e-108
NMR metabolomics,X23424.Total Lipids in VLDL,SERPINF1,Pigment epithelium-derived factor,39815,0.0592721057572286,0.00266186769901637,0.0540548450671566,0.0644893664473007,1.61448962707873e-107
NMR metabolomics,X23424.Total Lipids in VLDL,SERPINF2,Alpha-2-antiplasmin,39786,0.0302747558398346,0.00135999858597854,0.0276091586113167,0.0329403530683526,1.86966020571343e-107
NMR metabolomics,X23424.Total Lipids in VLDL,GGT1,Glutathione hydrolase 1 proenzyme,42113,0.116695472093539,0.00525733679604104,0.106391091973299,0.12699985221378,3.01905830427514e-107
NMR metabolomics,X23424.Total Lipids in VLDL,LECT2,Leukocyte cell-derived chemotaxin-2,39958,0.148556572769671,0.00668241166541985,0.135459045905448,0.161654099633894,3.27212959212667e-107
NMR metabolomics,X23424.Total Lipids in VLDL,FCN2,Ficolin-2,42116,0.0907897468565095,0.00410808342113216,0.0827379033510905,0.0988415903619285,2.37826121133164e-106
NMR metabolomics,X23424.Total Lipids in VLDL,RBP5,Retinol-binding protein 5,42070,0.126069771392574,0.00570454225115503,0.11488886858031,0.137250674204838,2.43228721242696e-106
NMR metabolomics,X23424.Total Lipids in VLDL,SMAD5,Mothers against decapentaplegic homolog 5,42070,0.0445319882267604,0.00202046614486329,0.0405718745828284,0.0484921018706925,8.64940521849315e-106
NMR metabolomics,X23424.Total Lipids in VLDL,MLN,Promotilin,42119,0.19796734290382,0.0090608566732984,0.180208063824155,0.215726621983485,5.00330281111187e-104
NMR metabolomics,X23424.Total Lipids in VLDL,ABL1,Tyrosine-protein kinase ABL1,42070,0.149151971453736,0.0068412470933831,0.135743127150705,0.162560815756767,1.36352768775903e-103
NMR metabolomics,X23424.Total Lipids in VLDL,FTCD,Formimidoyltransferase-cyclodeaminase,39910,0.191362017313119,0.008774528087404,0.174163942261807,0.208560092364431,2.53206927379431e-103
NMR metabolomics,X23424.Total Lipids in VLDL,IGSF8,Immunoglobulin superfamily member 8,42145,0.0684393584680858,0.00314427070431725,0.062276587887624,0.0746021290485476,2.81938631318545e-103
NMR metabolomics,X23424.Total Lipids in VLDL,TGFBI,Transforming growth factor-beta-induced protein ig-h3,42114,0.0590500341373783,0.00272314928093523,0.0537126615467453,0.0643874067280114,1.59368196516517e-102
NMR metabolomics,X23424.Total Lipids in VLDL,IL16,Pro-interleukin-16,42296,0.0929728897263444,0.00429223399067328,0.0845601111046248,0.101385668348064,2.49035466382374e-102
NMR metabolomics,X23424.Total Lipids in VLDL,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,39929,0.0907455838422527,0.00418319189480494,0.0825465277284351,0.0989446399560704,2.83928814118586e-102
NMR metabolomics,X23424.Total Lipids in VLDL,TJAP1,Tight junction-associated protein 1,42181,0.182419411429848,0.00842808211401711,0.165900370486375,0.198938452373322,3.63588212991897e-102
NMR metabolomics,X23424.Total Lipids in VLDL,PRCP,Lysosomal Pro-X carboxypeptidase,42238,0.0688217657441384,0.0032238739585512,0.062502972785378,0.0751405587028987,1.73155903726985e-99
NMR metabolomics,X23424.Total Lipids in VLDL,TNFSF10,Tumor necrosis factor ligand superfamily member 10,42296,0.0552854144749884,0.00259140097905729,0.0502062685560362,0.0603645603939407,2.24787923584376e-99
NMR metabolomics,X23424.Total Lipids in VLDL,SHBG,Sex hormone-binding globulin,39990,-0.101489520238518,0.00474923154878607,-0.110798014074139,-0.0921810264028976,2.2539350644154e-99
NMR metabolomics,X23424.Total Lipids in VLDL,LDLRAP1,Low density lipoprotein receptor adapter protein 1,39934,0.216112076694167,0.0101131436867943,0.19629031506805,0.235933838320284,2.31472383075206e-99
NMR metabolomics,X23424.Total Lipids in VLDL,FGFBP1,Fibroblast growth factor-binding protein 1,42181,0.0718785960936887,0.00337032752570951,0.065272754143298,0.0784844380440793,2.69555766612993e-99
NMR metabolomics,X23424.Total Lipids in VLDL,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,39757,0.247039602985045,0.0115663323481535,0.224369591582665,0.269709614387426,3.10608941042018e-99
NMR metabolomics,X23424.Total Lipids in VLDL,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,39930,0.0649945565864253,0.00304614085159938,0.0590241205172905,0.0709649926555601,4.54633794085318e-99
NMR metabolomics,X23424.Total Lipids in VLDL,STAB2,Stabilin-2,39966,0.0607158786767031,0.00285019479546733,0.0551294968775871,0.066302260475819,9.07705056296942e-99
NMR metabolomics,X23424.Total Lipids in VLDL,MTSS2,Protein MTSS 2,39919,0.216960890935193,0.0101883599258998,0.196991705480429,0.236930076389956,1.07533571892717e-98
NMR metabolomics,X23424.Total Lipids in VLDL,FGFR2,Fibroblast growth factor receptor 2,42181,0.0483917067888764,0.00228264459197865,0.0439177233885982,0.0528656901891545,3.70297219410064e-98
NMR metabolomics,X23424.Total Lipids in VLDL,CDHR5,Cadherin-related family member 5,42145,0.0831514229978696,0.00392779039238465,0.0754529538287957,0.0908498921669435,6.8992718428242e-98
NMR metabolomics,X23424.Total Lipids in VLDL,ISM1,Isthmin-1,42119,0.0847186642470167,0.00401030839505853,0.076858459792702,0.0925788687013314,1.74164699724104e-97
NMR metabolomics,X23424.Total Lipids in VLDL,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,39575,0.146957013673372,0.00694745393781049,0.133340003955264,0.160574023391481,2.25648778623414e-97
NMR metabolomics,X23424.Total Lipids in VLDL,HJV,Hemojuvelin,39934,0.0901696177993471,0.00426989692915079,0.0818006198182115,0.0985386157804826,4.02283524748874e-97
NMR metabolomics,X23424.Total Lipids in VLDL,CXCL10,C-X-C motif chemokine 10,42185,0.140857437267817,0.0066917415238292,0.127741623881112,0.153973250654523,8.07231256028536e-97
NMR metabolomics,X23424.Total Lipids in VLDL,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",39638,0.12284229373041,0.00583559969461158,0.111404518328971,0.134280069131848,1.75568522674125e-96
NMR metabolomics,X23424.Total Lipids in VLDL,DPY30,Protein dpy-30 homolog,42216,0.128013082698342,0.00610070853401724,0.116055693971669,0.139970471425016,3.08673563957423e-96
NMR metabolomics,X23424.Total Lipids in VLDL,IPCEF1,Interactor protein for cytohesin exchange factors 1,41992,0.19187495774501,0.0091430845153398,0.173954512094944,0.209795403395076,3.10732490706291e-96
NMR metabolomics,X23424.Total Lipids in VLDL,MAPK9,Mitogen-activated protein kinase 9,42119,0.091078964177771,0.0043508559097015,0.0825512865947561,0.099606641760786,8.70288298910826e-96
NMR metabolomics,X23424.Total Lipids in VLDL,BANK1,B-cell scaffold protein with ankyrin repeats,42119,0.225820400461991,0.010804016322938,0.204644528469032,0.246996272454949,1.66853798526695e-95
NMR metabolomics,X23424.Total Lipids in VLDL,SORD,Sorbitol dehydrogenase,42204,0.145363499368536,0.00697721740043544,0.131688153263682,0.159038845473389,6.41570732892914e-95
NMR metabolomics,X23424.Total Lipids in VLDL,MME,Neprilysin,42070,0.164415801680111,0.00790693970261527,0.148918199862986,0.179913403497237,1.49341714644303e-94
NMR metabolomics,X23424.Total Lipids in VLDL,APOE,Apolipoprotein E,39979,0.147731864844365,0.00709508038921604,0.133825507281502,0.161638222407228,1.57285942275824e-94
NMR metabolomics,X23424.Total Lipids in VLDL,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,41843,0.137677999882488,0.00662653218423264,0.124689996801392,0.150666002963584,2.23209109747935e-94
NMR metabolomics,X23424.Total Lipids in VLDL,CPB2,Carboxypeptidase B2,39959,0.0475187886635391,0.00228465902904155,0.0430408569666177,0.0519967203604606,2.49710265514719e-94
NMR metabolomics,X23424.Total Lipids in VLDL,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,41966,0.103263909251054,0.00498274561791265,0.0934977278399455,0.113030090662163,6.22909822733536e-94
NMR metabolomics,X23424.Total Lipids in VLDL,IL1R2,Interleukin-1 receptor type 2,42100,0.0421092828599437,0.00203353464766487,0.0381235549505205,0.0460950107693668,8.46251593281382e-94
NMR metabolomics,X23424.Total Lipids in VLDL,GLA,Alpha-galactosidase A,39713,0.0824787546854826,0.00397851518813237,0.0746808649167431,0.090276644454222,1.06473480018647e-93
NMR metabolomics,X23424.Total Lipids in VLDL,NT5E,5'-nucleotidase,42181,0.112925386345373,0.00546281890005751,0.10221826130126,0.123632511389485,1.70441214220477e-93
NMR metabolomics,X23424.Total Lipids in VLDL,MASP1,Mannan-binding lectin serine protease 1,41997,0.0484333613758588,0.00234344627736595,0.0438402066722216,0.0530265160794961,1.93305098545093e-93
NMR metabolomics,X23424.Total Lipids in VLDL,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",42070,0.204630843162947,0.00992629230376178,0.185175310247574,0.224086376078321,5.44741306798823e-93
NMR metabolomics,X23424.Total Lipids in VLDL,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",42119,0.209478625898256,0.0101653244155191,0.189554590043839,0.229402661752674,6.30164271780126e-93
NMR metabolomics,X23424.Total Lipids in VLDL,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,42070,0.0769813977958907,0.00373864049898685,0.0696536624178765,0.0843091331739049,8.85842020729535e-93
NMR metabolomics,X23424.Total Lipids in VLDL,PAK4,Serine/threonine-protein kinase PAK 4,41839,0.128130466504704,0.00622494185506157,0.115929580468783,0.140331352540625,1.08521510948704e-92
NMR metabolomics,X23424.Total Lipids in VLDL,BTD,Biotinidase,39979,0.0429868984224803,0.00208578606999502,0.0388987577252901,0.0470750391196706,1.10002892022849e-92
NMR metabolomics,X23424.Total Lipids in VLDL,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,39909,0.164003583083655,0.00796483222705082,0.148392511918636,0.179614654248675,1.62683378428742e-92
NMR metabolomics,X23424.Total Lipids in VLDL,STC1,Stanniocalcin-1,42249,0.0955885482855669,0.00465491284059763,0.0864649191179956,0.104712177453138,2.5894363266402e-92
NMR metabolomics,X23424.Total Lipids in VLDL,LEP,Leptin,42145,0.144970307335105,0.00706438369046219,0.131124115301799,0.158816499368411,3.48569966364381e-92
NMR metabolomics,X23424.Total Lipids in VLDL,ANGPTL3,Angiopoietin-related protein 3,42189,0.0717702261018658,0.00349886990895551,0.064912441080313,0.0786280111234186,4.12000335448909e-92
NMR metabolomics,X23424.Total Lipids in VLDL,DNAJC6,Putative tyrosine-protein phosphatase auxilin,39638,0.176947722752705,0.00861619530902793,0.16005997994701,0.1938354655584,5.25041341329942e-92
NMR metabolomics,X23424.Total Lipids in VLDL,CEP20,Centrosomal protein 20,41843,0.156225859289922,0.00764093122438549,0.141249634090127,0.171202084489718,1.6789620757449e-91
NMR metabolomics,X23424.Total Lipids in VLDL,PDGFC,Platelet-derived growth factor C,41843,0.0578563612817219,0.00283909659648896,0.0522917319526035,0.0634209906108402,6.40275631545539e-91
NMR metabolomics,X23424.Total Lipids in VLDL,TXLNA,Alpha-taxilin,42016,0.182149416598137,0.00894916638444755,0.16460905048462,0.199689782711655,1.00188252910674e-90
NMR metabolomics,X23424.Total Lipids in VLDL,AXIN1,Axin-1,42119,0.199485524603377,0.00981254649368159,0.180252933475761,0.218718115730993,1.57794091148386e-90
NMR metabolomics,X23424.Total Lipids in VLDL,SELPLG,P-selectin glycoprotein ligand 1,42119,0.0573516400862741,0.00282919377376891,0.051806420289687,0.0628968598828612,4.98652694654191e-90
NMR metabolomics,X23424.Total Lipids in VLDL,CD63,CD63 antigen,41992,0.103956483847908,0.00513021608154889,0.0939012603280719,0.114011707367744,5.98441061972817e-90
NMR metabolomics,X23424.Total Lipids in VLDL,HBEGF,Proheparin-binding EGF-like growth factor,42224,0.150134335812213,0.00741021356237083,0.135610317229966,0.16465835439446,6.04174620587512e-90
NMR metabolomics,X23424.Total Lipids in VLDL,MMP10,Stromelysin-2,42124,-0.11851984225248,0.005857381921325,-0.130000310818277,-0.107039373686683,1.03472036965657e-89
NMR metabolomics,X23424.Total Lipids in VLDL,KHK,Ketohexokinase,39638,0.129615913251653,0.00640598031476654,0.117060191834711,0.142171634668596,2.05159944102187e-89
NMR metabolomics,X23424.Total Lipids in VLDL,DKK1,Dickkopf-related protein 1,42249,0.120951618684712,0.00599162158464599,0.109208040378805,0.132695196990618,2.56163902998659e-89
NMR metabolomics,X23424.Total Lipids in VLDL,CCL22,C-C motif chemokine 22,41991,0.106391231571249,0.00527145600651601,0.0960591777984775,0.11672328534402,2.94841303045442e-89
NMR metabolomics,X23424.Total Lipids in VLDL,KAZN,Kazrin,39930,0.215312152841508,0.0106573442173374,0.194423758175527,0.236200547507489,3.38634243157358e-89
NMR metabolomics,X23424.Total Lipids in VLDL,F11R,Junctional adhesion molecule A,42137,0.114260110374197,0.00566673414062327,0.103153311458575,0.125366909289818,4.1621376930693e-89
NMR metabolomics,X23424.Total Lipids in VLDL,DNAJA2,DnaJ homolog subfamily A member 2,42259,0.167014872714027,0.00828763284876298,0.150771112330451,0.183258633097602,5.03137535577101e-89
NMR metabolomics,X23424.Total Lipids in VLDL,CSNK2A1,Casein kinase II subunit alpha,39934,-0.0912662098674092,0.00452694613425711,-0.100139024290553,-0.0823933954442652,7.75844403664346e-89
NMR metabolomics,X23424.Total Lipids in VLDL,PPY,Pancreatic prohormone,42089,0.210380162449063,0.010457244332987,0.189883963556408,0.230876361341718,1.0197359079083e-88
NMR metabolomics,X23424.Total Lipids in VLDL,KITLG,Kit ligand,42145,-0.0779847287080683,0.0038795087541362,-0.0855885658661752,-0.0703808915499614,1.3894697564219e-88
NMR metabolomics,X23424.Total Lipids in VLDL,EHBP1,EH domain-binding protein 1,39958,0.153216786012757,0.00761520782714927,0.138290978671544,0.168142593353969,1.7064704414513e-88
NMR metabolomics,X23424.Total Lipids in VLDL,CES3,Carboxylesterase 3,42070,0.145005752859047,0.00722322968288865,0.130848222680585,0.159163283037509,2.38402970965784e-88
NMR metabolomics,X23424.Total Lipids in VLDL,DCXR,L-xylulose reductase,42181,0.11065635457847,0.00551418070072502,0.0998485604050488,0.121464148751891,2.6860601997015e-88
NMR metabolomics,X23424.Total Lipids in VLDL,TCTN3,Tectonic-3,39958,0.0619901591070477,0.00309017429664639,0.0559334174856208,0.0680469007284746,5.42131770714387e-88
NMR metabolomics,X23424.Total Lipids in VLDL,ZBTB16,Zinc finger and BTB domain-containing protein 16,41843,0.14903925970476,0.00744733251119453,0.134442487982819,0.163636031426702,8.47604235710931e-88
NMR metabolomics,X23424.Total Lipids in VLDL,CEP85,Centrosomal protein of 85 kDa,41843,0.132382657483251,0.00662098127014775,0.119405534193761,0.14535978077274,1.20369157060571e-87
NMR metabolomics,X23424.Total Lipids in VLDL,AP3S2,AP-3 complex subunit sigma-2,39929,0.0978255923341993,0.00490304973690879,0.088215614849858,0.107435569818541,4.46723579478889e-87
NMR metabolomics,X23424.Total Lipids in VLDL,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,42016,0.106493302980588,0.0053461636950029,0.0960148221383828,0.116971783822794,4.96293725931912e-87
NMR metabolomics,X23424.Total Lipids in VLDL,ARF6,ADP-ribosylation factor 6,39930,0.220198274943205,0.0110491528011556,0.19854193545294,0.241854614433471,6.96537777715827e-87
NMR metabolomics,X23424.Total Lipids in VLDL,LEFTY2,Left-right determination factor 2,42247,0.104189464447582,0.00524073222702928,0.0939176292826046,0.114461299612559,1.00492545596186e-86
NMR metabolomics,X23424.Total Lipids in VLDL,GCC1,GRIP and coiled-coil domain-containing protein 1,39929,0.220401791747775,0.0110740975332559,0.198696560582593,0.242107022912956,1.16195386849052e-86
NMR metabolomics,X23424.Total Lipids in VLDL,NFX1,Transcriptional repressor NF-X1,39575,0.136716821549148,0.00686894944575871,0.123253680635461,0.150179962462835,1.26529152691125e-86
NMR metabolomics,X23424.Total Lipids in VLDL,PON3,Serum paraoxonase/lactonase 3,42185,-0.0593104067502243,0.00298513021510148,-0.0651612619718232,-0.0534595515286254,1.28615334593689e-86
NMR metabolomics,X23424.Total Lipids in VLDL,RNF41,E3 ubiquitin-protein ligase NRDP1,41843,0.13384685838171,0.00675702159005735,0.120603096065198,0.147090620698222,4.40730752197496e-86
NMR metabolomics,X23424.Total Lipids in VLDL,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,41900,0.112096573886624,0.00566948441542035,0.1009843844324,0.123208763340848,8.82350310491543e-86
NMR metabolomics,X23424.Total Lipids in VLDL,IL13RA1,Interleukin-13 receptor subunit alpha-1,41936,0.0482771810910657,0.00244324843668666,0.0434884141551599,0.0530659480269716,1.11388138628009e-85
NMR metabolomics,X23424.Total Lipids in VLDL,TARBP2,RISC-loading complex subunit TARBP2,41839,0.158813673558122,0.00804126742952667,0.14305278939625,0.174574557719994,1.36702951560443e-85
NMR metabolomics,X23424.Total Lipids in VLDL,CXCL17,C-X-C motif chemokine 17,42296,0.0855693671982357,0.00433388666705215,0.0770749493308135,0.0940637850656579,1.38708415290313e-85
NMR metabolomics,X23424.Total Lipids in VLDL,PDLIM7,PDZ and LIM domain protein 7,42185,0.251629558736407,0.012752512090427,0.22663463503917,0.276624482433644,1.80299425802622e-85
NMR metabolomics,X23424.Total Lipids in VLDL,SCLY,Selenocysteine lyase,42224,0.0975725435966313,0.00494837761174308,0.0878737234776149,0.107271363715648,2.32719413139362e-85
NMR metabolomics,X23424.Total Lipids in VLDL,YOD1,Ubiquitin thioesterase OTU1,39575,0.121741479061612,0.00617976684054653,0.109629136054141,0.133853822069083,6.26474865732398e-85
NMR metabolomics,X23424.Total Lipids in VLDL,FAM20A,Pseudokinase FAM20A,39958,0.0562578373170411,0.00286408287240254,0.0506442348871321,0.06187143974695,1.67785916992171e-84
NMR metabolomics,X23424.Total Lipids in VLDL,DAAM1,Disheveled-associated activator of morphogenesis 1,39736,0.165736483566225,0.00844008405592574,0.14919391881661,0.182279048315839,1.99136131618277e-84
NMR metabolomics,X23424.Total Lipids in VLDL,MAMDC4,Apical endosomal glycoprotein,39919,0.112854692559208,0.00575411178879277,0.101576633453174,0.124132751665242,2.98229324132104e-84
NMR metabolomics,X23424.Total Lipids in VLDL,CD2AP,CD2-associated protein,42145,0.125520310231966,0.0064153815612448,0.112946162371926,0.138094458092005,4.38795558445623e-84
NMR metabolomics,X23424.Total Lipids in VLDL,BECN1,Beclin-1,39638,0.118292648216121,0.00605226559381997,0.106430207652234,0.130155088780008,1.16679304496787e-83
NMR metabolomics,X23424.Total Lipids in VLDL,VEGFC,Vascular endothelial growth factor C,42181,0.109912038753153,0.0056353234909871,0.0988668047108182,0.120957272795488,1.40366647251717e-83
NMR metabolomics,X23424.Total Lipids in VLDL,PLXNA4,Plexin-A4,42119,0.15920516293727,0.00818988405846883,0.143152990182671,0.175257335691869,4.86932450427918e-83
NMR metabolomics,X23424.Total Lipids in VLDL,DAB2,Disabled homolog 2,42262,0.218630363277858,0.0112810066702615,0.196519590204146,0.240741136351571,1.44503633890854e-82
NMR metabolomics,X23424.Total Lipids in VLDL,RAB11FIP3,Rab11 family-interacting protein 3,39958,0.212604878267005,0.0109573172971421,0.191128536364606,0.234081220169403,1.5660376534199e-82
NMR metabolomics,X23424.Total Lipids in VLDL,EFCAB14,EF-hand calcium-binding domain-containing protein 14,39930,0.0556235691212896,0.00287429878795754,0.0499899434968928,0.0612571947456864,4.11333132444248e-82
NMR metabolomics,X23424.Total Lipids in VLDL,ERBIN,Erbin,42070,0.201487720084687,0.0104281648908986,0.181048516898526,0.221926923270848,4.55268581043806e-82
NMR metabolomics,X23424.Total Lipids in VLDL,PTS,6-pyruvoyl tetrahydrobiopterin synthase,41783,0.107605021514745,0.00556866964827449,0.0966904290041274,0.118519614025363,4.64795179625243e-82
NMR metabolomics,X23424.Total Lipids in VLDL,PBLD,Phenazine biosynthesis-like domain-containing protein,41839,0.103563392658626,0.00536696380487782,0.0930441436010655,0.114082641716187,7.62074041141976e-82
NMR metabolomics,X23424.Total Lipids in VLDL,OXT,Oxytocin-neurophysin 1,42249,0.283749263802467,0.0147476077721982,0.254843952568958,0.312654575035975,2.02828455275308e-81
NMR metabolomics,X23424.Total Lipids in VLDL,S100A4,Protein S100-A4,42181,0.109403270837569,0.0057024996700538,0.0982263714842632,0.120580170190874,5.78311587986453e-81
NMR metabolomics,X23424.Total Lipids in VLDL,CLEC1B,C-type lectin domain family 1 member B,42249,0.18592768956111,0.00972173810233291,0.166873082880538,0.204982296241683,1.76170922510718e-80
NMR metabolomics,X23424.Total Lipids in VLDL,CXCL5,C-X-C motif chemokine 5,42101,0.218746389996384,0.0114530050695439,0.196298500060078,0.24119427993269,2.90828976295953e-80
NMR metabolomics,X23424.Total Lipids in VLDL,EZR,Ezrin,42249,0.0471571874216535,0.00247468527810616,0.0423068042765654,0.0520075705667416,6.39064707925295e-80
NMR metabolomics,X23424.Total Lipids in VLDL,CD6,T-cell differentiation antigen CD6,42284,0.100908768479899,0.00530635136357398,0.0905083198072936,0.111309217152504,1.31757037947249e-79
NMR metabolomics,X23424.Total Lipids in VLDL,DCTN1,Dynactin subunit 1,42262,0.123454144094283,0.00650520234122286,0.110703947505486,0.13620434068308,2.7195406861998e-79
NMR metabolomics,X23424.Total Lipids in VLDL,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",39906,0.212746478984098,0.0112148753315457,0.190765323334269,0.234727634633928,5.06167347684812e-79
NMR metabolomics,X23424.Total Lipids in VLDL,BCR,Breakpoint cluster region protein,42119,0.177546511641253,0.00940679707811573,0.159109189368146,0.19598383391436,1.8878116902563e-78
NMR metabolomics,X23424.Total Lipids in VLDL,ATG16L1,Autophagy-related protein 16-1,39930,0.165726750249457,0.00878002702800114,0.148517897274575,0.182935603224339,2.8671948207169e-78
NMR metabolomics,X23424.Total Lipids in VLDL,MFAP5,Microfibrillar-associated protein 5,42310,0.0774970651486822,0.00411894942069018,0.0694239242841294,0.0855702060132349,5.47345723898772e-78
NMR metabolomics,X23424.Total Lipids in VLDL,SEMA3F,Semaphorin-3F,42145,0.051039454405446,0.00271388904759355,0.0457202318721626,0.0563586769387293,6.51533191743376e-78
NMR metabolomics,X23424.Total Lipids in VLDL,PLIN1,Perilipin-1,41839,0.0648502847003453,0.00345427529359813,0.0580799051248929,0.0716206642757976,1.25373521465545e-77
NMR metabolomics,X23424.Total Lipids in VLDL,APOA2,Apolipoprotein A-II,39990,-0.0944846351996454,0.00502946248391001,-0.104342381668109,-0.0846268887311817,1.44775307537186e-77
NMR metabolomics,X23424.Total Lipids in VLDL,TNIP1,TNFAIP3-interacting protein 1,39929,0.168851104706401,0.00900191423060948,0.151207352814407,0.186494856598396,2.49277706918973e-77
NMR metabolomics,X23424.Total Lipids in VLDL,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,42181,0.180946399508165,0.00966821077789572,0.161996706383489,0.19989609263284,3.44628207699847e-77
NMR metabolomics,X23424.Total Lipids in VLDL,FGFBP3,Fibroblast growth factor-binding protein 3,39929,0.0702536015498542,0.00375506256527676,0.0628936789219117,0.0776135241777966,6.00044991072085e-77
NMR metabolomics,X23424.Total Lipids in VLDL,STAT5B,Signal transducer and activator of transcription 5B,42070,0.260064607537165,0.0139646142593074,0.232693963588923,0.287435251485408,1.8979291071165e-76
NMR metabolomics,X23424.Total Lipids in VLDL,PPP1R9B,Neurabin-2,42296,0.179808474845266,0.00965869727454094,0.160877428187165,0.198739521503366,2.07594991072087e-76
NMR metabolomics,X23424.Total Lipids in VLDL,CCL17,C-C motif chemokine 17,42107,0.17347921160275,0.00931915901833743,0.155213659926809,0.191744763278692,2.1739604844822e-76
NMR metabolomics,X23424.Total Lipids in VLDL,CREG1,Protein CREG1,41960,0.0765615597224255,0.00411456814125172,0.0684970061655722,0.0846261132792789,2.57009072396005e-76
NMR metabolomics,X23424.Total Lipids in VLDL,SLA2,Src-like-adapter 2,39934,0.202309691949902,0.0108688823939811,0.181006682457699,0.223612701442105,3.38651437409147e-76
NMR metabolomics,X23424.Total Lipids in VLDL,NFKB1,Nuclear factor NF-kappa-B p105 subunit,39575,0.141638718347129,0.00761801871644214,0.126707401662903,0.156570035031356,5.38963629286866e-76
NMR metabolomics,X23424.Total Lipids in VLDL,IKBKG,NF-kappa-B essential modulator,42119,0.172657569686166,0.00931376129724037,0.154402597543575,0.190912541828757,8.85738205455418e-76
NMR metabolomics,X23424.Total Lipids in VLDL,ASAH2,Neutral ceramidase,42016,0.100499681580082,0.00542209043559046,0.089872384326325,0.11112697883384,9.449697028565e-76
NMR metabolomics,X23424.Total Lipids in VLDL,ARHGEF1,Rho guanine nucleotide exchange factor 1,39929,0.169611122537913,0.00914623396984883,0.15168450395701,0.187537741118817,1.18682839773242e-75
NMR metabolomics,X23424.Total Lipids in VLDL,ARHGEF12,Rho guanine nucleotide exchange factor 12,42119,0.196369985956331,0.0106050433037362,0.175584101081009,0.217155870831654,1.3015202029992e-75
NMR metabolomics,X23424.Total Lipids in VLDL,SELP,P-selectin,42217,0.10515351426294,0.00568456003091538,0.0940117766023455,0.116295251923534,1.79410401121155e-75
NMR metabolomics,X23424.Total Lipids in VLDL,CCL5,C-C motif chemokine 5,42217,0.190024176915274,0.0102770852923318,0.169881089742304,0.210167264088244,2.07380550837807e-75
NMR metabolomics,X23424.Total Lipids in VLDL,MINK1,Misshapen-like kinase 1,39929,0.175586220557953,0.00949694627300583,0.156972205862861,0.194200235253044,3.23689892744542e-75
NMR metabolomics,X23424.Total Lipids in VLDL,CD300LG,CMRF35-like molecule 9,42137,-0.0702081870363892,0.00380383643888056,-0.0776637064565951,-0.0627526676161833,3.80353327146566e-75
NMR metabolomics,X23424.Total Lipids in VLDL,NCK2,Cytoplasmic protein NCK2,42185,0.200892582142376,0.0108890937114102,0.179549958468012,0.22223520581674,4.38065636378208e-75
NMR metabolomics,X23424.Total Lipids in VLDL,SUGP1,SURP and G-patch domain-containing protein 1,39930,0.0764800738833759,0.00414431462464394,0.0683572172190738,0.084602930547678,6.0171717911326e-75
NMR metabolomics,X23424.Total Lipids in VLDL,CMIP,C-Maf-inducing protein,39919,0.157646986700333,0.00854714751060177,0.140894577579553,0.174399395821112,7.19492706879329e-75
NMR metabolomics,X23424.Total Lipids in VLDL,NPL,N-acetylneuraminate lyase,39958,0.0871985898259605,0.00473175208698916,0.0779243557354618,0.0964728239164593,9.50871513200421e-75
NMR metabolomics,X23424.Total Lipids in VLDL,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,39934,0.158256685965414,0.00859177666369637,0.141416803704569,0.175096568226259,1.12011038306363e-74
NMR metabolomics,X23424.Total Lipids in VLDL,COL4A1,Collagen alpha-1(IV) chain,42145,-0.0735289063394778,0.00400145561852839,-0.0813717593517935,-0.0656860533271622,1.65474186556252e-74
NMR metabolomics,X23424.Total Lipids in VLDL,FOXO1,Forkhead box protein O1,42119,0.161906782612548,0.00883404423504993,0.144592055911851,0.179221509313246,3.92983096330772e-74
NMR metabolomics,X23424.Total Lipids in VLDL,NTproBNP,N-terminal prohormone of brain natriuretic peptide,42145,-0.206497286025595,0.0112703928252637,-0.228587255963112,-0.184407316088078,4.31979421628128e-74
NMR metabolomics,X23424.Total Lipids in VLDL,TGFB1,Transforming growth factor beta-1 proprotein,42284,0.0725341820406082,0.00395938770497059,0.0647737821388658,0.0802945819423505,4.43039078870513e-74
NMR metabolomics,X23424.Total Lipids in VLDL,RNASE4,Ribonuclease 4,39645,0.0517813042317032,0.00282502699572773,0.0462442513200768,0.0573183571433295,5.97839156423485e-74
NMR metabolomics,X23424.Total Lipids in VLDL,CANT1,Soluble calcium-activated nucleotidase 1,42084,0.0373193034804659,0.00203971549547925,0.0333214611093265,0.0413171458516052,6.91843245844773e-74
NMR metabolomics,X23424.Total Lipids in VLDL,TPD52L2,Tumor protein D54,39736,0.203251019177541,0.011102443477412,0.181490229961814,0.225011808393268,8.7701172031158e-74
NMR metabolomics,X23424.Total Lipids in VLDL,CLIP2,CAP-Gly domain-containing linker protein 2,42119,0.210475258674087,0.0115244706450892,0.187887296209712,0.233063221138462,1.24195759981362e-73
NMR metabolomics,X23424.Total Lipids in VLDL,TIMP4,Metalloproteinase inhibitor 4,42137,-0.0741333120808776,0.00406105676555564,-0.0820929833413666,-0.0661736408203885,1.44572875053507e-73
NMR metabolomics,X23424.Total Lipids in VLDL,MVK,Mevalonate kinase,41913,0.153620821038653,0.00843556350067819,0.137087116577324,0.170154525499983,3.25435728269344e-73
NMR metabolomics,X23424.Total Lipids in VLDL,FUOM,Fucose mutarotase,39736,0.119831943055558,0.00657517175112908,0.106944606423345,0.132719279687771,3.76815814281719e-73
NMR metabolomics,X23424.Total Lipids in VLDL,IL18R1,Interleukin-18 receptor 1,42296,0.0612029061029698,0.00336807341113782,0.0546014822171397,0.0678043299888,6.22949203640789e-73
NMR metabolomics,X23424.Total Lipids in VLDL,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,39736,0.0926357155270135,0.00509499314436744,0.0826495289640533,0.102621902089974,8.10531636414497e-73
NMR metabolomics,X23424.Total Lipids in VLDL,PAXX,Protein PAXX,39736,0.0857122697540437,0.00472096119732377,0.0764591858072891,0.0949653537007983,1.28492008341542e-72
NMR metabolomics,X23424.Total Lipids in VLDL,EIF4B,Eukaryotic translation initiation factor 4B,42016,0.103686234335551,0.00572713310603605,0.0924610534477205,0.114911415223382,2.13552748061424e-72
NMR metabolomics,X23424.Total Lipids in VLDL,IGF2R,Cation-independent mannose-6-phosphate receptor,42137,0.0442748007247599,0.00244850758650526,0.0394757258552096,0.0490738755943102,3.10047430262447e-72
NMR metabolomics,X23424.Total Lipids in VLDL,CCN2,CCN family member 2,42146,0.104060518417086,0.00575650766381194,0.0927777633960144,0.115343273438157,3.40357676600607e-72
NMR metabolomics,X23424.Total Lipids in VLDL,GPD1,Glycerol-3-phosphate dehydrogenase,39919,0.0979318380524386,0.00542581379774704,0.0872972430088544,0.108566433096023,8.09116030061877e-72
NMR metabolomics,X23424.Total Lipids in VLDL,SNAP23,Synaptosomal-associated protein 23,42145,0.159555725104266,0.00885225756140499,0.142205300283912,0.17690614992462,8.64659337998005e-72
NMR metabolomics,X23424.Total Lipids in VLDL,BPIFB1,BPI fold-containing family B member 1,42098,-0.118916088955169,0.00659812385711973,-0.131848411715124,-0.105983766195215,8.95097371074039e-72
NMR metabolomics,X23424.Total Lipids in VLDL,ACE2,Angiotensin-converting enzyme 2,41900,0.100096964583129,0.00556551578471802,0.0891885536450814,0.111005375521176,1.78370883531449e-71
NMR metabolomics,X23424.Total Lipids in VLDL,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",39638,0.0469211524317064,0.00260973096134893,0.0418060797474625,0.0520362251159503,2.92593976686204e-71
NMR metabolomics,X23424.Total Lipids in VLDL,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,42070,0.0687184328056712,0.00383566325880952,0.0612005328184045,0.0762363327929378,5.91539514808927e-71
NMR metabolomics,X23424.Total Lipids in VLDL,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,39728,0.088819753428108,0.00495438671321444,0.0791091554702077,0.0985303513860083,7.11237244513199e-71
NMR metabolomics,X23424.Total Lipids in VLDL,IRAK1,Interleukin-1 receptor-associated kinase 1,41913,0.127716925131801,0.00713628232942476,0.113729811766128,0.141704038497473,8.41108857907824e-71
NMR metabolomics,X23424.Total Lipids in VLDL,ATP6V1G1,V-type proton ATPase subunit G 1,39638,0.133313239631776,0.00744029706716089,0.11873025738014,0.147896221883411,8.59153781033212e-71
NMR metabolomics,X23424.Total Lipids in VLDL,AGRN,Agrin,42185,0.0653009573157541,0.00365605650412178,0.0581350865676754,0.0724668280638328,1.51705162569109e-70
NMR metabolomics,X23424.Total Lipids in VLDL,CDH2,Cadherin-2,42145,0.0642291161999056,0.00359606348780336,0.057180831763811,0.0712774006360001,1.5275156045688e-70
NMR metabolomics,X23424.Total Lipids in VLDL,SRPK2,SRSF protein kinase 2,42119,0.154879026553683,0.0086839629323108,0.137858459206354,0.171899593901012,2.41089482671863e-70
NMR metabolomics,X23424.Total Lipids in VLDL,RBPMS2,RNA-binding protein with multiple splicing 2,39638,0.18729994829813,0.0104913385327557,0.166736924773929,0.207862971822332,2.66444868326276e-70
NMR metabolomics,X23424.Total Lipids in VLDL,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",39638,0.125021166985646,0.00700439540321363,0.111292551995348,0.138749781975945,2.84949850560108e-70
NMR metabolomics,X23424.Total Lipids in VLDL,NFKBIE,NF-kappa-B inhibitor epsilon,41843,0.0896766975907881,0.00503334235849579,0.0798113465681363,0.0995420486134398,3.46133610031042e-70
NMR metabolomics,X23424.Total Lipids in VLDL,SDCCAG8,Serologically defined colon cancer antigen 8,39919,0.207308471965953,0.0116394979237523,0.184495056035399,0.230121887896508,5.23897436380716e-70
NMR metabolomics,X23424.Total Lipids in VLDL,EPHA1,Ephrin type-A receptor 1,42162,0.0585123693439655,0.00328977600290707,0.0520644083782676,0.0649603303096634,5.63254476073059e-70
NMR metabolomics,X23424.Total Lipids in VLDL,NFE2,Transcription factor NF-E2 45 kDa subunit,39638,0.134654720760159,0.00757517255872065,0.119807382545067,0.149502058975252,1.01544121368186e-69
NMR metabolomics,X23424.Total Lipids in VLDL,SERPINE1,Plasminogen activator inhibitor 1,42310,0.120305087752092,0.00677813195625032,0.107019949117842,0.133590226386343,1.05473920829075e-69
NMR metabolomics,X23424.Total Lipids in VLDL,PCBP2,Poly(rC)-binding protein 2,39934,0.132278871642612,0.00744564939516042,0.117685398828097,0.146872344457126,1.13791822245796e-69
NMR metabolomics,X23424.Total Lipids in VLDL,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",42310,0.0536979032667154,0.00302757535420391,0.0477638555724758,0.0596319509609551,1.3162562484844e-69
NMR metabolomics,X23424.Total Lipids in VLDL,PLEKHO1,Pleckstrin homology domain-containing family O member 1,39929,0.126206272603255,0.00712632916370496,0.112238667442393,0.140173877764117,3.00686836009029e-69
NMR metabolomics,X23424.Total Lipids in VLDL,PDGFB,Platelet-derived growth factor subunit B,42185,0.154495776324498,0.0087411862010663,0.137363051370408,0.171628501278588,3.91208104340192e-69
NMR metabolomics,X23424.Total Lipids in VLDL,HGF,Hepatocyte growth factor,42296,0.0622231870072197,0.00352217725208888,0.0553197195931255,0.0691266544213139,4.45735284681124e-69
NMR metabolomics,X23424.Total Lipids in VLDL,SERPINH1,Serpin H1,39757,0.23193946163883,0.0131441885545787,0.206176852071856,0.257702071205805,9.38157976195064e-69
NMR metabolomics,X23424.Total Lipids in VLDL,DOK2,Docking protein 2,42145,0.220472441845954,0.0125269824063019,0.195919556329602,0.245025327362306,1.43043921170726e-68
NMR metabolomics,X23424.Total Lipids in VLDL,GFER,FAD-linked sulfhydryl oxidase ALR,41843,0.114393829883172,0.00650232605415919,0.10164927081702,0.127138388949324,1.68035546877106e-68
NMR metabolomics,X23424.Total Lipids in VLDL,RTBDN,Retbindin,42070,0.0537152769378692,0.00305750789172874,0.0477225614700809,0.0597079924056575,2.48569557122626e-68
NMR metabolomics,X23424.Total Lipids in VLDL,ANG,Angiogenin,42152,0.0587482601779453,0.0033450090939507,0.052192042353802,0.0653044780020887,2.69786311175256e-68
NMR metabolomics,X23424.Total Lipids in VLDL,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,39930,0.194160417363892,0.0110480022464036,0.172506332960941,0.215814501766843,3.10771741775669e-68
NMR metabolomics,X23424.Total Lipids in VLDL,BACH1,Transcription regulator protein BACH1,42119,0.134250795001404,0.00765341022579527,0.119250110958846,0.149251479043963,3.93330519216741e-68
NMR metabolomics,X23424.Total Lipids in VLDL,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",42056,0.188738688930973,0.0107616200473509,0.167645913638165,0.209831464223781,4.18744911492765e-68
NMR metabolomics,X23424.Total Lipids in VLDL,TANK,TRAF family member-associated NF-kappa-B activator,41913,0.126612469704475,0.0072372907563492,0.112427379822031,0.14079755958692,9.03139200406048e-68
NMR metabolomics,X23424.Total Lipids in VLDL,GHRL,Appetite-regulating hormone,42145,0.148177128706475,0.00847293219658017,0.131570181601178,0.164784075811772,9.74773643523621e-68
NMR metabolomics,X23424.Total Lipids in VLDL,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,42296,0.174210791057464,0.00997832577974676,0.154653272529161,0.193768309585768,1.58337735739193e-67
NMR metabolomics,X23424.Total Lipids in VLDL,SH2B3,SH2B adapter protein 3,41843,0.174681568539125,0.010058215812751,0.154967465546133,0.194395671532117,8.04644203133868e-67
NMR metabolomics,X23424.Total Lipids in VLDL,PLSCR3,Phospholipid scramblase 3,39911,0.102283051986728,0.00588848790137804,0.0907416157000267,0.113824488273429,1.01857301195533e-66
NMR metabolomics,X23424.Total Lipids in VLDL,NUCB2,Nucleobindin-2,42231,0.0660925387958303,0.00382439986990211,0.0585967150508222,0.0735883625408384,3.26965674197237e-66
NMR metabolomics,X23424.Total Lipids in VLDL,USO1,General vesicular transport factor p115,42070,0.156567364090582,0.00908556094554961,0.138759664637305,0.174375063543859,7.67722114839019e-66
NMR metabolomics,X23424.Total Lipids in VLDL,OTUD7B,OTU domain-containing protein 7B,39934,0.111228710843424,0.00645112725671202,0.0985845014202689,0.12387292026658,8.88200213113031e-66
NMR metabolomics,X23424.Total Lipids in VLDL,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,41997,0.196368820145787,0.0114159363311274,0.173993584936778,0.218744055354797,1.31349152879797e-65
NMR metabolomics,X23424.Total Lipids in VLDL,FETUB,Fetuin-B,42199,0.0564480515459855,0.0032831257284196,0.0500131251182831,0.0628829779736879,1.46579771101784e-65
NMR metabolomics,X23424.Total Lipids in VLDL,PDCD5,Programmed cell death protein 5,42249,0.100403717888546,0.00584452810132896,0.0889484428099415,0.111858992967151,1.85490480728914e-65
NMR metabolomics,X23424.Total Lipids in VLDL,SEC31A,Protein transport protein Sec31A,39638,0.136000029446658,0.00791192886791947,0.120492648865536,0.15150741002778,2.26043116062252e-65
NMR metabolomics,X23424.Total Lipids in VLDL,CCL13,C-C motif chemokine 13,42275,0.119251395170747,0.00695488475462633,0.105619821051679,0.132882969289815,3.20809599332588e-65
NMR metabolomics,X23424.Total Lipids in VLDL,CRELD1,Protein disulfide isomerase CRELD1,39736,0.0656516700906936,0.00382562588258255,0.0581534433608318,0.0731498968205554,3.56887878557971e-65
NMR metabolomics,X23424.Total Lipids in VLDL,VPS53,Vacuolar protein sorting-associated protein 53 homolog,42070,0.135447030947649,0.00791630805682135,0.11993106715628,0.150962994739019,6.07364216940789e-65
NMR metabolomics,X23424.Total Lipids in VLDL,LAT,Linker for activation of T-cells family member 1,42296,0.132305989594069,0.00773979343236321,0.117135994466637,0.147475984721501,7.69611811742533e-65
NMR metabolomics,X23424.Total Lipids in VLDL,CXCL3,C-X-C motif chemokine 3,42129,0.166341517064598,0.00973403198641593,0.147262814371223,0.185420219757973,8.61514456114779e-65
NMR metabolomics,X23424.Total Lipids in VLDL,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,42016,0.165445147947559,0.00968924643607099,0.14645422493286,0.184436070962258,1.09505347006467e-64
NMR metabolomics,X23424.Total Lipids in VLDL,GMPR,GMP reductase 1,42296,0.0830105813278942,0.00486222778420666,0.0734806148708491,0.0925405477849393,1.10799783508662e-64
NMR metabolomics,X23424.Total Lipids in VLDL,GP1BA,Platelet glycoprotein Ib alpha chain,42117,0.0579221174874709,0.00340344483665284,0.0512513656076313,0.0645928693673104,2.78597689906474e-64
NMR metabolomics,X23424.Total Lipids in VLDL,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,39958,0.134033139546828,0.00787182815344424,0.118604356366077,0.149461922727579,3.23766400316324e-64
NMR metabolomics,X23424.Total Lipids in VLDL,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,42212,0.176932694840319,0.0104561977609337,0.156438547228889,0.197426842451749,1.39768172727294e-63
NMR metabolomics,X23424.Total Lipids in VLDL,BIRC2,Baculoviral IAP repeat-containing protein 2,41843,0.109160025361901,0.00645297386735476,0.0965121965818858,0.121807854141916,1.58475655404269e-63
NMR metabolomics,X23424.Total Lipids in VLDL,SFRP4,Secreted frizzled-related protein 4,39736,0.0692187958738693,0.00408917997170299,0.0612040031293314,0.0772335886184071,1.75536116146315e-63
NMR metabolomics,X23424.Total Lipids in VLDL,AKT1S1,Proline-rich AKT1 substrate 1,41839,0.114586545796526,0.00678357892317399,0.101290731107105,0.127882360485947,2.38068503988373e-63
NMR metabolomics,X23424.Total Lipids in VLDL,ITGA5,Integrin alpha-5,42137,0.0428162000680807,0.00254010545259824,0.0378375933809882,0.0477948067551733,4.16202136033344e-63
NMR metabolomics,X23424.Total Lipids in VLDL,OPHN1,Oligophrenin-1,39929,0.186840252055049,0.0110835308604057,0.165116531568654,0.208563972541444,5.40244727017293e-63
NMR metabolomics,X23424.Total Lipids in VLDL,GOLM2,Protein GOLM2,42249,0.0390365125711977,0.00232246784582864,0.0344844755933735,0.0435885495490218,9.08043046732047e-63
NMR metabolomics,X23424.Total Lipids in VLDL,CEP43,Centrosomal protein 43,41797,0.120596554622808,0.00718758504138251,0.106508887941698,0.134684221303918,1.55810488796343e-62
NMR metabolomics,X23424.Total Lipids in VLDL,TIMP3,Metalloproteinase inhibitor 3,42185,0.218584907862555,0.0130451774630591,0.19301636003496,0.244153455690151,2.16346856611308e-62
NMR metabolomics,X23424.Total Lipids in VLDL,TOP2B,DNA topoisomerase 2-beta,39657,0.137949470543194,0.00822364623073485,0.121831123930954,0.154067817155435,2.1996259896829e-62
NMR metabolomics,X23424.Total Lipids in VLDL,C19orf12,Protein C19orf12,41839,0.114109210983426,0.00681580468736839,0.100750233796184,0.127468188170668,2.83366985628353e-62
NMR metabolomics,X23424.Total Lipids in VLDL,DUSP13,Dual specificity protein phosphatase 13 isoform A,39919,0.0737908453914866,0.00440910899874866,0.0651489917539392,0.082432699029034,3.98860782096474e-62
NMR metabolomics,X23424.Total Lipids in VLDL,GIT1,ARF GTPase-activating protein GIT1,39657,0.165736674763549,0.00991418927581221,0.146304863782957,0.185168485744141,5.65515613436286e-62
NMR metabolomics,X23424.Total Lipids in VLDL,PSIP1,PC4 and SFRS1-interacting protein,42119,0.11210720040523,0.00671805678220072,0.0989398091121164,0.125274591698343,6.72388997013141e-62
NMR metabolomics,X23424.Total Lipids in VLDL,GPC5,Glypican-5,42016,0.0960423605108831,0.00575532870432667,0.0847619162504028,0.107322804771363,6.78460918644702e-62
NMR metabolomics,X23424.Total Lipids in VLDL,AP3B1,AP-3 complex subunit beta-1,39930,0.131423326732663,0.00787602449171718,0.115986318728898,0.146860334736429,8.95201251040401e-62
NMR metabolomics,X23424.Total Lipids in VLDL,THOP1,Thimet oligopeptidase,42081,0.0532862821298628,0.0031980843574277,0.0470180367893045,0.0595545274704211,1.02557912249662e-61
NMR metabolomics,X23424.Total Lipids in VLDL,CDC42BPB,Serine/threonine-protein kinase MRCK beta,39930,0.174907726449435,0.0104896864610225,0.154347940985831,0.195467511913039,1.09354113209848e-61
NMR metabolomics,X23424.Total Lipids in VLDL,KRT18,"Keratin, type I cytoskeletal 18",42070,0.144334433735238,0.00867245589631773,0.127336420178455,0.161332447292021,1.40335160722825e-61
NMR metabolomics,X23424.Total Lipids in VLDL,KLK10,Kallikrein-10,42138,0.0693100031706862,0.00417339739454697,0.0611301442773741,0.0774898620639982,2.48124602254106e-61
NMR metabolomics,X23424.Total Lipids in VLDL,RAPGEF2,Rap guanine nucleotide exchange factor 2,39757,0.0916486284434161,0.00551323439239969,0.0808426890343127,0.102454567852519,2.57168101561253e-61
NMR metabolomics,X23424.Total Lipids in VLDL,DNAJB6,DnaJ homolog subfamily B member 6,39639,0.144442479569901,0.00869725922301502,0.127395851492791,0.16148910764701,3.37267426407041e-61
NMR metabolomics,X23424.Total Lipids in VLDL,CLUL1,Clusterin-like protein 1,42123,-0.075646004040422,0.00456142961355996,-0.0845864060829995,-0.0667056019978444,3.66102242926081e-61
NMR metabolomics,X23424.Total Lipids in VLDL,COL18A1,Collagen alpha-1(XVIII) chain,42194,0.0400153130363662,0.0024185063318105,0.0352750406260176,0.0447555854467148,6.79281456170533e-61
NMR metabolomics,X23424.Total Lipids in VLDL,CLEC4A,C-type lectin domain family 4 member A,42119,-0.0603144828989257,0.0036460248356521,-0.0674606915768038,-0.0531682742210476,7.17859653489968e-61
NMR metabolomics,X23424.Total Lipids in VLDL,RGCC,Regulator of cell cycle RGCC,39934,0.129529116682075,0.0078230811676496,0.114195877593482,0.144862355770668,7.33561898791559e-61
NMR metabolomics,X23424.Total Lipids in VLDL,ATP5IF1,"ATPase inhibitor, mitochondrial",42185,0.184472668686123,0.0111639943574678,0.162591239745486,0.20635409762676,9.65675854876818e-61
NMR metabolomics,X23424.Total Lipids in VLDL,NAGK,N-acetyl-D-glucosamine kinase,39627,0.0961362561260555,0.00581781865548827,0.0847333315612985,0.107539180690813,1.30646894491873e-60
NMR metabolomics,X23424.Total Lipids in VLDL,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",39934,0.131872127480798,0.00799213672984005,0.116207539490311,0.147536715471284,1.8488447957157e-60
NMR metabolomics,X23424.Total Lipids in VLDL,SYTL4,Synaptotagmin-like protein 4,39958,0.122593550948056,0.00743460970678006,0.108021715922768,0.137165385973345,2.18918961320861e-60
NMR metabolomics,X23424.Total Lipids in VLDL,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,39958,0.105437433105448,0.00639792613425252,0.0928974978823126,0.117977368328583,2.55799656016423e-60
NMR metabolomics,X23424.Total Lipids in VLDL,CDC27,Cell division cycle protein 27 homolog,41843,0.102492235679543,0.00622566922001392,0.090289924008316,0.114694547350771,2.69135664006149e-60
NMR metabolomics,X23424.Total Lipids in VLDL,AAMDC,Mth938 domain-containing protein,39638,0.089202824507081,0.00541784736174039,0.0785838436780698,0.0998218053360921,3.42895722900538e-60
NMR metabolomics,X23424.Total Lipids in VLDL,CMC1,COX assembly mitochondrial protein homolog,39958,0.153740456598195,0.00933973002554645,0.135434585748124,0.172046327448266,3.47796967751033e-60
NMR metabolomics,X23424.Total Lipids in VLDL,AMOT,Angiomotin,39736,0.0645067531361901,0.00391918496322943,0.0568251506082605,0.0721883556641198,3.68784509179507e-60
NMR metabolomics,X23424.Total Lipids in VLDL,PXN,Paxillin,41839,0.0860400215613162,0.00523665485188795,0.0757761780516158,0.0963038650710165,4.55528040338163e-60
NMR metabolomics,X23424.Total Lipids in VLDL,SCPEP1,Retinoid-inducible serine carboxypeptidase,39601,0.0859970952062926,0.00523050677468278,0.0757453019279144,0.0962488884846709,5.00923408779097e-60
NMR metabolomics,X23424.Total Lipids in VLDL,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,39757,0.177209584493297,0.0107803237706281,0.156080149902866,0.198339019083728,5.15635277380964e-60
NMR metabolomics,X23424.Total Lipids in VLDL,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",39934,0.136079993378905,0.00828384358222585,0.119843659957743,0.152316326800068,6.012822649731e-60
NMR metabolomics,X23424.Total Lipids in VLDL,KRT5,"Keratin, type II cytoskeletal 5",41839,0.0893890252141293,0.0054478729962929,0.0787111941413952,0.100066856286863,6.52823938899715e-60
NMR metabolomics,X23424.Total Lipids in VLDL,PHACTR2,Phosphatase and actin regulator 2,39934,0.191648472460643,0.0116738072437557,0.168767810262882,0.214529134658404,7.08504169211647e-60
NMR metabolomics,X23424.Total Lipids in VLDL,AZI2,5-azacytidine-induced protein 2,39934,0.093280523014194,0.00568315722220674,0.0821415348586688,0.104419511169719,7.49075038728283e-60
NMR metabolomics,X23424.Total Lipids in VLDL,SKAP2,Src kinase-associated phosphoprotein 2,42185,0.17393473746173,0.0106243093611491,0.153111091113878,0.194758383809583,1.13978817130607e-59
NMR metabolomics,X23424.Total Lipids in VLDL,TRIM5,Tripartite motif-containing protein 5,42119,0.14498607912518,0.00886969467099854,0.127601477570022,0.162370680680337,1.71994556843544e-59
NMR metabolomics,X23424.Total Lipids in VLDL,USP8,Ubiquitin carboxyl-terminal hydrolase 8,41900,0.158981727353344,0.00972725307272751,0.139916311330798,0.17804714337589,1.8227221508352e-59
NMR metabolomics,X23424.Total Lipids in VLDL,METAP2,Methionine aminopeptidase 2,42247,0.0930665257564443,0.0056951904096347,0.0819039525535603,0.104229098959328,1.84097100386535e-59
NMR metabolomics,X23424.Total Lipids in VLDL,HCLS1,Hematopoietic lineage cell-specific protein,42296,0.0922938150710222,0.00564966299603823,0.0812204755987873,0.103367154543257,1.98878163634727e-59
NMR metabolomics,X23424.Total Lipids in VLDL,SCAMP3,Secretory carrier-associated membrane protein 3,42070,0.139689261630087,0.00855185198279594,0.122927631743807,0.156450891516367,2.09066798066923e-59
NMR metabolomics,X23424.Total Lipids in VLDL,STK11,Serine/threonine-protein kinase STK11,41900,0.121743400569914,0.00745672065654026,0.107128228083095,0.136358573056733,2.40632691086753e-59
NMR metabolomics,X23424.Total Lipids in VLDL,VWA1,von Willebrand factor A domain-containing protein 1,42247,0.0703456981419801,0.00431448603949084,0.061889305504578,0.0788020907793821,3.32095827949111e-59
NMR metabolomics,X23424.Total Lipids in VLDL,LYN,Tyrosine-protein kinase Lyn,42070,0.141052573013296,0.00867074457124113,0.124057913653663,0.158047232372928,6.1008428014399e-59
NMR metabolomics,X23424.Total Lipids in VLDL,CTBS,Di-N-acetylchitobiase,39860,0.0458062514346052,0.00281444301590685,0.0402899431234278,0.0513225597457826,6.91777945415345e-59
NMR metabolomics,X23424.Total Lipids in VLDL,RABEP1,Rab GTPase-binding effector protein 1,39736,0.12822440245672,0.00788045555700933,0.112778709564981,0.143670095348458,7.52742028827966e-59
NMR metabolomics,X23424.Total Lipids in VLDL,CTSD,Cathepsin D,41225,0.0687710818043921,0.00422999297798079,0.0604802955675498,0.0770618680412345,7.75610649745982e-59
NMR metabolomics,X23424.Total Lipids in VLDL,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,42119,0.168956591813711,0.0104028951956052,0.148566917230324,0.189346266397097,9.25605473890191e-59
NMR metabolomics,X23424.Total Lipids in VLDL,C1S,Complement C1s subcomponent,39979,0.0350462598469886,0.00215979401528436,0.0308130635770312,0.0392794561169459,1.48121058531486e-58
NMR metabolomics,X23424.Total Lipids in VLDL,CA5A,"Carbonic anhydrase 5A, mitochondrial",41900,0.151957115947978,0.00937247056140653,0.133587073647621,0.170327158248335,1.48208618925244e-58
NMR metabolomics,X23424.Total Lipids in VLDL,NIT2,Omega-amidase NIT2,39903,0.121048451891922,0.00745994943153221,0.106426951006119,0.135669952777726,1.50144653716223e-58
NMR metabolomics,X23424.Total Lipids in VLDL,RLN2,Prorelaxin H2,39709,0.0853172415988012,0.00526707493300757,0.0749937747301064,0.0956407084674961,2.41395603567606e-58
NMR metabolomics,X23424.Total Lipids in VLDL,WASF1,Wiskott-Aldrich syndrome protein family member 1,41900,0.157239176197943,0.00972055039048111,0.1381868974326,0.176291454963286,2.6808807901465e-58
NMR metabolomics,X23424.Total Lipids in VLDL,LSP1,Lymphocyte-specific protein 1,42119,0.0669100506529183,0.00413855050817453,0.0587984916568962,0.0750216096489404,3.00466679552203e-58
NMR metabolomics,X23424.Total Lipids in VLDL,MSTN,Growth/differentiation factor 8,41900,0.0890708893145501,0.00551951617878169,0.0782526376041379,0.0998891410249622,4.94642822340042e-58
NMR metabolomics,X23424.Total Lipids in VLDL,BRAP,BRCA1-associated protein,39813,0.181098216911153,0.0112575108965778,0.15903349555386,0.203162938268445,1.38797750660174e-57
NMR metabolomics,X23424.Total Lipids in VLDL,SUSD1,Sushi domain-containing protein 1,41900,0.0798355069726111,0.00497532545321179,0.070083869084316,0.0895871448609062,2.09690316101203e-57
NMR metabolomics,X23424.Total Lipids in VLDL,F2,Prothrombin,39979,0.0244458152063948,0.00152249236876042,0.0214617301636244,0.0274299002491652,2.19603760899659e-57
NMR metabolomics,X23424.Total Lipids in VLDL,DNMBP,Dynamin-binding protein,42016,0.0994569908305733,0.00620023413751561,0.0873045319210427,0.111609449740104,2.261216721412e-57
NMR metabolomics,X23424.Total Lipids in VLDL,RTN4R,Reticulon-4 receptor,42262,0.0552084598968792,0.00344592348460388,0.0484544498670556,0.0619624699267029,3.00861384108724e-57
NMR metabolomics,X23424.Total Lipids in VLDL,SH3GLB2,Endophilin-B2,39929,0.107731603756249,0.00672728168266214,0.0945461316582312,0.120917075854267,4.30122882973166e-57
NMR metabolomics,X23424.Total Lipids in VLDL,HDGFL2,Hepatoma-derived growth factor-related protein 2,39929,0.104843599706496,0.0065473106573241,0.0920108708181405,0.117676328594851,4.36283906546692e-57
NMR metabolomics,X23424.Total Lipids in VLDL,HEXIM1,Protein HEXIM1,42119,0.131998493030038,0.00825238098866856,0.115823826292248,0.148173159767829,4.60406234271806e-57
NMR metabolomics,X23424.Total Lipids in VLDL,AMN,Protein amnionless,41913,0.0772480622426507,0.00483143102828382,0.0677784574272145,0.086717667058087,5.19931200266438e-57
NMR metabolomics,X23424.Total Lipids in VLDL,PDLIM5,PDZ and LIM domain protein 5,39934,0.194002730045203,0.0121338095766664,0.170220463274937,0.21778499681547,6.41907839134457e-57
NMR metabolomics,X23424.Total Lipids in VLDL,DBNL,Drebrin-like protein,42185,0.151313140432757,0.00947522516499272,0.132741699109371,0.169884581756143,6.87811148016236e-57
NMR metabolomics,X23424.Total Lipids in VLDL,CRELD2,Protein disulfide isomerase CRELD2,42166,0.0851122011060521,0.00533575480140084,0.0746541216953065,0.0955702805167978,9.15099265488308e-57
NMR metabolomics,X23424.Total Lipids in VLDL,TBL1X,F-box-like/WD repeat-containing protein TBL1X,41843,0.138750730918337,0.00871119646884624,0.121676785839398,0.155824675997276,1.36043741045318e-56
NMR metabolomics,X23424.Total Lipids in VLDL,USP25,Ubiquitin carboxyl-terminal hydrolase 25,39919,0.117506838468083,0.00738157555546205,0.103038950379378,0.131974726556789,1.91528886433867e-56
NMR metabolomics,X23424.Total Lipids in VLDL,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,39934,0.127339641875647,0.00800169349846803,0.11165632261865,0.143022961132644,2.0623544462393e-56
NMR metabolomics,X23424.Total Lipids in VLDL,IGSF3,Immunoglobulin superfamily member 3,42070,0.0600851479606334,0.0037844438564781,0.0526676380019363,0.0675026579193305,2.9643048751188e-56
NMR metabolomics,X23424.Total Lipids in VLDL,MITD1,MIT domain-containing protein 1,42016,0.156830664234665,0.00988094311919984,0.137464015721033,0.176197312748297,3.21254753413427e-56
NMR metabolomics,X23424.Total Lipids in VLDL,DAG1,Dystroglycan,42185,0.076957037020943,0.00485248456514666,0.0674461672732556,0.0864679067686305,3.86376677563972e-56
NMR metabolomics,X23424.Total Lipids in VLDL,GASK1A,Golgi-associated kinase 1A,39575,0.0694307872152898,0.0043733292032813,0.0608590619768585,0.0780025124537212,3.91129909332485e-56
NMR metabolomics,X23424.Total Lipids in VLDL,ZFYVE19,Abscission/NoCut checkpoint regulator,39930,0.146842819139408,0.00925349479129679,0.128705969348466,0.16497966893035,4.17644117334618e-56
NMR metabolomics,X23424.Total Lipids in VLDL,TBC1D23,TBC1 domain family member 23,42070,0.145913584060275,0.00920807748571212,0.127865752188279,0.16396141593227,4.78389412652215e-56
NMR metabolomics,X23424.Total Lipids in VLDL,EREG,Proepiregulin,41997,0.129991482256917,0.00820658357782108,0.113906578444388,0.146076386069447,5.31630895193833e-56
NMR metabolomics,X23424.Total Lipids in VLDL,STAMBP,STAM-binding protein,41997,0.102005887775639,0.00644490223770614,0.0893738793897345,0.114637896161543,6.46401926600075e-56
NMR metabolomics,X23424.Total Lipids in VLDL,ACP5,Tartrate-resistant acid phosphatase type 5,42211,0.0536370379343417,0.00338946984757596,0.0469936770330928,0.0602803988355905,6.6279150573764e-56
NMR metabolomics,X23424.Total Lipids in VLDL,SNX15,Sorting nexin-15,39736,0.0874574266221711,0.00552295596993394,0.0766324329211006,0.0982824203232416,7.22088360438387e-56
NMR metabolomics,X23424.Total Lipids in VLDL,SCGB3A2,Secretoglobin family 3A member 2,42166,-0.126637450228012,0.00803214384220439,-0.142380452158733,-0.110894448297291,1.6486430270106e-55
NMR metabolomics,X23424.Total Lipids in VLDL,CIRBP,Cold-inducible RNA-binding protein,39930,0.155663456763171,0.00986723844470011,0.136323669411559,0.175003244114784,1.77545147478144e-55
NMR metabolomics,X23424.Total Lipids in VLDL,EVI5,Ecotropic viral integration site 5 protein homolog,39657,0.146426536838536,0.00929688269707518,0.128204646752269,0.164648426924804,2.73237503208612e-55
NMR metabolomics,X23424.Total Lipids in VLDL,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,39934,0.106433630582268,0.00676763874334065,0.09316905864532,0.119698202519215,3.78458383552218e-55
NMR metabolomics,X23424.Total Lipids in VLDL,FAM13A,Protein FAM13A,39930,0.109089275930309,0.00695227698663939,0.0954628130364962,0.122715738824123,6.56875124859459e-55
NMR metabolomics,X23424.Total Lipids in VLDL,MPHOSPH8,M-phase phosphoprotein 8,41900,0.123281967526425,0.00786373191733306,0.107869052968452,0.138694882084398,6.70137517970627e-55
NMR metabolomics,X23424.Total Lipids in VLDL,TAX1BP1,Tax1-binding protein 1,39929,0.0996318010547154,0.00635281237210333,0.0871802888053929,0.112083313304038,7.43823264959154e-55
NMR metabolomics,X23424.Total Lipids in VLDL,CNST,Consortin,42145,0.174166498904704,0.0111303274850421,0.152351057034022,0.195981940775387,1.03361455030198e-54
NMR metabolomics,X23424.Total Lipids in VLDL,GDF2,Growth/differentiation factor 2,42145,0.0565038763699566,0.00361250047159373,0.0494233754456329,0.0635843772942803,1.14640983854323e-54
NMR metabolomics,X23424.Total Lipids in VLDL,PLXNB3,Plexin-B3,42099,0.0767943149942024,0.00491162444445273,0.0671675310830751,0.0864210989053298,1.26207107405591e-54
NMR metabolomics,X23424.Total Lipids in VLDL,TNFSF11,Tumor necrosis factor ligand superfamily member 11,42119,0.0979667370130658,0.00627230213591175,0.0856730248266788,0.110260449199453,1.6192196066996e-54
NMR metabolomics,X23424.Total Lipids in VLDL,IST1,IST1 homolog,39850,0.157555228863258,0.010080601255736,0.137797250402015,0.1773132073245,1.71110937889813e-54
NMR metabolomics,X23424.Total Lipids in VLDL,TACC3,Transforming acidic coiled-coil-containing protein 3,42070,0.186408681665327,0.0119481818204067,0.16299024529733,0.209827118033324,2.1288297934054e-54
NMR metabolomics,X23424.Total Lipids in VLDL,PON2,Serum paraoxonase/arylesterase 2,41900,0.0560021600135579,0.00359679155490327,0.0489524485659475,0.0630518714611683,3.49697359991962e-54
NMR metabolomics,X23424.Total Lipids in VLDL,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,39919,0.133526298269362,0.00857481600480356,0.116719658899947,0.150332937638777,4.1082365213966e-54
NMR metabolomics,X23424.Total Lipids in VLDL,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,39934,0.16959592026913,0.0108936647715319,0.148244337316927,0.190947503221332,4.33411358364779e-54
NMR metabolomics,X23424.Total Lipids in VLDL,ARSB,Arylsulfatase B,42070,0.0883046387252138,0.00567883743253709,0.0771741173574411,0.0994351600929865,4.70718429710289e-54
NMR metabolomics,X23424.Total Lipids in VLDL,CRKL,Crk-like protein,42143,0.167666811016562,0.0107853142046188,0.146527595175509,0.188806026857615,4.97094418590103e-54
NMR metabolomics,X23424.Total Lipids in VLDL,GOLGA3,Golgin subfamily A member 3,39934,0.123305319241532,0.0079460774752508,0.107731007390041,0.138879631093024,9.38341013055436e-54
NMR metabolomics,X23424.Total Lipids in VLDL,TIA1,Nucleolysin TIA-1 isoform p40,41728,0.195920084985731,0.0126596229924963,0.171107223920438,0.220732946051024,1.49645381710288e-53
NMR metabolomics,X23424.Total Lipids in VLDL,ARHGAP45,Rho GTPase-activating protein 45,39736,0.131802413075854,0.00851272192323634,0.11511747810631,0.148487348045397,1.62960968925323e-53
NMR metabolomics,X23424.Total Lipids in VLDL,BTN3A2,Butyrophilin subfamily 3 member A2,42119,0.0601352236579833,0.00388947943464621,0.0525118439660767,0.0677586033498898,1.82340397626988e-53
NMR metabolomics,X23424.Total Lipids in VLDL,AMBP,Protein AMBP,42239,0.0318480126416554,0.00206027200615745,0.0278098795095868,0.035886145773724,1.88667518919535e-53
NMR metabolomics,X23424.Total Lipids in VLDL,PYY,Peptide YY,39575,0.158326498508243,0.010240727779069,0.138254672061267,0.178398324955218,2.33796012827947e-53
NMR metabolomics,X23424.Total Lipids in VLDL,CTSO,Cathepsin O,42296,0.0483346938062744,0.00313064271332026,0.0421986340881667,0.0544707535243821,2.50736903903345e-53
NMR metabolomics,X23424.Total Lipids in VLDL,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,39930,0.140259050291678,0.00908431243683322,0.122453797915485,0.158064302667871,3.0800708259319e-53
NMR metabolomics,X23424.Total Lipids in VLDL,NHLRC3,NHL repeat-containing protein 3,39481,0.0510466521475791,0.00330681608354094,0.0445652926238389,0.0575280116713194,3.38610685742899e-53
NMR metabolomics,X23424.Total Lipids in VLDL,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,42070,-0.0308103102241523,0.002000370369984,-0.034731036149321,-0.0268895842989837,4.47356879412375e-53
NMR metabolomics,X23424.Total Lipids in VLDL,TBCC,Tubulin-specific chaperone C,42016,0.126469290582155,0.00822743188479509,0.110343524087957,0.142595057076354,7.15337291199509e-53
NMR metabolomics,X23424.Total Lipids in VLDL,ADGRD1,Adhesion G-protein coupled receptor D1,39736,0.0644839496637131,0.00420391219460813,0.0562442817622811,0.072723617565145,1.44348095078521e-52
NMR metabolomics,X23424.Total Lipids in VLDL,SULT2A1,Bile salt sulfotransferase,42119,0.0922031263325655,0.00601670511141138,0.0804103843141992,0.103995868350932,1.44959932655679e-52
NMR metabolomics,X23424.Total Lipids in VLDL,TRIM21,E3 ubiquitin-protein ligase TRIM21,42119,0.113911448117642,0.00743709742923918,0.0993347371563328,0.12848815907895,1.63274723765563e-52
NMR metabolomics,X23424.Total Lipids in VLDL,COCH,Cochlin,39958,0.0720336292111548,0.00470050808351326,0.0628206333674688,0.0812466250548408,1.75107337411218e-52
NMR metabolomics,X23424.Total Lipids in VLDL,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,42181,0.0582685882758011,0.00380948067982532,0.0508020061433435,0.0657351704082588,2.23143204496323e-52
NMR metabolomics,X23424.Total Lipids in VLDL,FKBPL,FK506-binding protein-like,39930,0.0928572637378524,0.00607631142881232,0.0809476933373803,0.104766834138325,3.34546620362386e-52
NMR metabolomics,X23424.Total Lipids in VLDL,GPKOW,G-patch domain and KOW motifs-containing protein,41839,0.0458386772845817,0.00300221390393886,0.0399543380328615,0.0517230165363019,3.46011039871072e-52
NMR metabolomics,X23424.Total Lipids in VLDL,MEP1A,Meprin A subunit alpha,39930,0.118609949632714,0.00778516030639499,0.10335103543218,0.133868863833248,6.72056730009977e-52
NMR metabolomics,X23424.Total Lipids in VLDL,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,41843,0.120427278456728,0.00791285231949414,0.10491808791052,0.135936469002937,7.23966322832666e-52
NMR metabolomics,X23424.Total Lipids in VLDL,MPRIP,Myosin phosphatase Rho-interacting protein,39892,0.0707988083444082,0.00464994212810613,0.0616849217733201,0.0799126949154962,7.7969247475044e-52
NMR metabolomics,X23424.Total Lipids in VLDL,BID,BH3-interacting domain death agonist,42119,0.103101156587588,0.00677756436494502,0.0898171304322956,0.11638518274288,7.88904398937927e-52
NMR metabolomics,X23424.Total Lipids in VLDL,FGFBP2,Fibroblast growth factor-binding protein 2,39966,0.0800940781542242,0.00526405342205971,0.0697765334469871,0.0904116228614612,9.04963089373083e-52
NMR metabolomics,X23424.Total Lipids in VLDL,SMNDC1,Survival of motor neuron-related-splicing factor 30,39930,0.0962937533997662,0.00633108003184216,0.0838848365373556,0.108702670262177,9.87701370737406e-52
NMR metabolomics,X23424.Total Lipids in VLDL,ANXA11,Annexin A11,42087,0.102964977902117,0.00677678044086196,0.0896824882380279,0.116247467566207,1.04126335859394e-51
NMR metabolomics,X23424.Total Lipids in VLDL,FGF19,Fibroblast growth factor 19,42185,0.120764545859196,0.00794858328953748,0.105185322611703,0.13634376910669,1.0429061979513e-51
NMR metabolomics,X23424.Total Lipids in VLDL,GYS1,"Glycogen [starch] synthase, muscle",41900,0.144249676073781,0.00949889516960777,0.12563184154135,0.162867510606212,1.18743983613469e-51
NMR metabolomics,X23424.Total Lipids in VLDL,NSFL1C,NSFL1 cofactor p47,42249,0.0976340395174499,0.00643116541721753,0.0850289552997036,0.110239123735196,1.2396636501712e-51
NMR metabolomics,X23424.Total Lipids in VLDL,SERPINC1,Antithrombin-III,39959,0.0225217708106097,0.00148329275260153,0.0196145170155107,0.0254290246057087,1.45413830167959e-51
NMR metabolomics,X23424.Total Lipids in VLDL,GTPBP2,GTP-binding protein 2,39649,0.127558328546755,0.00840619517143962,0.111082186010733,0.144034471082776,1.7256837462147e-51
NMR metabolomics,X23424.Total Lipids in VLDL,RAB27B,Ras-related protein Rab-27B,39958,0.12797291025258,0.0084494184723938,0.111412050046688,0.144533770458472,2.55940538538443e-51
NMR metabolomics,X23424.Total Lipids in VLDL,PENK,Proenkephalin-A,39736,0.0480452112917737,0.00317678197811818,0.0418187186146621,0.0542717039688854,3.62799872549626e-51
NMR metabolomics,X23424.Total Lipids in VLDL,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",41843,0.127506988460884,0.00843970166410357,0.110965173199241,0.144048803722527,3.82510616071303e-51
NMR metabolomics,X23424.Total Lipids in VLDL,NIT1,Deaminated glutathione amidase,39638,0.0686541126482716,0.00454990175064668,0.0597363052170041,0.0775719200795391,6.1412127707415e-51
NMR metabolomics,X23424.Total Lipids in VLDL,SELE,E-selectin,42310,0.077878692508232,0.0051674025212787,0.0677505835665257,0.0880068014499382,6.41001709471781e-51
NMR metabolomics,X23424.Total Lipids in VLDL,MYDGF,Myeloid-derived growth factor,39958,0.153630772916585,0.0101900197942714,0.133658334119813,0.173603211713357,7.16287399619356e-51
NMR metabolomics,X23424.Total Lipids in VLDL,SIAE,Sialate O-acetylesterase,42147,0.0715782181113738,0.0047547767867499,0.062258855609344,0.0808975806134036,8.37116167236707e-51
NMR metabolomics,X23424.Total Lipids in VLDL,HAVCR1,Hepatitis A virus cellular receptor 1,42239,0.0996937245625927,0.00662481560526793,0.0867090859762675,0.112678363148918,9.0182517064716e-51
NMR metabolomics,X23424.Total Lipids in VLDL,CRHBP,Corticotropin-releasing factor-binding protein,42123,0.0421541824481804,0.00280180329747361,0.0366626479851321,0.0476457169112286,9.52643865744432e-51
NMR metabolomics,X23424.Total Lipids in VLDL,HS1BP3,HCLS1-binding protein 3,39638,0.140402086620009,0.0093555710145565,0.122065167431478,0.15873900580854,2.06303442881474e-50
NMR metabolomics,X23424.Total Lipids in VLDL,IGBP1,Immunoglobulin-binding protein 1,39934,0.0921203094686253,0.00614092136479306,0.080084103593631,0.10415651534362,2.19748610186295e-50
NMR metabolomics,X23424.Total Lipids in VLDL,RRM2,Ribonucleoside-diphosphate reductase subunit M2,41843,0.0747980079535127,0.00499275173051531,0.0650122145617027,0.0845838013453227,2.51181310023301e-50
NMR metabolomics,X23424.Total Lipids in VLDL,SPON2,Spondin-2,42070,-0.0534512247288594,0.00356970080425306,-0.0604478383051954,-0.0464546111525234,2.77211814321159e-50
NMR metabolomics,X23424.Total Lipids in VLDL,LGALS8,Galectin-8,42249,0.0932240496245783,0.00622724101529622,0.0810186572345977,0.105429442014559,2.8726962363275e-50
NMR metabolomics,X23424.Total Lipids in VLDL,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,39485,0.0471562223747999,0.00314713366010035,0.0409878404010032,0.0533246043485966,2.96309096752919e-50
NMR metabolomics,X23424.Total Lipids in VLDL,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",42047,0.115587076440503,0.00774048422319847,0.100415727363034,0.130758425517972,5.0723946675527e-50
NMR metabolomics,X23424.Total Lipids in VLDL,ASPSCR1,Tether containing UBX domain for GLUT4,39934,0.101809503141484,0.00681820755404468,0.0884458163355566,0.115173189947412,6.08147051785876e-50
NMR metabolomics,X23424.Total Lipids in VLDL,CNPY4,Protein canopy homolog 4,42070,0.114742168307745,0.00769058001792563,0.099668631472611,0.129815705142879,6.13159101982853e-50
NMR metabolomics,X23424.Total Lipids in VLDL,TRIM58,E3 ubiquitin-protein ligase TRIM58,39919,0.131694193977951,0.00882771308009971,0.114391876340956,0.148996511614946,7.45301442785225e-50
NMR metabolomics,X23424.Total Lipids in VLDL,ALDH1A1,Retinal dehydrogenase 1,42137,0.0811859230987554,0.00545090940706585,0.0705021406609063,0.0918697055366045,8.92902549544217e-50
NMR metabolomics,X23424.Total Lipids in VLDL,RILPL2,RILP-like protein 2,39958,0.150841773145977,0.0101223086886252,0.131002048116272,0.170681498175683,9.44190732348779e-50
NMR metabolomics,X23424.Total Lipids in VLDL,ATXN2L,Ataxin-2-like protein,39934,0.0732603216178321,0.00492565188436914,0.0636060439244686,0.0829145993111956,1.44144205559645e-49
NMR metabolomics,X23424.Total Lipids in VLDL,NUDT5,ADP-sugar pyrophosphatase,42137,0.0759380681931556,0.00511064149132009,0.0659212108701683,0.085954925516143,1.4982094021807e-49
NMR metabolomics,X23424.Total Lipids in VLDL,KLB,Beta-klotho,41839,-0.113624837094053,0.0076472394874732,-0.1286134264895,-0.0986362476986051,1.54046604880598e-49
NMR metabolomics,X23424.Total Lipids in VLDL,LBR,Delta(14)-sterol reductase LBR,42249,0.103345248783439,0.0069641863977882,0.0896954434437743,0.116995054123104,1.97395727782955e-49
NMR metabolomics,X23424.Total Lipids in VLDL,LZTFL1,Leucine zipper transcription factor-like protein 1,39736,0.109806751454743,0.00739705438414118,0.0953085248618264,0.12430497804766,2.23125677083508e-49
NMR metabolomics,X23424.Total Lipids in VLDL,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,42070,0.0426961083381896,0.00288209777194759,0.0370471967051723,0.0483450199712069,2.89272748208025e-49
NMR metabolomics,X23424.Total Lipids in VLDL,ST13,Hsc70-interacting protein,39736,0.082583288737347,0.00557217254749151,0.0716618305442637,0.0935047469304304,3.16824011453066e-49
NMR metabolomics,X23424.Total Lipids in VLDL,GORASP2,Golgi reassembly-stacking protein 2,39930,0.0725299344627424,0.00489510861010097,0.0629355215869445,0.0821243473385403,3.29061494842906e-49
NMR metabolomics,X23424.Total Lipids in VLDL,COMMD1,COMM domain-containing protein 1,39638,0.0925281731982479,0.00625428927526435,0.0802697662187298,0.104786580177766,4.69417979833364e-49
NMR metabolomics,X23424.Total Lipids in VLDL,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",39930,0.221251553863621,0.0149595582448814,0.191930819703654,0.250572288023589,4.8676354185216e-49
NMR metabolomics,X23424.Total Lipids in VLDL,MGLL,Monoglyceride lipase,42166,0.131902332309371,0.00893026245049871,0.114399017906393,0.149405646712348,5.46921501846085e-49
NMR metabolomics,X23424.Total Lipids in VLDL,DLK1,Protein delta homolog 1,42310,0.0873824232679731,0.00592367237284663,0.0757720254171937,0.0989928211187525,7.13820342884487e-49
NMR metabolomics,X23424.Total Lipids in VLDL,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,42119,0.0924578417142129,0.0062680919678016,0.0801723814573218,0.104743301971104,7.31356560787233e-49
NMR metabolomics,X23424.Total Lipids in VLDL,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,42144,0.0387716231609007,0.00262938233113211,0.0336180337918818,0.0439252125299197,7.8576740337709e-49
NMR metabolomics,X23424.Total Lipids in VLDL,PSME1,Proteasome activator complex subunit 1,42002,0.054793129208858,0.00371735202288255,0.0475071192440082,0.0620791391737078,8.61627202662546e-49
NMR metabolomics,X23424.Total Lipids in VLDL,CNDP1,Beta-Ala-His dipeptidase,42217,0.0696646781703245,0.00472673701955144,0.0604002736120036,0.0789290827286453,8.67377700436821e-49
NMR metabolomics,X23424.Total Lipids in VLDL,SHMT1,"Serine hydroxymethyltransferase, cytosolic",42166,0.127779220149091,0.00867452391373282,0.110777153278175,0.144781287020007,9.78129222809237e-49
NMR metabolomics,X23424.Total Lipids in VLDL,DDHD2,Phospholipase DDHD2,39934,0.100032500148425,0.00679419192047685,0.0867158839842908,0.11334911631256,1.28450065109016e-48
NMR metabolomics,X23424.Total Lipids in VLDL,MSRA,Mitochondrial peptide methionine sulfoxide reductase,42181,0.108042514626668,0.00735491066681635,0.0936268897197076,0.122458139533628,1.76267012715935e-48
NMR metabolomics,X23424.Total Lipids in VLDL,PACS2,Phosphofurin acidic cluster sorting protein 2,39575,0.0941696587514409,0.00642389485711589,0.0815788248314937,0.106760492671388,3.35172682144566e-48
NMR metabolomics,X23424.Total Lipids in VLDL,CD36,Platelet glycoprotein 4,39657,0.0699151210528087,0.00477203338687396,0.0605619356145357,0.0792683064910817,3.74780116894297e-48
NMR metabolomics,X23424.Total Lipids in VLDL,SRP14,Signal recognition particle 14 kDa protein,42070,0.089478403158248,0.00612018241041021,0.077482845633844,0.101473960682652,4.86878127950605e-48
NMR metabolomics,X23424.Total Lipids in VLDL,DOK1,Docking protein 1,39929,0.205728738447154,0.0140655639792301,0.178160233047863,0.233297243846445,5.21541900642437e-48
NMR metabolomics,X23424.Total Lipids in VLDL,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,41843,0.0669290171315567,0.00458110832315014,0.0579500448181824,0.0759079894449309,5.74274360333464e-48
NMR metabolomics,X23424.Total Lipids in VLDL,IL7,Interleukin-7,42119,0.0966038012543276,0.00661300988768811,0.083642301874459,0.109565300634196,5.77953144790034e-48
NMR metabolomics,X23424.Total Lipids in VLDL,QDPR,Dihydropteridine reductase,42081,0.0629890164053571,0.00431187505672313,0.0545377412941797,0.0714402915165344,5.78294062534265e-48
NMR metabolomics,X23424.Total Lipids in VLDL,EGLN1,Egl nine homolog 1,42119,0.0835953005291988,0.00572350613772632,0.0723772284992552,0.0948133725591424,5.99500463519987e-48
NMR metabolomics,X23424.Total Lipids in VLDL,TWF2,Twinfilin-2,39966,0.127455641879005,0.0087286023049003,0.1103475813614,0.14456370239661,7.38328370046325e-48
NMR metabolomics,X23424.Total Lipids in VLDL,GAS6,Growth arrest-specific protein 6,42236,-0.0376748921220096,0.00258333452625487,-0.0427382277934691,-0.03261155645055,8.1526371500576e-48
NMR metabolomics,X23424.Total Lipids in VLDL,VAMP8,Vesicle-associated membrane protein 8,39657,0.131694680762344,0.0090225085778455,0.114010563949767,0.149378797574921,8.25333163829304e-48
NMR metabolomics,X23424.Total Lipids in VLDL,MAVS,Mitochondrial antiviral-signaling protein,41843,0.13519159425226,0.00928371549691603,0.116995511878305,0.153387676626216,1.14024184701332e-47
NMR metabolomics,X23424.Total Lipids in VLDL,MTDH,Protein LYRIC,39657,0.142346039436157,0.00977332959406148,0.123190313431796,0.161501765440517,1.29779943167348e-47
NMR metabolomics,X23424.Total Lipids in VLDL,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,39919,0.072916736411903,0.00501082753609032,0.063095514441166,0.08273795838264,1.52625510178793e-47
NMR metabolomics,X23424.Total Lipids in VLDL,TNFSF12,Tumor necrosis factor ligand superfamily member 12,42296,0.0415053917065124,0.00285588896127612,0.0359078493424112,0.0471029340706136,1.68265760563802e-47
NMR metabolomics,X23424.Total Lipids in VLDL,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,42070,0.067308844179825,0.00464270187761351,0.0582091484997025,0.0764085398599475,2.8391502857537e-47
NMR metabolomics,X23424.Total Lipids in VLDL,OGFR,Opioid growth factor receptor,42070,0.0476474240828746,0.00328678973106326,0.0412053162099906,0.0540895319557586,2.88550788896005e-47
NMR metabolomics,X23424.Total Lipids in VLDL,IRAK4,Interleukin-1 receptor-associated kinase 4,42119,0.154764070444319,0.0106794064296519,0.133832433842202,0.175695707046437,3.08300913630432e-47
NMR metabolomics,X23424.Total Lipids in VLDL,MED18,Mediator of RNA polymerase II transcription subunit 18,41843,0.11285250155319,0.00779499344016009,0.0975743144104765,0.128130688695904,3.84595141755307e-47
NMR metabolomics,X23424.Total Lipids in VLDL,SIGLEC7,Sialic acid-binding Ig-like lectin 7,42145,0.0411595110244357,0.0028433485503835,0.0355865478656841,0.0467324741831874,3.87735570171309e-47
NMR metabolomics,X23424.Total Lipids in VLDL,OGA,Protein O-GlcNAcase,39930,0.105838269776901,0.00731816385709789,0.0914946686169892,0.120181870936813,5.48238554964231e-47
NMR metabolomics,X23424.Total Lipids in VLDL,HTRA2,"Serine protease HTRA2, mitochondrial",42181,0.0900020669108486,0.0062279555223068,0.0777952740871272,0.10220885973457,5.48739411861769e-47
NMR metabolomics,X23424.Total Lipids in VLDL,FOXJ3,Forkhead box protein J3,39657,0.0671280882339979,0.00464242304261921,0.0580289390704642,0.0762272373975315,5.83278030276864e-47
NMR metabolomics,X23424.Total Lipids in VLDL,THPO,Thrombopoietin,41900,0.0576520054296649,0.00399259836598395,0.0498265126323364,0.0654774982269935,6.58455549793758e-47
NMR metabolomics,X23424.Total Lipids in VLDL,TRAF2,TNF receptor-associated factor 2,42119,0.102559989830601,0.00710543103320166,0.088633345005526,0.116486634655676,7.04950436423279e-47
NMR metabolomics,X23424.Total Lipids in VLDL,ESM1,Endothelial cell-specific molecule 1,42123,-0.051296568550301,0.0035545564073128,-0.0582634991086341,-0.0443296379919679,7.33671423428312e-47
NMR metabolomics,X23424.Total Lipids in VLDL,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",42070,0.0653590921112598,0.00453477507481842,0.0564709329646157,0.0742472512579039,9.56302589943273e-47
NMR metabolomics,X23424.Total Lipids in VLDL,CD99L2,CD99 antigen-like protein 2,42137,0.0362977075445826,0.00251931851415985,0.0313598432568292,0.0412355718323359,1.0246309705868e-46
NMR metabolomics,X23424.Total Lipids in VLDL,STAT2,Signal transducer and activator of transcription 2,39657,0.116155820619493,0.00806258864383521,0.100353146877576,0.13195849436141,1.23924458226104e-46
NMR metabolomics,X23424.Total Lipids in VLDL,LPP,Lipoma-preferred partner,39575,0.0974940357044415,0.00676991229840004,0.0842250075995774,0.110763063809306,1.35316742379079e-46
NMR metabolomics,X23424.Total Lipids in VLDL,RBM17,Splicing factor 45,39934,0.113296104626925,0.0078769864426084,0.097857211199413,0.128734998054438,1.69226906429444e-46
NMR metabolomics,X23424.Total Lipids in VLDL,MAX,Protein max,41839,0.156180682770441,0.0108663714231023,0.134882594781161,0.177478770759722,1.71418639337985e-46
NMR metabolomics,X23424.Total Lipids in VLDL,AHSG,Alpha-2-HS-glycoprotein,39990,0.0393869749625328,0.00273888611527654,0.0340187581765908,0.0447551917484748,1.74599250271772e-46
NMR metabolomics,X23424.Total Lipids in VLDL,SAMD9L,Sterile alpha motif domain-containing protein 9-like,42119,0.107093521017861,0.00745317917990712,0.0924852898252431,0.121701752210479,1.78503242897234e-46
NMR metabolomics,X23424.Total Lipids in VLDL,STIP1,Stress-induced-phosphoprotein 1,42105,0.0940130043799859,0.00654730177809922,0.0811802928949114,0.10684571586506,2.05329510603784e-46
NMR metabolomics,X23424.Total Lipids in VLDL,SPART,Spartin,39736,0.114448701843364,0.00797831607001857,0.0988112023461275,0.1300862013406,2.95663641563071e-46
NMR metabolomics,X23424.Total Lipids in VLDL,CLEC4G,C-type lectin domain family 4 member G,42119,0.0490699646505771,0.00342621893966698,0.0423545755288298,0.0557853537723244,3.47596011739321e-46
NMR metabolomics,X23424.Total Lipids in VLDL,F11,Coagulation factor XI,39822,0.0462365835415547,0.0032269516933957,0.0399117582224991,0.0525614088606102,3.71858081341882e-46
NMR metabolomics,X23424.Total Lipids in VLDL,TRIM40,E3 ubiquitin ligase TRIM40,39649,0.106961493168521,0.00746875881640266,0.0923227258883719,0.12160026044867,4.16907400673956e-46
NMR metabolomics,X23424.Total Lipids in VLDL,YJU2,Splicing factor YJU2,39919,0.0485281831375353,0.0033893251830472,0.0418851057787628,0.0551712604963078,4.2677660683954e-46
NMR metabolomics,X23424.Total Lipids in VLDL,CCL4,C-C motif chemokine 4,42148,0.091149079436038,0.00637297270042528,0.0786580529432045,0.103640105928872,4.57163081375996e-46
NMR metabolomics,X23424.Total Lipids in VLDL,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,39736,0.0424556754730948,0.00296751006130471,0.0366393557529376,0.048271995193252,5.06864812963077e-46
NMR metabolomics,X23424.Total Lipids in VLDL,MARS1,"Methionine--tRNA ligase, cytoplasmic",39713,0.126314154350319,0.00883160339051817,0.109004211704903,0.143624096995735,5.39749980728919e-46
NMR metabolomics,X23424.Total Lipids in VLDL,GIGYF2,GRB10-interacting GYF protein 2,39934,0.111910819270461,0.00782718788959964,0.0965695310068453,0.127252107534076,5.67325922199289e-46
NMR metabolomics,X23424.Total Lipids in VLDL,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,42216,0.0842649170950743,0.00590279226976138,0.072695444246342,0.0958343899438066,6.67345219509199e-46
NMR metabolomics,X23424.Total Lipids in VLDL,CD207,C-type lectin domain family 4 member K,41832,0.0570275227074105,0.00399529064729694,0.0491967530387085,0.0648582923761125,6.99171936437221e-46
NMR metabolomics,X23424.Total Lipids in VLDL,TDRKH,Tudor and KH domain-containing protein,41839,0.124174809525262,0.00870625457235613,0.107110550563444,0.14123906848708,8.16009725805936e-46
NMR metabolomics,X23424.Total Lipids in VLDL,IL17RB,Interleukin-17 receptor B,41934,-0.0789980766148612,0.00553924877864094,-0.0898550042209974,-0.068141149008725,8.25372041053748e-46
NMR metabolomics,X23424.Total Lipids in VLDL,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",39958,0.129574304534871,0.00908936032402849,0.111759158299775,0.147389450769966,1.02491611039032e-45
NMR metabolomics,X23424.Total Lipids in VLDL,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,41825,0.0860452942690349,0.0060421733473046,0.0742026345083179,0.0978879540297519,1.11267599527146e-45
NMR metabolomics,X23424.Total Lipids in VLDL,FNDC1,Fibronectin type III domain-containing protein 1,39929,0.0691633556404181,0.00485404679464138,0.059649423922921,0.0786772873579152,1.13367673413409e-45
NMR metabolomics,X23424.Total Lipids in VLDL,GDNF,Glial cell line-derived neurotrophic factor,41839,0.0557614389095905,0.00392041808440149,0.0480774194641636,0.0634454583550174,1.42147446721347e-45
NMR metabolomics,X23424.Total Lipids in VLDL,HMOX2,Heme oxygenase 2,41839,0.069542387945937,0.00489315413854604,0.0599518058343868,0.0791329700574873,1.66319581592001e-45
NMR metabolomics,X23424.Total Lipids in VLDL,NUDC,Nuclear migration protein nudC,42296,0.0922756880754387,0.00650511299515386,0.0795256666049371,0.10502570954594,2.37275746512331e-45
NMR metabolomics,X23424.Total Lipids in VLDL,HYOU1,Hypoxia up-regulated protein 1,42310,0.0332699620891945,0.00234703092063719,0.0286697814847456,0.0378701426936434,2.71934644794497e-45
NMR metabolomics,X23424.Total Lipids in VLDL,CASC3,Protein CASC3,39649,0.0627412940861283,0.00442396149088704,0.0540703295639897,0.0714122586082669,2.94559534873431e-45
NMR metabolomics,X23424.Total Lipids in VLDL,SMAD3,Mothers against decapentaplegic homolog 3,39919,0.0756773110375372,0.00534097537582552,0.0652089993009192,0.0861456227741553,3.45617832165894e-45
NMR metabolomics,X23424.Total Lipids in VLDL,NEXN,Nexilin,39990,0.101280841131453,0.00714974280450473,0.0872673452346233,0.115294337028282,3.61137128074546e-45
NMR metabolomics,X23424.Total Lipids in VLDL,FUS,RNA-binding protein FUS,41831,0.057565241851429,0.0040673069706432,0.0495933201889683,0.0655371635138896,3.81066518983858e-45
NMR metabolomics,X23424.Total Lipids in VLDL,CD226,CD226 antigen,39657,0.0618472562077308,0.00436814583650751,0.0532856903681761,0.0704088220472855,4.08653218171883e-45
NMR metabolomics,X23424.Total Lipids in VLDL,KLK13,Kallikrein-13,41839,0.065004346180324,0.00459505092240732,0.0559980463724057,0.0740106459882424,4.17548688194565e-45
NMR metabolomics,X23424.Total Lipids in VLDL,BMP6,Bone morphogenetic protein 6,41886,0.058031356313912,0.0041039500695132,0.0499876141776661,0.0660750984501579,4.54428373323774e-45
NMR metabolomics,X23424.Total Lipids in VLDL,VNN1,Pantetheinase,39990,0.106120773888778,0.00750135783351259,0.0914181125350935,0.120823435242463,4.69609949992573e-45
NMR metabolomics,X23424.Total Lipids in VLDL,CLEC3B,Tetranectin,39726,0.0304746959678126,0.00215698855040429,0.0262469984090202,0.034702393526605,6.20791112577708e-45
NMR metabolomics,X23424.Total Lipids in VLDL,BAG4,BAG family molecular chaperone regulator 4,39657,0.0733410934420165,0.00519196931505449,0.0631648335845097,0.0835173532995233,6.4619885656371e-45
NMR metabolomics,X23424.Total Lipids in VLDL,SIRT2,NAD-dependent protein deacetylase sirtuin-2,42070,0.125865680476457,0.00891771017337445,0.108386968536643,0.143344392416271,6.49349570196239e-45
NMR metabolomics,X23424.Total Lipids in VLDL,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",42137,0.0668908736202348,0.0047425651907254,0.057595445846413,0.0761863013940565,7.41550656612567e-45
NMR metabolomics,X23424.Total Lipids in VLDL,HPSE,Heparanase,39866,0.13791152955841,0.00979064821702756,0.118721859053036,0.157101200063784,1.10698996124926e-44
NMR metabolomics,X23424.Total Lipids in VLDL,IL1RN,Interleukin-1 receptor antagonist protein,42092,0.0759853798926245,0.00539909653911775,0.0654031506759537,0.0865676091092953,1.13998474249287e-44
NMR metabolomics,X23424.Total Lipids in VLDL,FARSA,Phenylalanine--tRNA ligase alpha subunit,39649,0.100829069247158,0.00718519590395834,0.0867460852753993,0.114912053218916,2.35481305872427e-44
NMR metabolomics,X23424.Total Lipids in VLDL,DIABLO,"Diablo homolog, mitochondrial",42107,0.157186258463008,0.0112139963598882,0.135206825597627,0.179165691328389,2.50870106066388e-44
NMR metabolomics,X23424.Total Lipids in VLDL,GET3,ATPase GET3,39958,0.0777253327347592,0.00554233136791887,0.0668623632536382,0.0885883022158802,2.60367452535033e-44
NMR metabolomics,X23424.Total Lipids in VLDL,APPL2,DCC-interacting protein 13-beta,39736,0.162385719237967,0.0115867679044859,0.139675654145175,0.185095784330759,3.0067730421763e-44
NMR metabolomics,X23424.Total Lipids in VLDL,DGKA,Diacylglycerol kinase alpha,39657,0.0795640703384193,0.00568202285374274,0.0684273055450835,0.0907008351317551,3.57066847980504e-44
NMR metabolomics,X23424.Total Lipids in VLDL,TXNDC5,Thioredoxin domain-containing protein 5,42249,0.0984549728505427,0.00704659883105715,0.0846436391416707,0.112266306559415,4.64681532944095e-44
NMR metabolomics,X23424.Total Lipids in VLDL,PGF,Placenta growth factor,42296,0.0374876618233288,0.0026834669670192,0.0322280665679711,0.0427472570786864,4.77410163195411e-44
NMR metabolomics,X23424.Total Lipids in VLDL,EHD3,EH domain-containing protein 3,39638,0.169392228969904,0.0121169060244168,0.145643093162047,0.193141364777761,4.91004989207125e-44
NMR metabolomics,X23424.Total Lipids in VLDL,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,41837,0.113531907237538,0.0081348141263415,0.0975876715499084,0.129476142925167,5.89824258584152e-44
NMR metabolomics,X23424.Total Lipids in VLDL,DPP4,Dipeptidyl peptidase 4,41948,0.039898392495153,0.00286055835531919,0.0342916981187274,0.0455050868715786,6.59777872781036e-44
NMR metabolomics,X23424.Total Lipids in VLDL,PMVK,Phosphomevalonate kinase,41832,0.15519826250203,0.0111288511489226,0.133385714250142,0.177010810753919,6.84204442834841e-44
NMR metabolomics,X23424.Total Lipids in VLDL,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,42249,0.0801319451069968,0.00574905222350161,0.0688638027489337,0.09140008746506,7.40511000912398e-44
NMR metabolomics,X23424.Total Lipids in VLDL,AP2B1,AP-2 complex subunit beta,39649,0.0695553792280953,0.00498661945085442,0.0597816051044207,0.07932915335177,7.56697360364852e-44
NMR metabolomics,X23424.Total Lipids in VLDL,PRKG1,cGMP-dependent protein kinase 1,39736,0.180620779188027,0.0129591871184011,0.155220772435961,0.206020785940093,8.71568408989892e-44
NMR metabolomics,X23424.Total Lipids in VLDL,CETN3,Centrin-3,39930,0.112347576569606,0.00806738441480165,0.0965355031165952,0.128159650022618,1.00678392532272e-43
NMR metabolomics,X23424.Total Lipids in VLDL,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",41976,0.0582363964866454,0.00418635374313503,0.0500311431501007,0.06644164982319,1.09409895238158e-43
NMR metabolomics,X23424.Total Lipids in VLDL,SDC4,Syndecan-4,42145,0.0674097722566089,0.00484893719352101,0.0579058553573077,0.0769136891559101,1.22854858657654e-43
NMR metabolomics,X23424.Total Lipids in VLDL,PCDH9,Protocadherin-9,39930,0.048240357886987,0.00347190676103659,0.0414354206353553,0.0550452951386187,1.55580816425172e-43
NMR metabolomics,X23424.Total Lipids in VLDL,DLG4,Disks large homolog 4,39929,0.102753715887394,0.0073991159257514,0.0882514486729208,0.117255983101866,1.71731185557533e-43
NMR metabolomics,X23424.Total Lipids in VLDL,FLT4,Vascular endothelial growth factor receptor 3,42181,0.0483694902753416,0.00348581175508621,0.0415372992353727,0.0552016813153106,1.7507181104478e-43
NMR metabolomics,X23424.Total Lipids in VLDL,SPRY2,Protein sprouty homolog 2,41913,0.13193768638334,0.00951996309090238,0.113278558725171,0.150596814041508,2.24326228344205e-43
NMR metabolomics,X23424.Total Lipids in VLDL,ICA1,Islet cell autoantigen 1,41913,0.113571424513357,0.00819764985725296,0.0975040307931416,0.129638818233573,2.39970573434424e-43
NMR metabolomics,X23424.Total Lipids in VLDL,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,39638,0.0695405910698721,0.00502378324727669,0.0596939759052098,0.0793872062345344,3.25050724542924e-43
NMR metabolomics,X23424.Total Lipids in VLDL,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,42145,0.116731652286289,0.00844810675182964,0.100173363052703,0.133289941519875,3.92051593781373e-43
NMR metabolomics,X23424.Total Lipids in VLDL,RWDD1,RWD domain-containing protein 1,42249,0.0881513127738439,0.00638011944355146,0.075646278664483,0.100656346883205,3.95069405417303e-43
NMR metabolomics,X23424.Total Lipids in VLDL,ELOA,Elongin-A,42070,0.0761305758789824,0.00551083857069788,0.0653293322804146,0.0869318194775503,4.08856141640272e-43
NMR metabolomics,X23424.Total Lipids in VLDL,IL32,Interleukin-32,42119,-0.0629097764323755,0.00455566339720345,-0.0718388766908943,-0.0539806761738567,4.40138512624459e-43
NMR metabolomics,X23424.Total Lipids in VLDL,FABP5,Fatty acid-binding protein 5,42218,0.0941019221499212,0.00682406912675042,0.0807267466614904,0.107477097638352,5.7135613005151e-43
NMR metabolomics,X23424.Total Lipids in VLDL,EGF,Pro-epidermal growth factor,42081,0.146946370915693,0.0106590247368725,0.126054682431423,0.167838059399963,6.04275635641587e-43
NMR metabolomics,X23424.Total Lipids in VLDL,FOXO3,Forkhead box protein O3,41843,0.135752487224499,0.00984692302742333,0.116452518090749,0.155052456358249,6.09981467164413e-43
NMR metabolomics,X23424.Total Lipids in VLDL,PARP1,Poly [ADP-ribose] polymerase 1,42119,0.0830506419462775,0.00603389506205354,0.0712242076246526,0.0948770762679025,8.15401841801265e-43
NMR metabolomics,X23424.Total Lipids in VLDL,IFNLR1,Interferon lambda receptor 1,42119,0.0512754300485177,0.00373069116362069,0.0439632753678211,0.0585875847292142,1.06813834696919e-42
NMR metabolomics,X23424.Total Lipids in VLDL,GRAP2,GRB2-related adapter protein 2,42145,0.181380948199273,0.013221773485946,0.155466272166819,0.207295624231727,1.51707045058717e-42
NMR metabolomics,X23424.Total Lipids in VLDL,WASHC3,WASH complex subunit 3,39929,0.106774475672394,0.00779321058541902,0.0914997829249731,0.122049168419816,2.17971655822489e-42
NMR metabolomics,X23424.Total Lipids in VLDL,ATP6AP2,Renin receptor,41843,0.0551435274880918,0.00403296195243078,0.0472389220613275,0.0630481329148561,2.84180155042999e-42
NMR metabolomics,X23424.Total Lipids in VLDL,TP53,Cellular tumor antigen p53,41843,0.0623092078916707,0.00455880531468472,0.0533739494748887,0.0712444663084528,3.0545413792661e-42
NMR metabolomics,X23424.Total Lipids in VLDL,TADA3,Transcriptional adapter 3,39919,0.0566995264824839,0.00414913527087916,0.0485672213515608,0.0648318316134071,3.5299826488615e-42
NMR metabolomics,X23424.Total Lipids in VLDL,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,41913,0.0614657312094617,0.00451036577237523,0.0526254142956063,0.0703060481233172,5.24575687927889e-42
NMR metabolomics,X23424.Total Lipids in VLDL,TRIM24,Transcription intermediary factor 1-alpha,39735,0.0923423028244859,0.00677247247048998,0.0790682567823255,0.105616348866646,5.39072083808932e-42
NMR metabolomics,X23424.Total Lipids in VLDL,PPP1R2,Protein phosphatase inhibitor 2,42145,0.112415713693677,0.00825117251928115,0.0962434155558861,0.128588011831468,5.43587430606756e-42
NMR metabolomics,X23424.Total Lipids in VLDL,CETN2,Centrin-2,41839,0.0949260861397914,0.00697320412170306,0.0812586060612534,0.108593566218329,6.41892349472132e-42
NMR metabolomics,X23424.Total Lipids in VLDL,FAP,Prolyl endopeptidase FAP,42310,0.0384061611316983,0.00282172242994285,0.0328755851690103,0.0439367370943863,6.45798542625881e-42
NMR metabolomics,X23424.Total Lipids in VLDL,RABGAP1L,Rab GTPase-activating protein 1-like,41913,0.0830443093917483,0.0061009841954517,0.071086380368663,0.0950022384148337,6.51402339561214e-42
NMR metabolomics,X23424.Total Lipids in VLDL,IDUA,Alpha-L-iduronidase,42262,0.0656929680649413,0.00482991210963664,0.0562263403300535,0.0751595957998291,7.36902274538251e-42
NMR metabolomics,X23424.Total Lipids in VLDL,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",42119,0.133496405168702,0.00981719371741025,0.114254705482578,0.152738104854826,7.72931024082224e-42
NMR metabolomics,X23424.Total Lipids in VLDL,CHMP1A,Charged multivesicular body protein 1a,42016,0.110613358210427,0.00813431358036672,0.0946701035929081,0.126556612827946,7.75204256048973e-42
NMR metabolomics,X23424.Total Lipids in VLDL,FIS1,Mitochondrial fission 1 protein,42125,0.10668880094959,0.00786343346721221,0.091276471353854,0.122101130545326,1.16558391364632e-41
NMR metabolomics,X23424.Total Lipids in VLDL,VASP,Vasodilator-stimulated phosphoprotein,39990,0.101980426912883,0.00751703995707285,0.0872470285970206,0.116713825228746,1.3297118287678e-41
NMR metabolomics,X23424.Total Lipids in VLDL,CTF1,Cardiotrophin-1,41900,0.117403461869485,0.0086654878660662,0.100419105651995,0.134387818086975,1.52721783338426e-41
NMR metabolomics,X23424.Total Lipids in VLDL,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",39757,0.069280454566078,0.00511192093600568,0.0592610895315068,0.0792998196006491,1.6257652116066e-41
NMR metabolomics,X23424.Total Lipids in VLDL,NACC1,Nucleus accumbens-associated protein 1,39919,0.076962091631904,0.00568211772036163,0.0658251408999952,0.0880990423638128,1.79317106006171e-41
NMR metabolomics,X23424.Total Lipids in VLDL,RRAS,Ras-related protein R-Ras,39649,0.182735929940031,0.0134908964237265,0.156293772949528,0.209178086930535,1.8131390876297e-41
NMR metabolomics,X23424.Total Lipids in VLDL,AHNAK,Neuroblast differentiation-associated protein AHNAK,39638,0.0443361389457526,0.00327487247966499,0.0379173888856092,0.050754889005896,1.98881343887821e-41
NMR metabolomics,X23424.Total Lipids in VLDL,SIT1,Signaling threshold-regulating transmembrane adapter 1,41913,0.075887872806182,0.00560980224326883,0.0648926604093751,0.0868830852029889,2.01444570582796e-41
NMR metabolomics,X23424.Total Lipids in VLDL,MAP2,Microtubule-associated protein 2,39929,0.0648590757473477,0.00480633864240406,0.0554386520082358,0.0742794994864597,3.50390166988943e-41
NMR metabolomics,X23424.Total Lipids in VLDL,PDGFA,Platelet-derived growth factor subunit A,42310,0.0993206311634618,0.00736681111674488,0.0848816813746419,0.113759580952282,3.64248005446287e-41
NMR metabolomics,X23424.Total Lipids in VLDL,SH2D1A,SH2 domain-containing protein 1A,42119,0.0827156034761564,0.00613529506442678,0.0706904251498799,0.0947407818024329,3.68554948504016e-41
NMR metabolomics,X23424.Total Lipids in VLDL,ARHGEF10,Rho guanine nucleotide exchange factor 10,39934,0.130455684756082,0.00968067168382953,0.111481568255776,0.149429801256388,4.48932832136587e-41
NMR metabolomics,X23424.Total Lipids in VLDL,SMOC2,SPARC-related modular calcium-binding protein 2,42185,0.0539080626672777,0.00400301607966433,0.0460621511511356,0.0617539741834198,4.4946730780195e-41
NMR metabolomics,X23424.Total Lipids in VLDL,TSC22D1,TSC22 domain family protein 1,39934,0.0910837526265121,0.00677147976238672,0.0778116522922342,0.10435585296079,6.2477467880103e-41
NMR metabolomics,X23424.Total Lipids in VLDL,IL1RL2,Interleukin-1 receptor-like 2,41913,0.052009904331187,0.00387005203313566,0.0444246023462411,0.0595952063161329,6.59319489056756e-41
NMR metabolomics,X23424.Total Lipids in VLDL,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,39919,0.0487530639464699,0.00362910612630127,0.0416400159389194,0.0558661119540204,7.85964848201131e-41
NMR metabolomics,X23424.Total Lipids in VLDL,XIAP,E3 ubiquitin-protein ligase XIAP,39657,0.0802215227033294,0.00599119613879081,0.0684787782712994,0.0919642671353594,1.43324379091471e-40
NMR metabolomics,X23424.Total Lipids in VLDL,HNMT,Histamine N-methyltransferase,41961,0.0657244623309319,0.00491257413075811,0.056095817034646,0.0753531076272178,1.46635754773229e-40
NMR metabolomics,X23424.Total Lipids in VLDL,F12,Coagulation factor XII,39979,0.0567225649505182,0.00423843120328632,0.048415239792077,0.0650298901089594,1.54056976976889e-40
NMR metabolomics,X23424.Total Lipids in VLDL,ORM1,Alpha-1-acid glycoprotein 1,39922,0.0275932659262453,0.00206180046286302,0.0235521370190338,0.0316343948334568,1.54236712833622e-40
NMR metabolomics,X23424.Total Lipids in VLDL,SEMA4D,Semaphorin-4D,42249,0.0412274385992708,0.00308344758211806,0.0351838813383194,0.0472709958602222,1.61580399358126e-40
NMR metabolomics,X23424.Total Lipids in VLDL,UBXN1,UBX domain-containing protein 1,39736,0.0945751200169454,0.00706992835600072,0.0807180604391839,0.108432179594707,1.68946486437075e-40
NMR metabolomics,X23424.Total Lipids in VLDL,ANGPT1,Angiopoietin-1,42085,0.114426533975993,0.008564607467518,0.0976399033396581,0.131213164612329,1.86230837162693e-40
NMR metabolomics,X23424.Total Lipids in VLDL,SPARC,SPARC,42181,0.0956584403306437,0.00716373801613176,0.0816175138190254,0.109699366842262,2.04164626034429e-40
NMR metabolomics,X23424.Total Lipids in VLDL,FGL1,Fibrinogen-like protein 1,39990,-0.0887488034348654,0.00664924556337001,-0.101781324739071,-0.0757162821306602,2.46960465455477e-40
NMR metabolomics,X23424.Total Lipids in VLDL,SERPINE2,Glia-derived nexin,39958,0.0887382252797066,0.00665655481158266,0.0756913778490045,0.101785072710409,3.06650837582291e-40
NMR metabolomics,X23424.Total Lipids in VLDL,HSPA1A,Heat shock 70 kDa protein 1A,42162,0.0959285468290353,0.00720320920299541,0.0818102567911643,0.110046836866906,3.27635728312262e-40
NMR metabolomics,X23424.Total Lipids in VLDL,DRG2,Developmentally-regulated GTP-binding protein 2,42070,0.0774351839040305,0.00582257303181529,0.0660229407616725,0.0888474270463884,4.19083756293791e-40
NMR metabolomics,X23424.Total Lipids in VLDL,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,41839,0.151917689390748,0.0114298766565506,0.129515131143909,0.174320247637587,4.69548601083339e-40
NMR metabolomics,X23424.Total Lipids in VLDL,KIFBP,KIF-binding protein,42070,0.112411277758324,0.00846309365762804,0.095823614189373,0.128998941327275,5.21731569483325e-40
NMR metabolomics,X23424.Total Lipids in VLDL,NID1,Nidogen-1,42189,0.0490309948026997,0.00369435627374829,0.0417900565061531,0.0562719330992464,5.97455331474637e-40
NMR metabolomics,X23424.Total Lipids in VLDL,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",39929,0.134734686716826,0.0101573387126474,0.114826302840037,0.154643070593615,7.34355449477319e-40
NMR metabolomics,X23424.Total Lipids in VLDL,RFC4,Replication factor C subunit 4,39919,0.0301336960397385,0.00227430259066365,0.0256760629620378,0.0345913291174393,8.96132589484327e-40
NMR metabolomics,X23424.Total Lipids in VLDL,A1BG,Alpha-1B-glycoprotein,39979,0.0225039593798082,0.00169852098544113,0.0191748582483436,0.0258330605112728,8.98738748529373e-40
NMR metabolomics,X23424.Total Lipids in VLDL,HAO1,Hydroxyacid oxidase 1,42262,0.167704977179234,0.0126690124539312,0.142873712769529,0.192536241588939,9.37294418237075e-40
NMR metabolomics,X23424.Total Lipids in VLDL,LRRC59,Leucine-rich repeat-containing protein 59,39958,0.0657256880695397,0.00496314548422699,0.0559979229204548,0.0754534532186246,9.78681375016737e-40
NMR metabolomics,X23424.Total Lipids in VLDL,CD40,Tumor necrosis factor receptor superfamily member 5,42129,0.0685502656678139,0.00518050924131454,0.0583964675548374,0.0787040637807905,1.00743106674734e-39
NMR metabolomics,X23424.Total Lipids in VLDL,IQGAP2,Ras GTPase-activating-like protein IQGAP2,42070,0.0727579451897881,0.0055008042531946,0.0619763688535266,0.0835395215260495,1.0863974985486e-39
NMR metabolomics,X23424.Total Lipids in VLDL,VEGFA,Vascular endothelial growth factor A,42253,0.0767862300948491,0.00580761003045304,0.0654033144351612,0.0881691457545371,1.15327104110311e-39
NMR metabolomics,X23424.Total Lipids in VLDL,PF4,Platelet factor 4,39914,0.132623259891406,0.0100270431836722,0.112970255251409,0.152276264531404,1.21321305755818e-39
NMR metabolomics,X23424.Total Lipids in VLDL,COMT,Catechol O-methyltransferase,41740,0.112880328948923,0.00854096633591267,0.0961400349305338,0.129620622967311,1.26371918643792e-39
NMR metabolomics,X23424.Total Lipids in VLDL,VPS28,Vacuolar protein sorting-associated protein 28 homolog,39757,0.0904613307216042,0.00684845513735629,0.0770383586523858,0.103884302790822,1.54082371736269e-39
NMR metabolomics,X23424.Total Lipids in VLDL,FST,Follistatin,42166,0.0659289312037106,0.00499556870138456,0.0561376165489968,0.0757202458584243,1.58921463830803e-39
NMR metabolomics,X23424.Total Lipids in VLDL,SSNA1,Sjoegren syndrome nuclear autoantigen 1,39930,0.0696550733744087,0.0052806645314547,0.0593049708927575,0.0800051758560599,1.94034528105259e-39
NMR metabolomics,X23424.Total Lipids in VLDL,CCL8,C-C motif chemokine 8,42239,0.081849134360703,0.00620943442178979,0.069678642893995,0.094019625827411,1.95561148181141e-39
NMR metabolomics,X23424.Total Lipids in VLDL,MEP1B,Meprin A subunit beta,42145,0.154656325540096,0.0117492230262992,0.13162784840855,0.177684802671643,2.49413158873261e-39
NMR metabolomics,X23424.Total Lipids in VLDL,SIGLEC8,Sialic acid-binding Ig-like lectin 8,39638,0.0629376276562332,0.0047912917109595,0.0535466959027526,0.0723285594097138,4.0309051397784e-39
NMR metabolomics,X23424.Total Lipids in VLDL,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,39736,0.077648033139446,0.00591160491745595,0.0660612875012323,0.0892347787776597,4.05915768127479e-39
NMR metabolomics,X23424.Total Lipids in VLDL,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,41843,0.131564795129666,0.0100248744531901,0.111916041201413,0.151213549057918,4.2164771944461e-39
NMR metabolomics,X23424.Total Lipids in VLDL,TMED8,Protein TMED8,39930,0.139281173494529,0.0106074091263668,0.11849065160685,0.160071695382208,4.24389967013709e-39
NMR metabolomics,X23424.Total Lipids in VLDL,HARS1,"Histidine--tRNA ligase, cytoplasmic",42137,0.103297365887742,0.00787851088997004,0.0878554845434011,0.118739247232084,4.90596693123476e-39
NMR metabolomics,X23424.Total Lipids in VLDL,MUC13,Mucin-13,41839,0.0707790150635893,0.00539958991254944,0.0601958188349924,0.0813622112921862,5.16807050732194e-39
NMR metabolomics,X23424.Total Lipids in VLDL,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,41768,0.112819987142584,0.00861673105626034,0.0959311942723137,0.129708780012854,6.30758888389763e-39
NMR metabolomics,X23424.Total Lipids in VLDL,GMPR2,GMP reductase 2,39736,0.089400998685613,0.00682532729168372,0.0760233571939129,0.102778640177313,6.51582446944861e-39
NMR metabolomics,X23424.Total Lipids in VLDL,CASP7,Caspase-7,39929,0.113574818664934,0.00867925874476991,0.0965634715251854,0.130586165804683,7.59202730603445e-39
NMR metabolomics,X23424.Total Lipids in VLDL,ATXN3,Ataxin-3,39929,0.0820210200354767,0.00626847316163387,0.0697348126386743,0.0943072274322791,7.6996090792438e-39
NMR metabolomics,X23424.Total Lipids in VLDL,CXCL1,Growth-regulated alpha protein,42117,0.124701026039494,0.00953681890646712,0.106008860982818,0.143393191096169,7.79390735183618e-39
NMR metabolomics,X23424.Total Lipids in VLDL,MATN2,Matrilin-2,42144,0.0397383890910703,0.00303931339092112,0.0337813348448649,0.0456954433372758,7.88270501315628e-39
NMR metabolomics,X23424.Total Lipids in VLDL,NECAP2,Adaptin ear-binding coat-associated protein 2,39575,0.0880131391423162,0.00673397981626013,0.0748145387024463,0.101211739582186,9.50715189554304e-39
NMR metabolomics,X23424.Total Lipids in VLDL,ANKRD54,Ankyrin repeat domain-containing protein 54,41843,0.0756888245926861,0.0058071783345169,0.064306755057033,0.0870708941283393,1.3598773064833e-38
NMR metabolomics,X23424.Total Lipids in VLDL,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,39736,0.11638986601206,0.00893405634543281,0.0988791155750114,0.133900616449108,1.62787871543924e-38
NMR metabolomics,X23424.Total Lipids in VLDL,KYAT1,Kynurenine--oxoglutarate transaminase 1,42130,0.0756417483653976,0.00581076518130989,0.0642526486100302,0.087030848120765,1.65669718017159e-38
NMR metabolomics,X23424.Total Lipids in VLDL,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,39919,0.0496638478795006,0.00381300563070192,0.0421903568433248,0.0571373389156764,1.67051981799604e-38
NMR metabolomics,X23424.Total Lipids in VLDL,STK24,Serine/threonine-protein kinase 24,41839,0.082916073214177,0.00637302174854762,0.0704249505870236,0.0954071958413303,1.83566840223103e-38
NMR metabolomics,X23424.Total Lipids in VLDL,ADD1,Alpha-adducin,39736,0.093237023068937,0.00716335587717372,0.0791968455496765,0.107277200588197,1.89633478617848e-38
NMR metabolomics,X23424.Total Lipids in VLDL,ARHGAP25,Rho GTPase-activating protein 25,41843,0.0809601780508074,0.00623272920902572,0.0687440288011169,0.0931763273004978,2.40568019441238e-38
NMR metabolomics,X23424.Total Lipids in VLDL,APOL1,Apolipoprotein L1,39990,0.0711417923284565,0.00548099898078229,0.0603990343261232,0.0818845503307898,2.977134853979e-38
NMR metabolomics,X23424.Total Lipids in VLDL,MAPKAPK2,MAP kinase-activated protein kinase 2,39757,0.0988736822393536,0.00762070514580567,0.0839371001535745,0.113810264325133,3.2311926618276e-38
NMR metabolomics,X23424.Total Lipids in VLDL,PLG,Plasminogen,39742,0.0291249580937657,0.00224695385544045,0.0247209285371024,0.033528987650429,3.79130123402943e-38
NMR metabolomics,X23424.Total Lipids in VLDL,IMPACT,Protein IMPACT,39929,0.0720711916095497,0.00556747703618968,0.0611589366186179,0.0829834466004815,4.6637342767357e-38
NMR metabolomics,X23424.Total Lipids in VLDL,PPBP,Platelet basic protein,39908,0.113893258811117,0.00881106764952942,0.0966235662180396,0.131162951404195,5.94773266057898e-38
NMR metabolomics,X23424.Total Lipids in VLDL,ERP29,Endoplasmic reticulum resident protein 29,39736,0.157995448126665,0.0123052214796311,0.133877214026588,0.182113682226742,1.81086255483067e-37
NMR metabolomics,X23424.Total Lipids in VLDL,C4BPB,C4b-binding protein beta chain,42181,0.050183505838643,0.0039173160612424,0.0425055663586079,0.0578614453186782,2.35033294364382e-37
NMR metabolomics,X23424.Total Lipids in VLDL,ELAC1,Zinc phosphodiesterase ELAC protein 1,39934,0.111963772154594,0.00874374493785325,0.0948260320764013,0.129101512232786,2.78530967619644e-37
NMR metabolomics,X23424.Total Lipids in VLDL,CASP10,Caspase-10,41839,0.0934764522287945,0.00731005267644101,0.0791487489829701,0.107804155474619,3.20170486726743e-37
NMR metabolomics,X23424.Total Lipids in VLDL,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,39958,0.0953101833005792,0.00745464027188077,0.0806990883676929,0.109921278233466,3.57025700611971e-37
NMR metabolomics,X23424.Total Lipids in VLDL,FAM172A,Cotranscriptional regulator FAM172A,39638,0.0802905392932597,0.00628117432624936,0.067979437613811,0.0926016409727085,3.75392428354794e-37
NMR metabolomics,X23424.Total Lipids in VLDL,ADGRF5,Adhesion G protein-coupled receptor F5,39958,0.0351964415116356,0.00275379614921771,0.0297990010591689,0.0405938819641023,3.76967292353165e-37
NMR metabolomics,X23424.Total Lipids in VLDL,DNM3,Dynamin-3,39934,0.0722924601276385,0.00565746685664106,0.061203825088622,0.083381095166655,3.91189150107061e-37
NMR metabolomics,X23424.Total Lipids in VLDL,VAV3,Guanine nucleotide exchange factor VAV3,39586,0.129680365364125,0.0101644449521103,0.109758053257989,0.149602677470261,5.13320083268771e-37
NMR metabolomics,X23424.Total Lipids in VLDL,CCT5,T-complex protein 1 subunit epsilon,41843,0.0591227917025663,0.00464173098868538,0.0500249989647429,0.0682205844403896,6.04773086503102e-37
NMR metabolomics,X23424.Total Lipids in VLDL,MOCS2,Molybdopterin synthase catalytic subunit,39736,0.0878744881177531,0.00690755100011327,0.0743356881575311,0.101413288077975,8.09780433180152e-37
NMR metabolomics,X23424.Total Lipids in VLDL,PPIB,Peptidyl-prolyl cis-trans isomerase B,42155,0.125066289506912,0.00984202399177234,0.105775922483038,0.144356656530785,8.72256573456296e-37
NMR metabolomics,X23424.Total Lipids in VLDL,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,42016,0.0752480761638535,0.00592437439816984,0.0636363023434406,0.0868598499842664,9.4485319060783e-37
NMR metabolomics,X23424.Total Lipids in VLDL,TALDO1,Transaldolase,39948,0.0575520283251924,0.0045393065671636,0.0486549874535517,0.066449069196833,1.37546670603875e-36
NMR metabolomics,X23424.Total Lipids in VLDL,HSPB1,Heat shock protein beta-1,41949,0.0910110996796016,0.00718642811389301,0.0769257005763713,0.105096498782832,1.51276405658698e-36
NMR metabolomics,X23424.Total Lipids in VLDL,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,39736,0.0831836528841996,0.00656626332644195,0.0703137767643734,0.0960535290040258,1.58165064589877e-36
NMR metabolomics,X23424.Total Lipids in VLDL,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,41843,0.109312402119022,0.00864563144942099,0.092366964478157,0.126257839759887,1.96893888219007e-36
NMR metabolomics,X23424.Total Lipids in VLDL,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,42203,-0.0415955102480795,0.00329122332557895,-0.0480463079662142,-0.0351447125299447,2.07914724861546e-36
NMR metabolomics,X23424.Total Lipids in VLDL,GPRC5C,G-protein coupled receptor family C group 5 member C,39919,0.0729979733684046,0.00577882608202033,0.0616714742476448,0.0843244724891645,2.47344831644885e-36
NMR metabolomics,X23424.Total Lipids in VLDL,TBCB,Tubulin-folding cofactor B,42016,0.129580826633082,0.0102641020770064,0.109463186562149,0.149698466704014,2.48413150930158e-36
NMR metabolomics,X23424.Total Lipids in VLDL,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,41843,0.0869944462981123,0.00689235728437992,0.0734854260207276,0.100503466575497,2.58860744734386e-36
NMR metabolomics,X23424.Total Lipids in VLDL,EDAR,Tumor necrosis factor receptor superfamily member EDAR,42119,0.118362343763951,0.00939691088256677,0.0999443984341206,0.136780289093782,3.55131624101218e-36
NMR metabolomics,X23424.Total Lipids in VLDL,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,42166,0.0982620790645015,0.00780876092275411,0.0829569076559034,0.1135672504731,4.13648982813308e-36
NMR metabolomics,X23424.Total Lipids in VLDL,WDR46,WD repeat-containing protein 46,39919,0.0473310645137269,0.00375993880525587,0.0399615844554254,0.0547005445720284,4.27443016475028e-36
NMR metabolomics,X23424.Total Lipids in VLDL,CRADD,Death domain-containing protein CRADD,41997,0.0962289508693231,0.00766287171264278,0.0812097223125433,0.111248179426103,5.7407155783322e-36
NMR metabolomics,X23424.Total Lipids in VLDL,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,42119,0.12785971601492,0.0101918444536274,0.107883700885811,0.14783573114403,6.68411193612315e-36
NMR metabolomics,X23424.Total Lipids in VLDL,AFP,Alpha-fetoprotein,41976,0.0839137297519008,0.00669016215156106,0.0708010119348412,0.0970264475689605,6.92467210944041e-36
NMR metabolomics,X23424.Total Lipids in VLDL,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,42159,0.0294069766667727,0.00234562855558472,0.0248095446978266,0.0340044086357187,7.40969228835551e-36
NMR metabolomics,X23424.Total Lipids in VLDL,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,42016,0.101528151394214,0.00810327728328089,0.0856457279189834,0.117410574869444,8.19146378187321e-36
NMR metabolomics,X23424.Total Lipids in VLDL,CEMIP2,Cell surface hyaluronidase,39657,0.0417304408958237,0.00332985674822704,0.0352039216692987,0.0482569601223487,8.70732829147554e-36
NMR metabolomics,X23424.Total Lipids in VLDL,CD69,Early activation antigen CD69,42082,0.112307825417368,0.00898063016487625,0.0947057902942106,0.129909860540526,1.09798263454824e-35
NMR metabolomics,X23424.Total Lipids in VLDL,CHRDL2,Chordin-like protein 2,42145,0.0586071278064458,0.00468775789588126,0.0494191223305185,0.0677951332823731,1.14294766921832e-35
NMR metabolomics,X23424.Total Lipids in VLDL,SERPINB9,Serpin B9,42016,0.0421109492086895,0.00336921752198459,0.0355072828655997,0.0487146155517793,1.19796921718278e-35
NMR metabolomics,X23424.Total Lipids in VLDL,LARP1,La-related protein 1,39919,0.0799398180194944,0.00639459806362832,0.0674064058147829,0.0924732302242059,1.26435266342016e-35
NMR metabolomics,X23424.Total Lipids in VLDL,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,41843,0.0835654903945411,0.00669294542830656,0.0704473173550603,0.096683663434022,1.41854036980292e-35
NMR metabolomics,X23424.Total Lipids in VLDL,NUB1,NEDD8 ultimate buster 1,42119,0.107635560029041,0.00863378477514503,0.0907133418697565,0.124557778188325,1.77516071771377e-35
NMR metabolomics,X23424.Total Lipids in VLDL,RBKS,Ribokinase,41830,0.0632506708998088,0.00508306725231092,0.0532878590852794,0.0732134827143382,2.39479010107293e-35
NMR metabolomics,X23424.Total Lipids in VLDL,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,39862,0.0374187836118527,0.00300583158770094,0.0315273536999589,0.0433102135237466,2.42632426778348e-35
NMR metabolomics,X23424.Total Lipids in VLDL,IL18,Interleukin-18,42069,0.0565658124969588,0.00454724833437281,0.0476532057615881,0.0654784192323296,2.49121010434822e-35
NMR metabolomics,X23424.Total Lipids in VLDL,DFFA,DNA fragmentation factor subunit alpha,42296,0.0852168236053372,0.00685504880714753,0.0717809279433281,0.0986527192673464,2.74115359107322e-35
NMR metabolomics,X23424.Total Lipids in VLDL,ZNRD2,Protein ZNRD2,39930,0.0891448634850485,0.00716840397019878,0.0750947917034589,0.103194935266638,2.83733138198926e-35
NMR metabolomics,X23424.Total Lipids in VLDL,TTF2,Transcription termination factor 2,39649,0.0635259150184532,0.00511238725844972,0.0535056359918918,0.0735461940450147,3.24993605213682e-35
NMR metabolomics,X23424.Total Lipids in VLDL,RNF5,E3 ubiquitin-protein ligase RNF5,39638,0.0937458049577103,0.00755710650309196,0.0789338762116501,0.108557733703771,4.20656763691174e-35
NMR metabolomics,X23424.Total Lipids in VLDL,MESD,LRP chaperone MESD,42137,0.155023781289536,0.0125063251093806,0.13051138407515,0.179536178503922,4.27794637433536e-35
NMR metabolomics,X23424.Total Lipids in VLDL,STXBP1,Syntaxin-binding protein 1,39934,0.09928816119496,0.00800818813800768,0.083592112444465,0.114984209945455,4.50271991239492e-35
NMR metabolomics,X23424.Total Lipids in VLDL,BIN2,Bridging integrator 2,42137,0.113463942045063,0.00915887977569785,0.0955125376846949,0.13141534640543,4.67641783601607e-35
NMR metabolomics,X23424.Total Lipids in VLDL,CD22,B-cell receptor CD22,42296,0.0541529729786339,0.00437725206593559,0.0455735589294002,0.0627323870278677,5.73391481086029e-35
NMR metabolomics,X23424.Total Lipids in VLDL,CACYBP,Calcyclin-binding protein,39713,0.131762783318173,0.0106656788367515,0.11085805279814,0.152667513838206,7.85244633309765e-35
NMR metabolomics,X23424.Total Lipids in VLDL,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,42016,0.118526759486417,0.00960600336878172,0.0996989928836052,0.13735452608923,8.64109218174085e-35
NMR metabolomics,X23424.Total Lipids in VLDL,KCTD5,BTB/POZ domain-containing protein KCTD5,39739,0.0584294751452392,0.00473487164491257,0.0491491267212106,0.0677098235692678,9.27267920463108e-35
NMR metabolomics,X23424.Total Lipids in VLDL,SCARA5,Scavenger receptor class A member 5,42249,0.0385980121544278,0.00313099602726606,0.0324612599409863,0.0447347643678693,9.83132165573473e-35
NMR metabolomics,X23424.Total Lipids in VLDL,SNCG,Gamma-synuclein,42016,0.0844916422203332,0.00685699426433923,0.0710519334622283,0.0979313509784381,1.06268276353559e-34
NMR metabolomics,X23424.Total Lipids in VLDL,UROD,Uroporphyrinogen decarboxylase,39736,0.085774471305792,0.00697021329119761,0.0721128532550446,0.0994360893565393,1.41250518822667e-34
NMR metabolomics,X23424.Total Lipids in VLDL,CST3,Cystatin-C,42184,0.036152813229665,0.00294179286296467,0.0303868992182542,0.0419187272410757,1.57558123851331e-34
NMR metabolomics,X23424.Total Lipids in VLDL,PNMA1,Paraneoplastic antigen Ma1,39638,0.0722375074163101,0.0058889242288977,0.0606952159276706,0.0837797989049496,2.2887139352641e-34
NMR metabolomics,X23424.Total Lipids in VLDL,CERT,Ceramide transfer protein,41839,0.0771851434178009,0.00629646622296947,0.0648440696207808,0.0895262172148211,2.32317860175333e-34
NMR metabolomics,X23424.Total Lipids in VLDL,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,39934,0.0616325012619322,0.005025999724208,0.0517815418024845,0.0714834607213799,2.3694082613759e-34
NMR metabolomics,X23424.Total Lipids in VLDL,NARS1,"Asparagine--tRNA ligase, cytoplasmic",39934,0.0590079250279402,0.00481327404313864,0.0495739079033885,0.0684419421524919,2.46717000457683e-34
NMR metabolomics,X23424.Total Lipids in VLDL,VSNL1,Visinin-like protein 1,39929,0.0488314804923261,0.00398372772046029,0.041023374160224,0.0566395868244283,2.51870813943172e-34
NMR metabolomics,X23424.Total Lipids in VLDL,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,39638,0.0952774773109143,0.00777988860680933,0.0800288956415681,0.110526058980261,2.92077512537372e-34
NMR metabolomics,X23424.Total Lipids in VLDL,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,42016,0.0539498042063443,0.00441562469300901,0.0452951798080467,0.062604428604642,3.7862597831017e-34
NMR metabolomics,X23424.Total Lipids in VLDL,CCL18,C-C motif chemokine 18,42020,0.0880153879620905,0.00720436908936866,0.0738948245469279,0.102135951377253,3.83148874478144e-34
NMR metabolomics,X23424.Total Lipids in VLDL,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,39958,0.112468364983699,0.00920391997789593,0.0944286818270232,0.130508048140375,3.9987283789744e-34
NMR metabolomics,X23424.Total Lipids in VLDL,FHIT,Bis(5'-adenosyl)-triphosphatase,41839,0.0902853219854716,0.00739496442436771,0.0757911917137109,0.104779452257232,4.24263804393778e-34
NMR metabolomics,X23424.Total Lipids in VLDL,SUGT1,Protein SGT1 homolog,41843,0.100051392231511,0.00819738198903667,0.0839845235329991,0.116118260930023,4.43939659853233e-34
NMR metabolomics,X23424.Total Lipids in VLDL,MYO9B,Unconventional myosin-IXb,41913,0.0825393247331438,0.00677045356640971,0.0692692357429807,0.0958094137233068,5.26193766117156e-34
NMR metabolomics,X23424.Total Lipids in VLDL,C1R,Complement C1r subcomponent,39979,0.0235703532044399,0.00193427710897801,0.019779170070843,0.0273615363380368,6.03360810698163e-34
NMR metabolomics,X23424.Total Lipids in VLDL,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,39424,0.135749447665729,0.0111403066400321,0.113914446651266,0.157584448680191,6.198292221009e-34
NMR metabolomics,X23424.Total Lipids in VLDL,SERPINB6,Serpin B6,42216,0.0729864966771297,0.00600874225461317,0.0612093618580879,0.0847636314961715,8.92806172576213e-34
NMR metabolomics,X23424.Total Lipids in VLDL,TBC1D5,TBC1 domain family member 5,42119,0.0972290813833988,0.00800495047329615,0.0815393784557384,0.112918784311059,9.01876234844e-34
NMR metabolomics,X23424.Total Lipids in VLDL,TMEM106A,Transmembrane protein 106A,39919,0.0893877730084742,0.00736357243497891,0.0749551710359156,0.103820374981033,1.06016557678608e-33
NMR metabolomics,X23424.Total Lipids in VLDL,GLOD4,Glyoxalase domain-containing protein 4,42106,0.0427040926201738,0.00352123146176383,0.0358024789551167,0.0496057062852309,1.1285301980581e-33
NMR metabolomics,X23424.Total Lipids in VLDL,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,41913,0.0681364900306886,0.00562723812839555,0.0571071032990333,0.0791658767623438,1.4321551698825e-33
NMR metabolomics,X23424.Total Lipids in VLDL,VPS4B,Vacuolar protein sorting-associated protein 4B,39919,0.117826318963577,0.00972771765862459,0.0987599923526733,0.136892645574482,1.46348938458904e-33
NMR metabolomics,X23424.Total Lipids in VLDL,ESYT2,Extended synaptotagmin-2,39929,0.103726417116528,0.00857017263118009,0.0869288787594149,0.120523955473641,1.6349873088317e-33
NMR metabolomics,X23424.Total Lipids in VLDL,MPI,Mannose-6-phosphate isomerase,42070,0.105412412623245,0.00873744120523729,0.0882870278609802,0.12253779738551,2.41758883413263e-33
NMR metabolomics,X23424.Total Lipids in VLDL,LTBP3,Latent-transforming growth factor beta-binding protein 3,41843,0.0658913512200394,0.00547142057689626,0.0551673668893227,0.0766153355507561,3.15533168536819e-33
NMR metabolomics,X23424.Total Lipids in VLDL,BCL2L1,Bcl-2-like protein 1,39929,0.123431062376515,0.010244722259761,0.103351406747383,0.143510718005646,3.16122130672259e-33
NMR metabolomics,X23424.Total Lipids in VLDL,CXCL16,C-X-C motif chemokine 16,42295,0.0288264607896814,0.00239446793505505,0.0241333036369735,0.0335196179423893,3.26924206259786e-33
NMR metabolomics,X23424.Total Lipids in VLDL,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",39627,0.0979566510439462,0.00813345611506522,0.0820150770584184,0.113898225029474,3.38241564744887e-33
NMR metabolomics,X23424.Total Lipids in VLDL,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",39736,0.129689855684894,0.0107741518406801,0.108572518077161,0.150807193292627,3.64077296211151e-33
NMR metabolomics,X23424.Total Lipids in VLDL,TP53I3,Quinone oxidoreductase PIG3,39513,0.0656288430375907,0.00546132794242958,0.0549246402704287,0.0763330458047527,4.67488319044866e-33
NMR metabolomics,X23424.Total Lipids in VLDL,PKD2,Polycystin-2,39575,0.0722618997842904,0.00601443774418481,0.0604736018056882,0.0840501977628927,4.7906020000118e-33
NMR metabolomics,X23424.Total Lipids in VLDL,TREH,Trehalase,39966,0.0929299621052562,0.00773764329386389,0.077764181249283,0.108095742961229,4.98105900290259e-33
NMR metabolomics,X23424.Total Lipids in VLDL,YWHAQ,14-3-3 protein theta,39736,0.0915747627298183,0.00762590838950711,0.0766279822863843,0.106521543173252,5.13359035346267e-33
NMR metabolomics,X23424.Total Lipids in VLDL,MANF,Mesencephalic astrocyte-derived neurotrophic factor,42185,0.148277009227161,0.0123586412735644,0.124054072330974,0.172499946123347,5.35361559643998e-33
NMR metabolomics,X23424.Total Lipids in VLDL,LGALS1,Galectin-1,42145,0.0430503101565974,0.00359138065772741,0.0360112040674517,0.0500894162457431,6.09208222836253e-33
NMR metabolomics,X23424.Total Lipids in VLDL,ATOX1,Copper transport protein ATOX1,42181,0.087324235970663,0.0072921719453582,0.0730315789577609,0.101616892983565,7.02781770298539e-33
NMR metabolomics,X23424.Total Lipids in VLDL,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,42202,0.139559974858746,0.0116689818373892,0.116688770457463,0.162431179260029,8.41493316205202e-33
NMR metabolomics,X23424.Total Lipids in VLDL,DNAJB14,DnaJ homolog subfamily B member 14,39930,0.0791703249500916,0.00661927213226295,0.0661965515708562,0.092144098329327,9.00120486526275e-33
NMR metabolomics,X23424.Total Lipids in VLDL,CASP2,Caspase-2,42119,0.0838193336562293,0.00701541430062888,0.0700691216269967,0.0975695456854619,9.73368916563545e-33
NMR metabolomics,X23424.Total Lipids in VLDL,CEBPB,CCAAT/enhancer-binding protein beta,41900,0.0460518397136084,0.00386396356177472,0.0384784711325299,0.0536252082946868,1.39235391910854e-32
NMR metabolomics,X23424.Total Lipids in VLDL,NUDT16,U8 snoRNA-decapping enzyme,39915,0.107399895297824,0.00901222007379399,0.0897359439531882,0.125063846642461,1.50841761258114e-32
NMR metabolomics,X23424.Total Lipids in VLDL,OTUD6B,Deubiquitinase OTUD6B,39930,0.0709484425309205,0.00595949926291836,0.0592678239756005,0.0826290610862405,1.73861209770075e-32
NMR metabolomics,X23424.Total Lipids in VLDL,CCL11,Eotaxin,42296,0.0456512270363455,0.00383720092518741,0.0381303132229782,0.0531721408497128,1.7727787127679e-32
NMR metabolomics,X23424.Total Lipids in VLDL,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,39919,0.131835680204545,0.0110885217327865,0.110102177608283,0.153569182800806,2.09488848240856e-32
NMR metabolomics,X23424.Total Lipids in VLDL,PPCDC,Phosphopantothenoylcysteine decarboxylase,42249,0.0563688750675895,0.00475473075812903,0.0470496027816566,0.0656881473535224,2.90741780439046e-32
NMR metabolomics,X23424.Total Lipids in VLDL,ERMAP,Erythroid membrane-associated protein,39657,0.0544005053557983,0.00458682308016978,0.0454103321186655,0.063390678592931,2.98871392344434e-32
NMR metabolomics,X23424.Total Lipids in VLDL,CHM,Rab proteins geranylgeranyltransferase component A 1,39649,0.074538289955532,0.00628832653268474,0.0622131699514699,0.0868634099595941,3.23666585813725e-32
NMR metabolomics,X23424.Total Lipids in VLDL,PRDX6,Peroxiredoxin-6,42262,-0.0729859544354562,0.00616379249215255,-0.0850669877200752,-0.0609049211508372,3.43892105511418e-32
NMR metabolomics,X23424.Total Lipids in VLDL,AKT2,RAC-beta serine/threonine-protein kinase,39934,0.155458757887542,0.0131298609568463,0.129724230412124,0.181193285362961,3.74572792258756e-32
NMR metabolomics,X23424.Total Lipids in VLDL,SERPINB1,Leukocyte elastase inhibitor,42093,0.108805283980535,0.00919512248008369,0.0907828439195714,0.126827724041499,3.80285243298492e-32
NMR metabolomics,X23424.Total Lipids in VLDL,ANXA3,Annexin A3,42224,0.0843611780539152,0.00713024906508982,0.0703858898863391,0.0983364662214912,3.85657767739011e-32
NMR metabolomics,X23424.Total Lipids in VLDL,STXBP3,Syntaxin-binding protein 3,41843,0.0527855825544433,0.00446280438495262,0.0440384859599362,0.0615326791489505,4.06340946804653e-32
NMR metabolomics,X23424.Total Lipids in VLDL,GNPDA2,Glucosamine-6-phosphate isomerase 2,39736,0.0454174205853856,0.00383895593440088,0.0378930669539598,0.0529417742168113,4.21734347718542e-32
NMR metabolomics,X23424.Total Lipids in VLDL,BMPER,BMP-binding endothelial regulator protein,39736,0.0281083167326666,0.00237692410528148,0.0234495454863149,0.0327670879790183,4.48177545396695e-32
NMR metabolomics,X23424.Total Lipids in VLDL,EGFR,Epidermal growth factor receptor,42310,0.0193664515220172,0.00163975287793749,0.0161525358812598,0.0225803671627747,4.9200259559923e-32
NMR metabolomics,X23424.Total Lipids in VLDL,C3,Complement C3,39445,0.0559572417291944,0.00473635559304773,0.0466739847668209,0.065240498691568,5.16607901044274e-32
NMR metabolomics,X23424.Total Lipids in VLDL,RAB33A,Ras-related protein Rab-33A,39575,0.0806078306914116,0.00683483422399977,0.067211555612372,0.0940041057704511,6.55458635669445e-32
NMR metabolomics,X23424.Total Lipids in VLDL,BAG3,BAG family molecular chaperone regulator 3,41992,0.0490588355325943,0.00416828527525322,0.040888996393098,0.0572286746720906,8.03711910995121e-32
NMR metabolomics,X23424.Total Lipids in VLDL,SCRG1,Scrapie-responsive protein 1,39958,0.0330680430423016,0.00280936658154591,0.0275616845424716,0.0385744015421316,8.46038664744133e-32
NMR metabolomics,X23424.Total Lipids in VLDL,AIF1,Allograft inflammatory factor 1,41843,0.0631320425340147,0.00536608431446474,0.0526145172776638,0.0736495677903655,8.51063863938498e-32
NMR metabolomics,X23424.Total Lipids in VLDL,AKT3,RAC-gamma serine/threonine-protein kinase,41791,0.0702117269061704,0.00596829207484983,0.0585138744394647,0.081909579372876,8.61193795900637e-32
NMR metabolomics,X23424.Total Lipids in VLDL,GGCT,Gamma-glutamylcyclotransferase,39952,0.0574949676763062,0.00488601477227775,0.0479183787226418,0.0670715566299706,8.80474642960564e-32
NMR metabolomics,X23424.Total Lipids in VLDL,ITGB1BP2,Integrin beta-1-binding protein 2,41900,0.135168807641487,0.011493938211494,0.112640688746959,0.157696926536015,9.01080253342562e-32
NMR metabolomics,X23424.Total Lipids in VLDL,RNASEH2A,Ribonuclease H2 subunit A,39934,0.0578905536819786,0.0049213518208499,0.0482447041131128,0.0675364032508444,9.24505860296682e-32
NMR metabolomics,X23424.Total Lipids in VLDL,FMNL1,Formin-like protein 1,41839,0.0762069582855807,0.00648689581311829,0.0634926424918688,0.0889212740792925,1.04097138412295e-31
NMR metabolomics,X23424.Total Lipids in VLDL,PSPN,Persephin,42119,0.104201512952603,0.00887684385766813,0.0868028989915733,0.121600126913632,1.15148268366417e-31
NMR metabolomics,X23424.Total Lipids in VLDL,LRG1,Leucine-rich alpha-2-glycoprotein,39979,-0.0321597158568588,0.00273867985628236,-0.0375275283751723,-0.0267919033385454,1.17110621810906e-31
NMR metabolomics,X23424.Total Lipids in VLDL,GLB1,Beta-galactosidase,42016,0.0519357359945517,0.00442700772948127,0.0432588008447684,0.060612671144335,1.25327500696883e-31
NMR metabolomics,X23424.Total Lipids in VLDL,ABRAXAS2,BRISC complex subunit Abraxas 2,39575,0.0801143757925099,0.00682727234488023,0.0667329219965446,0.0934958295884751,1.31049853714064e-31
NMR metabolomics,X23424.Total Lipids in VLDL,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,42070,0.112868332904356,0.00962793296830863,0.0939975842864707,0.131739081522241,1.38321925270426e-31
NMR metabolomics,X23424.Total Lipids in VLDL,CPPED1,Serine/threonine-protein phosphatase CPPED1,42249,0.0779163034345672,0.0066491754848235,0.0648839194843131,0.0909486873848213,1.45661375659312e-31
NMR metabolomics,X23424.Total Lipids in VLDL,PRSS2,Trypsin-2,42217,0.06873471791385,0.00586748869596202,0.0572344400697645,0.0802349957579356,1.52195580122482e-31
NMR metabolomics,X23424.Total Lipids in VLDL,EIF4E,Eukaryotic translation initiation factor 4E,39657,0.108881369138004,0.00929935113538501,0.0906546409126496,0.127108097363359,1.76838095983372e-31
NMR metabolomics,X23424.Total Lipids in VLDL,PQBP1,Polyglutamine-binding protein 1,41843,0.0679408736790554,0.00580653367465155,0.0565600676767384,0.0793216796813725,1.80423854729052e-31
NMR metabolomics,X23424.Total Lipids in VLDL,APP,Amyloid-beta precursor protein,42112,0.0794774960440597,0.0067942696851885,0.0661607274610903,0.0927942646270292,1.85619675774785e-31
NMR metabolomics,X23424.Total Lipids in VLDL,THTPA,Thiamine-triphosphatase,39897,0.105574118766684,0.00902080044679105,0.087893349890974,0.123254887642395,1.85939405645779e-31
NMR metabolomics,X23424.Total Lipids in VLDL,LRRN1,Leucine-rich repeat neuronal protein 1,41913,0.0486243220448146,0.00415672457634921,0.0404771418751702,0.056771502214459,1.86530704756694e-31
NMR metabolomics,X23424.Total Lipids in VLDL,GP1BB,Platelet glycoprotein Ib beta chain,39575,0.083437577383929,0.00713472882535843,0.0694535088862265,0.0974216458816316,2.08609608352114e-31
NMR metabolomics,X23424.Total Lipids in VLDL,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,42119,0.145759021133726,0.0124866582982661,0.121285170869124,0.170232871398328,2.4702930242203e-31
NMR metabolomics,X23424.Total Lipids in VLDL,PRG2,Bone marrow proteoglycan,39966,-0.0615470136677638,0.00527072998469805,-0.0718776444377719,-0.0512163828977556,2.5179687174998e-31
NMR metabolomics,X23424.Total Lipids in VLDL,BAG6,Large proline-rich protein BAG6,41900,0.0442349953569736,0.0037915586788572,0.0368035403464135,0.0516664503675337,2.67874754569241e-31
NMR metabolomics,X23424.Total Lipids in VLDL,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,39736,0.0514688152384186,0.00441274527766711,0.0428198344941911,0.0601177959826462,2.96892257478847e-31
NMR metabolomics,X23424.Total Lipids in VLDL,ARL13B,ADP-ribosylation factor-like protein 13B,39575,0.0826508417651827,0.00710793375832077,0.068719291598874,0.0965823919314914,4.51757102289737e-31
NMR metabolomics,X23424.Total Lipids in VLDL,PDIA4,Protein disulfide-isomerase A4,39966,0.0732619548027186,0.00630136376506844,0.0609112818231845,0.0856126277822528,4.53691607135281e-31
NMR metabolomics,X23424.Total Lipids in VLDL,SERPINA12,Serpin A12,41751,0.129203741130952,0.0111197833129989,0.107408965837474,0.15099851642443,4.66432962341015e-31
NMR metabolomics,X23424.Total Lipids in VLDL,REEP4,Receptor expression-enhancing protein 4,39934,0.0745217968802339,0.0064117059806017,0.0619548531582546,0.0870887406022133,4.73487862189222e-31
NMR metabolomics,X23424.Total Lipids in VLDL,PLPBP,Pyridoxal phosphate homeostasis protein,42145,0.0800577853251545,0.00689188958052067,0.066549681747334,0.093565888902975,4.7828398305373e-31
NMR metabolomics,X23424.Total Lipids in VLDL,GMFG,Glia maturation factor gamma,39958,0.0860376757664191,0.00740344485607953,0.0715269238485032,0.100548427684335,4.81194885444559e-31
NMR metabolomics,X23424.Total Lipids in VLDL,CCL3,C-C motif chemokine 3,42119,0.0707562445765063,0.00609399861213531,0.0588120072967211,0.0827004818562915,5.09626653259546e-31
NMR metabolomics,X23424.Total Lipids in VLDL,SUOX,"Sulfite oxidase, mitochondrial",39934,0.0757745576999334,0.00652537052779105,0.0629848314654629,0.0885642839344038,5.34448819795517e-31
NMR metabolomics,X23424.Total Lipids in VLDL,BLMH,Bleomycin hydrolase,42310,0.0368102238915975,0.00317440135519451,0.0305883972354163,0.0430320505477788,6.02368581315079e-31
NMR metabolomics,X23424.Total Lipids in VLDL,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,42249,-0.055419231158353,0.00478394057666318,-0.0647957546886128,-0.0460427076280931,6.89252040701259e-31
NMR metabolomics,X23424.Total Lipids in VLDL,C2,Complement C2,42199,0.026813655943177,0.00232004377399303,0.0222663701461507,0.0313609417402034,9.42861088672145e-31
NMR metabolomics,X23424.Total Lipids in VLDL,CD1C,T-cell surface glycoprotein CD1c,42181,0.0293292076024832,0.00253980550409515,0.0243511888144567,0.0343072263905097,1.05333125670688e-30
NMR metabolomics,X23424.Total Lipids in VLDL,MICALL2,MICAL-like protein 2,39649,0.0813611854809871,0.00704244098827839,0.0675580011439614,0.0951643698180127,1.06996483281881e-30
NMR metabolomics,X23424.Total Lipids in VLDL,JAM3,Junctional adhesion molecule C,39736,0.0604471899572825,0.00523280959095849,0.0501908831590039,0.0707034967555612,1.08399345686432e-30
NMR metabolomics,X23424.Total Lipids in VLDL,CRYBB1,Beta-crystallin B1,39958,0.0785308772162846,0.00680092601471726,0.0652010622274388,0.0918606922051304,1.1325392001587e-30
NMR metabolomics,X23424.Total Lipids in VLDL,RP2,Protein XRP2,42070,0.0504687568298531,0.00437339830537136,0.0418968961513252,0.0590406175083809,1.15644631304293e-30
NMR metabolomics,X23424.Total Lipids in VLDL,GIP,Gastric inhibitory polypeptide,39638,0.0601074567549555,0.00520767103825136,0.0499004215199828,0.0703144919899281,1.21300161494854e-30
NMR metabolomics,X23424.Total Lipids in VLDL,SETMAR,Histone-lysine N-methyltransferase SETMAR,41976,0.0351089661059828,0.00304860161332938,0.0291337069438572,0.0410842252681084,1.51919650720174e-30
NMR metabolomics,X23424.Total Lipids in VLDL,PLA2G4A,Cytosolic phospholipase A2,42185,0.10424158715655,0.00905806103782771,0.086487787522408,0.121995386790693,1.66193674910411e-30
NMR metabolomics,X23424.Total Lipids in VLDL,SEPTIN9,Septin-9,42070,0.0339630256426381,0.00295331061796261,0.0281745368314314,0.0397515144538449,1.83041217347016e-30
NMR metabolomics,X23424.Total Lipids in VLDL,PHLDB1,Pleckstrin homology-like domain family B member 1,39930,0.0626505906051905,0.00544695158259153,0.0519745655033111,0.0733266157070699,1.90280962977709e-30
NMR metabolomics,X23424.Total Lipids in VLDL,DNAJB2,DnaJ homolog subfamily B member 2,39736,0.0619686660002519,0.00539167338452767,0.0514009861665777,0.0725363458339262,2.1127074730733e-30
NMR metabolomics,X23424.Total Lipids in VLDL,TXNDC9,Thioredoxin domain-containing protein 9,39929,0.0631944148876211,0.0055096629980443,0.0523954754114543,0.073993354363788,2.75061631654807e-30
NMR metabolomics,X23424.Total Lipids in VLDL,CRLF1,Cytokine receptor-like factor 1,42185,0.0292478520757067,0.00255449332341179,0.0242410451618195,0.0342546589895938,3.25113863260202e-30
NMR metabolomics,X23424.Total Lipids in VLDL,CDC37,Hsp90 co-chaperone Cdc37,42181,0.0982133043014109,0.00858918072208732,0.0813785100861197,0.115048098516702,3.86034293292067e-30
NMR metabolomics,X23424.Total Lipids in VLDL,DYNLT1,Dynein light chain Tctex-type 1,39649,0.0933437797788718,0.00816101107794004,0.0773481980661093,0.109339361491634,3.9992440855355e-30
NMR metabolomics,X23424.Total Lipids in VLDL,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,39958,0.0723818856546311,0.00632884152992254,0.059977356255983,0.0847864150532793,4.00001205846045e-30
NMR metabolomics,X23424.Total Lipids in VLDL,CRYZL1,Quinone oxidoreductase-like protein 1,39638,0.10676015212121,0.00934256287179656,0.0884487288924884,0.125071575349931,4.50793597459912e-30
NMR metabolomics,X23424.Total Lipids in VLDL,LACTB2,Endoribonuclease LACTB2,42145,0.0772070483302947,0.00676450400252494,0.0639486204853458,0.0904654761752436,4.90758034315551e-30
NMR metabolomics,X23424.Total Lipids in VLDL,CES2,Cocaine esterase,42070,0.0652349478237667,0.00571654480220586,0.0540305200114432,0.0764393756360901,5.02668505819085e-30
NMR metabolomics,X23424.Total Lipids in VLDL,DCTD,Deoxycytidylate deaminase,39736,0.112392238157742,0.00985781018909689,0.0930709301871123,0.131713546128372,6.03401185141962e-30
NMR metabolomics,X23424.Total Lipids in VLDL,RBP2,Retinol-binding protein 2,42070,-0.0911454118560574,0.00800311780091086,-0.106831522745843,-0.0754593009662721,6.52021489262911e-30
NMR metabolomics,X23424.Total Lipids in VLDL,FABP2,"Fatty acid-binding protein, intestinal",42145,-0.0934231408728732,0.00821020229885568,-0.10951513737863,-0.0773311443671161,7.27797911080418e-30
NMR metabolomics,X23424.Total Lipids in VLDL,LAMP1,Lysosome-associated membrane glycoprotein 1,39661,0.0320591671758097,0.00281697558672796,0.0265378950258229,0.0375804393257965,7.64514535902044e-30
NMR metabolomics,X23424.Total Lipids in VLDL,HPGDS,Hematopoietic prostaglandin D synthase,41843,0.0444240710294199,0.00390614777370096,0.036768021392966,0.0520801206658737,7.8505952919241e-30
NMR metabolomics,X23424.Total Lipids in VLDL,BGLAP,Osteocalcin,39966,0.0984930316616693,0.008659626749499,0.0815201632326513,0.115465900090687,8.18200877538959e-30
NMR metabolomics,X23424.Total Lipids in VLDL,CIAPIN1,Anamorsin,42181,0.0714867326624526,0.00629356007106367,0.0591513549231678,0.0838221104017374,9.14508365492413e-30
NMR metabolomics,X23424.Total Lipids in VLDL,CFHR5,Complement factor H-related protein 5,39864,0.0486680256700519,0.0042876656487614,0.0402642009984796,0.0570718503416243,1.06644463711863e-29
NMR metabolomics,X23424.Total Lipids in VLDL,CD244,Natural killer cell receptor 2B4,42296,0.0320734753329901,0.00282746874302132,0.0265316365966683,0.0376153140693119,1.08337471980632e-29
NMR metabolomics,X23424.Total Lipids in VLDL,PRDX1,Peroxiredoxin-1,41742,-0.106737555550423,0.00942832265906494,-0.12521706796219,-0.0882580431386556,1.41653914714834e-29
NMR metabolomics,X23424.Total Lipids in VLDL,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,39657,0.0571453123475655,0.00505090297238866,0.0472455425216838,0.0670450821734473,1.62726593375779e-29
NMR metabolomics,X23424.Total Lipids in VLDL,VASH1,Tubulinyl-Tyr carboxypeptidase 1,42119,0.0961175999516442,0.00850124814939512,0.0794551535788298,0.112780046324459,1.65698265237345e-29
NMR metabolomics,X23424.Total Lipids in VLDL,PAM,Peptidyl-glycine alpha-amidating monooxygenase,42246,0.0328334419714202,0.00290888949221779,0.0271320185666733,0.0385348653761671,2.04754945864687e-29
NMR metabolomics,X23424.Total Lipids in VLDL,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,39657,0.0938948009831502,0.00831680413214991,0.0775938648841363,0.110195737082164,2.13478224326326e-29
NMR metabolomics,X23424.Total Lipids in VLDL,DTD1,D-aminoacyl-tRNA deacylase 1,39736,0.101555771652375,0.00900045271409202,0.0839148843327548,0.119196658971996,2.28714441214382e-29
NMR metabolomics,X23424.Total Lipids in VLDL,FGF23,Fibroblast growth factor 23,42250,0.0585148770002323,0.00518974445828953,0.0483429778619848,0.0686867761384798,2.34840587856272e-29
NMR metabolomics,X23424.Total Lipids in VLDL,RILP,Rab-interacting lysosomal protein,42224,0.0677012516495713,0.00601702823265391,0.0559078763135697,0.079494626985573,3.06012687234565e-29
NMR metabolomics,X23424.Total Lipids in VLDL,GPI,Glucose-6-phosphate isomerase,39990,0.0553308303082093,0.00491794241427742,0.0456916631762255,0.064969997440193,3.27147258531117e-29
NMR metabolomics,X23424.Total Lipids in VLDL,CASP3,Caspase-3,42310,0.101613538809545,0.00904410030647436,0.0838871022088556,0.119339975410235,3.66663628142532e-29
NMR metabolomics,X23424.Total Lipids in VLDL,PRSS8,Prostasin,42080,0.04816916054749,0.00428885671746193,0.0397630013812646,0.0565753197137153,3.85850308456027e-29
NMR metabolomics,X23424.Total Lipids in VLDL,CD164,Sialomucin core protein 24,42137,0.0311379748918019,0.00277529828010235,0.0256983902628013,0.0365775595208025,4.38632791606948e-29
NMR metabolomics,X23424.Total Lipids in VLDL,MIF,Macrophage migration inhibitory factor,42105,0.0771457891598378,0.0068805166724275,0.0636599764818798,0.0906316018377957,4.77277362054339e-29
NMR metabolomics,X23424.Total Lipids in VLDL,ASRGL1,Isoaspartyl peptidase/L-asparaginase,39638,0.117585853359711,0.0104860781816705,0.0970331401236365,0.138138566595785,5.02181051222761e-29
NMR metabolomics,X23424.Total Lipids in VLDL,RAB6A,Ras-related protein Rab-6A,42119,0.0510418142145665,0.0045594640550403,0.0421052646666875,0.0599783637624455,5.8039932472828e-29
NMR metabolomics,X23424.Total Lipids in VLDL,PCSK9,Proprotein convertase subtilisin/kexin type 9,42310,0.0457089061750216,0.0040859535475232,0.0377004372218762,0.0537173751281671,6.31101341294437e-29
NMR metabolomics,X23424.Total Lipids in VLDL,DBN1,Drebrin,39657,0.0586198733758666,0.00525159004457332,0.0483267568885028,0.0689129898632303,8.88320423372791e-29
NMR metabolomics,X23424.Total Lipids in VLDL,JPT2,Jupiter microtubule associated homolog 2,39930,0.100910582905798,0.00904266201668554,0.083186965353094,0.118634200458501,9.09923624215828e-29
NMR metabolomics,X23424.Total Lipids in VLDL,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,41843,0.0664603910124605,0.00595946064588929,0.0547798481465175,0.0781409338784035,9.39371491613214e-29
NMR metabolomics,X23424.Total Lipids in VLDL,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,39657,0.0636203991647585,0.00570404325500662,0.0524404743849456,0.0748003239445715,9.79081208306611e-29
NMR metabolomics,X23424.Total Lipids in VLDL,ATG4A,Cysteine protease ATG4A,41843,0.0665450943864839,0.00597779816245038,0.0548286099880812,0.0782615787848867,1.17401390354546e-28
NMR metabolomics,X23424.Total Lipids in VLDL,MRI1,Methylthioribose-1-phosphate isomerase,39649,0.0767503540550536,0.00689288897780105,0.0632402916585635,0.0902604164515437,1.20738482835797e-28
NMR metabolomics,X23424.Total Lipids in VLDL,RASSF2,Ras association domain-containing protein 2,41843,0.0651310971387698,0.00586412794204496,0.0536374063723617,0.0766247879051779,1.55557436682585e-28
NMR metabolomics,X23424.Total Lipids in VLDL,CBLN4,Cerebellin-4,42262,0.0361634560435706,0.00325995917517312,0.0297739360602313,0.0425529760269099,1.79034984042089e-28
NMR metabolomics,X23424.Total Lipids in VLDL,CD5,T-cell surface glycoprotein CD5,42239,0.0404864519743454,0.00365320296795779,0.0333261741571481,0.0476467297915426,2.01814380928125e-28
NMR metabolomics,X23424.Total Lipids in VLDL,PTP4A3,Protein tyrosine phosphatase type IVA 3,39657,0.0588359272257634,0.00530858403706215,0.0484311025131216,0.0692407519384052,2.1362160032222e-28
NMR metabolomics,X23424.Total Lipids in VLDL,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,41839,0.0732322507485432,0.00661162837397308,0.0602734591355559,0.0861910423615304,2.17901551026446e-28
NMR metabolomics,X23424.Total Lipids in VLDL,SPOCK1,Testican-1,42016,0.0296700437134963,0.00268408429650282,0.0244092384923508,0.0349308489346418,2.77501578195068e-28
NMR metabolomics,X23424.Total Lipids in VLDL,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,39934,0.113807153560694,0.010291520496799,0.0936357733869679,0.13397853373442,2.78644671179557e-28
NMR metabolomics,X23424.Total Lipids in VLDL,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,39736,0.0676769123240354,0.00612946165218689,0.0556631674857491,0.0796906571623217,3.3837149232242e-28
NMR metabolomics,X23424.Total Lipids in VLDL,SCG2,Secretogranin-2,42193,0.0373453128774552,0.00338913108997554,0.0307026159411032,0.0439880098138073,4.06385092701835e-28
NMR metabolomics,X23424.Total Lipids in VLDL,CPXM2,Inactive carboxypeptidase-like protein X2,39958,0.0288679180922191,0.00261868352168872,0.0237352983897092,0.034000537794729,4.07199166851365e-28
NMR metabolomics,X23424.Total Lipids in VLDL,RAD23B,UV excision repair protein RAD23 homolog B,41843,0.052334256077419,0.00475232099713179,0.0430197069230407,0.0616488052317973,4.41045552998057e-28
NMR metabolomics,X23424.Total Lipids in VLDL,CCL24,C-C motif chemokine 24,42166,0.0930513329869251,0.00845995004144868,0.0764698309056857,0.109632835068164,5.07223311354636e-28
NMR metabolomics,X23424.Total Lipids in VLDL,PDAP1,28 kDa heat- and acid-stable phosphoprotein,39958,0.111499554011375,0.0101352787933663,0.091634407576377,0.131364700446373,5.22485922890076e-28
NMR metabolomics,X23424.Total Lipids in VLDL,STX8,Syntaxin-8,42119,0.0538835491687058,0.00491575357864959,0.0442486721545526,0.063518426182859,7.6729110663573e-28
NMR metabolomics,X23424.Total Lipids in VLDL,PARK7,Parkinson disease protein 7,42137,0.0570127649547422,0.00520236903932268,0.0468161216376698,0.0672094082718147,7.87456608358806e-28
NMR metabolomics,X23424.Total Lipids in VLDL,NRGN,Neurogranin,39990,0.104187778144604,0.0095037128742227,0.085560500911128,0.122815055378081,7.94019185146749e-28
NMR metabolomics,X23424.Total Lipids in VLDL,SNAP25,Synaptosomal-associated protein 25,39586,0.0542600812634257,0.00495268756742176,0.0445528136312791,0.0639673488955724,8.68797556836246e-28
NMR metabolomics,X23424.Total Lipids in VLDL,GRK5,G protein-coupled receptor kinase 5,41900,0.0575888925892965,0.00528653045850781,0.0472272928906211,0.0679504922879718,1.617407175777e-27
NMR metabolomics,X23424.Total Lipids in VLDL,CPA1,Carboxypeptidase A1,42310,0.0724154150928434,0.00664918182582567,0.059383018714225,0.0854478114714617,1.6513435463885e-27
NMR metabolomics,X23424.Total Lipids in VLDL,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",39958,0.0813720850908777,0.00747292351034746,0.0667251550105967,0.0960190151711587,1.77918664942237e-27
NMR metabolomics,X23424.Total Lipids in VLDL,TST,Thiosulfate sulfurtransferase,41809,0.0843074011772365,0.00775298312409388,0.0691115542540125,0.0995032481004605,1.99940651386208e-27
NMR metabolomics,X23424.Total Lipids in VLDL,CCS,Copper chaperone for superoxide dismutase,42016,0.0517748469269943,0.00476162353299347,0.0424420648023271,0.0611076290516615,2.00923280113251e-27
NMR metabolomics,X23424.Total Lipids in VLDL,BAP18,Chromatin complexes subunit BAP18,39929,0.0762215892195142,0.00701331374902056,0.0624754942714339,0.0899676841675945,2.23153592882912e-27
NMR metabolomics,X23424.Total Lipids in VLDL,AMIGO2,Amphoterin-induced protein 2,42070,0.026130246686762,0.00240635657082234,0.0214137878079502,0.0308467055655738,2.34993006588199e-27
NMR metabolomics,X23424.Total Lipids in VLDL,ANGPTL7,Angiopoietin-related protein 7,42262,0.04096116428826,0.00377571058842507,0.0335607715349469,0.0483615570415732,2.61667692253308e-27
NMR metabolomics,X23424.Total Lipids in VLDL,BLNK,B-cell linker protein,39657,0.0466010545116809,0.00430713084456241,0.0381590780563385,0.0550430309670232,3.80485581511829e-27
NMR metabolomics,X23424.Total Lipids in VLDL,PTPRM,Receptor-type tyrosine-protein phosphatase mu,42100,0.0270099687185915,0.00250906170030213,0.0220922077859993,0.0319277296511837,6.47871961605921e-27
NMR metabolomics,X23424.Total Lipids in VLDL,CCL2,C-C motif chemokine 2,41992,0.057272325742003,0.00533225810974482,0.0468210998469032,0.0677235516371029,8.42472696071117e-27
NMR metabolomics,X23424.Total Lipids in VLDL,VCAM1,Vascular cell adhesion protein 1,42199,-0.0305356604060388,0.00284981403351738,-0.0361212959117329,-0.0249500249003447,1.10645212116566e-26
NMR metabolomics,X23424.Total Lipids in VLDL,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,39958,0.044297831419708,0.00413495072846517,0.0361933279919163,0.0524023348474998,1.18526780698368e-26
NMR metabolomics,X23424.Total Lipids in VLDL,NPPB,Natriuretic peptides B,41900,-0.154316409328782,0.0144166321138529,-0.182573008271933,-0.12605981038563,1.25043818500739e-26
NMR metabolomics,X23424.Total Lipids in VLDL,FRMD4B,FERM domain-containing protein 4B,39575,0.0774201581707109,0.00723884720494552,0.0632320176490176,0.0916082986924041,1.45019286170138e-26
NMR metabolomics,X23424.Total Lipids in VLDL,CALCA,Calcitonin,41997,0.0758924586879613,0.00714231934972394,0.0618935127625024,0.0898914046134202,2.87769406401667e-26
NMR metabolomics,X23424.Total Lipids in VLDL,NBN,Nibrin,41913,0.05936645916502,0.00558829738341733,0.0484133962935221,0.070319522036518,2.95620074313794e-26
NMR metabolomics,X23424.Total Lipids in VLDL,GIPC3,PDZ domain-containing protein GIPC3,39930,0.108038371750479,0.0101804689727676,0.0880846525638548,0.127992090937104,3.46607140153516e-26
NMR metabolomics,X23424.Total Lipids in VLDL,LTBP2,Latent-transforming growth factor beta-binding protein 2,42310,-0.0349644911645049,0.00329728772609052,-0.0414271751076423,-0.0285018072213675,3.60486091654824e-26
NMR metabolomics,X23424.Total Lipids in VLDL,GNAS,Neuroendocrine secretory protein 55,39934,0.0943047783287566,0.00889593790742678,0.0768687400302001,0.111740816627313,3.91214504821652e-26
NMR metabolomics,X23424.Total Lipids in VLDL,PVR,Poliovirus receptor,42249,0.0406418582528938,0.00384239012840364,0.0331107736012227,0.0481729429045649,4.79279260529153e-26
NMR metabolomics,X23424.Total Lipids in VLDL,TRIAP1,TP53-regulated inhibitor of apoptosis 1,42262,0.0675913745746682,0.00639202599700149,0.0550630036205453,0.0801197455287911,4.94140530560879e-26
NMR metabolomics,X23424.Total Lipids in VLDL,SLMAP,Sarcolemmal membrane-associated protein,39930,0.0908373240785774,0.0085904162310024,0.0740001082658127,0.107674539891342,5.18455893196595e-26
NMR metabolomics,X23424.Total Lipids in VLDL,BRSK2,Serine/threonine-protein kinase BRSK2,39934,0.0405160813644485,0.0038366477948639,0.0329962516865153,0.0480359110423818,6.00854100658399e-26
NMR metabolomics,X23424.Total Lipids in VLDL,PKN3,Serine/threonine-protein kinase N3,39757,0.0800135516326049,0.00757682585618917,0.0651629729544742,0.0948641303107357,6.03372151300346e-26
NMR metabolomics,X23424.Total Lipids in VLDL,STX4,Syntaxin-4,42070,0.0639878292049193,0.00606225824813771,0.0521058030385694,0.0758698553712693,6.07399051347083e-26
NMR metabolomics,X23424.Total Lipids in VLDL,CLTA,Clathrin light chain A,41900,0.050724710865782,0.00480988794373937,0.0412973304960529,0.0601520912355112,6.71263499880231e-26
NMR metabolomics,X23424.Total Lipids in VLDL,ECHS1,"Enoyl-CoA hydratase, mitochondrial",39638,0.105249556108477,0.00997994984438266,0.0856888544134874,0.124810257803467,7.02895705167432e-26
NMR metabolomics,X23424.Total Lipids in VLDL,TSNAX,Translin-associated protein X,39575,0.0426646819549443,0.00404624835230468,0.0347340351844272,0.0505953287254615,7.17837043984358e-26
NMR metabolomics,X23424.Total Lipids in VLDL,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,39930,0.0696407055760595,0.00660635193537537,0.0566922557827238,0.0825891553693952,7.32645006076205e-26
NMR metabolomics,X23424.Total Lipids in VLDL,MGMT,Methylated-DNA--protein-cysteine methyltransferase,42119,0.130023182345241,0.0123406357798533,0.105835536216728,0.154210828473753,7.41090042219013e-26
NMR metabolomics,X23424.Total Lipids in VLDL,SCRIB,Protein scribble homolog,39638,0.0949692657463377,0.00901972337463431,0.0772906079320544,0.112647923560621,8.40918216539135e-26
NMR metabolomics,X23424.Total Lipids in VLDL,IFT20,Intraflagellar transport protein 20 homolog,39649,0.0471907571420268,0.00448921119107526,0.0383919032075193,0.0559896110765343,1.00542411405405e-25
NMR metabolomics,X23424.Total Lipids in VLDL,SMTN,Smoothelin,39897,0.100029935595602,0.00953961561670605,0.0813322889868578,0.118727582204346,1.31675889967652e-25
NMR metabolomics,X23424.Total Lipids in VLDL,FABP4,"Fatty acid-binding protein, adipocyte",42310,0.0541672709075904,0.00517285561462427,0.0440284739029268,0.0643060679122539,1.45897786019508e-25
NMR metabolomics,X23424.Total Lipids in VLDL,TNFSF14,Tumor necrosis factor ligand superfamily member 14,42016,0.0621171448310806,0.00593390493354325,0.0504866911613358,0.0737475985008254,1.51717964604021e-25
NMR metabolomics,X23424.Total Lipids in VLDL,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,42217,0.0460302600042224,0.00440150708190376,0.0374033061236911,0.0546572138847538,1.68494894942561e-25
NMR metabolomics,X23424.Total Lipids in VLDL,FAS,Tumor necrosis factor receptor superfamily member 6,42272,0.0357332908974175,0.0034186207329426,0.02903279426085,0.042433787533985,1.77936356979994e-25
NMR metabolomics,X23424.Total Lipids in VLDL,FUT8,"Alpha-(1,6)-fucosyltransferase",42016,0.0622632325432748,0.00596102955670049,0.0505796146121418,0.0739468504744077,1.93262206669772e-25
NMR metabolomics,X23424.Total Lipids in VLDL,MIA,Melanoma-derived growth regulatory protein,42181,0.0396695044987664,0.00379910423813481,0.0322232601920221,0.0471157488055106,1.99382333107208e-25
NMR metabolomics,X23424.Total Lipids in VLDL,NT5C1A,Cytosolic 5'-nucleotidase 1A,39929,0.03319524464225,0.00317854925000592,0.0269652881122384,0.0394252011722616,2.04608199924251e-25
NMR metabolomics,X23424.Total Lipids in VLDL,SPINT2,Kunitz-type protease inhibitor 2,42185,0.0423511980060011,0.00405792854244687,0.0343976580628052,0.050304737949197,2.10392922188583e-25
NMR metabolomics,X23424.Total Lipids in VLDL,INPP1,Inositol polyphosphate 1-phosphatase,42070,0.057013990999895,0.00546676574732385,0.0462991301351402,0.0677288518646497,2.27853738826921e-25
NMR metabolomics,X23424.Total Lipids in VLDL,DDT,D-dopachrome decarboxylase,39966,0.0436372190117861,0.00418762571050622,0.0354294726191939,0.0518449654043783,2.59847821356766e-25
NMR metabolomics,X23424.Total Lipids in VLDL,MDH1,"Malate dehydrogenase, cytoplasmic",39950,0.0420481108714256,0.00403710309743206,0.0341353888004588,0.0499608329423924,2.74117621055386e-25
NMR metabolomics,X23424.Total Lipids in VLDL,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",39958,0.0318375124502171,0.00305801796165246,0.0258437972453783,0.0378312276550559,2.86484461110753e-25
NMR metabolomics,X23424.Total Lipids in VLDL,CCDC80,Coiled-coil domain-containing protein 80,42145,0.0375955079942845,0.0036137263915081,0.0305126042669286,0.0446784117216403,2.97420678623215e-25
NMR metabolomics,X23424.Total Lipids in VLDL,PEBP1,Phosphatidylethanolamine-binding protein 1,42137,0.0595643557465101,0.00573401367215922,0.048325688949078,0.0708030225439421,3.50002334194067e-25
NMR metabolomics,X23424.Total Lipids in VLDL,DMP1,Dentin matrix acidic phosphoprotein 1,39638,-0.0604666096753219,0.00582273855089599,-0.0718791772350781,-0.0490540421155658,3.80523345858605e-25
NMR metabolomics,X23424.Total Lipids in VLDL,CCN4,CCN family member 4,42262,0.0417232247602681,0.00401972066377009,0.0338445722592787,0.0496018772612575,3.80655787481379e-25
NMR metabolomics,X23424.Total Lipids in VLDL,NFAT5,Nuclear factor of activated T-cells 5,39657,0.0910934407375376,0.00878825222937506,0.0738684663679625,0.108318415107113,4.64135988063887e-25
NMR metabolomics,X23424.Total Lipids in VLDL,CPB1,Carboxypeptidase B,42310,0.0660750501063287,0.00637890322889028,0.0535723997777038,0.0785777004349537,4.74322153426086e-25
NMR metabolomics,X23424.Total Lipids in VLDL,CA13,Carbonic anhydrase 13,41967,0.11199417247685,0.0108140896515222,0.0907985567598666,0.133189788193834,4.87158602661516e-25
NMR metabolomics,X23424.Total Lipids in VLDL,PCYT2,Ethanolamine-phosphate cytidylyltransferase,39930,0.0807953920388827,0.0078009682057356,0.0655054943556409,0.0960852897221244,5.02441899481143e-25
NMR metabolomics,X23424.Total Lipids in VLDL,EGFL7,Epidermal growth factor-like protein 7,41843,0.0412333551003204,0.00398662000226363,0.0334195798958837,0.0490471303047572,5.60757359336943e-25
NMR metabolomics,X23424.Total Lipids in VLDL,SWAP70,Switch-associated protein 70,39930,0.0389113858607157,0.00377344893371909,0.0315154259506263,0.0463073457708051,8.01581108926062e-25
NMR metabolomics,X23424.Total Lipids in VLDL,CCL26,C-C motif chemokine 26,42119,0.0951541887689863,0.00923133388025844,0.0770607743636798,0.113247603174293,8.03301871254653e-25
NMR metabolomics,X23424.Total Lipids in VLDL,SH3BP1,SH3 domain-binding protein 1,39930,0.0524145978092343,0.00508724862043265,0.0424435905131863,0.0623856051052823,8.77281021712712e-25
NMR metabolomics,X23424.Total Lipids in VLDL,BPIFB2,BPI fold-containing family B member 2,39927,0.0650030399456652,0.00630943393853309,0.0526365494261404,0.0773695304651901,8.8293696373973e-25
NMR metabolomics,X23424.Total Lipids in VLDL,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,42231,0.0322769707787397,0.00313479449938494,0.0261327735599452,0.0384211679975342,9.01819485680657e-25
NMR metabolomics,X23424.Total Lipids in VLDL,ITGA2,Integrin alpha-2,39736,0.0366848188887237,0.00356542205716245,0.0296965916566853,0.0436730461207621,1.01852211011936e-24
NMR metabolomics,X23424.Total Lipids in VLDL,LRP11,Low-density lipoprotein receptor-related protein 11,42145,0.0390940503200117,0.00380343326904318,0.0316393211126871,0.0465487795273363,1.08407153968442e-24
NMR metabolomics,X23424.Total Lipids in VLDL,MMP7,Matrilysin,41881,0.0547681203822338,0.00533118321027921,0.0443190012900865,0.065217239474381,1.15143045142299e-24
NMR metabolomics,X23424.Total Lipids in VLDL,F2R,Proteinase-activated receptor 1,42166,0.0604351489672806,0.00588989767801108,0.0488909495183789,0.0719793484161823,1.30154136785303e-24
NMR metabolomics,X23424.Total Lipids in VLDL,TPK1,Thiamin pyrophosphokinase 1,39958,0.0295489711841654,0.0028798630937555,0.0239044395204046,0.0351935028479262,1.35839512967668e-24
NMR metabolomics,X23424.Total Lipids in VLDL,POMC,Pro-opiomelanocortin,39638,0.0775380077918449,0.00756273702751544,0.0627150432179146,0.0923609723657751,1.48367628256315e-24
NMR metabolomics,X23424.Total Lipids in VLDL,CEP170,Centrosomal protein of 170 kDa,39638,0.0814903168977683,0.00795860967306528,0.0658914419385603,0.0970891918569762,1.70151613867908e-24
NMR metabolomics,X23424.Total Lipids in VLDL,PPP3R1,Calcineurin subunit B type 1,42016,0.0424755245166802,0.00415135268638731,0.034338873251361,0.0506121757819993,1.75822020895519e-24
NMR metabolomics,X23424.Total Lipids in VLDL,GBP1,Guanylate-binding protein 1,39911,0.0680980307522761,0.00665585115560797,0.0550525624872845,0.0811434990172677,1.83487690641041e-24
NMR metabolomics,X23424.Total Lipids in VLDL,CD40LG,CD40 ligand,42296,0.0833163180673318,0.00814781400906628,0.0673466026095619,0.0992860335251017,1.86427696650631e-24
NMR metabolomics,X23424.Total Lipids in VLDL,CCL7,C-C motif chemokine 7,42119,0.0590513787655226,0.0057766594125717,0.0477291263168821,0.0703736312141631,1.9313520938906e-24
NMR metabolomics,X23424.Total Lipids in VLDL,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,41843,0.0605447914736438,0.00592426985909145,0.0489332225498245,0.072156360397463,1.99228967523892e-24
NMR metabolomics,X23424.Total Lipids in VLDL,CFB,Complement factor B,39794,0.034530734841743,0.00337873076475316,0.0279084225428268,0.0411530471406592,2.06429887130096e-24
NMR metabolomics,X23424.Total Lipids in VLDL,CD72,B-cell differentiation antigen CD72,39736,0.045659656676229,0.00447353859074368,0.0368915210383714,0.0544277923140866,2.370658652826e-24
NMR metabolomics,X23424.Total Lipids in VLDL,BDNF,Brain-derived neurotrophic factor,39966,0.0882040625246635,0.00864481567541655,0.071260223800847,0.10514790124848,2.44451621584327e-24
NMR metabolomics,X23424.Total Lipids in VLDL,PAGR1,PAXIP1-associated glutamate-rich protein 1,39638,0.0445468193366759,0.00436633504299802,0.0359888026523998,0.053104836020952,2.4816844455147e-24
NMR metabolomics,X23424.Total Lipids in VLDL,OPLAH,5-oxoprolinase,39638,0.0728989389639414,0.00715194036153225,0.0588811358553382,0.0869167420725446,2.73265659501785e-24
NMR metabolomics,X23424.Total Lipids in VLDL,DXO,Decapping and exoribonuclease protein,39929,0.0475495821749801,0.00466668810351852,0.0384028734920838,0.0566962908578764,2.82096854363679e-24
NMR metabolomics,X23424.Total Lipids in VLDL,DYNLT3,Dynein light chain Tctex-type 3,39919,0.0459957846199244,0.00451443038665877,0.0371475010620732,0.0548440681777755,2.83702889323611e-24
NMR metabolomics,X23424.Total Lipids in VLDL,SFRP1,Secreted frizzled-related protein 1,41968,0.0450399547720822,0.00442400507224016,0.0363689048304915,0.0537110047136729,2.96120956457717e-24
NMR metabolomics,X23424.Total Lipids in VLDL,GGACT,Gamma-glutamylaminecyclotransferase,39958,0.0744717803607715,0.00731241470529274,0.0601394475383977,0.0888041131831453,2.96224102590005e-24
NMR metabolomics,X23424.Total Lipids in VLDL,DCTN6,Dynactin subunit 6,41839,0.0755051335347417,0.00742157004278045,0.060958856250892,0.0900514108185914,3.18875353289032e-24
NMR metabolomics,X23424.Total Lipids in VLDL,CRIM1,Cysteine-rich motor neuron 1 protein,42185,-0.0213103258783541,0.00209488929018045,-0.0254163088871078,-0.0172043428696004,3.21159821809201e-24
NMR metabolomics,X23424.Total Lipids in VLDL,DNAJC9,DnaJ homolog subfamily C member 9,39930,0.0790983355971106,0.00777524237034631,0.0638588605512318,0.0943378106429894,3.3217398736269e-24
NMR metabolomics,X23424.Total Lipids in VLDL,LEPR,Leptin receptor,42145,-0.0327972724825816,0.00322997848239123,-0.0391280303080684,-0.0264665146570948,3.87992767464205e-24
NMR metabolomics,X23424.Total Lipids in VLDL,MCFD2,Multiple coagulation factor deficiency protein 2,42062,0.0473354394748463,0.00466665621864513,0.0381887932863018,0.0564820856633907,4.33073301319973e-24
NMR metabolomics,X23424.Total Lipids in VLDL,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",39958,0.0795473189548287,0.00784368876096669,0.0641736889833339,0.0949209489263234,4.57369318460249e-24
NMR metabolomics,X23424.Total Lipids in VLDL,ACYP1,Acylphosphatase-1,39701,0.0679260258550915,0.00670250212340834,0.0547891216932112,0.0810629300169719,4.9440037310436e-24
NMR metabolomics,X23424.Total Lipids in VLDL,PRSS27,Serine protease 27,42107,0.0418173801837403,0.00412869335548457,0.0337251412069906,0.0499096191604901,5.03249529734244e-24
NMR metabolomics,X23424.Total Lipids in VLDL,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,42119,0.0634894716102376,0.00627143497458255,0.0511974590600558,0.0757814841604194,5.28714790784492e-24
NMR metabolomics,X23424.Total Lipids in VLDL,RAB2B,Ras-related protein Rab-2B,39919,0.0649373480401056,0.00641596428242284,0.0523620580465569,0.0775126380336544,5.62636536198157e-24
NMR metabolomics,X23424.Total Lipids in VLDL,SRC,Proto-oncogene tyrosine-protein kinase Src,42166,0.12408581977512,0.0122731163420214,0.100030511744758,0.148141127805482,6.04127072744901e-24
NMR metabolomics,X23424.Total Lipids in VLDL,IFNGR2,Interferon gamma receptor 2,42016,0.0548817419288269,0.00542931940951507,0.0442402758861773,0.0655232079714764,6.17669866206822e-24
NMR metabolomics,X23424.Total Lipids in VLDL,UNC79,Protein unc-79 homolog,39560,0.0581182007724727,0.00574899556346835,0.0468501694680748,0.0693862320768707,6.39722961372264e-24
NMR metabolomics,X23424.Total Lipids in VLDL,LGALS9,Galectin-9,42129,0.0325667129274219,0.00322845235962442,0.026238946302558,0.0388944795522858,7.62616976269297e-24
NMR metabolomics,X23424.Total Lipids in VLDL,KLF4,Krueppel-like factor 4,39586,0.0421268833366474,0.00417813209885273,0.0339377444228961,0.0503160222503988,8.36166543480147e-24
NMR metabolomics,X23424.Total Lipids in VLDL,CARHSP1,Calcium-regulated heat-stable protein 1,41839,0.0515158704797469,0.00511331895655834,0.0414937653248925,0.0615379756346012,8.69505028046559e-24
NMR metabolomics,X23424.Total Lipids in VLDL,SOD1,Superoxide dismutase [Cu-Zn],41874,0.0490153530388798,0.00487174089265557,0.0394667408892749,0.0585639651884848,9.97687255825396e-24
NMR metabolomics,X23424.Total Lipids in VLDL,HEPH,Hephaestin,39958,0.0288712504215221,0.00287328737165497,0.0232396071730784,0.0345028936699659,1.17505257455526e-23
NMR metabolomics,X23424.Total Lipids in VLDL,ARFIP1,Arfaptin-1,39934,0.0714339542478722,0.00712625563401375,0.0574664932052053,0.0854014152905392,1.49772531086442e-23
NMR metabolomics,X23424.Total Lipids in VLDL,ING1,Inhibitor of growth protein 1,41820,0.0490939795338438,0.0048993901814595,0.0394911747781832,0.0586967842895044,1.50426777162301e-23
NMR metabolomics,X23424.Total Lipids in VLDL,NPDC1,Neural proliferation differentiation and control protein 1,42145,0.0342207879507076,0.00341856536610614,0.0275203998331396,0.0409211760682756,1.65793510985524e-23
NMR metabolomics,X23424.Total Lipids in VLDL,GP5,Platelet glycoprotein V,39736,0.0377264210835932,0.0037693201098882,0.0303385536682123,0.0451142884989741,1.75187759666496e-23
NMR metabolomics,X23424.Total Lipids in VLDL,DBI,Acyl-CoA-binding protein,42085,0.0800352179006818,0.00800862696047721,0.0643383090581464,0.0957321267432171,1.96080175192176e-23
NMR metabolomics,X23424.Total Lipids in VLDL,SPINK2,Serine protease inhibitor Kazal-type 2,39736,0.0368179882958772,0.00368304360836538,0.029599222823481,0.0440367537682733,1.97931377660593e-23
NMR metabolomics,X23424.Total Lipids in VLDL,AKR1B1,Aldo-keto reductase family 1 member B1,41843,0.0761849931249756,0.00763229700094292,0.0612256910031274,0.0911442952468237,2.21205973337155e-23
NMR metabolomics,X23424.Total Lipids in VLDL,LAMB1,Laminin subunit beta-1,39638,0.0322884831651385,0.00323375409585893,0.025950325137255,0.038626641193022,2.23143785485894e-23
NMR metabolomics,X23424.Total Lipids in VLDL,IL10RB,Interleukin-10 receptor subunit beta,42185,0.0305572345290693,0.00306356068736765,0.0245526555818286,0.0365618134763099,2.37316156186366e-23
NMR metabolomics,X23424.Total Lipids in VLDL,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,39930,-0.0368151081274188,0.00369337263087142,-0.0440541184839268,-0.0295760977709108,2.62750784905342e-23
NMR metabolomics,X23424.Total Lipids in VLDL,GP6,Platelet glycoprotein VI,42115,0.0899768178133436,0.00906118574289257,0.0722168937572741,0.107736741869413,3.70318110718431e-23
NMR metabolomics,X23424.Total Lipids in VLDL,MZT1,Mitotic-spindle organizing protein 1,41843,0.0536386493931216,0.00540379691278708,0.0430472074440589,0.0642300913421843,3.86078377338135e-23
NMR metabolomics,X23424.Total Lipids in VLDL,PRDX5,"Peroxiredoxin-5, mitochondrial",42296,0.0671383129743369,0.00679141017170006,0.0538271490378048,0.0804494769108691,5.72831077767569e-23
NMR metabolomics,X23424.Total Lipids in VLDL,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,39657,0.0471088413502858,0.00476604354514082,0.0377673960018098,0.0564502866987618,6.06363384303371e-23
NMR metabolomics,X23424.Total Lipids in VLDL,FXYD5,FXYD domain-containing ion transport regulator 5,41913,0.0661600105952704,0.00669780051642525,0.0530323215830769,0.0792876996074639,6.22606976309282e-23
NMR metabolomics,X23424.Total Lipids in VLDL,NT5C3A,Cytosolic 5'-nucleotidase 3A,42087,0.087741548380189,0.00888472974683675,0.070327478076389,0.105155618683989,6.35634452795297e-23
NMR metabolomics,X23424.Total Lipids in VLDL,SDHB,Succinate dehydrogenase,39930,0.0667487836574379,0.00675926914374182,0.053500616135704,0.0799969511791719,6.60133815450815e-23
NMR metabolomics,X23424.Total Lipids in VLDL,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,39638,0.0541526372858759,0.00549467441790924,0.0433830754267737,0.064922199144978,8.06210467173097e-23
NMR metabolomics,X23424.Total Lipids in VLDL,MCAM,Cell surface glycoprotein MUC18,42217,-0.0324263786737896,0.00329249254084416,-0.0388796640538441,-0.025973093293735,8.28503213275579e-23
NMR metabolomics,X23424.Total Lipids in VLDL,RAB10,Ras-related protein Rab-10,39958,0.0542074606365584,0.00550482140350998,0.0434180106856789,0.064996910587438,8.689188789783e-23
NMR metabolomics,X23424.Total Lipids in VLDL,DTX3,Probable E3 ubiquitin-protein ligase DTX3,42070,0.0246169547841099,0.00250543574390361,0.0197063007260588,0.029527608842161,1.0431907971721e-22
NMR metabolomics,X23424.Total Lipids in VLDL,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,42144,0.0318228495699483,0.00324505158818617,0.0254625484571034,0.0381831506827932,1.25462237495234e-22
NMR metabolomics,X23424.Total Lipids in VLDL,GSR,"Glutathione reductase, mitochondrial",39949,0.0231502816933504,0.00236185115170674,0.0185210534360052,0.0277795099506956,1.36011583394481e-22
NMR metabolomics,X23424.Total Lipids in VLDL,DEFB103A_DEFB103B,Beta-defensin 103,39596,0.0419952462043168,0.00428676255692899,0.033593191592736,0.0503973008158976,1.44161001833366e-22
NMR metabolomics,X23424.Total Lipids in VLDL,KLK7,Kallikrein-7,39475,0.0399265102892696,0.00408003876811446,0.0319296343037652,0.0479233862747739,1.60449496766409e-22
NMR metabolomics,X23424.Total Lipids in VLDL,SERPING1,Plasma protease C1 inhibitor,39959,0.0186721622753068,0.00190886314717313,0.0149307905068475,0.0224135340437661,1.65347654784898e-22
NMR metabolomics,X23424.Total Lipids in VLDL,GFRA1,GDNF family receptor alpha-1,42247,0.0286949290721047,0.00293476110835578,0.0229427972997274,0.034447060844482,1.66554366906648e-22
NMR metabolomics,X23424.Total Lipids in VLDL,ARHGAP1,Rho GTPase-activating protein 1,41843,0.0468372435034226,0.00479020896340419,0.0374484339351504,0.0562260530716949,1.67251802052286e-22
NMR metabolomics,X23424.Total Lipids in VLDL,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,42145,0.0630477521591393,0.00644872707316687,0.0504082470957322,0.0756872572225464,1.68127152081507e-22
NMR metabolomics,X23424.Total Lipids in VLDL,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,39575,0.0283042939524652,0.00290094727196929,0.0226184372994054,0.033990150605525,2.12489285881306e-22
NMR metabolomics,X23424.Total Lipids in VLDL,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",39638,0.0443867740386193,0.00454975694628328,0.0354692504239041,0.0533042976533346,2.14442965559008e-22
NMR metabolomics,X23424.Total Lipids in VLDL,CDNF,Cerebral dopamine neurotrophic factor,42070,0.0328515461934823,0.00337089161368727,0.0262445986306553,0.0394584937563094,2.2824207980417e-22
NMR metabolomics,X23424.Total Lipids in VLDL,PECAM1,Platelet endothelial cell adhesion molecule,42137,0.0302844720230963,0.00310940819265111,0.0241900319655001,0.0363789120806925,2.41894415796658e-22
NMR metabolomics,X23424.Total Lipids in VLDL,CDC26,Anaphase-promoting complex subunit CDC26,39911,0.0703864743685621,0.00722837682108411,0.0562188557992372,0.0845540929378869,2.55209915410455e-22
NMR metabolomics,X23424.Total Lipids in VLDL,GZMA,Granzyme A,42296,0.0339343163329838,0.00348946757333525,0.0270949598892467,0.0407736727767209,2.79077660540264e-22
NMR metabolomics,X23424.Total Lipids in VLDL,AK2,"Adenylate kinase 2, mitochondrial",39929,0.107101448269911,0.0110330797668179,0.0854766119269485,0.128726284612874,3.42459269385166e-22
NMR metabolomics,X23424.Total Lipids in VLDL,CTRB1,Chymotrypsinogen B,42137,0.058295351955444,0.00600854076360957,0.0465186120587692,0.0700720918521187,3.48867224660508e-22
NMR metabolomics,X23424.Total Lipids in VLDL,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,39934,0.0656730368972158,0.00676910631398985,0.0524055885217957,0.0789404852726359,3.60983304325551e-22
NMR metabolomics,X23424.Total Lipids in VLDL,CTSZ,Cathepsin Z,42168,0.0321674639220903,0.00331711928595597,0.0256659101216166,0.038669017722564,3.64959702016779e-22
NMR metabolomics,X23424.Total Lipids in VLDL,TCOF1,Treacle protein,39958,0.0323479628382659,0.00334239449269964,0.0257968696325746,0.0388990560439572,4.54636383981703e-22
NMR metabolomics,X23424.Total Lipids in VLDL,FEN1,Flap endonuclease 1,41843,0.0639921761583959,0.00661471995403801,0.0510273250484814,0.0769570272683104,4.59118190963932e-22
NMR metabolomics,X23424.Total Lipids in VLDL,CCDC134,Coiled-coil domain-containing protein 134,39919,0.0481029629681637,0.00498116212781348,0.0383398851976493,0.0578660407386781,5.58161436241224e-22
NMR metabolomics,X23424.Total Lipids in VLDL,LGALS3BP,Galectin-3-binding protein,39979,0.0310563785840651,0.00322000941823292,0.0247451601243286,0.0373675970438016,6.27228044440627e-22
NMR metabolomics,X23424.Total Lipids in VLDL,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,39930,0.0486739230993716,0.00504896691198853,0.0387779479518741,0.0585698982468691,6.55255204156172e-22
NMR metabolomics,X23424.Total Lipids in VLDL,EPPK1,Epiplakin,39638,0.0735786837615807,0.00763238116211311,0.058619216683839,0.0885381508393224,6.58864444548255e-22
NMR metabolomics,X23424.Total Lipids in VLDL,BTC,Probetacellulin,41843,0.0726799789795387,0.00754541109761573,0.0578909732282119,0.0874689847308655,6.8872825157295e-22
NMR metabolomics,X23424.Total Lipids in VLDL,NFASC,Neurofascin,42296,0.0288601867481455,0.00299796152664888,0.0229841821559137,0.0347361913403773,7.24058372924697e-22
NMR metabolomics,X23424.Total Lipids in VLDL,LAP3,Cytosol aminopeptidase,41913,0.0475434046326523,0.00493997650943296,0.0378610506741637,0.0572257585911409,7.443359069899e-22
NMR metabolomics,X23424.Total Lipids in VLDL,TBCA,Tubulin-specific chaperone A,39736,0.0833682114127395,0.00866154172459727,0.0663915896325289,0.10034483319295,7.61899773991768e-22
NMR metabolomics,X23424.Total Lipids in VLDL,RGS10,Regulator of G-protein signaling 10,39934,0.0589793292542534,0.00612855907369261,0.0469673534698159,0.0709913050386909,7.6974585285179e-22
NMR metabolomics,X23424.Total Lipids in VLDL,CPXM1,Probable carboxypeptidase X1,42181,0.0678737687546662,0.00707195723329702,0.0540127325774041,0.0817348049319284,9.59216104987199e-22
NMR metabolomics,X23424.Total Lipids in VLDL,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",42119,0.0815617808072059,0.00850560195563281,0.0648908009741656,0.0982327606402462,1.04088138882499e-21
NMR metabolomics,X23424.Total Lipids in VLDL,ZHX2,Zinc fingers and homeoboxes protein 2,39929,0.0333621536772897,0.00347992707175957,0.026541496616641,0.0401828107379385,1.09568494590217e-21
NMR metabolomics,X23424.Total Lipids in VLDL,ROBO2,Roundabout homolog 2,42249,0.0223054694899822,0.00232761933732353,0.0177433355888281,0.0268676033911363,1.1035259458597e-21
NMR metabolomics,X23424.Total Lipids in VLDL,PCDH7,Protocadherin-7,39930,0.0343879436777833,0.00359397477328222,0.0273437531221502,0.0414321342334165,1.3125090189803e-21
NMR metabolomics,X23424.Total Lipids in VLDL,FADD,FAS-associated death domain protein,42145,0.074839918503454,0.00784349413457297,0.059466669999691,0.090213167007217,1.64242677009682e-21
NMR metabolomics,X23424.Total Lipids in VLDL,TREM2,Triggering receptor expressed on myeloid cells 2,42123,0.0529991551088865,0.00555585206536693,0.0421096850607673,0.0638886251570057,1.67970363344416e-21
NMR metabolomics,X23424.Total Lipids in VLDL,BOLA2_BOLA2B,BolA-like protein 2,39638,0.0518234611753605,0.0054385287283823,0.0411639448677312,0.0624829774829898,1.92090956462478e-21
NMR metabolomics,X23424.Total Lipids in VLDL,SLIT2,Slit homolog 2 protein,41839,0.0505441264878436,0.00531175048990489,0.04013309552763,0.0609551574480572,2.11627020615288e-21
NMR metabolomics,X23424.Total Lipids in VLDL,PROK1,Prokineticin-1,42119,0.0486469796818552,0.00511439209309623,0.0386227711793866,0.0586711881843238,2.18633304232841e-21
NMR metabolomics,X23424.Total Lipids in VLDL,SLAMF6,SLAM family member 6,41843,0.0378113874993281,0.00397671765040601,0.0300170209045323,0.0456057540941239,2.26984104982489e-21
NMR metabolomics,X23424.Total Lipids in VLDL,STX16,Syntaxin-16,41843,0.0558101248358945,0.00587034334560538,0.0443042518785079,0.067315997793281,2.29289909842771e-21
NMR metabolomics,X23424.Total Lipids in VLDL,XCL1,Lymphotactin,42262,0.0532488600658734,0.00560897875997108,0.0422552616963301,0.0642424584354167,2.59876977292809e-21
NMR metabolomics,X23424.Total Lipids in VLDL,PALM2,Paralemmin-2,39929,0.0379144565002405,0.0039936603496151,0.0300868822149949,0.0457420307854861,2.67654761745714e-21
NMR metabolomics,X23424.Total Lipids in VLDL,PARD3,Partitioning defective 3 homolog,39757,0.072557121294194,0.00764334428455968,0.057576166496457,0.087538076091931,2.70483197965871e-21
NMR metabolomics,X23424.Total Lipids in VLDL,LBP,Lipopolysaccharide-binding protein,42217,-0.0571976726667386,0.00602935584132012,-0.069015210115726,-0.0453801352177511,2.77869990973997e-21
NMR metabolomics,X23424.Total Lipids in VLDL,ANXA2,Annexin A2,39492,0.068985891268868,0.00727091583970648,0.0547348962230433,0.0832368863146927,2.8473652875849e-21
NMR metabolomics,X23424.Total Lipids in VLDL,ABHD14B,Protein ABHD14B,41976,0.0543626485284421,0.00575282054124475,0.0430871202676023,0.0656381767892818,3.95316669622858e-21
NMR metabolomics,X23424.Total Lipids in VLDL,DNAJC21,DnaJ homolog subfamily C member 21,39929,0.038343508595778,0.00405991117597301,0.0303860826908709,0.0463009345006851,4.27238903221094e-21
NMR metabolomics,X23424.Total Lipids in VLDL,FGF2,Fibroblast growth factor 2,42119,0.0671013070083549,0.00710799300253016,0.0531696407233958,0.0810329732933141,4.31813661060413e-21
NMR metabolomics,X23424.Total Lipids in VLDL,RARRES1,Retinoic acid receptor responder protein 1,41843,0.0306933976025591,0.00325225636179761,0.0243189751334358,0.0370678200716825,4.44344039185623e-21
NMR metabolomics,X23424.Total Lipids in VLDL,MMP3,Stromelysin-1,42137,-0.0482012240149399,0.00511294947557216,-0.0582226049870613,-0.0381798430428184,4.88216189997987e-21
NMR metabolomics,X23424.Total Lipids in VLDL,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,41843,0.0421270725377276,0.00447312404610245,0.0333597494073668,0.0508943956680884,5.35714945320077e-21
NMR metabolomics,X23424.Total Lipids in VLDL,PSMG3,Proteasome assembly chaperone 3,42119,0.0478691964878648,0.00508374469317462,0.0379050568892425,0.057833336086487,5.4267646972295e-21
NMR metabolomics,X23424.Total Lipids in VLDL,SCARF1,Scavenger receptor class F member 1,42310,0.0409360255661025,0.00437101453424446,0.0323688370789833,0.0495032140532216,8.74491147017423e-21
NMR metabolomics,X23424.Total Lipids in VLDL,LRRC37A2,Leucine-rich repeat-containing protein 37A2,39930,0.0421234105839697,0.00450890551930604,0.0332859557661298,0.0509608654018095,1.11879773723828e-20
NMR metabolomics,X23424.Total Lipids in VLDL,TIMP1,Metalloproteinase inhibitor 1,42032,0.0276250702751359,0.00296165835181624,0.021820219905576,0.0334299206446957,1.25042618562293e-20
NMR metabolomics,X23424.Total Lipids in VLDL,NGRN,Neugrin,39929,0.0214998623614774,0.00231015303157995,0.0169719624195807,0.0260277623033741,1.56091261462365e-20
NMR metabolomics,X23424.Total Lipids in VLDL,CCL19,C-C motif chemokine 19,42249,0.108023931643227,0.0116138904252289,0.0852607064097788,0.130787156876676,1.59577753301134e-20
NMR metabolomics,X23424.Total Lipids in VLDL,AMOTL2,Angiomotin-like protein 2,39882,0.0467630890611304,0.00503073433713316,0.0369028497603494,0.0566233283619113,1.73420536767618e-20
NMR metabolomics,X23424.Total Lipids in VLDL,DSC2,Desmocollin-2,41984,-0.0336326153658881,0.00362034731448513,-0.0407284961022789,-0.0265367346294972,1.77969750676156e-20
NMR metabolomics,X23424.Total Lipids in VLDL,MCEMP1,Mast cell-expressed membrane protein 1,39657,0.0849031191751714,0.00913633103746605,0.0669959103417379,0.102810328008605,1.78230524054833e-20
NMR metabolomics,X23424.Total Lipids in VLDL,FRZB,Secreted frizzled-related protein 3,41973,0.0235732786603229,0.00254127258695222,0.0185923843898965,0.0285541729307492,2.02283915997814e-20
NMR metabolomics,X23424.Total Lipids in VLDL,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,39641,0.034580044200542,0.00373068568706703,0.0272679002538906,0.0418921881471934,2.22569158062533e-20
NMR metabolomics,X23424.Total Lipids in VLDL,ASS1,Argininosuccinate synthase,39575,0.0737050831687435,0.00796969846769536,0.0580844741720606,0.0893256921654264,2.7060077813677e-20
NMR metabolomics,X23424.Total Lipids in VLDL,INSL3,Insulin-like 3,39929,0.0857832608962516,0.00927836402045543,0.067597667416159,0.103968854376344,2.75877831762766e-20
NMR metabolomics,X23424.Total Lipids in VLDL,C5,Complement C5,39979,0.014309921990687,0.00154994327676763,0.0112720331682224,0.0173478108131515,3.10922017821056e-20
NMR metabolomics,X23424.Total Lipids in VLDL,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",42070,0.032687476182596,0.00354184478628802,0.0257454604014715,0.0396294919637205,3.13518501305549e-20
NMR metabolomics,X23424.Total Lipids in VLDL,BST2,Bone marrow stromal antigen 2,42249,0.0484025371459467,0.00524501701160084,0.038122303803209,0.0586827704886843,3.1485304495233e-20
NMR metabolomics,X23424.Total Lipids in VLDL,ITGB6,Integrin beta-6,41913,0.0290921862215797,0.00316268265472258,0.0228933282183235,0.035291044224836,4.1598340700497e-20
NMR metabolomics,X23424.Total Lipids in VLDL,TF,Serotransferrin,39979,0.0203207500466261,0.00221096904556417,0.0159872507173203,0.0246542493759319,4.57101887932265e-20
NMR metabolomics,X23424.Total Lipids in VLDL,MSR1,Macrophage scavenger receptor types I and II,42249,0.0446795909420119,0.00486442718600116,0.0351453136574497,0.0542138682265742,4.70170947043511e-20
NMR metabolomics,X23424.Total Lipids in VLDL,ARSA,Arylsulfatase A,42137,0.0425977096084748,0.00464264381108229,0.0334981277387535,0.0516972914781961,5.145369470959e-20
NMR metabolomics,X23424.Total Lipids in VLDL,SPAG1,Sperm-associated antigen 1,39934,0.0552111648384608,0.00601762476722877,0.0434166202946924,0.0670057093822292,5.29953230439502e-20
NMR metabolomics,X23424.Total Lipids in VLDL,PTX3,Pentraxin-related protein PTX3,42119,-0.0469267276855394,0.00511625113132576,-0.0569545799029379,-0.0368988754681409,5.30143182079294e-20
NMR metabolomics,X23424.Total Lipids in VLDL,LONP1,"Lon protease homolog, mitochondrial",39638,0.0829811540072719,0.00904970590257765,0.0652437304382197,0.100718577576324,5.59464663809387e-20
NMR metabolomics,X23424.Total Lipids in VLDL,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",39930,0.0982183377753058,0.0107176141340635,0.0772118140725414,0.11922486147807,5.84921527424352e-20
NMR metabolomics,X23424.Total Lipids in VLDL,DNM1,Dynamin-1,39930,0.109047896187191,0.0119216445557332,0.0856814728579537,0.132414319516428,6.84801272298975e-20
NMR metabolomics,X23424.Total Lipids in VLDL,PSG1,Pregnancy-specific beta-1-glycoprotein 1,42016,-0.106041597994573,0.0115990471377205,-0.128775730384505,-0.0833074656046404,6.98363926498002e-20
NMR metabolomics,X23424.Total Lipids in VLDL,ITPA,Inosine triphosphate pyrophosphatase,39575,0.0632315614670466,0.00692906754138381,0.0496505890859344,0.0768125338481589,8.38340741178095e-20
NMR metabolomics,X23424.Total Lipids in VLDL,SNX9,Sorting nexin-9,42145,0.0637284782986363,0.00698784793406454,0.0500322963478698,0.0774246602494028,8.56496638653548e-20
NMR metabolomics,X23424.Total Lipids in VLDL,ENTR1,Endosome-associated-trafficking regulator 1,39638,0.0581902535764631,0.00637971940618748,0.0456860035403357,0.0706945036125906,8.72193188933384e-20
NMR metabolomics,X23424.Total Lipids in VLDL,IFNAR1,Interferon alpha/beta receptor 1,39930,0.0231142074417478,0.0025345906164969,0.0181464098334139,0.0280820050500818,8.81672603666335e-20
NMR metabolomics,X23424.Total Lipids in VLDL,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,39757,0.0818177171880285,0.00897413861236381,0.0642284055077954,0.0994070288682616,9.03826774168183e-20
NMR metabolomics,X23424.Total Lipids in VLDL,VGF,Neurosecretory protein VGF,39934,0.0283153219470198,0.00310812276430022,0.0222234013289914,0.0344072425650483,9.60846499893545e-20
NMR metabolomics,X23424.Total Lipids in VLDL,DHPS,Deoxyhypusine synthase,39919,0.0378038575771152,0.00415029250314558,0.0296692842709498,0.0459384308832805,9.73279462074659e-20
NMR metabolomics,X23424.Total Lipids in VLDL,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",41913,0.0675778597280447,0.00742734180540667,0.0530202697894477,0.0821354496666418,1.04408001614174e-19
NMR metabolomics,X23424.Total Lipids in VLDL,MAGED1,Melanoma-associated antigen D1,41843,0.0451475478118007,0.00496494709710973,0.0354162515014656,0.0548788441221358,1.09636504634605e-19
NMR metabolomics,X23424.Total Lipids in VLDL,ADM,Pro-adrenomedullin,42262,0.0243189166807739,0.00269153675223979,0.0190435046463839,0.0295943287151639,1.851782083484e-19
NMR metabolomics,X23424.Total Lipids in VLDL,FCN1,Ficolin-1,39978,0.0518919677830237,0.00574330296490635,0.0406350939718073,0.0631488415942402,1.90036742613234e-19
NMR metabolomics,X23424.Total Lipids in VLDL,CDCP1,CUB domain-containing protein 1,42016,0.0519037594298984,0.00576365440106778,0.0406069968038055,0.0632005220559912,2.43603717493239e-19
NMR metabolomics,X23424.Total Lipids in VLDL,LAMA4,Laminin subunit alpha-4,42185,0.0316260829107327,0.00351937066015763,0.0247281164168237,0.0385240494046416,2.89037143606848e-19
NMR metabolomics,X23424.Total Lipids in VLDL,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,39657,0.0337867516777716,0.00375903883364842,0.0264190355638207,0.0411544677917225,2.92290784397095e-19
NMR metabolomics,X23424.Total Lipids in VLDL,SLITRK2,SLIT and NTRK-like protein 2,42262,0.0374762304293172,0.00417210349239186,0.0292989075842291,0.0456535532744052,2.98702575849272e-19
NMR metabolomics,X23424.Total Lipids in VLDL,CTSS,Cathepsin S,39358,0.0224281026091738,0.00249790892598435,0.0175322011142445,0.0273240041041031,3.19450459730852e-19
NMR metabolomics,X23424.Total Lipids in VLDL,VIT,Vitrin,39958,0.0355456363040507,0.00396088920261136,0.0277822934669325,0.043308979141169,3.30287024723481e-19
NMR metabolomics,X23424.Total Lipids in VLDL,ENO2,Gamma-enolase,42249,0.060067811182679,0.00669770708335984,0.0469403052992937,0.0731953170660642,3.39490266701038e-19
NMR metabolomics,X23424.Total Lipids in VLDL,B4GAT1,"Beta-1,4-glucuronyltransferase 1",42137,0.0222108360409831,0.00247875409234232,0.0173524780199921,0.027069194061974,3.65027299716631e-19
NMR metabolomics,X23424.Total Lipids in VLDL,PTGR1,Prostaglandin reductase 1,39958,0.0772521803894133,0.00861978849703466,0.0603573949352253,0.0941469658436012,3.6790077293636e-19
NMR metabolomics,X23424.Total Lipids in VLDL,MTIF3,"Translation initiation factor IF-3, mitochondrial",39930,0.0816034199548995,0.00910826071988939,0.0637512289439163,0.0994556109658827,3.77817911824411e-19
NMR metabolomics,X23424.Total Lipids in VLDL,BPIFA2,BPI fold-containing family A member 2,39281,-0.102467371488251,0.0114383654847259,-0.124886567838314,-0.0800481751381887,3.84791001579719e-19
NMR metabolomics,X23424.Total Lipids in VLDL,SERPINA9,Serpin A9,42025,0.0665505626952977,0.00743850817835978,0.0519710866657125,0.0811300387248828,4.13476216482452e-19
NMR metabolomics,X23424.Total Lipids in VLDL,PPM1F,Protein phosphatase 1F,39958,0.0491608949477833,0.00549770793804977,0.0383853873892057,0.0599364025063608,4.40907765529388e-19
NMR metabolomics,X23424.Total Lipids in VLDL,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,42016,0.0335575117578468,0.00376799965226336,0.0261722324394106,0.040942791076283,5.96762669608895e-19
NMR metabolomics,X23424.Total Lipids in VLDL,CORO1A,Coronin-1A,41883,0.0811698224952429,0.00913141977852223,0.0632722397293393,0.0990674052611465,6.94791677969894e-19
NMR metabolomics,X23424.Total Lipids in VLDL,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,39929,0.0437884492958118,0.00492582458113691,0.0341338331167834,0.0534430654748401,7.06103276543138e-19
NMR metabolomics,X23424.Total Lipids in VLDL,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,39640,0.0245622432565327,0.00276638358360626,0.0191401314326644,0.0299843550804009,7.80029948191391e-19
NMR metabolomics,X23424.Total Lipids in VLDL,GRPEL1,"GrpE protein homolog 1, mitochondrial",42070,0.0558252980584348,0.00629113687074696,0.0434946697917708,0.0681559263250989,7.96201804118035e-19
NMR metabolomics,X23424.Total Lipids in VLDL,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",41900,0.081225426326321,0.00915455122768927,0.0632825059200501,0.099168346732592,8.04258051785875e-19
NMR metabolomics,X23424.Total Lipids in VLDL,HRG,Histidine-rich glycoprotein,39925,0.0284875865900456,0.00321049783626518,0.0221950108309658,0.0347801623491253,8.16811426597151e-19
NMR metabolomics,X23424.Total Lipids in VLDL,IGF1R,Insulin-like growth factor 1 receptor,42070,0.0195349019498957,0.00220577869070734,0.0152115757161093,0.0238582281836821,9.29964851659368e-19
NMR metabolomics,X23424.Total Lipids in VLDL,PER3,Period circadian protein homolog 3,39657,0.112140479204036,0.0126726536413372,0.0873020780670155,0.136978880341057,1.01717131276183e-18
NMR metabolomics,X23424.Total Lipids in VLDL,TEK,Angiopoietin-1 receptor,42181,0.0200945286400847,0.00227742158157561,0.0156307823401965,0.0245582749399729,1.24477580280441e-18
NMR metabolomics,X23424.Total Lipids in VLDL,TPMT,Thiopurine S-methyltransferase,41843,0.0648131891855157,0.00736205670879841,0.0503835580362708,0.0792428203347606,1.48665900848756e-18
NMR metabolomics,X23424.Total Lipids in VLDL,ITGAL,Integrin alpha-L,39657,0.039687337286793,0.0045080017405322,0.0308516538753499,0.0485230206982361,1.51994725878861e-18
NMR metabolomics,X23424.Total Lipids in VLDL,C7orf50,Uncharacterized protein C7orf50,39929,0.0206240801891811,0.00234998317506885,0.0160181131660462,0.0252300472123161,1.93162566593508e-18
NMR metabolomics,X23424.Total Lipids in VLDL,TMSB10,Thymosin beta-10,42137,0.0685970032683433,0.0078221601258719,0.0532655694216344,0.0839284371150522,2.00526066790305e-18
NMR metabolomics,X23424.Total Lipids in VLDL,DSCAM,Down syndrome cell adhesion molecule,39934,0.0328198447056606,0.00374192845019535,0.0254856649432777,0.0401540244680434,2.02632314980251e-18
NMR metabolomics,X23424.Total Lipids in VLDL,CD274,Programmed cell death 1 ligand 1,42016,0.030440705223113,0.00347411897369016,0.0236314320346803,0.0372499784115457,2.14344285490395e-18
NMR metabolomics,X23424.Total Lipids in VLDL,TSHB,Thyrotropin subunit beta,42145,0.0612704902197201,0.00700359248692888,0.0475434489453395,0.0749975314941007,2.41604521924206e-18
NMR metabolomics,X23424.Total Lipids in VLDL,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,39657,0.0401793620047538,0.00459393348396482,0.0311752523761828,0.0491834716333249,2.52630755713642e-18
NMR metabolomics,X23424.Total Lipids in VLDL,SNRPB2,U2 small nuclear ribonucleoprotein B'',39929,0.03993571839241,0.00456918592917016,0.0309801139712364,0.0488913228135835,2.65350565283337e-18
NMR metabolomics,X23424.Total Lipids in VLDL,SDK2,Protein sidekick-2,39736,0.0353517157987539,0.00405822930554316,0.0273975863598893,0.0433058452376185,3.43371385592565e-18
NMR metabolomics,X23424.Total Lipids in VLDL,CFHR4,Complement factor H-related protein 4,39945,0.0656177712923442,0.00754548160608757,0.0508286273444126,0.0804069152402759,3.90004810760249e-18
NMR metabolomics,X23424.Total Lipids in VLDL,SCRN1,Secernin-1,42119,0.0495146406097696,0.00569718102294651,0.0383481658047944,0.0606811154147447,3.99918711294749e-18
NMR metabolomics,X23424.Total Lipids in VLDL,PNLIPRP1,Inactive pancreatic lipase-related protein 1,39929,0.0748468587462505,0.00861087728508733,0.0579695392674794,0.0917241782250217,4.04570056191474e-18
NMR metabolomics,X23424.Total Lipids in VLDL,COX6B1,Cytochrome c oxidase subunit 6B1,39958,0.0290055552858886,0.00333767819150461,0.0224637060305395,0.0355474045412376,4.10819307075442e-18
NMR metabolomics,X23424.Total Lipids in VLDL,IL17D,Interleukin-17D,41913,0.0304972287774911,0.00351022180085837,0.0236171940478087,0.0373772635071736,4.11087371831303e-18
NMR metabolomics,X23424.Total Lipids in VLDL,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,39575,0.0359694267315937,0.00414145273814659,0.0278521793648263,0.044086674098361,4.31536988830714e-18
NMR metabolomics,X23424.Total Lipids in VLDL,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",39736,0.0798408146520784,0.00920446877236934,0.0618000558582345,0.0978815734459223,4.74489338714054e-18
NMR metabolomics,X23424.Total Lipids in VLDL,ENAH,Protein enabled homolog,41913,0.042967360050158,0.00496168532994957,0.0332424568034568,0.0526922632968591,5.26347439036159e-18
NMR metabolomics,X23424.Total Lipids in VLDL,GLO1,Lactoylglutathione lyase,41900,0.0502700488726991,0.00581427409291898,0.0388740716505779,0.0616660260948203,5.93999232146972e-18
NMR metabolomics,X23424.Total Lipids in VLDL,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,42310,0.0207472475942067,0.00240330887891549,0.0160367621915323,0.025457732996881,6.64123735396673e-18
NMR metabolomics,X23424.Total Lipids in VLDL,CHGA,Chromogranin-A,39966,-0.0755967101441996,0.0087635877348889,-0.0927733421045819,-0.0584200781838174,7.18154563172244e-18
NMR metabolomics,X23424.Total Lipids in VLDL,PTN,Pleiotrophin,41900,0.0441789768948203,0.00512555069874208,0.0341328975252858,0.0542250562643548,7.48669636748433e-18
NMR metabolomics,X23424.Total Lipids in VLDL,CYB5R2,NADH-cytochrome b5 reductase 2,39803,0.04976570915813,0.00578288483324691,0.038431254884966,0.0611001634312939,8.59712135820958e-18
NMR metabolomics,X23424.Total Lipids in VLDL,AGXT,Serine--pyruvate aminotransferase,42145,0.0678972159945255,0.00789481712087535,0.0524233744376098,0.0833710575514411,8.82178553235562e-18
NMR metabolomics,X23424.Total Lipids in VLDL,ANGPTL1,Angiopoietin-related protein 1,41920,0.0254138790502303,0.0029566977030029,0.0196187515523446,0.031209006548116,9.21772848775445e-18
NMR metabolomics,X23424.Total Lipids in VLDL,ERI1,3'-5' exoribonuclease 1,39757,0.0304162401074189,0.00354119678778818,0.0234754944033541,0.0373569858114838,9.91608993008451e-18
NMR metabolomics,X23424.Total Lipids in VLDL,CXCL11,C-X-C motif chemokine 11,42249,0.0688454423181728,0.00803301003969484,0.053100742640371,0.0845901419959747,1.14183206157719e-17
NMR metabolomics,X23424.Total Lipids in VLDL,DARS1,"Aspartate--tRNA ligase, cytoplasmic",41997,0.0636371052020237,0.00742843158431043,0.0490773792967753,0.0781968311072721,1.18034613956131e-17
NMR metabolomics,X23424.Total Lipids in VLDL,ASAH1,Acid ceramidase,39876,0.0416025697893566,0.00487315125293388,0.0320511933336062,0.051153946245107,1.5525485082504e-17
NMR metabolomics,X23424.Total Lipids in VLDL,ACRBP,Acrosin-binding protein,39919,0.0350389262998579,0.00411381679331608,0.0269758453849584,0.0431020072147575,1.83818242596344e-17
NMR metabolomics,X23424.Total Lipids in VLDL,DPT,Dermatopontin,42310,0.0222317936572582,0.00261410993084148,0.0171081381928089,0.0273554491217075,2.01028540661608e-17
NMR metabolomics,X23424.Total Lipids in VLDL,ECE1,Endothelin-converting enzyme 1,41839,0.0309107122307822,0.00363594518460061,0.023784259668965,0.0380371647925994,2.07179438811707e-17
NMR metabolomics,X23424.Total Lipids in VLDL,MYOM3,Myomesin-3,39736,-0.0850252989543243,0.010005480431064,-0.10463604059921,-0.0654145573094388,2.17667965249758e-17
NMR metabolomics,X23424.Total Lipids in VLDL,NID2,Nidogen-2,42137,0.0637240807116862,0.00750599516604941,0.0490123301862293,0.078435831237143,2.28443197733147e-17
NMR metabolomics,X23424.Total Lipids in VLDL,REN,Renin,42145,-0.0708332883997353,0.00835004181122521,-0.0871993703497367,-0.0544672064497339,2.42055214804057e-17
NMR metabolomics,X23424.Total Lipids in VLDL,SPP1,Osteopontin,42286,-0.0383829116353962,0.00452895643670408,-0.0472596662513362,-0.0295061570194562,2.58894962640028e-17
NMR metabolomics,X23424.Total Lipids in VLDL,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",39966,0.0549923243393154,0.00649571699351994,0.0422607190320164,0.0677239296466145,2.85254235707477e-17
NMR metabolomics,X23424.Total Lipids in VLDL,IMPA1,Inositol monophosphatase 1,42016,0.0532548385008912,0.00629420503081742,0.040918196640489,0.0655914803612933,2.92503029786797e-17
NMR metabolomics,X23424.Total Lipids in VLDL,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,39929,0.0757973996327132,0.00895722199027165,0.0582412445317808,0.0933535547336456,2.94709985995039e-17
NMR metabolomics,X23424.Total Lipids in VLDL,PTPRC,Receptor-type tyrosine-protein phosphatase C,39966,0.0202382531436694,0.00239203950799542,0.0155498557079984,0.0249266505793404,2.98355262605886e-17
NMR metabolomics,X23424.Total Lipids in VLDL,ABCA2,ATP-binding cassette sub-family A member 2,39575,0.0313744679125352,0.00371111908129944,0.0241006745131883,0.0386482613118821,3.16600590184563e-17
NMR metabolomics,X23424.Total Lipids in VLDL,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",42070,0.0601929962874031,0.00712462601022929,0.0462287293073537,0.0741572632674525,3.24845610038602e-17
NMR metabolomics,X23424.Total Lipids in VLDL,DGKZ,Diacylglycerol kinase zeta,41913,0.0313710561081623,0.003719190451046,0.0240814428241121,0.0386606693922124,3.65338495491059e-17
NMR metabolomics,X23424.Total Lipids in VLDL,ITGA6,Integrin alpha-6,42119,0.044085687896437,0.00524218101193912,0.0338110131130363,0.0543603626798376,4.51541968739928e-17
NMR metabolomics,X23424.Total Lipids in VLDL,PTPRR,Receptor-type tyrosine-protein phosphatase R,39929,0.0327696179202548,0.00389784176889931,0.0251298480532121,0.0404093877872974,4.70416554449873e-17
NMR metabolomics,X23424.Total Lipids in VLDL,SLC27A4,Long-chain fatty acid transport protein 4,41839,0.0590176511127659,0.00702555290214819,0.0452475674245555,0.0727877348009764,4.89845671174453e-17
NMR metabolomics,X23424.Total Lipids in VLDL,XRCC4,DNA repair protein XRCC4,41839,0.0318876380075202,0.00379809623701923,0.0244433693829625,0.0393319066320779,5.09901122648093e-17
NMR metabolomics,X23424.Total Lipids in VLDL,OCLN,Occludin,39934,0.0382598817862683,0.00456019386745107,0.0293219018060642,0.0471978617664724,5.43859570048377e-17
NMR metabolomics,X23424.Total Lipids in VLDL,DNER,Delta and Notch-like epidermal growth factor-related receptor,42089,0.0224253071689681,0.00267469362944558,0.0171829076552548,0.0276677066826815,5.60719486533742e-17
NMR metabolomics,X23424.Total Lipids in VLDL,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,39736,0.0605705567832749,0.00722602431109496,0.0464075491335288,0.0747335644330211,5.81512279971351e-17
NMR metabolomics,X23424.Total Lipids in VLDL,CCN5,CCN family member 5,42137,0.0327510628882067,0.00390865434336181,0.0250901003752176,0.0404120254011959,5.85417582216804e-17
NMR metabolomics,X23424.Total Lipids in VLDL,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,39934,0.0568262287222229,0.00678070928478306,0.0435360385240481,0.0701164189203977,5.88791051514351e-17
NMR metabolomics,X23424.Total Lipids in VLDL,TNF,Tumor necrosis factor,41880,0.0313522413473457,0.00374440952531419,0.0240131986777299,0.0386912840169615,6.1714334741458e-17
NMR metabolomics,X23424.Total Lipids in VLDL,ICAM1,Intercellular adhesion molecule 1,42126,0.0250843292592728,0.00299676986332525,0.0192106603271553,0.0309579981913903,6.29889994964312e-17
NMR metabolomics,X23424.Total Lipids in VLDL,GLRX,Glutaredoxin-1,42057,0.0478352548028365,0.00571483597972186,0.0366341762825816,0.0590363333230913,6.30679592424442e-17
NMR metabolomics,X23424.Total Lipids in VLDL,IL12A_IL12B,Interleukin-12,42070,0.0661932033996303,0.0079236327295282,0.050662883249755,0.0817235235495056,7.24591168573768e-17
NMR metabolomics,X23424.Total Lipids in VLDL,LGMN,Legumain,42185,0.0311794148084717,0.003737734598153,0.0238534549960918,0.0385053746208516,8.01698665813924e-17
NMR metabolomics,X23424.Total Lipids in VLDL,CD84,SLAM family member 5,42119,0.0273615842379734,0.00328038420098705,0.0209320312040388,0.033791137271908,8.07644707134316e-17
NMR metabolomics,X23424.Total Lipids in VLDL,STK4,Serine/threonine-protein kinase 4,42145,0.0748089906579612,0.00899141221158774,0.0571858227232493,0.0924321585926732,9.62723601105483e-17
NMR metabolomics,X23424.Total Lipids in VLDL,REG3A,Regenerating islet-derived protein 3-alpha,42310,-0.0540811144384827,0.0065159132330913,-0.0668523043753416,-0.0413099245016237,1.13913894363566e-16
NMR metabolomics,X23424.Total Lipids in VLDL,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,42016,0.0621442000046488,0.00748867314065926,0.0474664006489566,0.0768219993603409,1.15505685817754e-16
NMR metabolomics,X23424.Total Lipids in VLDL,NADK,NAD kinase,42145,0.0466663197181123,0.00562397665058524,0.0356433254829653,0.0576893139532594,1.16067070716201e-16
NMR metabolomics,X23424.Total Lipids in VLDL,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,39934,0.0508099647537978,0.00612292982235745,0.0388090223019772,0.0628109072056184,1.17551344611646e-16
NMR metabolomics,X23424.Total Lipids in VLDL,COL15A1,Collagen alpha-1(XV) chain,39966,0.023061045708922,0.00278463114006484,0.0176031686743949,0.028518922743449,1.35189231881994e-16
NMR metabolomics,X23424.Total Lipids in VLDL,PPL,Periplakin,39657,0.027581857469963,0.00333052594038207,0.0210540266268142,0.0341096883131119,1.35602422902752e-16
NMR metabolomics,X23424.Total Lipids in VLDL,IL6R,Interleukin-6 receptor subunit alpha,42114,0.0290453171813713,0.0035128101186532,0.022160209348811,0.0359304250139316,1.48359579946927e-16
NMR metabolomics,X23424.Total Lipids in VLDL,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,39410,0.0422698952267011,0.00511522098920979,0.0322440620878499,0.0522957283655523,1.57923696125475e-16
NMR metabolomics,X23424.Total Lipids in VLDL,PDZD2,PDZ domain-containing protein 2,39575,0.0502057531236345,0.00607579790004726,0.0382971892395419,0.0621143170077271,1.58078010700038e-16
NMR metabolomics,X23424.Total Lipids in VLDL,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,41843,0.0399164370542476,0.0048415656732248,0.030426968334727,0.0494059057737682,1.8132774152334e-16
NMR metabolomics,X23424.Total Lipids in VLDL,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",39934,0.0785864109642156,0.00954722511134948,0.0598738497459706,0.0972989721824605,2.05391916025612e-16
NMR metabolomics,X23424.Total Lipids in VLDL,LPA,Apolipoprotein(a),39775,-0.155117384207421,0.0188468934572732,-0.192057295383677,-0.118177473031166,2.07305068513383e-16
NMR metabolomics,X23424.Total Lipids in VLDL,DENR,Density-regulated protein,39657,0.0487863950642398,0.00593231387689089,0.0371590598655337,0.060413730262946,2.19135585568761e-16
NMR metabolomics,X23424.Total Lipids in VLDL,DTNB,Dystrobrevin beta,39900,0.0384073758753724,0.0046856203357473,0.0292235600173077,0.0475911917334371,2.7335908793935e-16
NMR metabolomics,X23424.Total Lipids in VLDL,MENT,Protein MENT,39736,-0.0200856323743903,0.00245307561033542,-0.0248936605706478,-0.0152776041781329,2.94710795270462e-16
NMR metabolomics,X23424.Total Lipids in VLDL,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,42162,0.041861878625338,0.00511884253279633,0.0318289472610572,0.0518948099896187,3.14087309760302e-16
NMR metabolomics,X23424.Total Lipids in VLDL,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,42262,0.0222895413268749,0.00273116259386863,0.0169364626428923,0.0276426200108574,3.60563576621901e-16
NMR metabolomics,X23424.Total Lipids in VLDL,LGALS7_LGALS7B,Galectin-7,42076,0.0369511623933893,0.00452974193047043,0.0280728682096673,0.0458294565771113,3.7226376390141e-16
NMR metabolomics,X23424.Total Lipids in VLDL,FXN,"Frataxin, mitochondrial",42262,0.0609812654152993,0.00748062652413352,0.0463192374279976,0.075643293402601,3.89260891729758e-16
NMR metabolomics,X23424.Total Lipids in VLDL,CLU,Clusterin,39979,0.0253263750785536,0.00310723572086004,0.0192361930656679,0.0314165570914393,3.99427328039604e-16
NMR metabolomics,X23424.Total Lipids in VLDL,DCTN2,Dynactin subunit 2,42070,0.0795291503966854,0.00976712534068861,0.0603855847289358,0.0986727160644351,4.2090754576472e-16
NMR metabolomics,X23424.Total Lipids in VLDL,LACRT,Extracellular glycoprotein lacritin,39895,0.0380903490359076,0.00468832244111647,0.0289012370513193,0.0472794610204959,4.95872520592893e-16
NMR metabolomics,X23424.Total Lipids in VLDL,RPL14,60S ribosomal protein L14,39638,0.0327264092555632,0.0040301368790984,0.0248273409725303,0.040625477538596,5.13967226734561e-16
NMR metabolomics,X23424.Total Lipids in VLDL,FLT3LG,Fms-related tyrosine kinase 3 ligand,42296,0.0293889325277083,0.00362145082603084,0.0222908889086878,0.0364869761467287,5.25899380620753e-16
NMR metabolomics,X23424.Total Lipids in VLDL,SAA4,Serum amyloid A-4 protein,39979,0.0276044649448523,0.00340156111993267,0.0209374051497842,0.0342715247399203,5.34657220232174e-16
NMR metabolomics,X23424.Total Lipids in VLDL,KLK6,Kallikrein-6,42158,0.025770470124516,0.00317987441614425,0.0195379162688732,0.0320030239801587,5.75930970063456e-16
NMR metabolomics,X23424.Total Lipids in VLDL,NEK7,Serine/threonine-protein kinase Nek7,39757,0.0619883795556956,0.00765221625396102,0.0469900356979319,0.0769867234134592,6.03273831548594e-16
NMR metabolomics,X23424.Total Lipids in VLDL,ADAMTSL4,ADAMTS-like protein 4,39638,0.0206507639489114,0.00254986640343668,0.0156530257981755,0.0256485020996473,6.13596403059149e-16
NMR metabolomics,X23424.Total Lipids in VLDL,MANSC1,MANSC domain-containing protein 1,42181,-0.02304063410414,0.00286041617753236,-0.0286470498121035,-0.0174342183961766,8.60696949528807e-16
NMR metabolomics,X23424.Total Lipids in VLDL,LAG3,Lymphocyte activation gene 3 protein,42070,-0.033673208678158,0.00418415243272553,-0.0418741474463001,-0.025472269910016,9.13174675339227e-16
NMR metabolomics,X23424.Total Lipids in VLDL,CTSE,Cathepsin E,39736,0.0439836312751974,0.00547578485967262,0.033251092950239,0.0547161696001557,1.05220917613531e-15
NMR metabolomics,X23424.Total Lipids in VLDL,ARAF,Serine/threonine-protein kinase A-Raf,39757,0.0565565660122095,0.00705884372246404,0.0427212323161799,0.070391899708239,1.2392620808668e-15
NMR metabolomics,X23424.Total Lipids in VLDL,CLEC5A,C-type lectin domain family 5 member A,42107,-0.0250308918478891,0.00313117776439062,-0.0311680002660947,-0.0188937834296835,1.41089718090337e-15
NMR metabolomics,X23424.Total Lipids in VLDL,SF3B4,Splicing factor 3B subunit 4,42070,0.0595510175912489,0.0074557596556335,0.0449377286662073,0.0741643065162906,1.49122512474769e-15
NMR metabolomics,X23424.Total Lipids in VLDL,DAPK2,Death-associated protein kinase 2,39657,0.0454785801355544,0.00571427229814672,0.0342786064311868,0.0566785538399219,1.90731914769753e-15
NMR metabolomics,X23424.Total Lipids in VLDL,TREML2,Trem-like transcript 2 protein,42137,0.0282117509111634,0.00354979323577461,0.0212541561690452,0.0351693456532816,2.05398811793335e-15
NMR metabolomics,X23424.Total Lipids in VLDL,SMARCA2,Probable global transcription activator SNF2L2,41839,0.0601641512626567,0.0075757670561303,0.0453156478326413,0.0750126546926721,2.15515573940969e-15
NMR metabolomics,X23424.Total Lipids in VLDL,NAP1L4,Nucleosome assembly protein 1-like 4,39911,0.0329634366771903,0.00415227145956701,0.024824984616439,0.0411018887379416,2.23688479125061e-15
NMR metabolomics,X23424.Total Lipids in VLDL,CLC,Galectin-10,42119,-0.0548042738592094,0.0069093501968687,-0.068346600245072,-0.0412619474733467,2.32691873172074e-15
NMR metabolomics,X23424.Total Lipids in VLDL,IMMT,MICOS complex subunit MIC60,39919,0.0364634138568166,0.00459645795583789,0.0274543562633743,0.0454724714502588,2.34154414506928e-15
NMR metabolomics,X23424.Total Lipids in VLDL,POSTN,Periostin,39966,-0.0309185192150461,0.00390273822115386,-0.0385678861285077,-0.0232691523015846,2.5494977938643e-15
NMR metabolomics,X23424.Total Lipids in VLDL,C7,Complement component C7,39722,-0.0271583129821188,0.00344447646875872,-0.0339094868608859,-0.0204071391033517,3.45029645947348e-15
NMR metabolomics,X23424.Total Lipids in VLDL,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",41913,0.0501016658546356,0.00635620998041274,0.0376434942930267,0.0625598374162446,3.4624654712359e-15
NMR metabolomics,X23424.Total Lipids in VLDL,THBS4,Thrombospondin-4,42189,0.0368036395616179,0.00467968456635116,0.0276314578115697,0.0459758213116662,3.98230884304562e-15
NMR metabolomics,X23424.Total Lipids in VLDL,FOLR2,Folate receptor beta,42249,-0.0235228650157792,0.0029910332337399,-0.0293852901539094,-0.0176604398776491,3.98403305676477e-15
NMR metabolomics,X23424.Total Lipids in VLDL,CTSL,Cathepsin L1,42145,0.0197998708592905,0.00251843887216505,0.014863730669847,0.024736011048734,4.06622859246532e-15
NMR metabolomics,X23424.Total Lipids in VLDL,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,42145,0.0398387400584944,0.00507777181532321,0.0298863073004609,0.0497911728165278,4.6262780445401e-15
NMR metabolomics,X23424.Total Lipids in VLDL,RELT,Tumor necrosis factor receptor superfamily member 19L,42137,0.024380780067426,0.0031079810530199,0.018289137203507,0.030472422931345,4.66855020659664e-15
NMR metabolomics,X23424.Total Lipids in VLDL,CSNK1D,Casein kinase I isoform delta,39657,0.0520087166070125,0.00663978747858429,0.0389947331489872,0.0650227000650377,5.2040811427107e-15
NMR metabolomics,X23424.Total Lipids in VLDL,CHRDL1,Chordin-like protein 1,42166,0.0263713148360477,0.00336781618900927,0.0197703951055895,0.0329722345665058,5.22308290796237e-15
NMR metabolomics,X23424.Total Lipids in VLDL,ADAMTSL2,ADAMTS-like protein 2,39966,0.0280072880314825,0.00357788455961115,0.0209946342946446,0.0350199417683203,5.40117502306511e-15
NMR metabolomics,X23424.Total Lipids in VLDL,DMD,Dystrophin,39638,0.0415562582756507,0.00530937313458434,0.0311498869318654,0.051962629619436,5.45470208572956e-15
NMR metabolomics,X23424.Total Lipids in VLDL,WAS,Wiskott-Aldrich syndrome protein,41913,0.0528961197426393,0.00676058158295785,0.0396453798400419,0.0661468596452367,5.49291581706267e-15
NMR metabolomics,X23424.Total Lipids in VLDL,PCDH1,Protocadherin-1,42264,0.0165892538817066,0.00212155095472745,0.0124310140104408,0.0207474937529724,5.69479833327555e-15
NMR metabolomics,X23424.Total Lipids in VLDL,CD101,Immunoglobulin superfamily member 2,39930,0.0348622966058011,0.00445859164775208,0.0261234569762071,0.0436011362353952,5.79012264526904e-15
NMR metabolomics,X23424.Total Lipids in VLDL,ANXA4,Annexin A4,42088,0.0582804099707484,0.00745918437200018,0.0436604086016281,0.0729004113398688,5.98431648794195e-15
NMR metabolomics,X23424.Total Lipids in VLDL,PRSS22,Brain-specific serine protease 4,39657,0.0279172509529159,0.0035738709210785,0.020912463947602,0.0349220379582297,6.16296509217019e-15
NMR metabolomics,X23424.Total Lipids in VLDL,DNAJB8,DnaJ homolog subfamily B member 8,41900,0.0452135533477311,0.00579168801676772,0.0338618448348663,0.0565652618605958,6.31153216181204e-15
NMR metabolomics,X23424.Total Lipids in VLDL,COL1A1,Collagen alpha-1(I) chain,42310,-0.0188671188615126,0.00241843137669177,-0.0236072443598285,-0.0141269933631967,6.56402290672345e-15
NMR metabolomics,X23424.Total Lipids in VLDL,WFDC1,WAP four-disulfide core domain protein 1,39699,0.0436606344805561,0.00559547623335747,0.0326935010631754,0.0546277678979367,6.59564183512234e-15
NMR metabolomics,X23424.Total Lipids in VLDL,SFTPA2,Pulmonary surfactant-associated protein A2,41843,0.0416473555661573,0.00534014964651023,0.0311806622589972,0.0521140488733173,6.70982895704236e-15
NMR metabolomics,X23424.Total Lipids in VLDL,ITGA11,Integrin alpha-11,42119,-0.0271893720024577,0.00348697662552983,-0.0340238461884962,-0.0203548978164192,6.78006329699504e-15
NMR metabolomics,X23424.Total Lipids in VLDL,EFCAB2,Dynein regulatory complex protein 8,39757,0.0284155151844958,0.00364388131942809,0.0212735077984167,0.0355575225705748,6.84151285384895e-15
NMR metabolomics,X23424.Total Lipids in VLDL,SMS,Spermine synthase,39586,0.051591853712262,0.00662846760007414,0.0386000572161167,0.0645836502084073,7.69515599113829e-15
NMR metabolomics,X23424.Total Lipids in VLDL,REG1A,Lithostathine-1-alpha,42105,-0.0399241394822112,0.00513448222771536,-0.0499877246485333,-0.0298605543158891,8.04531835605796e-15
NMR metabolomics,X23424.Total Lipids in VLDL,CTSC,Dipeptidyl peptidase 1,42123,0.0355128608638151,0.00456905838324912,0.0265575064326469,0.0444682152949834,8.25095561421727e-15
NMR metabolomics,X23424.Total Lipids in VLDL,C2orf69,UPF0565 protein C2orf69,39649,0.0471279126915892,0.00608001596040195,0.0352110814092013,0.059044743973977,9.89491746813815e-15
NMR metabolomics,X23424.Total Lipids in VLDL,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,39657,0.0298695884112282,0.00385618825325969,0.0223114594348392,0.0374277173876172,1.03214340369258e-14
NMR metabolomics,X23424.Total Lipids in VLDL,MNDA,Myeloid cell nuclear differentiation antigen,42119,0.078111786232544,0.0100891826830182,0.0583369881738283,0.0978865842912597,1.04688569424627e-14
NMR metabolomics,X23424.Total Lipids in VLDL,TLR3,Toll-like receptor 3,42296,0.0487277747544757,0.00629599895206226,0.0363876168084337,0.0610679327005177,1.06789380547562e-14
NMR metabolomics,X23424.Total Lipids in VLDL,EDF1,Endothelial differentiation-related factor 1,39934,0.0528796624785738,0.00684500285658371,0.0394634568796697,0.0662958680774779,1.20997711722626e-14
NMR metabolomics,X23424.Total Lipids in VLDL,FGR,Tyrosine-protein kinase Fgr,41839,0.0466533631591985,0.00604284247207221,0.034809391913937,0.05849733440446,1.24231341465234e-14
NMR metabolomics,X23424.Total Lipids in VLDL,DDX58,Antiviral innate immune response receptor RIG-I,41843,0.0449159105685752,0.00583521671082951,0.0334788858153493,0.056352935321801,1.48694139270676e-14
NMR metabolomics,X23424.Total Lipids in VLDL,NTRK2,BDNF/NT-3 growth factors receptor,42145,0.0199319258591087,0.00259509105156806,0.0148455473980353,0.0250183043201821,1.69147379989103e-14
NMR metabolomics,X23424.Total Lipids in VLDL,SGSH,N-sulphoglucosamine sulphohydrolase,39807,0.0444275326366386,0.00578618322192391,0.0330866135216677,0.0557684517516094,1.7473936329191e-14
NMR metabolomics,X23424.Total Lipids in VLDL,C1RL,Complement C1r subcomponent-like protein,39958,0.0155982346089524,0.0020366724627165,0.0116063565820281,0.0195901126358768,2.03088647069579e-14
NMR metabolomics,X23424.Total Lipids in VLDL,MARCO,Macrophage receptor MARCO,42145,0.0203589902309045,0.00265956855675219,0.0151462358596702,0.0255717446021388,2.06368997219895e-14
NMR metabolomics,X23424.Total Lipids in VLDL,KIF22,Kinesin-like protein KIF22,39575,0.0980847967630466,0.0128172511622846,0.0729629844849689,0.123206609041124,2.13527748282425e-14
NMR metabolomics,X23424.Total Lipids in VLDL,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,39649,0.0425691954215344,0.00556438262812988,0.0316630054703998,0.053475385372669,2.17179582449387e-14
NMR metabolomics,X23424.Total Lipids in VLDL,XPNPEP2,Xaa-Pro aminopeptidase 2,42181,0.0860822276392948,0.0113018783794704,0.0639305460155329,0.108233909263057,2.77563416192555e-14
NMR metabolomics,X23424.Total Lipids in VLDL,MOG,Myelin-oligodendrocyte glycoprotein,42262,0.0259941628344265,0.00342306424406333,0.0192849569160624,0.0327033687527906,3.30710113587936e-14
NMR metabolomics,X23424.Total Lipids in VLDL,CRYM,Ketimine reductase mu-crystallin,39586,0.0592794492899068,0.00780478448238251,0.0439820717044371,0.0745768268753765,3.32088763430933e-14
NMR metabolomics,X23424.Total Lipids in VLDL,TCL1A,T-cell leukemia/lymphoma protein 1A,42005,0.0795779458077743,0.0105196624185141,0.0589594074674867,0.100196484148062,4.14089185838488e-14
NMR metabolomics,X23424.Total Lipids in VLDL,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,39958,0.0240395726893174,0.00319327971276473,0.0177807444522985,0.0302984009263363,5.53467233479181e-14
NMR metabolomics,X23424.Total Lipids in VLDL,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,41820,0.0374566520722723,0.00498353492887779,0.0276889236116718,0.0472243805328728,6.00704435027974e-14
NMR metabolomics,X23424.Total Lipids in VLDL,AKR7L,Aflatoxin B1 aldehyde reductase member 4,39657,0.0536832347823141,0.00714734498411207,0.0396744386134545,0.0676920309511738,6.3231296127393e-14
NMR metabolomics,X23424.Total Lipids in VLDL,TSPYL1,Testis-specific Y-encoded-like protein 1,39657,0.031405815920254,0.00418238557997694,0.0232083401834992,0.0396032916570088,6.41345040781226e-14
NMR metabolomics,X23424.Total Lipids in VLDL,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,39638,0.0334120168967729,0.00445800588198737,0.0246743253680777,0.0421497084254682,7.14621799629898e-14
NMR metabolomics,X23424.Total Lipids in VLDL,LAMP3,Lysosome-associated membrane glycoprotein 3,42284,0.040068447421172,0.00534865731952043,0.0295850790749119,0.050551815767432,7.23638579610916e-14
NMR metabolomics,X23424.Total Lipids in VLDL,BRDT,Bromodomain testis-specific protein,39575,0.0282470418527383,0.00377412246844796,0.0208497618145804,0.0356443218908963,7.73766734098321e-14
NMR metabolomics,X23424.Total Lipids in VLDL,ATP6V1F,V-type proton ATPase subunit F,41820,0.051269599631016,0.00687339717643382,0.0377977411652057,0.0647414580968263,9.25202445933245e-14
NMR metabolomics,X23424.Total Lipids in VLDL,ASGR2,Asialoglycoprotein receptor 2,39990,0.0203119874268893,0.00272583578340618,0.0149693492914131,0.0256546255623654,9.88471421501666e-14
NMR metabolomics,X23424.Total Lipids in VLDL,MEGF10,Multiple epidermal growth factor-like domains protein 10,42123,0.0304458121314627,0.00409728738603879,0.0224151288548267,0.0384764954080988,1.14480723414053e-13
NMR metabolomics,X23424.Total Lipids in VLDL,RABEPK,Rab9 effector protein with kelch motifs,41843,0.0441368977572391,0.00594671930883987,0.0324813279119129,0.0557924676025652,1.22345093635505e-13
NMR metabolomics,X23424.Total Lipids in VLDL,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",39934,0.0364782606575155,0.004915397151041,0.0268440822414751,0.0461124390735558,1.24344666618454e-13
NMR metabolomics,X23424.Total Lipids in VLDL,ARID4B,AT-rich interactive domain-containing protein 4B,41839,0.0317384371870723,0.00427865802302468,0.0233522674619439,0.0401246069122007,1.26281918347965e-13
NMR metabolomics,X23424.Total Lipids in VLDL,IDO1,"Indoleamine 2,3-dioxygenase 1",39638,0.0478850832474433,0.00647016851861475,0.0352035529509584,0.0605666135439282,1.45096425088488e-13
NMR metabolomics,X23424.Total Lipids in VLDL,NAA10,N-alpha-acetyltransferase 10,39575,0.0386736816552495,0.00523130905265323,0.0284203159120492,0.0489270473984498,1.54311258744895e-13
NMR metabolomics,X23424.Total Lipids in VLDL,WARS,"Tryptophan--tRNA ligase, cytoplasmic",42137,0.0294021581800561,0.00398046790502652,0.0216004410862041,0.0372038752739081,1.59428438015826e-13
NMR metabolomics,X23424.Total Lipids in VLDL,ELOB,Elongin-B,39575,0.0298988835795355,0.00404711379409517,0.021966540543109,0.037831226615962,1.60230528027881e-13
NMR metabolomics,X23424.Total Lipids in VLDL,SLITRK6,SLIT and NTRK-like protein 6,41900,-0.0263097342584259,0.00356359301006197,-0.0332943765581474,-0.0193250919587044,1.64052718570188e-13
NMR metabolomics,X23424.Total Lipids in VLDL,IL5RA,Interleukin-5 receptor subunit alpha,42119,-0.0431547805902928,0.00586228360247404,-0.054644856451142,-0.0316647047294437,1.92460645099438e-13
NMR metabolomics,X23424.Total Lipids in VLDL,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",41997,0.0737353891900208,0.0100213118802008,0.0540936179048272,0.0933771604752144,1.97757063607408e-13
NMR metabolomics,X23424.Total Lipids in VLDL,GGH,Gamma-glutamyl hydrolase,41933,0.0257548894545957,0.00350049778712824,0.0188939137918243,0.032615865117367,1.98349143810604e-13
NMR metabolomics,X23424.Total Lipids in VLDL,PRELP,Prolargin,42123,0.0176940082568507,0.00241143507636196,0.0129675955071813,0.0224204210065201,2.29947057439798e-13
NMR metabolomics,X23424.Total Lipids in VLDL,PMM2,Phosphomannomutase 2,39575,0.045441326339638,0.00619180080524819,0.0333053967613516,0.0575772559179245,2.30488714081286e-13
NMR metabolomics,X23424.Total Lipids in VLDL,CASP9,Caspase-9,39657,0.0482837679497139,0.00659131094647762,0.0353647984946177,0.06120273740481,2.54831919912891e-13
NMR metabolomics,X23424.Total Lipids in VLDL,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,41900,0.0431453214295824,0.00589770249575042,0.0315858245379116,0.0547048183212532,2.70876798388456e-13
NMR metabolomics,X23424.Total Lipids in VLDL,APOF,Apolipoprotein F,39990,-0.0195280546174059,0.00267149365315343,-0.0247641821775866,-0.0142919270572252,2.85472347555252e-13
NMR metabolomics,X23424.Total Lipids in VLDL,HDGF,Hepatoma-derived growth factor,42243,0.0687527789522613,0.00940834149714828,0.0503124296178507,0.0871931282866719,2.86975016101556e-13
NMR metabolomics,X23424.Total Lipids in VLDL,MAN2B2,Epididymis-specific alpha-mannosidase,39958,0.0448630286059609,0.00613958455548846,0.0328294428772035,0.0568966143347183,2.91101822295444e-13
NMR metabolomics,X23424.Total Lipids in VLDL,CCL15,C-C motif chemokine 15,42310,0.032757278183814,0.00448490062796051,0.0239668729530114,0.0415476834146166,2.94955930490602e-13
NMR metabolomics,X23424.Total Lipids in VLDL,NOTCH1,Neurogenic locus notch homolog protein 1,42310,0.0121221740980818,0.00166230516251651,0.00886405597954942,0.0153802922166142,3.21197172455057e-13
NMR metabolomics,X23424.Total Lipids in VLDL,BGN,Biglycan,41820,-0.0883969376394539,0.0121563137439085,-0.112223312577515,-0.0645705627013933,3.74984877900558e-13
NMR metabolomics,X23424.Total Lipids in VLDL,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,39934,-0.0284703832730122,0.00391777230526544,-0.0361492169913325,-0.020791549554692,3.91756510550107e-13
NMR metabolomics,X23424.Total Lipids in VLDL,MMP1,Interstitial collagenase,41693,0.0672605177471585,0.00928376118841532,0.0490643458178645,0.0854566896764525,4.56759353848572e-13
NMR metabolomics,X23424.Total Lipids in VLDL,TPR,Nucleoprotein TPR,39575,0.0364900460624321,0.00504127263626439,0.0266091516953539,0.0463709404295103,4.84847101972543e-13
NMR metabolomics,X23424.Total Lipids in VLDL,ECI2,Enoyl-CoA delta isomerase 2,39575,0.0453791019905353,0.00627728899481797,0.0330756155606921,0.0576825884203785,5.18560834110476e-13
NMR metabolomics,X23424.Total Lipids in VLDL,CDA,Cytidine deaminase,39946,0.0354853437059166,0.00491554035559009,0.02585088460896,0.0451198028028732,5.5712426605179e-13
NMR metabolomics,X23424.Total Lipids in VLDL,AMFR,E3 ubiquitin-protein ligase AMFR,41839,0.0469892028502631,0.00652344318139509,0.0342032542147287,0.0597751514857974,6.20270602715474e-13
NMR metabolomics,X23424.Total Lipids in VLDL,HPCAL1,Hippocalcin-like protein 1,42296,0.0545937075070336,0.00758376482542161,0.0397295284492072,0.0694578865648599,6.39268525884002e-13
NMR metabolomics,X23424.Total Lipids in VLDL,ESAM,Endothelial cell-selective adhesion molecule,42310,0.0241207297297165,0.00335283867377447,0.0175491659291186,0.0306922935303145,6.61261726654395e-13
NMR metabolomics,X23424.Total Lipids in VLDL,CD34,Hematopoietic progenitor cell antigen CD34,42211,0.0177502523426757,0.00247048043771361,0.012908110684757,0.0225923940005944,7.07339558791106e-13
NMR metabolomics,X23424.Total Lipids in VLDL,CILP,Cartilage intermediate layer protein 1,39966,0.040901553173244,0.00570056456175763,0.029728446632199,0.0520746597142889,7.68057102647429e-13
NMR metabolomics,X23424.Total Lipids in VLDL,LY75,Lymphocyte antigen 75,42119,0.028571884978211,0.00398559932485422,0.0207601103014967,0.0363836596549252,7.95962059490513e-13
NMR metabolomics,X23424.Total Lipids in VLDL,FES,Tyrosine-protein kinase Fes/Fps,41843,0.0349527298420134,0.00488724816617942,0.0253737234363018,0.0445317362477251,9.01295635692353e-13
NMR metabolomics,X23424.Total Lipids in VLDL,CD276,CD276 antigen,42123,-0.0263890416799779,0.00370019120277635,-0.0336414164374195,-0.0191366669225362,1.04095196393222e-12
NMR metabolomics,X23424.Total Lipids in VLDL,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,39657,0.0431374489151364,0.00604871644758003,0.0312819646778796,0.0549929331523933,1.05351645906042e-12
NMR metabolomics,X23424.Total Lipids in VLDL,PPM1A,Protein phosphatase 1A,41843,0.0230022555122459,0.00323040528098438,0.0166706611615165,0.0293338498629753,1.13044421283895e-12
NMR metabolomics,X23424.Total Lipids in VLDL,GAS2,Growth arrest-specific protein 2,39757,0.0382538175024595,0.00537998527350422,0.0277090463663912,0.0487985886385278,1.22786414315138e-12
NMR metabolomics,X23424.Total Lipids in VLDL,CXADR,Coxsackievirus and adenovirus receptor,42119,0.0358318808287707,0.0050442053193666,0.0259452384028122,0.0457185232547293,1.27654121494131e-12
NMR metabolomics,X23424.Total Lipids in VLDL,CA4,Carbonic anhydrase 4,42310,-0.0177407361336711,0.00249969614462433,-0.0226401405771348,-0.0128413316902074,1.3360695910981e-12
NMR metabolomics,X23424.Total Lipids in VLDL,ACOT13,Acyl-coenzyme A thioesterase 13,39930,0.0839043918059908,0.0118303090442549,0.0607169860792513,0.10709179753273,1.39733363945144e-12
NMR metabolomics,X23424.Total Lipids in VLDL,GIMAP8,GTPase IMAP family member 8,39560,0.0366808403868693,0.00517892294087999,0.0265301514227445,0.046831529350994,1.50020829267086e-12
NMR metabolomics,X23424.Total Lipids in VLDL,EPCAM,Epithelial cell adhesion molecule,42125,-0.0682069190289481,0.00963909081192952,-0.08709953702033,-0.0493143010375663,1.55596826421798e-12
NMR metabolomics,X23424.Total Lipids in VLDL,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",39919,0.027278845972289,0.00385805063188844,0.0197170667337877,0.0348406252107904,1.63316103562096e-12
NMR metabolomics,X23424.Total Lipids in VLDL,CFC1,Cryptic protein,41843,0.0348473368917466,0.00493019762165319,0.0251841495533063,0.0445105242301868,1.6488524591343e-12
NMR metabolomics,X23424.Total Lipids in VLDL,TSPAN8,Tetraspanin-8,39930,0.0693350891167843,0.0098430832271297,0.0500426459916101,0.0886275322419585,1.97563775739083e-12
NMR metabolomics,X23424.Total Lipids in VLDL,CA9,Carbonic anhydrase 9,42262,-0.0338277433382893,0.00480900820934611,-0.0432533994286077,-0.0244020872479709,2.09875354337496e-12
NMR metabolomics,X23424.Total Lipids in VLDL,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,41900,-0.0227621253023999,0.00323937551198907,-0.0291113013058985,-0.0164129492989013,2.21770769599506e-12
NMR metabolomics,X23424.Total Lipids in VLDL,COL2A1,Collagen alpha-1(II) chain,39638,0.0571546433362163,0.00813526044584303,0.0412095328623639,0.0730997538100686,2.2578959883243e-12
NMR metabolomics,X23424.Total Lipids in VLDL,MCTS1,Malignant T-cell-amplified sequence 1,39930,0.0189504936099405,0.00269940837926366,0.0136596531865837,0.0242413340332972,2.34149390671918e-12
NMR metabolomics,X23424.Total Lipids in VLDL,CD300LF,CMRF35-like molecule 1,42262,0.0433917243950121,0.00618472690117687,0.0312696596687054,0.0555137891213188,2.39149283682792e-12
NMR metabolomics,X23424.Total Lipids in VLDL,CTSV,Cathepsin L2,42200,0.0289384597914109,0.00412565524078112,0.02085217551948,0.0370247440633419,2.42077518750966e-12
NMR metabolomics,X23424.Total Lipids in VLDL,TAFA5,Chemokine-like protein TAFA-5,42070,0.0264971749517713,0.00378494482419644,0.0190786830963463,0.0339156668071963,2.6679279249147e-12
NMR metabolomics,X23424.Total Lipids in VLDL,CD14,Monocyte differentiation antigen CD14,41932,0.0297297553947992,0.00424720426096399,0.0214052350433098,0.0380542757462887,2.68510941453168e-12
NMR metabolomics,X23424.Total Lipids in VLDL,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",41843,0.0361023295934788,0.0051607757037441,0.0259872092141403,0.0462174499728172,2.76966555603105e-12
NMR metabolomics,X23424.Total Lipids in VLDL,ICAM4,Intercellular adhesion molecule 4,42119,-0.0378308335784208,0.00541153665909925,-0.0484374454302553,-0.0272242217265862,2.86198109430174e-12
NMR metabolomics,X23424.Total Lipids in VLDL,APOB,Apolipoprotein B-100,39990,0.0164352846047353,0.00235224607442059,0.011824882298871,0.0210456869105997,2.9636445638206e-12
NMR metabolomics,X23424.Total Lipids in VLDL,MTUS1,Microtubule-associated tumor suppressor 1,39757,0.0408203576887446,0.00588515480599085,0.0292854542690025,0.0523552611084867,4.2520042976077e-12
NMR metabolomics,X23424.Total Lipids in VLDL,GPR15L,Protein GPR15L,39930,0.0444108475637032,0.00643505959420797,0.0317981307590556,0.0570235643683508,5.42449970195797e-12
NMR metabolomics,X23424.Total Lipids in VLDL,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,42217,-0.0304918545560972,0.00442989321681208,-0.0391744452610489,-0.0218092638511455,6.10828887394289e-12
NMR metabolomics,X23424.Total Lipids in VLDL,INSL5,Insulin-like peptide INSL5,39930,0.0727461804921561,0.0105690090672487,0.0520309227203487,0.0934614382639634,6.17120609965068e-12
NMR metabolomics,X23424.Total Lipids in VLDL,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,39979,0.0174153269019739,0.00253105868156425,0.0124544518861079,0.0223762019178398,6.27081742251395e-12
NMR metabolomics,X23424.Total Lipids in VLDL,NPHS1,Nephrin,39657,0.023647539675996,0.00343791518228596,0.0169092259187155,0.0303858534332764,6.37726458698752e-12
NMR metabolomics,X23424.Total Lipids in VLDL,CLSTN3,Calsyntenin-3,39929,0.0214697188673329,0.0031220440661889,0.0153505124976026,0.0275889252370631,6.44259686351468e-12
NMR metabolomics,X23424.Total Lipids in VLDL,BOLA1,BolA-like protein 1,39586,0.0386661369686621,0.00562709715026934,0.0276370265541342,0.04969524738319,6.70074501073699e-12
NMR metabolomics,X23424.Total Lipids in VLDL,ADA,Adenosine deaminase,42296,0.0250943113384941,0.00365856812987749,0.0179235178039342,0.032265104873054,7.2292720805454e-12
NMR metabolomics,X23424.Total Lipids in VLDL,CD93,Complement component C1q receptor,41654,-0.0222112205207976,0.00324335474891763,-0.0285681958286761,-0.015854245212919,7.81199705678314e-12
NMR metabolomics,X23424.Total Lipids in VLDL,CD46,Membrane cofactor protein,42107,0.0201789834345146,0.0029525545818014,0.0143919764541838,0.0259659904148453,8.58722048984379e-12
NMR metabolomics,X23424.Total Lipids in VLDL,KLRD1,Natural killer cells antigen CD94,42296,0.0331991857691028,0.00486080638192201,0.0236720052605357,0.04272636627767,8.85118933737495e-12
NMR metabolomics,X23424.Total Lipids in VLDL,PLXNB2,Plexin-B2,42255,0.0172044784359958,0.00252109413035508,0.0122631339404998,0.0221458229314917,9.21378617894245e-12
NMR metabolomics,X23424.Total Lipids in VLDL,STX6,Syntaxin-6,41843,0.0461240189370298,0.00675889886189132,0.0328765771677228,0.0593714607063368,9.22686958720002e-12
NMR metabolomics,X23424.Total Lipids in VLDL,TPP1,Tripeptidyl-peptidase 1,42057,0.0332799860032648,0.00487991451084781,0.0237153535620031,0.0428446184445265,9.50666410654906e-12
NMR metabolomics,X23424.Total Lipids in VLDL,CASP8,Caspase-8,42224,0.0429013772741002,0.00629193095838416,0.0305691925956672,0.0552335619525331,9.58875101019627e-12
NMR metabolomics,X23424.Total Lipids in VLDL,CSDE1,Cold shock domain-containing protein E1,39575,0.0846897995556857,0.0124460487438935,0.0602955440176545,0.109084055093717,1.06643982721194e-11
NMR metabolomics,X23424.Total Lipids in VLDL,IL12B,Interleukin-12 subunit beta,42296,0.0383708265867475,0.00564708236895574,0.0273025451435942,0.0494391080299007,1.12940251406212e-11
NMR metabolomics,X23424.Total Lipids in VLDL,LTA,Lymphotoxin-alpha,42119,0.028003943116074,0.00412515428397646,0.0199186407194801,0.0360892455126679,1.1796619927431e-11
NMR metabolomics,X23424.Total Lipids in VLDL,MDK,Midkine,42129,0.0356973918125023,0.00527047777463437,0.025367255374219,0.0460275282507857,1.31272682944233e-11
NMR metabolomics,X23424.Total Lipids in VLDL,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,39930,0.0837812244349332,0.0123850476678951,0.0595065310058589,0.108055917864008,1.40158109664403e-11
NMR metabolomics,X23424.Total Lipids in VLDL,RCOR1,REST corepressor 1,41900,0.0311014347832436,0.00459988276382776,0.0220856645661412,0.040117205000346,1.4241474330575e-11
NMR metabolomics,X23424.Total Lipids in VLDL,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,39757,0.0275386405390495,0.00408082817209479,0.0195402173217437,0.0355370637563552,1.57002662575236e-11
NMR metabolomics,X23424.Total Lipids in VLDL,PKD1,Polycystin-1,39958,0.0189386299791279,0.00280699964759209,0.0134369106698474,0.0244403492884084,1.58347263649575e-11
NMR metabolomics,X23424.Total Lipids in VLDL,CCL14,C-C motif chemokine 14,42152,0.0280351209623941,0.00416589926988936,0.019869958393411,0.0362002835313773,1.76884677595361e-11
NMR metabolomics,X23424.Total Lipids in VLDL,TSPAN1,Tetraspanin-1,41900,0.0504241287008757,0.00750620055104241,0.0357119756208326,0.0651362817809188,1.92172919738292e-11
NMR metabolomics,X23424.Total Lipids in VLDL,SCT,Secretin,39649,0.0333068215141846,0.00496746859798711,0.0235705830621299,0.0430430599662394,2.11245150715247e-11
NMR metabolomics,X23424.Total Lipids in VLDL,IGFBP4,Insulin-like growth factor-binding protein 4,41930,0.0314836762712614,0.00469686431568094,0.0222778222125268,0.0406895303299961,2.12214411448557e-11
NMR metabolomics,X23424.Total Lipids in VLDL,PODXL,Podocalyxin,42070,0.0104280988892602,0.00155936155630961,0.00737175023889337,0.013484447539627,2.36104043407805e-11
NMR metabolomics,X23424.Total Lipids in VLDL,PRKD2,Serine/threonine-protein kinase D2,39575,0.0301709523894891,0.00451254565013991,0.0213263629152149,0.0390155418637634,2.40462315468605e-11
NMR metabolomics,X23424.Total Lipids in VLDL,GC,Vitamin D-binding protein,39979,0.0178297361780434,0.00266866562608544,0.012599151550916,0.0230603208051709,2.48147710132594e-11
NMR metabolomics,X23424.Total Lipids in VLDL,AFAP1,Actin filament-associated protein 1,39736,0.0576280401791712,0.00863394111476062,0.0407055155942403,0.074550564764102,2.59698234629983e-11
NMR metabolomics,X23424.Total Lipids in VLDL,S100A12,Protein S100-A12,41910,0.0504596386351139,0.00756546068189202,0.0356313356986056,0.0652879415716223,2.66383349762569e-11
NMR metabolomics,X23424.Total Lipids in VLDL,SCGB3A1,Secretoglobin family 3A member 1,39736,-0.0180630718414926,0.00270870877654748,-0.0233721410435256,-0.0127540026394595,2.7063201122969e-11
NMR metabolomics,X23424.Total Lipids in VLDL,C2CD2L,Phospholipid transfer protein C2CD2L,41820,0.0280377608293261,0.00420561525317058,0.0197947549331118,0.0362807667255405,2.71924361065066e-11
NMR metabolomics,X23424.Total Lipids in VLDL,APRT,Adenine phosphoribosyltransferase,42002,0.0323174714501069,0.00484902916627093,0.0228133742842159,0.0418215686159979,2.75521253438523e-11
NMR metabolomics,X23424.Total Lipids in VLDL,AGT,Angiotensinogen,39990,0.0149683722286969,0.00224660258336998,0.0105650311652917,0.019371713292102,2.8129197497794e-11
NMR metabolomics,X23424.Total Lipids in VLDL,IGHMBP2,DNA-binding protein SMUBP-2,39575,0.03851461296679,0.00579176759620277,0.0271627484782326,0.0498664774553474,3.07249164614308e-11
NMR metabolomics,X23424.Total Lipids in VLDL,CWC15,Spliceosome-associated protein CWC15 homolog,39872,0.0430402520431043,0.00647676719160747,0.0303457883475537,0.0557347157386549,3.16488654751643e-11
NMR metabolomics,X23424.Total Lipids in VLDL,ZBTB17,Zinc finger and BTB domain-containing protein 17,41900,0.0287914843423159,0.00433360741509844,0.020297613808723,0.0372853548759089,3.17663204272837e-11
NMR metabolomics,X23424.Total Lipids in VLDL,SERPINA6,Corticosteroid-binding globulin,39979,0.0105835274031288,0.00159286503328589,0.00746151193788847,0.0137055428683692,3.18491760683839e-11
NMR metabolomics,X23424.Total Lipids in VLDL,CD83,CD83 antigen,42119,0.0236251744321878,0.00355635711022256,0.0166547144961516,0.030595634368224,3.18943574041627e-11
NMR metabolomics,X23424.Total Lipids in VLDL,PEPD,Xaa-Pro dipeptidase,39990,0.0180386958265444,0.00272105859315947,0.0127054209839519,0.023371970669137,3.52537050838116e-11
NMR metabolomics,X23424.Total Lipids in VLDL,ROBO1,Roundabout homolog 1,42144,0.0163537611741684,0.00246820731565093,0.0115160748354925,0.0211914475128442,3.58511959773441e-11
NMR metabolomics,X23424.Total Lipids in VLDL,CD200R1,Cell surface glycoprotein CD200 receptor 1,42076,0.0241391837992087,0.00364848994637307,0.0169881435043175,0.0312902240940999,3.82439325405125e-11
NMR metabolomics,X23424.Total Lipids in VLDL,CD27,CD27 antigen,42181,-0.0290662251544479,0.00439941374031922,-0.0376890760854735,-0.0204433742234222,4.07239166516473e-11
NMR metabolomics,X23424.Total Lipids in VLDL,CFHR2,Complement factor H-related protein 2,39904,0.0389356208191176,0.0058955691763798,0.0273803052334132,0.050490936404822,4.17544675166326e-11
NMR metabolomics,X23424.Total Lipids in VLDL,CDH5,Cadherin-5,42310,-0.0206704807438742,0.00313082992032537,-0.026806907387712,-0.0145340541000365,4.199064530573e-11
NMR metabolomics,X23424.Total Lipids in VLDL,CD74,HLA class II histocompatibility antigen gamma chain,42249,0.0235632103744059,0.00357027945007065,0.0165654626522674,0.0305609580965444,4.26848762718e-11
NMR metabolomics,X23424.Total Lipids in VLDL,HGFAC,Hepatocyte growth factor activator,39897,0.0184147207448392,0.00279157973987082,0.0129432244546924,0.023886217034986,4.39712424271852e-11
NMR metabolomics,X23424.Total Lipids in VLDL,TPM3,Tropomyosin alpha-3 chain,39575,-0.0315105020473423,0.00477870630449214,-0.0408767664041468,-0.0221442376905377,4.47978176443394e-11
NMR metabolomics,X23424.Total Lipids in VLDL,FASLG,Tumor necrosis factor ligand superfamily member 6,42296,0.0249998263599003,0.00379413837880049,0.0175633151374514,0.0324363375823493,4.58782093737343e-11
NMR metabolomics,X23424.Total Lipids in VLDL,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,41913,0.0292373852057391,0.00443740343978799,0.0205400744637547,0.0379346959477236,4.59920347860391e-11
NMR metabolomics,X23424.Total Lipids in VLDL,ASPN,Asporin,39958,0.0189108576750438,0.00287202265984341,0.0132816932617507,0.0245400220883369,4.76519721447775e-11
NMR metabolomics,X23424.Total Lipids in VLDL,SFTPD,Pulmonary surfactant-associated protein D,42145,0.0458130410143297,0.00696040603276194,0.0321706451901163,0.0594554368385431,4.81410323143776e-11
NMR metabolomics,X23424.Total Lipids in VLDL,PTGDS,Prostaglandin-H2 D-isomerase,42083,0.0214002440927792,0.00326149026167693,0.0150077231798925,0.027792765005666,5.52176101215617e-11
NMR metabolomics,X23424.Total Lipids in VLDL,LEO1,RNA polymerase-associated protein LEO1,39934,0.0196704416225961,0.00300370088955567,0.013783187879067,0.0255576953661252,6.05357801568249e-11
NMR metabolomics,X23424.Total Lipids in VLDL,LGALS4,Galectin-4,42123,-0.0380123044587567,0.00581272712085922,-0.0494052496156407,-0.0266193593018726,6.39445723944701e-11
NMR metabolomics,X23424.Total Lipids in VLDL,GCLM,Glutamate--cysteine ligase regulatory subunit,39575,0.0297902144753323,0.00455791132274781,0.0208567082827466,0.0387237206679181,6.60159736329885e-11
NMR metabolomics,X23424.Total Lipids in VLDL,SEL1L,Protein sel-1 homolog 1,39638,0.0211364620888831,0.00324579842623816,0.0147746971734563,0.0274982270043099,7.74061679252676e-11
NMR metabolomics,X23424.Total Lipids in VLDL,NXPH1,Neurexophilin-1,41839,0.0260427817061247,0.00400049041852975,0.0182018204858064,0.033883742926443,7.79139261311113e-11
NMR metabolomics,X23424.Total Lipids in VLDL,TREML1,Trem-like transcript 1 protein,39990,0.0356000969146891,0.00546905539242124,0.0248807483455434,0.0463194454838347,7.86374545953615e-11
NMR metabolomics,X23424.Total Lipids in VLDL,FCRL1,Fc receptor-like protein 1,42145,0.030687557606062,0.00471830046766965,0.0214396886894295,0.0399354265226945,8.09881075726199e-11
NMR metabolomics,X23424.Total Lipids in VLDL,RPE,Ribulose-phosphate 3-epimerase,39757,0.0479804221301426,0.00739161664084684,0.0334928535140828,0.0624679907462024,8.87711190500718e-11
NMR metabolomics,X23424.Total Lipids in VLDL,EBI3_IL27,Interleukin-27,42247,-0.0204504337725351,0.00315530117905355,-0.0266348240834801,-0.0142660434615901,9.40639269260152e-11
NMR metabolomics,X23424.Total Lipids in VLDL,ADGRG2,Adhesion G-protein coupled receptor G2,42145,0.0180072092322762,0.00278200525466267,0.0125544789331374,0.023459939531415,9.95530230634366e-11
NMR metabolomics,X23424.Total Lipids in VLDL,CA2,Carbonic anhydrase 2,42103,0.044238383058586,0.0068360889613753,0.0308396486942904,0.0576371174228816,1.00517100384052e-10
NMR metabolomics,X23424.Total Lipids in VLDL,SCARB2,Lysosome membrane protein 2,41777,0.0219952088791452,0.00339929982642687,0.0153325812193485,0.0286578365389418,1.01126084545201e-10
NMR metabolomics,X23424.Total Lipids in VLDL,CD28,T-cell-specific surface glycoprotein CD28,41843,0.0247899807359648,0.00383550591708317,0.0172723891384818,0.0323075723334478,1.06040968881875e-10
NMR metabolomics,X23424.Total Lipids in VLDL,PDIA3,Protein disulfide-isomerase A3,39736,0.0164014189767718,0.00253906402426677,0.0114248534892089,0.0213779844643346,1.09333368134746e-10
NMR metabolomics,X23424.Total Lipids in VLDL,CSF3R,Granulocyte colony-stimulating factor receptor,39657,0.0201826145467503,0.00312490206904892,0.0140578064914144,0.0263074226020862,1.10082279105349e-10
NMR metabolomics,X23424.Total Lipids in VLDL,RANBP1,Ran-specific GTPase-activating protein,39638,0.0343487518445589,0.00532552366819735,0.0239107254548921,0.0447867782342257,1.16653159383663e-10
NMR metabolomics,X23424.Total Lipids in VLDL,MDM1,Nuclear protein MDM1,39649,0.020933450969764,0.00324595213987942,0.0145713847756003,0.0272955171639276,1.17218252399348e-10
NMR metabolomics,X23424.Total Lipids in VLDL,SNX5,Sorting nexin-5,39638,0.0198328334056536,0.00307667188094938,0.0138025565189928,0.0258631102923144,1.19475996951689e-10
NMR metabolomics,X23424.Total Lipids in VLDL,MYOM2,Myomesin-2,39575,-0.0370076146192348,0.00575364965104888,-0.0482847679352906,-0.025730461303179,1.31152874949952e-10
NMR metabolomics,X23424.Total Lipids in VLDL,SV2A,Synaptic vesicle glycoprotein 2A,39649,0.0413812827790306,0.00644028294905823,0.0287583281988765,0.0540042373591848,1.36949701864461e-10
NMR metabolomics,X23424.Total Lipids in VLDL,ACTN2,Alpha-actinin-2,39575,-0.0426728319694463,0.0066691927122268,-0.0557444496854108,-0.0296012142534818,1.63302425480952e-10
NMR metabolomics,X23424.Total Lipids in VLDL,PLA2G15,Phospholipase A2 group XV,42181,0.0180808104569004,0.00283161479954301,0.0125308454497961,0.0236307754640047,1.76587547336741e-10
NMR metabolomics,X23424.Total Lipids in VLDL,LTB,Lymphotoxin-beta,39919,0.0226458205725124,0.00354916561231607,0.0156894559723729,0.0296021851726519,1.83277141607919e-10
NMR metabolomics,X23424.Total Lipids in VLDL,SCARF2,Scavenger receptor class F member 2,42249,-0.0186908796317374,0.00293049921010831,-0.0244346580835497,-0.0129471011799251,1.85134144467653e-10
NMR metabolomics,X23424.Total Lipids in VLDL,CTSF,Cathepsin F,42181,0.0264626263185048,0.00415286530878415,0.0183230103132878,0.0346022423237217,1.92429034123106e-10
NMR metabolomics,X23424.Total Lipids in VLDL,PTGES2,Prostaglandin E synthase 2,39579,0.0367073136025559,0.00576015502109723,0.0254174097612053,0.0479972174439065,1.93264449583521e-10
NMR metabolomics,X23424.Total Lipids in VLDL,NCF2,Neutrophil cytosol factor 2,42097,0.0545305853902631,0.00856720027672981,0.0377388728478727,0.0713222979326535,2.01550236748304e-10
NMR metabolomics,X23424.Total Lipids in VLDL,NPC2,NPC intracellular cholesterol transporter 2,39820,0.0217196243585785,0.00341400250995683,0.0150281794390631,0.0284110692780939,2.06999330896088e-10
NMR metabolomics,X23424.Total Lipids in VLDL,CAT,Catalase,39827,0.0342285223545078,0.00539869130128909,0.0236470874039812,0.0448099573050345,2.38349105007879e-10
NMR metabolomics,X23424.Total Lipids in VLDL,ITGB1BP1,Integrin beta-1-binding protein 1,41843,0.0261423093778882,0.00413865620923709,0.0180305432077835,0.0342540755479929,2.75900182371778e-10
NMR metabolomics,X23424.Total Lipids in VLDL,LXN,Latexin,41960,-0.0446513511640021,0.00707014314867142,-0.0585088317353981,-0.0307938705926061,2.7785438149194e-10
NMR metabolomics,X23424.Total Lipids in VLDL,S100P,Protein S100-P,41900,0.034820087915926,0.00551585231614842,0.0240090173762751,0.0456311584555769,2.8286382574778e-10
NMR metabolomics,X23424.Total Lipids in VLDL,PRSS53,Serine protease 53,39929,0.0248835462240681,0.00394229827725338,0.0171566416006515,0.0326104508474847,2.85856586606009e-10
NMR metabolomics,X23424.Total Lipids in VLDL,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",39638,0.0318322470613253,0.00505252626895243,0.0219292955741785,0.041735198548472,3.0845590778883e-10
NMR metabolomics,X23424.Total Lipids in VLDL,UXS1,UDP-glucuronic acid decarboxylase 1,41843,0.0332573034385367,0.00528789247748113,0.0228930341826737,0.0436215726943998,3.2886173466075e-10
NMR metabolomics,X23424.Total Lipids in VLDL,CBS,Cystathionine beta-synthase,39638,0.0335933085314319,0.00534212556234883,0.0231227424292282,0.0440638746336356,3.32924190349276e-10
NMR metabolomics,X23424.Total Lipids in VLDL,APLP1,Amyloid-like protein 1,42145,-0.0329103094768631,0.0052351054487559,-0.0431711161564247,-0.0226495027973016,3.34736980479758e-10
NMR metabolomics,X23424.Total Lipids in VLDL,CCL20,C-C motif chemokine 20,42296,0.0560127594342852,0.00891792005194252,0.0385336361324778,0.0734918827360925,3.46743786856585e-10
NMR metabolomics,X23424.Total Lipids in VLDL,CD300A,CMRF35-like molecule 8,39736,0.0198355129605559,0.0031588609909606,0.0136441454182732,0.0260268805028387,3.52712881274567e-10
NMR metabolomics,X23424.Total Lipids in VLDL,ACP6,Lysophosphatidic acid phosphatase type 6,42247,0.0437189314005763,0.00696813082796357,0.0300613949777677,0.0573764678233849,3.6222348205883e-10
NMR metabolomics,X23424.Total Lipids in VLDL,TGFA,Protransforming growth factor alpha,42119,0.0292537661327192,0.00466361460992856,0.0201130814972593,0.0383944507681792,3.65494965107523e-10
NMR metabolomics,X23424.Total Lipids in VLDL,IGSF21,Immunoglobulin superfamily member 21,39638,0.0259738069491488,0.004153614376186,0.0178327227718243,0.0341148911264734,4.1671868394653e-10
NMR metabolomics,X23424.Total Lipids in VLDL,CXCL8,Interleukin-8,42035,0.0436940767460594,0.00699027752112756,0.0299931328046494,0.0573950206874694,4.20991700538364e-10
NMR metabolomics,X23424.Total Lipids in VLDL,EPHB4,Ephrin type-B receptor 4,42310,-0.0162851269052074,0.00261460930329587,-0.0214097611396673,-0.0111604926707475,4.84637919283184e-10
NMR metabolomics,X23424.Total Lipids in VLDL,AK1,Adenylate kinase isoenzyme 1,42145,0.0394106658994995,0.00633543275559585,0.0269932176985316,0.0518281141004673,5.09585945966341e-10
NMR metabolomics,X23424.Total Lipids in VLDL,NAGA,Alpha-N-acetylgalactosaminidase,39636,0.0369517899854833,0.00594244759763109,0.0253045926941264,0.0485989872768402,5.20816102555055e-10
NMR metabolomics,X23424.Total Lipids in VLDL,IDS,Iduronate 2-sulfatase,42296,0.00589364283531179,0.000948145577726762,0.00403527750296733,0.00775200816765624,5.24886778286779e-10
NMR metabolomics,X23424.Total Lipids in VLDL,SERPINI2,Serpin I2,39930,0.0370560293417955,0.00596603693160985,0.0253625969558402,0.0487494617277508,5.44370568365504e-10
NMR metabolomics,X23424.Total Lipids in VLDL,ITGAM,Integrin alpha-M,42137,-0.020197762599491,0.00325558285629225,-0.0265787049978238,-0.0138168202011582,5.6635202435826e-10
NMR metabolomics,X23424.Total Lipids in VLDL,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",39638,0.0589892675614209,0.0095087157367269,0.0403521847174361,0.0776263504054056,5.71244087346003e-10
NMR metabolomics,X23424.Total Lipids in VLDL,CELA3A,Chymotrypsin-like elastase family member 3A,42293,0.0384144125459008,0.00620387106790619,0.0262548252528047,0.050573999838997,6.11002432947112e-10
NMR metabolomics,X23424.Total Lipids in VLDL,RGMB,RGM domain family member B,42249,0.0178772743672905,0.0028888714335328,0.0122150863575663,0.0235394623770148,6.25459780908175e-10
NMR metabolomics,X23424.Total Lipids in VLDL,DDR1,Epithelial discoidin domain-containing receptor 1,42249,0.0150964335712494,0.00244143509981856,0.010311220775605,0.0198816463668938,6.45133321153018e-10
NMR metabolomics,X23424.Total Lipids in VLDL,CST5,Cystatin-D,41846,0.0358386406103718,0.00579793028034072,0.024474697260904,0.0472025839598396,6.54492065650584e-10
NMR metabolomics,X23424.Total Lipids in VLDL,CD302,CD302 antigen,42070,0.0197980225721573,0.00320904765170257,0.0135082891748203,0.0260877559694943,7.04953109746927e-10
NMR metabolomics,X23424.Total Lipids in VLDL,SLC16A1,Monocarboxylate transporter 1,41839,0.0350345686043915,0.00568151024655207,0.0238988085211495,0.0461703286876336,7.18858390796338e-10
NMR metabolomics,X23424.Total Lipids in VLDL,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,39638,-0.0215226848275712,0.00349394366509363,-0.0283708144111547,-0.0146745552439876,7.52795412816187e-10
NMR metabolomics,X23424.Total Lipids in VLDL,ZBP1,Z-DNA-binding protein 1,39657,0.0262909476598012,0.00427103152273462,0.0179197258752413,0.034662169444361,7.73655391854255e-10
NMR metabolomics,X23424.Total Lipids in VLDL,AGER,Advanced glycosylation end product-specific receptor,42093,0.0260203079121202,0.00423180493172787,0.0177259702459336,0.0343146455783068,8.0299256984017e-10
NMR metabolomics,X23424.Total Lipids in VLDL,C1QA,Complement C1q subcomponent subunit A,42230,-0.0141676210121462,0.00230607023633188,-0.0186875186753567,-0.00964772334893576,8.29060741376215e-10
NMR metabolomics,X23424.Total Lipids in VLDL,TDO2,"Tryptophan 2,3-dioxygenase",39649,0.0248953863530425,0.00405408435049732,0.0169493810260678,0.0328413916800173,8.49198668645975e-10
NMR metabolomics,X23424.Total Lipids in VLDL,CLEC14A,C-type lectin domain family 14 member A,42137,-0.0203164368140479,0.00331145524767471,-0.0268068890994903,-0.0138259845286055,8.7423247115392e-10
NMR metabolomics,X23424.Total Lipids in VLDL,PRTG,Protogenin,42262,0.0154953508318136,0.0025315124582816,0.0105335864135817,0.0204571152500456,9.55430319483038e-10
NMR metabolomics,X23424.Total Lipids in VLDL,SERPINI1,Neuroserpin,39713,0.0182454704607909,0.00299089808759013,0.0123833102091143,0.0241076307124676,1.09371220392647e-09
NMR metabolomics,X23424.Total Lipids in VLDL,KLRF1,Killer cell lectin-like receptor subfamily F member 1,39657,0.0279752380366096,0.00458591474619057,0.0189868451340761,0.0369636309391432,1.09443340355065e-09
NMR metabolomics,X23424.Total Lipids in VLDL,SUSD2,Sushi domain-containing protein 2,42137,-0.0178196901497426,0.00292325808954332,-0.0235492760052475,-0.0120901042942377,1.1182792999963e-09
NMR metabolomics,X23424.Total Lipids in VLDL,EFNA4,Ephrin-A4,41992,0.0202682253673856,0.00333348505091916,0.0137345946675841,0.0268018560671872,1.23303736537103e-09
NMR metabolomics,X23424.Total Lipids in VLDL,FGA,Fibrinogen alpha chain,39735,0.0195413445613626,0.00321723447047505,0.0132355649992315,0.0258471241234937,1.28870396129382e-09
NMR metabolomics,X23424.Total Lipids in VLDL,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,39575,0.0409733010774501,0.00675517674104399,0.0277331546650039,0.0542134474898964,1.35905892504697e-09
NMR metabolomics,X23424.Total Lipids in VLDL,CA7,Carbonic anhydrase 7,39757,-0.0210063241493789,0.00346415605197549,-0.0277960700112508,-0.0142165782875069,1.37153558065682e-09
NMR metabolomics,X23424.Total Lipids in VLDL,SERPINB8,Serpin B8,42296,0.0364757068307502,0.00602498090384088,0.0246667442592221,0.0482846694022784,1.44914599312144e-09
NMR metabolomics,X23424.Total Lipids in VLDL,S100A13,Protein S100-A13,39657,0.0222508232557459,0.00367832405851699,0.0150413081010526,0.0294603384104392,1.50300587892101e-09
NMR metabolomics,X23424.Total Lipids in VLDL,SLAMF7,SLAM family member 7,42119,-0.0371680318572926,0.00615240086747272,-0.0492267375575391,-0.0251093261570461,1.56965783037484e-09
NMR metabolomics,X23424.Total Lipids in VLDL,MUC16,Mucin-16,42070,0.118769391381459,0.0196756449704161,0.0802051272394436,0.157333655523475,1.61764806811584e-09
NMR metabolomics,X23424.Total Lipids in VLDL,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,39930,0.0250117670093685,0.00414860689977299,0.0168804974858134,0.0331430365329235,1.70162884696213e-09
NMR metabolomics,X23424.Total Lipids in VLDL,VSIG4,V-set and immunoglobulin domain-containing protein 4,42113,-0.0268749405014141,0.00445856528738844,-0.0356137284646954,-0.0181361525381327,1.70629060066159e-09
NMR metabolomics,X23424.Total Lipids in VLDL,CA1,Carbonic anhydrase 1,41890,0.034984368443626,0.00580881391089253,0.0235990931782766,0.0463696437089753,1.76128878046561e-09
NMR metabolomics,X23424.Total Lipids in VLDL,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,39757,0.0438157468735815,0.00727469742636939,0.0295573399178975,0.0580741538292655,1.76572758425512e-09
NMR metabolomics,X23424.Total Lipids in VLDL,HIP1R,Huntingtin-interacting protein 1-related protein,39904,0.0283249072934212,0.00471487231581477,0.0190837575544243,0.0375660570324182,1.94126928066006e-09
NMR metabolomics,X23424.Total Lipids in VLDL,PVALB,Parvalbumin alpha,42208,0.0691183708668301,0.0115115282859413,0.0465557754263851,0.0916809663072751,1.9708335039483e-09
NMR metabolomics,X23424.Total Lipids in VLDL,CR1,Complement receptor type 1,39970,0.0219557530953453,0.00366211660208832,0.0147780045552522,0.0291335016354384,2.0918332683638e-09
NMR metabolomics,X23424.Total Lipids in VLDL,MEPE,Matrix extracellular phosphoglycoprotein,42123,0.0145223883433853,0.00242403812202361,0.00977127362421903,0.0192735030625516,2.13865182172768e-09
NMR metabolomics,X23424.Total Lipids in VLDL,NCAN,Neurocan core protein,42249,0.0230784385913251,0.00386136439434128,0.0155101643784162,0.030646712804234,2.3329709746123e-09
NMR metabolomics,X23424.Total Lipids in VLDL,CTSH,Pro-cathepsin H,41865,0.0459648505969672,0.00769498615246535,0.0308826777381351,0.0610470234557993,2.38380023676687e-09
NMR metabolomics,X23424.Total Lipids in VLDL,ANPEP,Aminopeptidase N,42187,0.0167875741774756,0.00281099355384266,0.011278026811944,0.0222971215430072,2.40046042296213e-09
NMR metabolomics,X23424.Total Lipids in VLDL,TOR1AIP1,Torsin-1A-interacting protein 1,39638,0.0323241694272271,0.0054226705504499,0.0216957351483453,0.0429526037061089,2.58473595543353e-09
NMR metabolomics,X23424.Total Lipids in VLDL,PNLIP,Pancreatic triacylglycerol lipase,39990,0.0405064947764946,0.00685770647549342,0.0270653900845275,0.0539475994684617,3.58976725972109e-09
NMR metabolomics,X23424.Total Lipids in VLDL,FAM3C,Protein FAM3C,42129,0.0184627324389651,0.00313113314372187,0.0123257114772703,0.02459975340066,3.80143211785193e-09
NMR metabolomics,X23424.Total Lipids in VLDL,BSG,Basigin,42284,0.0126701598287983,0.00215304723038822,0.00845018725723742,0.0168901324003593,4.07963891118802e-09
NMR metabolomics,X23424.Total Lipids in VLDL,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",39638,0.0229758469085346,0.00390379656093871,0.0153244056490948,0.0306272881679745,4.08360799713317e-09
NMR metabolomics,X23424.Total Lipids in VLDL,IL1B,Interleukin-1 beta,41825,0.0342296704196985,0.00581968223367372,0.022823093241698,0.045636247597699,4.15865898500168e-09
NMR metabolomics,X23424.Total Lipids in VLDL,CA6,Carbonic anhydrase 6,42103,-0.0379525900605381,0.00645589995528911,-0.0506061539729047,-0.0252990261481714,4.23149732246911e-09
NMR metabolomics,X23424.Total Lipids in VLDL,MYL3,Myosin light chain 3,39638,-0.047563723331477,0.00811673679543817,-0.0634725274505359,-0.0316549192124182,4.76224595470509e-09
NMR metabolomics,X23424.Total Lipids in VLDL,TDP1,Tyrosyl-DNA phosphodiesterase 1,39919,0.0432528515107838,0.00739195267573554,0.0287646242663422,0.0577410787552255,5.01130215626355e-09
NMR metabolomics,X23424.Total Lipids in VLDL,ACVRL1,Serine/threonine-protein kinase receptor R3,41992,0.0155250276373807,0.00265557553361421,0.0103200995914969,0.0207299556832646,5.14643389622251e-09
NMR metabolomics,X23424.Total Lipids in VLDL,CIT,Citron Rho-interacting kinase,39649,0.027622050503015,0.00472875090433783,0.0183536987305128,0.0368904022755171,5.3255904622574e-09
NMR metabolomics,X23424.Total Lipids in VLDL,FAM3B,Protein FAM3B,42070,0.0211591541745545,0.00362598316175081,0.0140522271775229,0.028266081171586,5.48871355375895e-09
NMR metabolomics,X23424.Total Lipids in VLDL,LRRC38,Leucine-rich repeat-containing protein 38,39649,0.0283567973810485,0.00486055921088756,0.0188301013277089,0.0378834934343881,5.56125674238593e-09
NMR metabolomics,X23424.Total Lipids in VLDL,TACSTD2,Tumor-associated calcium signal transducer 2,40518,-0.0187897990552011,0.00322185195932602,-0.0251046288954801,-0.0124749692149221,5.61929790323239e-09
NMR metabolomics,X23424.Total Lipids in VLDL,SMPD1,Sphingomyelin phosphodiesterase,42176,-0.0307604720128259,0.00527657386861883,-0.0411025567953188,-0.020418387230333,5.68127268076046e-09
NMR metabolomics,X23424.Total Lipids in VLDL,WASF3,Wiskott-Aldrich syndrome protein family member 3,41839,0.0510260788004881,0.00876462622585458,0.0338474113978131,0.0682047462031631,5.95596602980226e-09
NMR metabolomics,X23424.Total Lipids in VLDL,DGCR6,Protein DGCR6,39586,0.0251523062583417,0.0043241054257666,0.0166770596238391,0.0336275528928442,6.16711647418522e-09
NMR metabolomics,X23424.Total Lipids in VLDL,CABP2,Calcium-binding protein 2,39649,0.0392385112242534,0.00675413157672054,0.0260004133338811,0.0524766091146256,6.43674319037583e-09
NMR metabolomics,X23424.Total Lipids in VLDL,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",42119,0.0246710321159463,0.00424771458840974,0.0163455115226632,0.0329965527092294,6.46175766468432e-09
NMR metabolomics,X23424.Total Lipids in VLDL,TXN,Thioredoxin,39854,0.0257638104848334,0.00443597233510831,0.0170693047080212,0.0344583162616457,6.49623260017822e-09
NMR metabolomics,X23424.Total Lipids in VLDL,TFPI2,Tissue factor pathway inhibitor 2,42142,0.0228113287429429,0.00393228225270526,0.0151040555276406,0.0305186019582452,6.73772354312506e-09
NMR metabolomics,X23424.Total Lipids in VLDL,NFIC,Nuclear factor 1 C-type,39934,0.0273302307675331,0.00472037011159954,0.018078305348798,0.0365821561862682,7.23196495362864e-09
NMR metabolomics,X23424.Total Lipids in VLDL,SCGN,Secretagogin,41913,-0.0264998158133457,0.00458139198917492,-0.0354793441121285,-0.0175202875145629,7.44832416073284e-09
NMR metabolomics,X23424.Total Lipids in VLDL,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",42181,-0.0208801564940845,0.00361759811822617,-0.0279706488058078,-0.0137896641823612,8.01285621658661e-09
NMR metabolomics,X23424.Total Lipids in VLDL,PCSK7,Proprotein convertase subtilisin/kexin type 7,39919,0.0266733427029064,0.00462087876003768,0.0176164203332325,0.0357302650725802,8.02253300426566e-09
NMR metabolomics,X23424.Total Lipids in VLDL,EDA2R,Tumor necrosis factor receptor superfamily member 27,42262,-0.0246321092494612,0.00427716591562591,-0.033015354444088,-0.0162488640548344,8.64454227491447e-09
NMR metabolomics,X23424.Total Lipids in VLDL,TFF3,Trefoil factor 3,42143,-0.0214091541150182,0.00371852105788232,-0.0286974553884676,-0.0141208528415688,8.72524744127084e-09
NMR metabolomics,X23424.Total Lipids in VLDL,CALB2,Calretinin,41839,0.0174258622451619,0.0030316606224809,0.0114838074250994,0.0233679170652245,9.23185553116238e-09
NMR metabolomics,X23424.Total Lipids in VLDL,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,39919,0.0319605653018562,0.00556505040574675,0.0210530665065926,0.0428680640971199,9.53595937963512e-09
NMR metabolomics,X23424.Total Lipids in VLDL,CBLIF,Cobalamin binding intrinsic factor,42129,0.0450875798613236,0.00786385225519784,0.0296744294411358,0.0605007302815113,1.00466699901115e-08
NMR metabolomics,X23424.Total Lipids in VLDL,GLYR1,Putative oxidoreductase GLYR1,39919,0.0342654902894537,0.00598242986414101,0.0225399277557373,0.0459910528231701,1.04402173603514e-08
NMR metabolomics,X23424.Total Lipids in VLDL,EFHD1,EF-hand domain-containing protein D1,39934,0.0212491406984595,0.00371491865322275,0.0139679001381429,0.0285303812587761,1.09253183921708e-08
NMR metabolomics,X23424.Total Lipids in VLDL,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,39657,0.0183872601921427,0.00321508647868013,0.0120856906939296,0.0246888296903557,1.0989489040823e-08
NMR metabolomics,X23424.Total Lipids in VLDL,PALM,Paralemmin-1,39859,0.0180623264896619,0.00316028625562049,0.0118681654286457,0.024256487550678,1.12220208042432e-08
NMR metabolomics,X23424.Total Lipids in VLDL,CHCHD6,MICOS complex subunit MIC25,39919,0.0170970231442703,0.00299614427153769,0.0112245803720564,0.0229694659164842,1.1832770067056e-08
NMR metabolomics,X23424.Total Lipids in VLDL,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",39638,0.0185365470303168,0.00325092541839051,0.0121647332102714,0.0249083608503623,1.21499794563171e-08
NMR metabolomics,X23424.Total Lipids in VLDL,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,39966,-0.0240367289062398,0.00421670656857076,-0.0323014737806385,-0.0157719840318411,1.22533771799674e-08
NMR metabolomics,X23424.Total Lipids in VLDL,GRSF1,G-rich sequence factor 1,39486,0.0489981632677566,0.00860032295668207,0.0321415302726598,0.0658547962628535,1.24916975097899e-08
NMR metabolomics,X23424.Total Lipids in VLDL,ACAN,Aggrecan core protein,41994,0.0160418177596681,0.00281842254433606,0.0105177095727694,0.0215659259465668,1.28364075095574e-08
NMR metabolomics,X23424.Total Lipids in VLDL,VSIG10,V-set and immunoglobulin domain-containing protein 10,39919,0.0203170096482153,0.00357398337008991,0.0133120022428391,0.0273220170535915,1.34286191657626e-08
NMR metabolomics,X23424.Total Lipids in VLDL,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,39919,0.0382375424734122,0.00673042167272081,0.0250459159948794,0.051429168951945,1.36973079035823e-08
NMR metabolomics,X23424.Total Lipids in VLDL,STX7,Syntaxin-7,39657,0.0288009369589798,0.00507075448969129,0.0188622581591849,0.0387396157587748,1.38245148972134e-08
NMR metabolomics,X23424.Total Lipids in VLDL,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",41843,0.0459080729574248,0.00809789614965361,0.0300361965041037,0.0617799494107458,1.46516238688237e-08
NMR metabolomics,X23424.Total Lipids in VLDL,TNFSF13,Tumor necrosis factor ligand superfamily member 13,42185,0.0161369282407133,0.00284674486041688,0.0105573083142962,0.0217165481671304,1.46936628542919e-08
NMR metabolomics,X23424.Total Lipids in VLDL,PBK,Lymphokine-activated killer T-cell-originated protein kinase,39560,-0.0182503083555611,0.0032238720426315,-0.0245690975591188,-0.0119315191520034,1.54284466207976e-08
NMR metabolomics,X23424.Total Lipids in VLDL,COPB2,Coatomer subunit beta',39575,0.0251459282143502,0.00444403354053246,0.0164356224749066,0.0338562339537938,1.56657696948546e-08
NMR metabolomics,X23424.Total Lipids in VLDL,IGFBP6,Insulin-like growth factor-binding protein 6,42129,0.0181982745220838,0.00322445948580954,0.0118783339298971,0.0245182151142705,1.69655778089585e-08
NMR metabolomics,X23424.Total Lipids in VLDL,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,39638,0.0371891054517571,0.00659887708579668,0.0242553063635956,0.0501229045399186,1.78652548409263e-08
NMR metabolomics,X23424.Total Lipids in VLDL,HLA_E,,42119,0.0170323740437443,0.00302519568459315,0.0111029905019417,0.0229617575855469,1.83612671542935e-08
NMR metabolomics,X23424.Total Lipids in VLDL,APOA1,Apolipoprotein A-I,39979,-0.0159541984723032,0.00283622624096753,-0.0215132019045995,-0.0103951950400068,1.89721221502801e-08
NMR metabolomics,X23424.Total Lipids in VLDL,PPME1,Protein phosphatase methylesterase 1,42070,0.0336835393623481,0.00599300351030004,0.02193725248216,0.0454298262425362,1.94209458937308e-08
NMR metabolomics,X23424.Total Lipids in VLDL,AARSD1,Alanyl-tRNA editing protein Aarsd1,42070,0.0310629295280875,0.00552790521864025,0.0202282352995526,0.0418976237566223,1.95539862778192e-08
NMR metabolomics,X23424.Total Lipids in VLDL,XG,Glycoprotein Xg,42261,0.0200128015220074,0.00357094096360473,0.0130137572333421,0.0270118458106726,2.13082099829496e-08
NMR metabolomics,X23424.Total Lipids in VLDL,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],42070,0.0326711703451012,0.00583231721944335,0.0212398285949923,0.0441025120952102,2.16357082687991e-08
NMR metabolomics,X23424.Total Lipids in VLDL,IL34,Interleukin-34,41814,0.0210934391778641,0.00376683232066368,0.0137104478293633,0.0284764305263649,2.18901348277671e-08
NMR metabolomics,X23424.Total Lipids in VLDL,PTPRH,Receptor-type tyrosine-protein phosphatase H,39930,0.0290268241841111,0.00518351969282488,0.0188671255861744,0.0391865227820479,2.19560242054006e-08
NMR metabolomics,X23424.Total Lipids in VLDL,IGFBPL1,Insulin-like growth factor-binding protein-like 1,42145,0.0195558960678271,0.00349333365052787,0.0127089621127924,0.0264028300228617,2.20972787002906e-08
NMR metabolomics,X23424.Total Lipids in VLDL,ATP6V1G2,V-type proton ATPase subunit G 2,39575,0.0563574258995016,0.0100872548988976,0.0365864062976623,0.076128445501341,2.36541113380753e-08
NMR metabolomics,X23424.Total Lipids in VLDL,SBSN,Suprabasin,39954,-0.0204795195067268,0.00366856091655161,-0.0276698989031679,-0.0132891401102856,2.42612841094591e-08
NMR metabolomics,X23424.Total Lipids in VLDL,CDH15,Cadherin-15,42230,0.0397527669515809,0.00713107214245536,0.0257758655523684,0.0537296683507934,2.52832216272576e-08
NMR metabolomics,X23424.Total Lipids in VLDL,TMPRSS11D,Transmembrane protease serine 11D,39906,0.0220520172528406,0.00395846154982641,0.0142934326151809,0.0298106018905004,2.59288557103009e-08
NMR metabolomics,X23424.Total Lipids in VLDL,NRP2,Neuropilin-2,42137,-0.0161507511936524,0.00289994141029848,-0.0218346363578374,-0.0104668660294674,2.60581532340314e-08
NMR metabolomics,X23424.Total Lipids in VLDL,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,39958,0.0196908242638301,0.00353979155661171,0.0127528328128711,0.026628815714789,2.71632978098341e-08
NMR metabolomics,X23424.Total Lipids in VLDL,LETM1,Mitochondrial proton/calcium exchanger protein,39934,0.0307458385662481,0.00553808076225008,0.0198912002722379,0.0416004768602583,2.89249231085898e-08
NMR metabolomics,X23424.Total Lipids in VLDL,DKK4,Dickkopf-related protein 4,41992,0.0263863951754344,0.0047559083283504,0.0170648148518676,0.0357079754990012,2.94220014484278e-08
NMR metabolomics,X23424.Total Lipids in VLDL,HMBS,Porphobilinogen deaminase,42262,0.0229848520673297,0.00414360120938286,0.0148633936969393,0.0311063104377201,2.95891450083982e-08
NMR metabolomics,X23424.Total Lipids in VLDL,PECR,Peroxisomal trans-2-enoyl-CoA reductase,39638,0.0158445709241872,0.00286119020724078,0.0102366381179953,0.0214525037303791,3.13385418690351e-08
NMR metabolomics,X23424.Total Lipids in VLDL,CPA2,Carboxypeptidase A2,42205,0.037947722731535,0.00685696355675681,0.0245080741602917,0.0513873713027784,3.18455395731669e-08
NMR metabolomics,X23424.Total Lipids in VLDL,GRN,Progranulin,42077,0.0143383736579361,0.00259196494792392,0.00925812236000521,0.019418624955867,3.22767204150276e-08
NMR metabolomics,X23424.Total Lipids in VLDL,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,39575,0.0290442187029528,0.00525000468686509,0.0187542095166972,0.0393342278892084,3.23440486848852e-08
NMR metabolomics,X23424.Total Lipids in VLDL,SCN4B,Sodium channel subunit beta-4,39638,0.0248496971967362,0.00449646533988602,0.0160366251305596,0.0336627692629128,3.34107834510276e-08
NMR metabolomics,X23424.Total Lipids in VLDL,ODAM,Odontogenic ameloblast-associated protein,41814,0.030607723110666,0.0055504670994296,0.019728807595784,0.041486638625548,3.56460087354592e-08
NMR metabolomics,X23424.Total Lipids in VLDL,KIF1C,Kinesin-like protein KIF1C,39575,0.0198468351539426,0.00360142458970412,0.0127880429581226,0.0269056273497627,3.65213754169423e-08
NMR metabolomics,X23424.Total Lipids in VLDL,GPNMB,Transmembrane glycoprotein NMB,41802,0.0165268297220467,0.00300169707472388,0.0106435034555879,0.0224101559885055,3.74299225726153e-08
NMR metabolomics,X23424.Total Lipids in VLDL,ENSA,Alpha-endosulfine,39919,0.0301046270414754,0.00547071947421616,0.0193820168720117,0.040827237210939,3.81804336053077e-08
NMR metabolomics,X23424.Total Lipids in VLDL,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,42296,0.0199663508903474,0.00363067217094825,0.0128502334352888,0.027082468345406,3.88015564389859e-08
NMR metabolomics,X23424.Total Lipids in VLDL,INSR,Insulin receptor,39657,0.00973279514501483,0.00177060778906375,0.00626240387844987,0.0132031864115798,3.95178839829905e-08
NMR metabolomics,X23424.Total Lipids in VLDL,SORCS2,VPS10 domain-containing receptor SorCS2,41843,0.0202283668014135,0.00368219816608262,0.0130112583958915,0.0274454752069354,4.01188475144331e-08
NMR metabolomics,X23424.Total Lipids in VLDL,HSD17B3,Testosterone 17-beta-dehydrogenase 3,39575,0.0271419856163414,0.00494606840432072,0.0174476915438728,0.03683627968881,4.16510443112632e-08
NMR metabolomics,X23424.Total Lipids in VLDL,LYAR,Cell growth-regulating nucleolar protein,41843,0.0300983635599512,0.00549892843560887,0.0193204638261578,0.0408762632937446,4.49271767736075e-08
NMR metabolomics,X23424.Total Lipids in VLDL,TCN2,Transcobalamin-2,42286,-0.017072029196074,0.00311941229709773,-0.0231860772983855,-0.0109579810937624,4.50684959748443e-08
NMR metabolomics,X23424.Total Lipids in VLDL,SIL1,Nucleotide exchange factor SIL1,39638,0.0185303193416079,0.00338930153432748,0.0118872883343261,0.0251733503488898,4.66896071683351e-08
NMR metabolomics,X23424.Total Lipids in VLDL,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,42144,0.0195933424927958,0.00358724052633576,0.0125623510611777,0.0266243339244139,4.79230964409579e-08
NMR metabolomics,X23424.Total Lipids in VLDL,FABP6,Gastrotropin,41881,0.0318569005413081,0.00585937218857087,0.0203725310517092,0.043341270030907,5.51695905115975e-08
NMR metabolomics,X23424.Total Lipids in VLDL,PIGR,Polymeric immunoglobulin receptor,41987,0.0207987162186835,0.00382893616077047,0.0132940013435734,0.0283034310937936,5.67049672307475e-08
NMR metabolomics,X23424.Total Lipids in VLDL,GUCA2A,Guanylin,42083,-0.0196906661427744,0.0036308510265526,-0.0268071341548174,-0.0125741981307313,5.95656639132584e-08
NMR metabolomics,X23424.Total Lipids in VLDL,NRCAM,Neuronal cell adhesion molecule,42145,0.016039617741797,0.00296010161021268,0.0102378185857802,0.0218414168978139,6.10934842804631e-08
NMR metabolomics,X23424.Total Lipids in VLDL,NFYA,Nuclear transcription factor Y subunit alpha,39575,0.0215433871353272,0.003983276390312,0.0137361654103157,0.0293506088603387,6.49034216363362e-08
NMR metabolomics,X23424.Total Lipids in VLDL,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,42137,-0.0205631699565233,0.00380790422839077,-0.0280266622441692,-0.0130996776688774,6.77178080539138e-08
NMR metabolomics,X23424.Total Lipids in VLDL,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,39662,0.0219557097445225,0.00406534502274567,0.013987633499941,0.029923785989104,6.77555952522042e-08
NMR metabolomics,X23424.Total Lipids in VLDL,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",42094,0.0377544849642396,0.00700135352579582,0.0240318320536798,0.0514771378747994,7.06722109915113e-08
NMR metabolomics,X23424.Total Lipids in VLDL,GDF15,Growth/differentiation factor 15,42310,-0.0254368186454004,0.00471969409726486,-0.0346874190760395,-0.0161862182147612,7.18204698466094e-08
NMR metabolomics,X23424.Total Lipids in VLDL,SCGB2A2,Mammaglobin-A,39575,-0.0173009524950889,0.0032161989329638,-0.0236047024036979,-0.0109972025864798,7.63054264222598e-08
NMR metabolomics,X23424.Total Lipids in VLDL,ICOSLG,ICOS ligand,42070,0.0105985796050329,0.00197126050670266,0.0067349090118957,0.0144622501981701,7.71934587212168e-08
NMR metabolomics,X23424.Total Lipids in VLDL,GALNT7,N-acetylgalactosaminyltransferase 7,42070,0.0115172139177761,0.00214256734606843,0.00731778191948192,0.0157166459160702,7.76749777214891e-08
NMR metabolomics,X23424.Total Lipids in VLDL,PDCD6,Programmed cell death protein 6,42145,-0.0390666871492163,0.00727179533516794,-0.0533194060061454,-0.0248139682922871,7.89989354315348e-08
NMR metabolomics,X23424.Total Lipids in VLDL,TRAF3,"TNF receptor-associated factor 3, Isoform 2",39657,0.0207602667421129,0.00386481918761564,0.0131852211343862,0.0283353123498396,7.96232787586689e-08
NMR metabolomics,X23424.Total Lipids in VLDL,SNU13,NHP2-like protein 1,39575,0.0350007537540351,0.00651612318257492,0.0222291523161883,0.047772355191882,7.97204527051376e-08
NMR metabolomics,X23424.Total Lipids in VLDL,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",41820,0.0260075908072424,0.00484502862010761,0.0165113347118315,0.0355038469026534,8.1007926673828e-08
NMR metabolomics,X23424.Total Lipids in VLDL,KLRB1,Killer cell lectin-like receptor subfamily B member 1,42296,0.0214271889186688,0.00400201271862709,0.0135832439901597,0.0292711338471779,8.73694810190075e-08
NMR metabolomics,X23424.Total Lipids in VLDL,VAMP5,Vesicle-associated membrane protein 5,41900,0.0285385637288558,0.00534507900648043,0.0180622088761541,0.0390149185815574,9.48811977137379e-08
NMR metabolomics,X23424.Total Lipids in VLDL,UBAC1,Ubiquitin-associated domain-containing protein 1,42070,0.0181837784972176,0.0034060126109979,0.0115079937796618,0.0248595632147735,9.5119418314452e-08
NMR metabolomics,X23424.Total Lipids in VLDL,RAB37,Ras-related protein Rab-37,41913,0.0447112718135691,0.00837716319680998,0.0282920319478215,0.0611305116793167,9.58986304523778e-08
NMR metabolomics,X23424.Total Lipids in VLDL,SART1,U4/U6.U5 tri-snRNP-associated protein 1,39575,0.0207298569308475,0.00388474308618719,0.0131157604819207,0.0283439533797744,9.67921490254228e-08
NMR metabolomics,X23424.Total Lipids in VLDL,LUZP2,Leucine zipper protein 2,39919,0.0246940108430443,0.00463912641055523,0.015601323078356,0.0337866986077325,1.04028149186347e-07
NMR metabolomics,X23424.Total Lipids in VLDL,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,39649,0.0299642746887481,0.0056407375020468,0.0189084291847364,0.0410201201927598,1.10462653115215e-07
NMR metabolomics,X23424.Total Lipids in VLDL,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",39934,0.0221962352232389,0.00418827301309446,0.0139872201175738,0.0304052503289041,1.18224629069914e-07
NMR metabolomics,X23424.Total Lipids in VLDL,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,42310,-0.0133887887848266,0.00252750090250374,-0.0183426905537339,-0.00843488701591928,1.1938176005081e-07
NMR metabolomics,X23424.Total Lipids in VLDL,PDGFRA,Platelet-derived growth factor receptor alpha,42145,-0.0155347301065687,0.00293670405969936,-0.0212906700635795,-0.00977879014955796,1.24321309840381e-07
NMR metabolomics,X23424.Total Lipids in VLDL,CR2,Complement receptor type 2,42217,0.0254379918896226,0.00480988071793491,0.0160106256824702,0.034865358096775,1.25098397846846e-07
NMR metabolomics,X23424.Total Lipids in VLDL,IL1RL1,Interleukin-1 receptor-like 1,42272,-0.0259666532055758,0.00491912950572653,-0.0356081470367998,-0.0163251593743518,1.32087465249511e-07
NMR metabolomics,X23424.Total Lipids in VLDL,REG1B,Lithostathine-1-beta,42310,-0.0310134163397777,0.00588323692847662,-0.0425445607195918,-0.0194822719599635,1.37375121185622e-07
NMR metabolomics,X23424.Total Lipids in VLDL,NELL1,Protein kinase C-binding protein NELL1,42181,0.0228893888597482,0.00434283604189239,0.0143774302176391,0.0314013475018573,1.38053823864565e-07
NMR metabolomics,X23424.Total Lipids in VLDL,NTF4,Neurotrophin-4,41843,0.0205747168720626,0.003904959342829,0.0129209965601177,0.0282284371840074,1.39420022689351e-07
NMR metabolomics,X23424.Total Lipids in VLDL,RALY,RNA-binding protein Raly,39919,0.0261688456620559,0.00496626684616931,0.0164349626435641,0.0359027286805478,1.39446616903683e-07
NMR metabolomics,X23424.Total Lipids in VLDL,L1CAM,Neural cell adhesion molecule L1,42181,0.0160787869730516,0.00305981771821109,0.0100815442453578,0.0220760297007453,1.50412511565035e-07
NMR metabolomics,X23424.Total Lipids in VLDL,PSMD9,26S proteasome non-ATPase regulatory subunit 9,42070,0.0289146575768275,0.0055054919510092,0.0181238933528495,0.0397054218008056,1.5277518122526e-07
NMR metabolomics,X23424.Total Lipids in VLDL,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,42295,0.0150815197093328,0.00288427857434309,0.00942833370362035,0.0207347057150453,1.73058794618937e-07
NMR metabolomics,X23424.Total Lipids in VLDL,THBD,Thrombomodulin,42145,0.0158987453700742,0.00304578124880047,0.00992901412242529,0.0218684766177231,1.8164317539301e-07
NMR metabolomics,X23424.Total Lipids in VLDL,CENPF,Centromere protein F,39757,0.0290689463306196,0.0055686981038896,0.018154298046996,0.0399835946142433,1.82078438707605e-07
NMR metabolomics,X23424.Total Lipids in VLDL,GNLY,Granulysin,42137,0.0290237664687336,0.00556422433562046,0.0181178867709175,0.0399296461665497,1.8538610248389e-07
NMR metabolomics,X23424.Total Lipids in VLDL,MUC2,Mucin-2,39966,0.0498974642347486,0.00958080560542932,0.0311190852481071,0.06867584322139,1.94155442002775e-07
NMR metabolomics,X23424.Total Lipids in VLDL,MMP13,Collagenase 3,41839,-0.0172910644830051,0.00332721844146417,-0.0238124126282749,-0.0107697163377353,2.05704489546172e-07
NMR metabolomics,X23424.Total Lipids in VLDL,SFTPA1,Pulmonary surfactant-associated protein A1,41843,0.0304045525775396,0.00586682391578294,0.0189055777026051,0.0419035274524742,2.22203963411612e-07
NMR metabolomics,X23424.Total Lipids in VLDL,SNX2,Sorting nexin-2,39919,0.0456968414434279,0.0088187268752836,0.0284121367678721,0.0629815461189838,2.23542537858301e-07
NMR metabolomics,X23424.Total Lipids in VLDL,AKR1C4,Aldo-keto reductase family 1 member C4,41900,0.027199770022077,0.00525054513941515,0.0169087015488233,0.0374908384953307,2.24682590405115e-07
NMR metabolomics,X23424.Total Lipids in VLDL,MRPL46,"39S ribosomal protein L46, mitochondrial",41839,0.014811761665479,0.00286429154333248,0.00919775024054732,0.0204257730904107,2.36015540518637e-07
NMR metabolomics,X23424.Total Lipids in VLDL,STAM,Signal transducing adapter molecule 1,39919,0.0193043287833543,0.00373347299852238,0.0119867217062504,0.0266219358604581,2.37315140533036e-07
NMR metabolomics,X23424.Total Lipids in VLDL,COL6A3,Collagen alpha-3(VI) chain,42310,0.0190612291299696,0.00369564210797433,0.0118177705983399,0.0263046876615992,2.53407628682755e-07
NMR metabolomics,X23424.Total Lipids in VLDL,CLIC5,Chloride intracellular channel protein 5,39649,-0.0166912367565875,0.00325282618034825,-0.0230667760700701,-0.010315697443105,2.92628283622627e-07
NMR metabolomics,X23424.Total Lipids in VLDL,RNASE3,Eosinophil cationic protein,42081,0.0574997911890849,0.0112226871426292,0.0355033243895317,0.079496257988638,3.04008289411013e-07
NMR metabolomics,X23424.Total Lipids in VLDL,CA12,Carbonic anhydrase 12,42070,-0.0172837644134091,0.00337482093066537,-0.0238984134375132,-0.010669115389305,3.07483095110321e-07
NMR metabolomics,X23424.Total Lipids in VLDL,FCRL3,Fc receptor-like protein 3,41913,0.0282850129782798,0.00552433561286371,0.0174573151770669,0.0391127107794926,3.09675870091007e-07
NMR metabolomics,X23424.Total Lipids in VLDL,EPO,Erythropoietin,42119,0.0383450741425116,0.00751911966058843,0.0236075996077583,0.0530825486772649,3.44838365496057e-07
NMR metabolomics,X23424.Total Lipids in VLDL,ITGBL1,Integrin beta-like protein 1,39966,0.020712129989617,0.00406765115391097,0.0127395337279515,0.0286847262512825,3.60142953463177e-07
NMR metabolomics,X23424.Total Lipids in VLDL,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,42249,-0.0235593670651635,0.00462824906575793,-0.032630735234049,-0.0144879988962779,3.62174955588014e-07
NMR metabolomics,X23424.Total Lipids in VLDL,S100A11,Protein S100-A11,42027,0.0242820557572209,0.00477020561904334,0.014932452743896,0.0336316587705459,3.62221472149248e-07
NMR metabolomics,X23424.Total Lipids in VLDL,CSTB,Cystatin-B,41959,0.0227526182844714,0.00447336670029765,0.013984819551888,0.0315204170170548,3.70180823946422e-07
NMR metabolomics,X23424.Total Lipids in VLDL,SPINK6,Serine protease inhibitor Kazal-type 6,42262,0.0279894334715915,0.00552676454172229,0.0171569749698158,0.0388218919733672,4.15150198203384e-07
NMR metabolomics,X23424.Total Lipids in VLDL,REPS1,RalBP1-associated Eps domain-containing protein 1,39657,0.0198983208502845,0.00393318876238634,0.0121892708760072,0.0276073708245617,4.28045290940753e-07
NMR metabolomics,X23424.Total Lipids in VLDL,SATB1,DNA-binding protein SATB1,39934,0.0152867019070102,0.00302175328756381,0.00936406546338512,0.0212093383506353,4.28318459544262e-07
NMR metabolomics,X23424.Total Lipids in VLDL,APOD,Apolipoprotein D,39468,-0.0220752010416898,0.00439338276106852,-0.0306862312533841,-0.0134641708299955,5.1238055529831e-07
NMR metabolomics,X23424.Total Lipids in VLDL,CSPG4,Chondroitin sulfate proteoglycan 4,39966,-0.0171199561351455,0.00340756695099889,-0.0237987873591033,-0.0104411249111876,5.13487850284509e-07
NMR metabolomics,X23424.Total Lipids in VLDL,SPRR3,Small proline-rich protein 3,39929,0.032682872307519,0.0065076731039095,0.0199278330238563,0.0454379115911816,5.18593235042315e-07
NMR metabolomics,X23424.Total Lipids in VLDL,CPQ,Carboxypeptidase Q,39960,0.0194134972626988,0.00386715430764196,0.0118338748197205,0.026993119705677,5.2427878636417e-07
NMR metabolomics,X23424.Total Lipids in VLDL,VIPR1,Vasoactive intestinal polypeptide receptor 1,39638,-0.012233903611687,0.0024399626982149,-0.0170162305001882,-0.00745157672318579,5.41460324450839e-07
NMR metabolomics,X23424.Total Lipids in VLDL,BCAN,Brevican core protein,42016,0.0178251157166627,0.00356029846693334,0.0108469307214734,0.0248033007118521,5.60928186634487e-07
NMR metabolomics,X23424.Total Lipids in VLDL,VIM,Vimentin,41900,0.0592652232823058,0.0118441861075107,0.0360506185115847,0.0824798280530268,5.69470529114231e-07
NMR metabolomics,X23424.Total Lipids in VLDL,BRD1,Bromodomain-containing protein 1,39757,-0.0156907843063354,0.0031427254328271,-0.0218505261546765,-0.00953104245799426,6.04310890299153e-07
NMR metabolomics,X23424.Total Lipids in VLDL,DDC,Aromatic-L-amino-acid decarboxylase,42129,-0.0244225188052212,0.00489997141497653,-0.0340264627785752,-0.0148185748318672,6.29829038019385e-07
NMR metabolomics,X23424.Total Lipids in VLDL,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,41900,-0.0113424363077404,0.00227974168423686,-0.0158107300088446,-0.00687414260663616,6.5955175594487e-07
NMR metabolomics,X23424.Total Lipids in VLDL,COLEC12,Collectin-12,42123,0.0140372033195935,0.00282284666001816,0.00850442386595794,0.0195699827732291,6.68324668103442e-07
NMR metabolomics,X23424.Total Lipids in VLDL,FBP1,"Fructose-1,6-bisphosphatase 1",42145,0.0376896227627802,0.00758396380566977,0.0228250537036675,0.052554191821893,6.78942562099987e-07
NMR metabolomics,X23424.Total Lipids in VLDL,SERPINA1,Alpha-1-antitrypsin,39795,-0.00419847658753292,0.000845897384152544,-0.0058564354604719,-0.00254051771459393,7.03111168788875e-07
NMR metabolomics,X23424.Total Lipids in VLDL,F3,Tissue factor,42174,-0.0133648861160533,0.00269436561532145,-0.0186458427220833,-0.00808392951002328,7.12327752972549e-07
NMR metabolomics,X23424.Total Lipids in VLDL,TK1,"Thymidine kinase, cytosolic",39757,0.0240759521747212,0.00487365833613731,0.0145235818358921,0.0336283225135504,7.92490704592865e-07
NMR metabolomics,X23424.Total Lipids in VLDL,CGREF1,Cell growth regulator with EF hand domain protein 1,42145,0.0220252562002744,0.00446467498632609,0.0132744932270752,0.0307760191734735,8.18422170524703e-07
NMR metabolomics,X23424.Total Lipids in VLDL,TNC,Tenascin,42217,-0.0245192103875067,0.00497916507321819,-0.0342783739310144,-0.014760046843999,8.56286527393333e-07
NMR metabolomics,X23424.Total Lipids in VLDL,CSF2,Granulocyte-macrophage colony-stimulating factor,39575,0.0183717653864827,0.00373720190685938,0.0110468496490384,0.0256966811239271,8.96476195110988e-07
NMR metabolomics,X23424.Total Lipids in VLDL,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",39657,0.0226869511666948,0.00461904680905483,0.0136336194209473,0.0317402829124423,9.16250787150934e-07
NMR metabolomics,X23424.Total Lipids in VLDL,CRTAP,Cartilage-associated protein,39649,0.0250156526474323,0.00509383237002211,0.015031741202189,0.0349995640926756,9.19249115190844e-07
NMR metabolomics,X23424.Total Lipids in VLDL,STC2,Stanniocalcin-2,42113,0.0121374118406151,0.00247508803245673,0.00728623929699995,0.0169885843842303,9.5078555050414e-07
NMR metabolomics,X23424.Total Lipids in VLDL,LYZL2,Lysozyme-like protein 2,39560,0.018438061767872,0.00376072007018809,0.0110670504303034,0.0258090731054407,9.58346359213901e-07
NMR metabolomics,X23424.Total Lipids in VLDL,VEGFB,Vascular endothelial growth factor B,39657,0.0149645459218959,0.00305232276043708,0.00898199331143924,0.0209470985323526,9.58840982229473e-07
NMR metabolomics,X23424.Total Lipids in VLDL,CST1,Cystatin-SN,38503,0.0539285401434803,0.0110186254174027,0.0323320343253711,0.0755250459615896,1.00208730815634e-06
NMR metabolomics,X23424.Total Lipids in VLDL,DSG3,Desmoglein-3,42196,0.0176276335717429,0.00362293180516553,0.0105266872336184,0.0247285799098673,1.15406156322074e-06
NMR metabolomics,X23424.Total Lipids in VLDL,CD80,T-lymphocyte activation antigen CD80,39958,0.0172003259076718,0.0035378337186888,0.0102661718190417,0.0241344799963018,1.17866566810851e-06
NMR metabolomics,X23424.Total Lipids in VLDL,NXPH3,Neurexophilin-3,39657,0.0150354969878173,0.00310115424272169,0.00895723467208282,0.0211137593035519,1.26184035332141e-06
NMR metabolomics,X23424.Total Lipids in VLDL,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,42129,0.0288957708888705,0.00596420356426523,0.0172059319029107,0.0405856098748304,1.28100993706498e-06
NMR metabolomics,X23424.Total Lipids in VLDL,AHCY,Adenosylhomocysteinase,42145,0.0334152412375021,0.00693122429206325,0.0198300416250581,0.047000440849946,1.44411677444669e-06
NMR metabolomics,X23424.Total Lipids in VLDL,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,42262,0.0166365775446085,0.0034561173406447,0.0098625875569449,0.0234105675322721,1.4977633874346e-06
NMR metabolomics,X23424.Total Lipids in VLDL,NEO1,Neogenin,39934,0.0112260184558285,0.00233227128597153,0.00665476673532428,0.0157972701763327,1.5034358468443e-06
NMR metabolomics,X23424.Total Lipids in VLDL,CX3CL1,Fractalkine,42016,-0.0165862895110743,0.00344685781907975,-0.0233421308364706,-0.00983044818567795,1.51052055700464e-06
NMR metabolomics,X23424.Total Lipids in VLDL,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",39929,0.0206781270418938,0.00430658426165344,0.012237221889053,0.0291190321947345,1.59484798194878e-06
NMR metabolomics,X23424.Total Lipids in VLDL,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,42085,0.0949820989070823,0.0197953935980815,0.0561831274548425,0.133781070359322,1.61819242249182e-06
NMR metabolomics,X23424.Total Lipids in VLDL,IL17C,Interleukin-17C,41913,-0.0349581388192325,0.00731394619749744,-0.0492934733663274,-0.0206228042721375,1.77473373069768e-06
NMR metabolomics,X23424.Total Lipids in VLDL,VWC2,Brorin,41973,0.0201647704858501,0.00422471512201409,0.0118843288467025,0.0284452121249977,1.83378676556845e-06
NMR metabolomics,X23424.Total Lipids in VLDL,AHSP,Alpha-hemoglobin-stabilizing protein,42115,0.0395844453386094,0.00830566711143166,0.0233053378002034,0.0558635528770155,1.89917365781337e-06
NMR metabolomics,X23424.Total Lipids in VLDL,CXCL12,Stromal cell-derived factor 1,41913,0.0194086264278645,0.00407427817225371,0.0114230412102473,0.0273942116454818,1.92083697333841e-06
NMR metabolomics,X23424.Total Lipids in VLDL,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,42119,-0.0194095080539795,0.00407628953827685,-0.0273990355490022,-0.0114199805589569,1.94092274889382e-06
NMR metabolomics,X23424.Total Lipids in VLDL,CRYGD,Gamma-crystallin D,39929,0.0481443956200905,0.0101272161471732,0.028295051971631,0.0679937392685499,2.01924839211446e-06
NMR metabolomics,X23424.Total Lipids in VLDL,DUSP3,Dual specificity protein phosphatase 3,41839,0.0420965512474479,0.00885681346729229,0.024737196851555,0.0594559056433408,2.02515556531351e-06
NMR metabolomics,X23424.Total Lipids in VLDL,PSAP,Prosaposin,39886,0.0139919978016601,0.00294851233049001,0.00821291363389965,0.0197710819694205,2.10603789208165e-06
NMR metabolomics,X23424.Total Lipids in VLDL,ECM1,Extracellular matrix protein 1,39720,0.0178734604620155,0.00377260317817903,0.0104791582327846,0.0252677626912464,2.18833823112175e-06
NMR metabolomics,X23424.Total Lipids in VLDL,SIGLEC9,Sialic acid-binding Ig-like lectin 9,42239,0.0148949678608526,0.00315079686865408,0.00871940599829057,0.0210705297234146,2.29726191812026e-06
NMR metabolomics,X23424.Total Lipids in VLDL,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,39560,0.032848184966407,0.0069545107274733,0.0192173439405594,0.0464790259922547,2.34938036147266e-06
NMR metabolomics,X23424.Total Lipids in VLDL,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,42119,0.0184273167001236,0.00390277956287487,0.0107778687568889,0.0260767646433584,2.36360167453482e-06
NMR metabolomics,X23424.Total Lipids in VLDL,CLEC10A,C-type lectin domain family 10 member A,42016,-0.0177698660115731,0.0037695541210565,-0.0251581920888438,-0.0103815399343023,2.45283282120921e-06
NMR metabolomics,X23424.Total Lipids in VLDL,EGFLAM,Pikachurin,39930,0.0150093877777579,0.00319312943670827,0.00875085408180966,0.0212679214737061,2.62550369966587e-06
NMR metabolomics,X23424.Total Lipids in VLDL,IL6ST,Interleukin-6 receptor subunit beta,42145,0.00848389242220106,0.00180896635788381,0.0049383183607488,0.0120294664836533,2.75991984595023e-06
NMR metabolomics,X23424.Total Lipids in VLDL,CCL25,C-C motif chemokine 25,42296,0.0236890012372127,0.00506540039873695,0.0137608164556882,0.0336171860187371,2.94413965650498e-06
NMR metabolomics,X23424.Total Lipids in VLDL,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,42070,0.0216819461322528,0.0046369866977183,0.0125934522047249,0.0307704400597807,2.95551494240058e-06
NMR metabolomics,X23424.Total Lipids in VLDL,CD55,Complement decay-accelerating factor,41714,0.0126991070495205,0.00271745323861925,0.00737289870182675,0.0180253153972142,2.99544259081594e-06
NMR metabolomics,X23424.Total Lipids in VLDL,CD300C,CMRF35-like molecule 6,42249,0.0169691686578948,0.00363274628128695,0.00984898594657238,0.0240893513692172,3.02349358179776e-06
NMR metabolomics,X23424.Total Lipids in VLDL,NECTIN1,Nectin-1,39657,0.0159281710634506,0.00341089464647507,0.00924281755635948,0.0226135245705418,3.05054115354412e-06
NMR metabolomics,X23424.Total Lipids in VLDL,FABP9,Fatty acid-binding protein 9,42119,0.0271321522620615,0.00581319493269642,0.0157382901939765,0.0385260143301465,3.08055733255796e-06
NMR metabolomics,X23424.Total Lipids in VLDL,CD79B,B-cell antigen receptor complex-associated protein beta chain,42296,-0.0219165862559886,0.00470861646393265,-0.0311454745252965,-0.0126876979866806,3.2770218918317e-06
NMR metabolomics,X23424.Total Lipids in VLDL,NECTIN2,Nectin-2,42129,0.0148258308517753,0.00318752644554586,0.00857827901850539,0.0210733826850452,3.33130032374381e-06
NMR metabolomics,X23424.Total Lipids in VLDL,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",39638,0.0342603072246023,0.0073774616295052,0.0198004824307721,0.0487201320184324,3.45814833888883e-06
NMR metabolomics,X23424.Total Lipids in VLDL,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",41839,0.0144336153819337,0.00311456267787146,0.00832907253330559,0.0205381582305617,3.61678405786765e-06
NMR metabolomics,X23424.Total Lipids in VLDL,IL22RA1,Interleukin-22 receptor subunit alpha-1,41913,0.0203055027658677,0.00439711343526947,0.0116871604327396,0.0289238450989959,3.9124053512244e-06
NMR metabolomics,X23424.Total Lipids in VLDL,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,39757,0.0300241043032252,0.00651412564266856,0.0172564180435948,0.0427917905628556,4.08948934586458e-06
NMR metabolomics,X23424.Total Lipids in VLDL,COL24A1,Collagen alpha-1(XXIV) chain,39930,0.0267226851839749,0.00582397122266879,0.015307701587544,0.0381376687804057,4.51461340197828e-06
NMR metabolomics,X23424.Total Lipids in VLDL,SEMA7A,Semaphorin-7A,42272,0.013463423934196,0.00294585299791215,0.00768955205828821,0.0192372958101038,4.91298294001768e-06
NMR metabolomics,X23424.Total Lipids in VLDL,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,39736,0.0173610223751762,0.00380151135690308,0.00991006011564615,0.0248119846347062,5.00363779335334e-06
NMR metabolomics,X23424.Total Lipids in VLDL,NAMPT,Nicotinamide phosphoribosyltransferase,41843,0.0244268967805942,0.00535242934380307,0.0139361352667402,0.0349176582944482,5.07111777412884e-06
NMR metabolomics,X23424.Total Lipids in VLDL,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",42070,-0.020058547477608,0.00440517942893127,-0.0286926991583133,-0.0114243957969027,5.32481908631882e-06
NMR metabolomics,X23424.Total Lipids in VLDL,LCP1,Plastin-2,39966,0.0225262771125275,0.00494831621934001,0.0128275773226211,0.0322249769024339,5.36106199342573e-06
NMR metabolomics,X23424.Total Lipids in VLDL,STX3,Syntaxin-3,39929,0.0179281889454813,0.00393937826151895,0.0102070075529042,0.0256493703380585,5.39420361340397e-06
NMR metabolomics,X23424.Total Lipids in VLDL,PRUNE2,Protein prune homolog 2,39757,0.0135597565946525,0.00298345817893123,0.00771217856394726,0.0194073346253577,5.55181786547155e-06
NMR metabolomics,X23424.Total Lipids in VLDL,IL12RB1,Interleukin-12 receptor subunit beta-1,41913,0.0176534264001049,0.00388590783622445,0.0100370470411049,0.0252698057591048,5.59640063329864e-06
NMR metabolomics,X23424.Total Lipids in VLDL,DKK3,Dickkopf-related protein 3,42310,-0.0138107156061887,0.00304102331371718,-0.0197711213010743,-0.00785030991130299,5.63395530077872e-06
NMR metabolomics,X23424.Total Lipids in VLDL,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",39930,0.0487187850502903,0.0107455720083142,0.0276574639139945,0.069780106186586,5.85128027760379e-06
NMR metabolomics,X23424.Total Lipids in VLDL,CAPG,Macrophage-capping protein,42015,0.0275154436760573,0.00607137888987546,0.0156155410519014,0.0394153463002132,5.8934886559534e-06
NMR metabolomics,X23424.Total Lipids in VLDL,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,39979,0.0085684422762792,0.00189832003149951,0.00484773501454016,0.0122891495380182,6.43465311607089e-06
NMR metabolomics,X23424.Total Lipids in VLDL,TINAGL1,Tubulointerstitial nephritis antigen-like,42126,0.0102875982008566,0.00228840043425923,0.00580233334970853,0.0147728630520047,6.99698654630965e-06
NMR metabolomics,X23424.Total Lipids in VLDL,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,41913,0.0170979991713235,0.00380377707941738,0.0096425960956654,0.0245534022469815,7.01552005775723e-06
NMR metabolomics,X23424.Total Lipids in VLDL,GSTT2B,Glutathione S-transferase theta-2B,39929,0.111944901191265,0.0249249457083435,0.063092007602912,0.160797794779618,7.14967551196807e-06
NMR metabolomics,X23424.Total Lipids in VLDL,ACHE,Acetylcholinesterase,39736,0.0158408807822361,0.00354135058553854,0.00889983363458059,0.0227819279298917,7.78507676527852e-06
NMR metabolomics,X23424.Total Lipids in VLDL,KLK4,Kallikrein-4,42262,-0.0288590957406491,0.0064540849447346,-0.041509102232329,-0.0162090892489693,7.83183648117878e-06
NMR metabolomics,X23424.Total Lipids in VLDL,GSTP1,Glutathione S-transferase P,41759,-0.0321948031247635,0.00720992313144627,-0.0463262524623982,-0.0180633537871288,8.060476198071e-06
NMR metabolomics,X23424.Total Lipids in VLDL,PMS1,PMS1 protein homolog 1,39649,0.0227878479693537,0.00510512579632024,0.0127818014085661,0.0327938945301414,8.13469898461626e-06
NMR metabolomics,X23424.Total Lipids in VLDL,MTPN,Myotrophin,41900,0.0149490338670876,0.00335181688646848,0.00837947276960933,0.0215185949645658,8.26394904226704e-06
NMR metabolomics,X23424.Total Lipids in VLDL,TGFB2,Transforming growth factor beta-2 proprotein,39919,0.0238967296667111,0.00536894100412385,0.0133736052986283,0.0344198540347938,8.63205917763122e-06
NMR metabolomics,X23424.Total Lipids in VLDL,IL2RA,Interleukin-2 receptor subunit alpha,42041,-0.018696354828451,0.00420526223954727,-0.0269386688179637,-0.0104540408389384,8.82085319261211e-06
NMR metabolomics,X23424.Total Lipids in VLDL,B4GALT1,"Beta-1,4-galactosyltransferase 1",42185,0.012763638558331,0.0028754948284763,0.00712766869451742,0.0183996084221445,9.11905055565262e-06
NMR metabolomics,X23424.Total Lipids in VLDL,SERPINA7,Thyroxine-binding globulin,39979,0.00841752120526803,0.0018989285205547,0.00469562130498082,0.0121394211055552,9.38994074046017e-06
NMR metabolomics,X23424.Total Lipids in VLDL,IFNG,Interferon gamma,41913,0.0521913757553949,0.0117836641072117,0.0290953941052599,0.0752873574055299,9.53686176370639e-06
NMR metabolomics,X23424.Total Lipids in VLDL,FGF16,Fibroblast growth factor 16,39657,0.0212735856818079,0.00480673262315517,0.0118523897404237,0.030694781623192,9.7010772737968e-06
NMR metabolomics,X23424.Total Lipids in VLDL,OMD,Osteomodulin,42185,-0.0186769866411838,0.00423241138805235,-0.0269725129617664,-0.0103814603206011,1.02805804198721e-05
NMR metabolomics,X23424.Total Lipids in VLDL,FOSB,Protein fosB,41839,0.0174999766588491,0.00396740920434253,0.00972385461833769,0.0252760986993604,1.03738539510349e-05
NMR metabolomics,X23424.Total Lipids in VLDL,SSH3,Protein phosphatase Slingshot homolog 3,39560,0.0135006159415929,0.00306301807544578,0.00749710051371913,0.0195041313694666,1.05507542698126e-05
NMR metabolomics,X23424.Total Lipids in VLDL,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,42178,-0.0221953529481556,0.00503762023380335,-0.0320690886064102,-0.0123216172899011,1.06142829033753e-05
NMR metabolomics,X23424.Total Lipids in VLDL,SDC1,Syndecan-1,42145,0.0183617578738768,0.00417260767979871,0.0101834468214713,0.0265400689262823,1.08803645784541e-05
NMR metabolomics,X23424.Total Lipids in VLDL,UMOD,Uromodulin,42274,-0.0243680812146663,0.00555059124911314,-0.0352472400629281,-0.0134889223664046,1.14108102729379e-05
NMR metabolomics,X23424.Total Lipids in VLDL,GIMAP7,GTPase IMAP family member 7,39736,-0.0145715620546585,0.00332757214527978,-0.0210936034594069,-0.00804952064991015,1.20293348385593e-05
NMR metabolomics,X23424.Total Lipids in VLDL,ADA2,Adenosine deaminase 2,42096,-0.0198040144580972,0.00452445502557139,-0.0286719463082171,-0.0109360826079773,1.21170190790401e-05
NMR metabolomics,X23424.Total Lipids in VLDL,NELL2,Protein kinase C-binding protein NELL2,42185,0.0130501809339964,0.00298638817190367,0.00719686011706524,0.0189035017509276,1.25232981972672e-05
NMR metabolomics,X23424.Total Lipids in VLDL,C8B,Complement component C8 beta chain,39979,0.0136566184783022,0.00312748290986112,0.00752675197497439,0.01978648498163,1.27282797732364e-05
NMR metabolomics,X23424.Total Lipids in VLDL,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",39638,0.034390564730443,0.00791318778202907,0.018880716677666,0.04990041278322,1.39895377132567e-05
NMR metabolomics,X23424.Total Lipids in VLDL,AZU1,Azurocidin,41751,0.0337213519832965,0.00776573793388374,0.0185005056328844,0.0489421983337086,1.42038296661404e-05
NMR metabolomics,X23424.Total Lipids in VLDL,AOC3,Membrane primary amine oxidase,42217,-0.0132737797210073,0.00305864305926139,-0.0192687201171597,-0.00727883932485502,1.43666249975475e-05
NMR metabolomics,X23424.Total Lipids in VLDL,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,42166,0.0401772068374944,0.00926521552298518,0.0220173844124434,0.0583370292625453,1.45914284520827e-05
NMR metabolomics,X23424.Total Lipids in VLDL,C1QL2,Complement C1q-like protein 2,39657,0.0191699544573916,0.00445135668479532,0.0104452953551927,0.0278946135595904,1.67257170111879e-05
NMR metabolomics,X23424.Total Lipids in VLDL,LGALS3,Galectin-3,42196,0.013120833708365,0.00305565428165329,0.00713175131632457,0.0191099161004055,1.76737315366325e-05
NMR metabolomics,X23424.Total Lipids in VLDL,PCDH12,Protocadherin-12,39934,0.011306100173454,0.00263299440036707,0.00614543114873449,0.0164667691981734,1.76936269667356e-05
NMR metabolomics,X23424.Total Lipids in VLDL,KRT19,"Keratin, type I cytoskeletal 19",42094,-0.0298992456458999,0.00699470531189868,-0.0436088680572213,-0.0161896232345785,1.92835449252068e-05
NMR metabolomics,X23424.Total Lipids in VLDL,FGFR4,Fibroblast growth factor receptor 4,39736,0.0231609680552821,0.00542288387270378,0.0125321156647827,0.0337898204457815,1.96240780835627e-05
NMR metabolomics,X23424.Total Lipids in VLDL,RHOC,Rho-related GTP-binding protein RhoC,41963,0.051686466268123,0.0121254829034664,0.0279205197773289,0.0754524127589171,2.03419605710521e-05
NMR metabolomics,X23424.Total Lipids in VLDL,CLASP1,CLIP-associating protein 1,39560,0.0331053748265453,0.00777186960963138,0.0178725103916678,0.0483382392614228,2.06464639162788e-05
NMR metabolomics,X23424.Total Lipids in VLDL,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,41973,0.0151752676009032,0.00356366970388829,0.00819047498128215,0.0221600602205242,2.07369981434668e-05
NMR metabolomics,X23424.Total Lipids in VLDL,MILR1,Allergin-1,41913,-0.0224273651875589,0.00527822263025625,-0.0327726815428611,-0.0120820488322566,2.16151711557991e-05
NMR metabolomics,X23424.Total Lipids in VLDL,LYPD3,Ly6/PLAUR domain-containing protein 3,42082,0.0148076296576587,0.00348542801156308,0.00797619075499503,0.0216390685603223,2.16710195095372e-05
NMR metabolomics,X23424.Total Lipids in VLDL,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,39649,0.045519765785323,0.0107144542954277,0.0245194353662846,0.0665200962043613,2.17024355276862e-05
NMR metabolomics,X23424.Total Lipids in VLDL,IL31RA,Interleukin-31 receptor subunit alpha,39616,0.0164434197873459,0.00388119514216834,0.008836277308696,0.0240505622659959,2.28684591191431e-05
NMR metabolomics,X23424.Total Lipids in VLDL,CPA4,Carboxypeptidase A4,39518,0.0192345881855522,0.00454842225133364,0.0103196805729382,0.0281494957981661,2.36805048942252e-05
NMR metabolomics,X23424.Total Lipids in VLDL,CNTN5,Contactin-5,42170,0.0161295574615717,0.00381862541909655,0.00864505164014241,0.0236140632830009,2.41658875373619e-05
NMR metabolomics,X23424.Total Lipids in VLDL,GZMB,Granzyme B,42119,0.0295520610275733,0.00699672262195582,0.0158384846885399,0.0432656373666067,2.41897024284064e-05
NMR metabolomics,X23424.Total Lipids in VLDL,DCC,Netrin receptor DCC,39649,0.00974826080963838,0.00230914375886561,0.00522233904226178,0.014274182577015,2.44524770936389e-05
NMR metabolomics,X23424.Total Lipids in VLDL,TMEM25,Transmembrane protein 25,39934,-0.0204005328472814,0.00483948102780851,-0.0298859156617861,-0.0109151500327767,2.51227254527124e-05
NMR metabolomics,X23424.Total Lipids in VLDL,ERC2,ERC protein 2,39649,0.0319886284446997,0.00761543095208841,0.0170623837786065,0.046914873110793,2.68415048453887e-05
NMR metabolomics,X23424.Total Lipids in VLDL,JAM2,Junctional adhesion molecule B,42249,0.0118203379925761,0.00281725741007633,0.00629851346882651,0.0173421625163257,2.73762608037034e-05
NMR metabolomics,X23424.Total Lipids in VLDL,SPTLC1,Serine palmitoyltransferase 1,39929,0.0167390010361575,0.00399568168626293,0.00890746493108212,0.0245705371412328,2.81970179308296e-05
NMR metabolomics,X23424.Total Lipids in VLDL,BMP10,Bone morphogenetic protein 10,39736,0.0121622226434499,0.00292393610821402,0.00643130787135043,0.0178931374155494,3.21284769038157e-05
NMR metabolomics,X23424.Total Lipids in VLDL,COL9A2,Collagen alpha-2(IX) chain,39757,0.0190700458271707,0.00460960794414358,0.0100352142566493,0.0281048773976921,3.54424369669506e-05
NMR metabolomics,X23424.Total Lipids in VLDL,IL17A,Interleukin-17A,41877,-0.0183168045487486,0.00442966648967423,-0.0269989508685101,-0.00963465822898711,3.57090658735909e-05
NMR metabolomics,X23424.Total Lipids in VLDL,CA14,Carbonic anhydrase 14,42262,-0.0156248390560153,0.00378479936456756,-0.0230430458105677,-0.0082066323014629,3.67603780726837e-05
NMR metabolomics,X23424.Total Lipids in VLDL,USP47,Ubiquitin carboxyl-terminal hydrolase 47,39575,0.0371843094366266,0.0090215940506618,0.0195019850973295,0.0548666337759238,3.78850920113515e-05
NMR metabolomics,X23424.Total Lipids in VLDL,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",39958,0.0222989213911005,0.00542795316352167,0.011660133190598,0.032937709591603,4.01614848715495e-05
NMR metabolomics,X23424.Total Lipids in VLDL,NBL1,Neuroblastoma suppressor of tumorigenicity 1,42181,0.0115902082436397,0.00282628471924951,0.0060506901939107,0.0171297262933688,4.1400873476063e-05
NMR metabolomics,X23424.Total Lipids in VLDL,CCN3,CCN family member 3,42299,0.0143042623248762,0.0035042629565684,0.00743590693000218,0.0211726177197503,4.49108203522623e-05
NMR metabolomics,X23424.Total Lipids in VLDL,IL1R1,Interleukin-1 receptor type 1,42113,-0.0100392994016593,0.00246177722131694,-0.0148643827554405,-0.00521421604787809,4.56714124127865e-05
NMR metabolomics,X23424.Total Lipids in VLDL,CD8A,T-cell surface glycoprotein CD8 alpha chain,42249,0.0213604569141898,0.00523828386430195,0.011093420540158,0.0316274932882216,4.57299019911737e-05
NMR metabolomics,X23424.Total Lipids in VLDL,LMNB1,Lamin-B1,39908,0.0257414636764029,0.00631286336137508,0.0133682514881078,0.0381146758646981,4.58105014194307e-05
NMR metabolomics,X23424.Total Lipids in VLDL,LCN2,Neutrophil gelatinase-associated lipocalin,41747,-0.0164785364810404,0.0040418642922142,-0.0244005904937802,-0.00855648246830053,4.58960339881316e-05
NMR metabolomics,X23424.Total Lipids in VLDL,TPPP3,Tubulin polymerization-promoting protein family member 3,41839,0.0162732992069701,0.00400399942829614,0.00842546032750963,0.0241211380864305,4.84631565624732e-05
NMR metabolomics,X23424.Total Lipids in VLDL,FGF5,Fibroblast growth factor 5,41913,-0.0142976024488219,0.00351838392327397,-0.0211936349384389,-0.00740156995920493,4.8581376830427e-05
NMR metabolomics,X23424.Total Lipids in VLDL,AMPD3,AMP deaminase 3,39929,0.0288547484207081,0.00711867424047579,0.0149021469093755,0.0428073499320406,5.08185651162826e-05
NMR metabolomics,X23424.Total Lipids in VLDL,ATXN2,Ataxin-2,39586,0.0443095321464332,0.0109554638897322,0.0228368229225581,0.0657822413703083,5.27900596891301e-05
NMR metabolomics,X23424.Total Lipids in VLDL,NRTN,Neurturin,41913,0.0206774208850624,0.00511399542154198,0.0106539898588402,0.0307008519112847,5.30007894237274e-05
NMR metabolomics,X23424.Total Lipids in VLDL,DDX25,ATP-dependent RNA helicase DDX25,39649,-0.0149699320376817,0.00370230797548466,-0.0222264556696316,-0.00771340840573174,5.30380755034547e-05
NMR metabolomics,X23424.Total Lipids in VLDL,VWF,von Willebrand factor,42310,-0.0308290724043128,0.00763907599133129,-0.0458016613473221,-0.0158564834613035,5.47336894407305e-05
NMR metabolomics,X23424.Total Lipids in VLDL,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,39929,0.0266019370365317,0.00659523478995614,0.0136752768482177,0.0395285972248458,5.53105935852676e-05
NMR metabolomics,X23424.Total Lipids in VLDL,BRD3,Bromodomain-containing protein 3,39575,0.0197464043312381,0.00490856650282938,0.0101256139856925,0.0293671946767837,5.78847077046189e-05
NMR metabolomics,X23424.Total Lipids in VLDL,HSPA2,Heat shock-related 70 kDa protein 2,39919,0.0146073494534192,0.00363182804156334,0.00748896649195506,0.0217257324148834,5.80715401717351e-05
NMR metabolomics,X23424.Total Lipids in VLDL,METAP1,Methionine aminopeptidase 1,41839,0.0120400028251455,0.00299518833084942,0.00616943369668062,0.0179105719536104,5.8574798427944e-05
NMR metabolomics,X23424.Total Lipids in VLDL,MB,Myoglobin,42310,-0.0232630882021056,0.00578739314301955,-0.034606378762424,-0.0119197976417873,5.86052348285651e-05
NMR metabolomics,X23424.Total Lipids in VLDL,ROBO4,Roundabout homolog 4,39638,-0.00758073833473436,0.00188591848431362,-0.0112771385639891,-0.00388433810547966,5.86711929095306e-05
NMR metabolomics,X23424.Total Lipids in VLDL,GFAP,Glial fibrillary acidic protein,41820,0.0188853023761383,0.00469996107071482,0.00967337867753723,0.0280972260747393,5.89735566319001e-05
NMR metabolomics,X23424.Total Lipids in VLDL,ICAM5,Intercellular adhesion molecule 5,42145,0.0190353362663828,0.00474580244829886,0.00973356346771706,0.0283371090650486,6.07909299485686e-05
NMR metabolomics,X23424.Total Lipids in VLDL,COL28A1,Collagen alpha-1(XXVIII) chain,39649,0.0338527513525386,0.00848299687096886,0.0172260774854397,0.0504794252196376,6.63154250999907e-05
NMR metabolomics,X23424.Total Lipids in VLDL,CENPJ,Centromere protein J,39757,0.0289748075096703,0.00726087484984068,0.0147434928039826,0.0432061222153581,6.63448015935726e-05
NMR metabolomics,X23424.Total Lipids in VLDL,DIPK2B,Divergent protein kinase domain 2B,39736,0.0123441034750854,0.00309374829446607,0.00628035681793191,0.0184078501322389,6.64921319467405e-05
NMR metabolomics,X23424.Total Lipids in VLDL,BCL2,Apoptosis regulator Bcl-2,39930,0.0219396396204038,0.00551489582259042,0.0111304438081266,0.0327488354326811,6.98562028694473e-05
NMR metabolomics,X23424.Total Lipids in VLDL,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,42224,-0.0144590239462865,0.00363485106494057,-0.02158333203357,-0.00733471585900296,6.989028920131e-05
NMR metabolomics,X23424.Total Lipids in VLDL,CD86,T-lymphocyte activation antigen CD86,39930,0.0124666130075019,0.00313894869385012,0.00631427356755562,0.0186189524474481,7.18365034136865e-05
NMR metabolomics,X23424.Total Lipids in VLDL,ANGPTL4,Angiopoietin-related protein 4,42166,-0.0182540589347387,0.00459921798434076,-0.0272685261840466,-0.0092395916854308,7.25623406350199e-05
NMR metabolomics,X23424.Total Lipids in VLDL,SAFB2,Scaffold attachment factor B2,39934,0.0111419102272129,0.0028141158976981,0.00562624306772462,0.0166575773867012,7.56312170986553e-05
NMR metabolomics,X23424.Total Lipids in VLDL,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,39575,-0.0127945061564316,0.00323706646635069,-0.0191391564304789,-0.00644985588238421,7.78237475326125e-05
NMR metabolomics,X23424.Total Lipids in VLDL,CEP112,Centrosomal protein of 112 kDa,39575,0.0181072667438607,0.00458869422337796,0.00911342606603991,0.0271011074216815,7.99424879631236e-05
NMR metabolomics,X23424.Total Lipids in VLDL,IL1RAP,Interleukin-1 receptor accessory protein,42137,-0.0181279079506316,0.00461646332971028,-0.0271761760768637,-0.0090796398243994,8.65118141117936e-05
NMR metabolomics,X23424.Total Lipids in VLDL,SEPTIN3,Neuronal-specific septin-3,39934,-0.0317348970747603,0.00808803121912821,-0.0475874382642516,-0.015882355885269,8.77192222980523e-05
NMR metabolomics,X23424.Total Lipids in VLDL,ACE,Angiotensin-converting enzyme,39990,-0.0109512436375369,0.0027912000099044,-0.0164219956569496,-0.00548049161812432,8.77883344996004e-05
NMR metabolomics,X23424.Total Lipids in VLDL,RPA2,Replication protein A 32 kDa subunit,39657,0.0125266753542587,0.00320095257592395,0.00625280830544776,0.0188005424030696,9.15430358313675e-05
NMR metabolomics,X23424.Total Lipids in VLDL,TBC1D17,TBC1 domain family member 17,41839,0.0173815372347374,0.00444221615916856,0.00867479356276697,0.0260882809067077,9.16854473639448e-05
NMR metabolomics,X23424.Total Lipids in VLDL,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,41913,0.0174978579346567,0.00447498728083445,0.00872688286422119,0.0262688330050922,9.26975250126975e-05
NMR metabolomics,X23424.Total Lipids in VLDL,GBP4,Guanylate-binding protein 4,41839,0.0197398653030658,0.00505876812305255,0.00982467978188285,0.0296550508242489,9.58301125931317e-05
NMR metabolomics,X23424.Total Lipids in VLDL,RBPMS,RNA-binding protein with multiple splicing,39657,0.0259772092016251,0.00666736030972813,0.012909182994558,0.0390452354086922,9.82993838609063e-05
NMR metabolomics,X23424.Total Lipids in VLDL,CYTL1,Cytokine-like protein 1,39966,0.0102524229856674,0.00263775877128481,0.00508241579394918,0.0154224301773856,0.000102154310882026
NMR metabolomics,X23424.Total Lipids in VLDL,LIPF,Gastric triacylglycerol lipase,39638,0.0251939862279027,0.00649895891587206,0.0124560267527934,0.0379319457030119,0.000106531692013164
NMR metabolomics,X23424.Total Lipids in VLDL,UROS,Uroporphyrinogen-III synthase,39649,0.0264568914627503,0.00682906447578483,0.013071925090212,0.0398418578352885,0.000107610614188518
NMR metabolomics,X23424.Total Lipids in VLDL,IL7R,Interleukin-7 receptor subunit alpha,42137,-0.0208164526188117,0.00537776271589901,-0.0313568675419738,-0.0102760376956497,0.000108970751331672
NMR metabolomics,X23424.Total Lipids in VLDL,CDH3,Cadherin-3,42249,0.0147025797812193,0.00379862234920167,0.00725727997678404,0.0221478795856546,0.000109116551498398
NMR metabolomics,X23424.Total Lipids in VLDL,PFDN2,Prefoldin subunit 2,41839,0.0220166666957583,0.00569221672865662,0.0108599219075913,0.0331734114839253,0.000110322709416466
NMR metabolomics,X23424.Total Lipids in VLDL,ITGB1,Integrin beta-1,42167,0.0084073044710241,0.00217568049639482,0.00414297069809026,0.0126716382439579,0.000111964243790533
NMR metabolomics,X23424.Total Lipids in VLDL,GART,Trifunctional purine biosynthetic protein adenosine-3,39934,0.0107946297511996,0.00280210328175364,0.00530250731896246,0.0162867521834367,0.000117643191104262
NMR metabolomics,X23424.Total Lipids in VLDL,DPP10,Inactive dipeptidyl peptidase 10,42119,0.0145689779392565,0.00378426448037924,0.00715181955771318,0.0219861363207998,0.000118718267056975
NMR metabolomics,X23424.Total Lipids in VLDL,FCRL2,Fc receptor-like protein 2,42229,0.0198725099636079,0.00516495420493422,0.00974919972193678,0.0299958202052789,0.000119840221142721
NMR metabolomics,X23424.Total Lipids in VLDL,TRIM26,Tripartite motif-containing protein 26,39560,0.022842410463159,0.00593966294159858,0.0112006710976258,0.0344841498286923,0.000120868573347925
NMR metabolomics,X23424.Total Lipids in VLDL,MZB1,Marginal zone B- and B1-cell-specific protein,42163,-0.0203580333849764,0.00529622344935787,-0.0307386313457178,-0.00997743542423493,0.000121658286011681
NMR metabolomics,X23424.Total Lipids in VLDL,PADI4,Protein-arginine deiminase type-4,41814,0.0289162895930837,0.00753780987564817,0.0141421822368133,0.0436903969493541,0.00012555102297335
NMR metabolomics,X23424.Total Lipids in VLDL,SPESP1,Sperm equatorial segment protein 1,39958,0.0132886997459075,0.00346583643951924,0.0064956603244498,0.0200817391673652,0.000126655427654801
NMR metabolomics,X23424.Total Lipids in VLDL,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",42144,-0.0130193578389788,0.00339652267727402,-0.0196765422864359,-0.00636217339152171,0.000127088421931806
NMR metabolomics,X23424.Total Lipids in VLDL,YAP1,Transcriptional coactivator YAP1,39929,0.0108797058306521,0.00285151737226821,0.0052907317810064,0.0164686798802978,0.000136679950974281
NMR metabolomics,X23424.Total Lipids in VLDL,RNF149,E3 ubiquitin-protein ligase RNF149,39638,0.0124779933052951,0.00327107601750842,0.00606668431097857,0.0188893022996116,0.000137122291045954
NMR metabolomics,X23424.Total Lipids in VLDL,NPTX1,Neuronal pentraxin-1,42137,0.016369494425224,0.00430871050551217,0.00792442183442015,0.0248145670160278,0.000145820702059264
NMR metabolomics,X23424.Total Lipids in VLDL,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",39575,-0.0159017738395179,0.00418969852248334,-0.0241135829435852,-0.00768996473545056,0.000148171072745113
NMR metabolomics,X23424.Total Lipids in VLDL,OSM,Oncostatin-M,42051,0.0268977413552338,0.0071248466629546,0.0129330418958428,0.0408624408146249,0.00016056492166542
NMR metabolomics,X23424.Total Lipids in VLDL,CREBZF,CREB/ATF bZIP transcription factor,39560,-0.0101759995150324,0.00269776564473236,-0.0154636201787078,-0.00488837885135695,0.000162789712726599
NMR metabolomics,X23424.Total Lipids in VLDL,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,42224,0.0117991385091066,0.00313031130147989,0.00566372835820598,0.0179345486600072,0.000164385064099615
NMR metabolomics,X23424.Total Lipids in VLDL,CNPY2,Protein canopy homolog 2,41900,0.0236797913173823,0.00628278052133201,0.0113655414955716,0.0359940411391931,0.000164612100586855
NMR metabolomics,X23424.Total Lipids in VLDL,CRISP3,Cysteine-rich secretory protein 3,39889,-0.0105985449742681,0.00281831063447678,-0.0161224338178426,-0.00507465613069358,0.000170360877238537
NMR metabolomics,X23424.Total Lipids in VLDL,SELENOP,Selenoprotein P,39979,0.00878568781029286,0.00233972168168526,0.00419983331418975,0.013371542306396,0.000174195312902753
NMR metabolomics,X23424.Total Lipids in VLDL,RCC1,Regulator of chromosome condensation,39919,0.0202005396796609,0.00538400436302904,0.009647891128124,0.0307531882311978,0.000176337398421186
NMR metabolomics,X23424.Total Lipids in VLDL,NPTXR,Neuronal pentraxin receptor,42145,0.0132050650042401,0.00351999820069557,0.00630586853087679,0.0201042614776034,0.000176554302918212
NMR metabolomics,X23424.Total Lipids in VLDL,NPR1,Atrial natriuretic peptide receptor 1,39575,-0.0165429846036155,0.00441203062211536,-0.0251905646229616,-0.00789540458426938,0.000178085588331015
NMR metabolomics,X23424.Total Lipids in VLDL,PROCR,Endothelial protein C receptor,39575,-0.0133977468418571,0.00357986567978471,-0.0204142835742351,-0.00638121010947905,0.000183107742993736
NMR metabolomics,X23424.Total Lipids in VLDL,RSPO1,R-spondin-1,42016,0.0131535495688513,0.00351669330338388,0.0062608306942189,0.0200462684434837,0.000184552989466305
NMR metabolomics,X23424.Total Lipids in VLDL,ICAM3,Intercellular adhesion molecule 3,42310,-0.0104391364940093,0.00279369078610651,-0.0159147704347781,-0.00496350255324053,0.000187220604601275
NMR metabolomics,X23424.Total Lipids in VLDL,CEP152,Centrosomal protein of 152 kDa,39560,0.0162148935745564,0.00435018597420126,0.00768852906512194,0.0247412580839909,0.000194436796078987
NMR metabolomics,X23424.Total Lipids in VLDL,M6PR,Cation-dependent mannose-6-phosphate receptor,39638,0.0149236278569052,0.00400814049972248,0.00706767247744916,0.0227795832363613,0.000197590787044312
NMR metabolomics,X23424.Total Lipids in VLDL,CEBPA,CCAAT/enhancer-binding protein alpha,39657,0.0139678784257835,0.00375307150294187,0.00661185828001739,0.0213238985715495,0.000198852078531806
NMR metabolomics,X23424.Total Lipids in VLDL,CDHR1,Cadherin-related family member 1,41839,0.0158442284642437,0.00426692627765982,0.00748105296003044,0.0242074039684569,0.000205442204979024
NMR metabolomics,X23424.Total Lipids in VLDL,QPCT,Glutaminyl-peptide cyclotransferase,42170,0.0103244738808644,0.00278442446402579,0.00486700193137381,0.0157819458303549,0.000209785866953643
NMR metabolomics,X23424.Total Lipids in VLDL,GAST,Gastrin,39929,0.0501284039407204,0.0135254682255036,0.0236184862187335,0.0766383216627074,0.000211375097376086
NMR metabolomics,X23424.Total Lipids in VLDL,BAX,Apoptosis regulator BAX,41814,0.0350727401574461,0.00946629040770957,0.0165188109583353,0.0536266693565568,0.000212240970187215
NMR metabolomics,X23424.Total Lipids in VLDL,ERBB4,Receptor tyrosine-protein kinase erbB-4,42181,-0.00894886390091986,0.00241605683659994,-0.0136843353006557,-0.00421339250118398,0.000213140685612037
NMR metabolomics,X23424.Total Lipids in VLDL,RNF43,E3 ubiquitin-protein ligase RNF43,39757,0.0219267822623697,0.00592105829691084,0.0103215080004244,0.033532056524315,0.00021393510395889
NMR metabolomics,X23424.Total Lipids in VLDL,PTPRF,Receptor-type tyrosine-protein phosphatase F,42310,-0.0108422308641796,0.00292827444489312,-0.0165816487761702,-0.00510281295218912,0.00021423738064174
NMR metabolomics,X23424.Total Lipids in VLDL,CHI3L1,Chitinase-3-like protein 1,41907,0.0319664076334706,0.00863534434384656,0.0150411327195314,0.0488916825474099,0.000214930645942111
NMR metabolomics,X23424.Total Lipids in VLDL,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,41900,0.0119937845156564,0.00324918304587735,0.00562538574573676,0.018362183285576,0.000223981946465238
NMR metabolomics,X23424.Total Lipids in VLDL,PDGFRB,Platelet-derived growth factor receptor beta,42310,0.0132137807850578,0.00358523704439059,0.00618671617805221,0.0202408453920633,0.000229035937560079
NMR metabolomics,X23424.Total Lipids in VLDL,ANGPT2,Angiopoietin-2,42262,-0.0141914356495883,0.00385051923560442,-0.0217384533513729,-0.0066444179478036,0.000229055711422501
NMR metabolomics,X23424.Total Lipids in VLDL,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,42123,0.0111855296021047,0.00303673934835445,0.00523352047933002,0.0171375387248795,0.000231039595479952
NMR metabolomics,X23424.Total Lipids in VLDL,BABAM1,BRISC and BRCA1-A complex member 1,39657,0.0112007442663522,0.0030549837552153,0.00521297610613021,0.0171885124265742,0.000247157184787534
NMR metabolomics,X23424.Total Lipids in VLDL,CHAD,Chondroadherin,39736,0.0177596480668202,0.00485098359278768,0.00825172022495636,0.0272675759086841,0.000252355448749004
NMR metabolomics,X23424.Total Lipids in VLDL,NCAM2,Neural cell adhesion molecule 2,42137,-0.0101685763585249,0.00278005104549139,-0.015617476407688,-0.00471967630936179,0.000255459835520537
NMR metabolomics,X23424.Total Lipids in VLDL,SULT1A1,Sulfotransferase 1A1,42249,-0.0484670803150597,0.0132559008497203,-0.0744486459805115,-0.0224855146496078,0.000256878593831883
NMR metabolomics,X23424.Total Lipids in VLDL,ARHGAP5,Rho GTPase-activating protein 5,39560,0.0287620415622338,0.00787094255514957,0.0133349941541406,0.0441890889703269,0.000259184254536185
NMR metabolomics,X23424.Total Lipids in VLDL,OMG,Oligodendrocyte-myelin glycoprotein,42070,0.0259076481071717,0.00710056018365328,0.0119905501472113,0.0398247460671322,0.000264590191369206
NMR metabolomics,X23424.Total Lipids in VLDL,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,42016,0.0153033683004732,0.00419530750716943,0.00708056558642108,0.0235261710145252,0.000265564995678825
NMR metabolomics,X23424.Total Lipids in VLDL,DDI2,Protein DDI1 homolog 2,39736,0.0281966366905611,0.00774706977522819,0.0130123799311139,0.0433808934500084,0.000274242929590639
NMR metabolomics,X23424.Total Lipids in VLDL,FOLH1,Glutamate carboxypeptidase 2,39657,0.0392797133333629,0.010819418000542,0.0180736540523007,0.0604857726144252,0.000284169081792699
NMR metabolomics,X23424.Total Lipids in VLDL,CLPS,Colipase,42115,0.027589580426486,0.00761070230960794,0.0126726038996545,0.0425065569533176,0.000289907385110062
NMR metabolomics,X23424.Total Lipids in VLDL,SAT2,Thialysine N-epsilon-acetyltransferase,39757,0.026532795445282,0.00732841973127174,0.0121690927719894,0.0408964981185746,0.000295297724488746
NMR metabolomics,X23424.Total Lipids in VLDL,OSMR,Oncostatin-M-specific receptor subunit beta,42230,-0.00714339522791588,0.0019843456907527,-0.0110327127817912,-0.00325407767404058,0.000319500735002765
NMR metabolomics,X23424.Total Lipids in VLDL,FMR1,Synaptic functional regulator FMR1,41843,0.0133469319218141,0.00372784984384391,0.00604034622788005,0.0206535176157482,0.000344388888910012
NMR metabolomics,X23424.Total Lipids in VLDL,KLK8,Kallikrein-8,41668,0.0135270070484223,0.00378250584114226,0.00611329559978349,0.0209407184970611,0.000349880484805098
NMR metabolomics,X23424.Total Lipids in VLDL,QSOX1,Sulfhydryl oxidase 1,39767,0.0147448958010024,0.004126032570641,0.00665787196254603,0.0228319196394587,0.000353556277257366
NMR metabolomics,X23424.Total Lipids in VLDL,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,42137,0.0131430564203015,0.0036916265579208,0.00590746836677677,0.0203786444738263,0.000371793838141771
NMR metabolomics,X23424.Total Lipids in VLDL,COMP,Cartilage oligomeric matrix protein,42042,0.0122032546143667,0.00343666041077788,0.00546740020924209,0.0189391090194914,0.00038522136531519
NMR metabolomics,X23424.Total Lipids in VLDL,ADGRG1,Adhesion G-protein coupled receptor G1,42070,-0.0293567540139717,0.00828761511290419,-0.0456004796352639,-0.0131130283926794,0.000398079591186792
NMR metabolomics,X23424.Total Lipids in VLDL,NFKB2,Nuclear factor NF-kappa-B p100 subunit,39757,0.0202211713050831,0.00572977250500455,0.00899081719527418,0.031451525414892,0.000418590415922616
NMR metabolomics,X23424.Total Lipids in VLDL,CRH,Corticoliberin,41830,0.0311672160725383,0.0088460460553412,0.0138289658040696,0.0485054663410071,0.000427656995636172
NMR metabolomics,X23424.Total Lipids in VLDL,DLL1,Delta-like protein 1,42181,-0.0111422337883336,0.0031654788108842,-0.0173465722576666,-0.00493789531900055,0.0004330896362954
NMR metabolomics,X23424.Total Lipids in VLDL,SPINK4,Serine protease inhibitor Kazal-type 4,42119,-0.0238923514509488,0.00680577214033318,-0.0372316648460018,-0.0105530380558958,0.000448550885421825
NMR metabolomics,X23424.Total Lipids in VLDL,APOH,Beta-2-glycoprotein 1,42137,-0.0132314789494467,0.00377613076474439,-0.0206326952483457,-0.00583026265054766,0.000459843738888564
NMR metabolomics,X23424.Total Lipids in VLDL,PTPRS,Receptor-type tyrosine-protein phosphatase S,42310,-0.00908709476481522,0.00259455866113707,-0.0141724297406439,-0.00400175978898656,0.000462613278088407
NMR metabolomics,X23424.Total Lipids in VLDL,HSPB6,Heat shock protein beta-6,42262,0.0146062034207259,0.00419508235014017,0.00638384201445114,0.0228285648270006,0.000499716222242489
NMR metabolomics,X23424.Total Lipids in VLDL,DEFB104A_DEFB104B,Beta-defensin 104,39586,0.0201056619774007,0.00577493732913974,0.00878678481228682,0.0314245391425146,0.000500481153296507
NMR metabolomics,X23424.Total Lipids in VLDL,CSF3,Granulocyte colony-stimulating factor,41913,0.0172113478999599,0.00495419919826754,0.00750111747135551,0.0269215783285643,0.000514214146202151
NMR metabolomics,X23424.Total Lipids in VLDL,ACP1,Low molecular weight phosphotyrosine protein phosphatase,39657,0.0158792828942615,0.0045823791031169,0.00689781985215236,0.0248607459363706,0.000531665363787806
NMR metabolomics,X23424.Total Lipids in VLDL,ANXA1,Annexin A1,39699,0.0159192709529935,0.0045976054019778,0.00690796436511705,0.02493057754087,0.000537171959771834
NMR metabolomics,X23424.Total Lipids in VLDL,ITM2A,Integral membrane protein 2A,42119,-0.0220958407767924,0.00640280649599619,-0.0346453415089449,-0.00954634004463984,0.000560299259862699
NMR metabolomics,X23424.Total Lipids in VLDL,CCND2,G1/S-specific cyclin-D2,39757,0.0132029184945465,0.0038373695331397,0.00568167420959263,0.0207241627795003,0.000582514858751085
NMR metabolomics,X23424.Total Lipids in VLDL,NOS1,"Nitric oxide synthase, brain",41839,-0.0208378057228802,0.00606275604916144,-0.0327208075792367,-0.00895480386652383,0.000589962637690446
NMR metabolomics,X23424.Total Lipids in VLDL,LIF,Leukemia inhibitory factor,41839,0.0177024367989026,0.00516516493087429,0.00757871353438905,0.0278261600634162,0.000611526976407553
NMR metabolomics,X23424.Total Lipids in VLDL,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,39958,0.0101809589072101,0.00297111420328867,0.00435757506876432,0.0160043427456559,0.000613248305038869
NMR metabolomics,X23424.Total Lipids in VLDL,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,39930,0.0299390259899578,0.00874321491196237,0.0128023247625116,0.0470757272174041,0.000618663760494338
NMR metabolomics,X23424.Total Lipids in VLDL,TMOD4,Tropomodulin-4,39560,-0.0141840196514544,0.00414306394528777,-0.0223044249842185,-0.0060636143186904,0.000620332291562116
NMR metabolomics,X23424.Total Lipids in VLDL,EDN1,Endothelin-1,39638,0.0103172708376731,0.00303831774467827,0.00436216805810366,0.0162723736172425,0.000686900461926434
NMR metabolomics,X23424.Total Lipids in VLDL,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",39560,0.0182214743403,0.00536883731293746,0.00769855320694259,0.0287443954736574,0.000691406191354486
NMR metabolomics,X23424.Total Lipids in VLDL,HAVCR2,Hepatitis A virus cellular receptor 2,42137,-0.0126225434994613,0.00372200914750747,-0.0199176814285759,-0.00532740557034666,0.000697544074324212
NMR metabolomics,X23424.Total Lipids in VLDL,CNTN4,Contactin-4,42137,-0.00821917518425959,0.00242528275750745,-0.0129727293889742,-0.00346562097954499,0.000703595148399019
NMR metabolomics,X23424.Total Lipids in VLDL,MYBPC1,"Myosin-binding protein C, slow-type",39958,-0.0269782978961305,0.00796584456294021,-0.0425913532394933,-0.0113652425527677,0.000709665306783938
NMR metabolomics,X23424.Total Lipids in VLDL,SIRT1,NAD-dependent protein deacetylase sirtuin-1,39657,0.0302596951301213,0.00893492720097077,0.0127472378162186,0.047772152444024,0.000709915854777947
NMR metabolomics,X23424.Total Lipids in VLDL,RAB44,Ras-related protein Rab-44,39919,0.0156979131521222,0.00463531434296192,0.00661269703991687,0.0247831292643276,0.000710076421978406
NMR metabolomics,X23424.Total Lipids in VLDL,CD163,Scavenger receptor cysteine-rich type 1 protein M130,42217,0.015078999214985,0.0044567742881371,0.00634372161023628,0.0238142768197337,0.000717990194812747
NMR metabolomics,X23424.Total Lipids in VLDL,FCRL5,Fc receptor-like protein 5,42137,-0.0206437399946664,0.0061021044418283,-0.0326038647006498,-0.0086836152886829,0.000718880474173416
NMR metabolomics,X23424.Total Lipids in VLDL,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",42085,-0.0222635220902274,0.00658270308261742,-0.0351656201321576,-0.00936142404829727,0.000721319083506186
NMR metabolomics,X23424.Total Lipids in VLDL,DSG4,Desmoglein-4,42018,0.0167014994833433,0.00494267712436596,0.00701385231958598,0.0263891466471005,0.000729466863992982
NMR metabolomics,X23424.Total Lipids in VLDL,KEL,Kell blood group glycoprotein,41839,0.0125721986132857,0.00373398290785885,0.00525359211388234,0.019890805112689,0.000762160263690646
NMR metabolomics,X23424.Total Lipids in VLDL,SORBS1,Sorbin and SH3 domain-containing protein 1,39934,0.0136015341966018,0.00404660437701549,0.0056701896176515,0.0215328787755522,0.000778549609860402
NMR metabolomics,X23424.Total Lipids in VLDL,MMP12,Macrophage metalloelastase,42146,0.0188870943889035,0.00563912135072023,0.00783441654149182,0.0299397722363151,0.000812378231752192
NMR metabolomics,X23424.Total Lipids in VLDL,ART3,Ecto-ADP-ribosyltransferase 3,42217,-0.0123750436776626,0.00369941215161701,-0.0196258914948319,-0.00512419586049322,0.000824638582152101
NMR metabolomics,X23424.Total Lipids in VLDL,SCGB1A1,Uteroglobin,42165,0.0184718497462995,0.00552765850261172,0.00763763908118056,0.0293060604114185,0.000834879702969393
NMR metabolomics,X23424.Total Lipids in VLDL,FCER2,Low affinity immunoglobulin epsilon Fc receptor,42137,0.0183408761026375,0.00549085338305174,0.00757880347185611,0.0291029487334189,0.000839263181755994
NMR metabolomics,X23424.Total Lipids in VLDL,SEPTIN8,Septin-8,39906,0.0112559367563314,0.00337123415400699,0.00464831781447767,0.0178635556981851,0.000844076031900924
NMR metabolomics,X23424.Total Lipids in VLDL,GGA1,ADP-ribosylation factor-binding protein GGA1,41839,0.0230239455360772,0.00689688212677278,0.00950605656760252,0.0365418345045518,0.000845214446991765
NMR metabolomics,X23424.Total Lipids in VLDL,FUCA1,Tissue alpha-L-fucosidase,42212,0.0287907074953373,0.00863183953359616,0.0118723020094888,0.0457091129811857,0.000854020137249944
NMR metabolomics,X23424.Total Lipids in VLDL,EPHB6,Ephrin type-B receptor 6,41997,0.0112546266093562,0.0033832055875245,0.00462354365780823,0.0178857095609043,0.000881438182871856
NMR metabolomics,X23424.Total Lipids in VLDL,NME3,Nucleoside diphosphate kinase 3,42144,0.00819395250774105,0.00246536888899453,0.00336182948531178,0.0130260755301703,0.000890924126093501
NMR metabolomics,X23424.Total Lipids in VLDL,CD99,CD99 antigen,42137,-0.00680637941445483,0.00205672740735866,-0.0108375651328778,-0.00277519369603185,0.000937654128360506
NMR metabolomics,X23424.Total Lipids in VLDL,HMOX1,Heme oxygenase 1,42007,-0.0168042371720808,0.00508076615841936,-0.0267625388425828,-0.00684593550157889,0.000944066930242459
NMR metabolomics,X23424.Total Lipids in VLDL,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,39934,0.01072981309982,0.00324461334938272,0.00437037093502988,0.0170892552646101,0.000946070854001446
NMR metabolomics,X23424.Total Lipids in VLDL,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",39560,0.0192284500141813,0.00587781735300287,0.00770792800229566,0.0307489720260669,0.00107362803790896
NMR metabolomics,X23424.Total Lipids in VLDL,LSM1,U6 snRNA-associated Sm-like protein LSm1,41843,0.0182711780114156,0.00558642123896757,0.00732179238303916,0.029220563639792,0.00107578271170502
NMR metabolomics,X23424.Total Lipids in VLDL,BCL7B,B-cell CLL/lymphoma 7 protein family member B,39919,0.0155286052473329,0.00476696145402504,0.00618536079744387,0.024871849697222,0.00112710384744239
NMR metabolomics,X23424.Total Lipids in VLDL,PSME2,Proteasome activator complex subunit 2,41955,0.0118417454826532,0.00363970745897358,0.00470791886306496,0.0189755721022414,0.001142807465056
NMR metabolomics,X23424.Total Lipids in VLDL,KLK15,Kallikrein-15,39900,0.0175472216465009,0.00543162381895687,0.00690123896134544,0.0281932043316563,0.00123898749547461
NMR metabolomics,X23424.Total Lipids in VLDL,BCAM,Basal cell adhesion molecule,42137,-0.00815072337221705,0.0025333000768752,-0.0131159915228924,-0.00318545522154167,0.00129647547809563
NMR metabolomics,X23424.Total Lipids in VLDL,PRR4,Proline-rich protein 4,39652,-0.0236214115176856,0.00734648934631346,-0.03802053063646,-0.00922229239891125,0.00130667818637599
NMR metabolomics,X23424.Total Lipids in VLDL,ACSL1,Long-chain-fatty-acid--CoA ligase 1,39575,-0.0123228751981996,0.00384214266385134,-0.0198534748193482,-0.00479227557705096,0.00134375124274003
NMR metabolomics,X23424.Total Lipids in VLDL,NAPRT,Nicotinate phosphoribosyltransferase,39929,0.0110892506756504,0.00346197248276307,0.00430378460943478,0.017874716741866,0.00136304582874939
NMR metabolomics,X23424.Total Lipids in VLDL,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,39736,-0.0138460880969716,0.00432629695747755,-0.0223256301336276,-0.00536654606031559,0.00137599093302393
NMR metabolomics,X23424.Total Lipids in VLDL,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,39575,0.0152705237912339,0.00477261793198781,0.00591619264453782,0.02462485493793,0.00138004226943779
NMR metabolomics,X23424.Total Lipids in VLDL,PDIA5,Protein disulfide-isomerase A5,39560,0.0203756746430473,0.00637735677880751,0.00787605535658457,0.03287529392951,0.00140225415388951
NMR metabolomics,X23424.Total Lipids in VLDL,GOT1,"Aspartate aminotransferase, cytoplasmic",39966,0.0143009563396001,0.00448144648443327,0.00551732123011091,0.0230845914490893,0.00142094288238696
NMR metabolomics,X23424.Total Lipids in VLDL,CDH1,Cadherin-1,41697,0.0131852322886956,0.00414366588815319,0.00506364714791537,0.0213068174294759,0.00146592623464476
NMR metabolomics,X23424.Total Lipids in VLDL,GLP1R,Glucagon-like peptide 1 receptor,39586,-0.0123156272716559,0.00387169000576396,-0.0199041396829533,-0.00472711486035857,0.00147204374343089
NMR metabolomics,X23424.Total Lipids in VLDL,EXTL1,Exostosin-like 1,39575,0.0156110344002924,0.00492031980419247,0.00596720758407519,0.0252548612165097,0.00151409261629276
NMR metabolomics,X23424.Total Lipids in VLDL,HLA_DRA,,42060,-0.0118834286120548,0.00375272436920253,-0.0192387683756917,-0.00452808884841782,0.00154569163538056
NMR metabolomics,X23424.Total Lipids in VLDL,SLC12A2,Solute carrier family 12 member 2,39575,-0.00862902945008357,0.00273047491464127,-0.0139807602827805,-0.00327729861738668,0.00158052949494038
NMR metabolomics,X23424.Total Lipids in VLDL,CCDC28A,Coiled-coil domain-containing protein 28A,39649,0.00983226188751309,0.00311264658665669,0.00373147457766597,0.0159330491973602,0.00158841057202218
NMR metabolomics,X23424.Total Lipids in VLDL,MST1,Hepatocyte growth factor-like protein,39854,0.0219924128721217,0.0069677812815965,0.00833556156019259,0.0356492641840509,0.00160205455773755
NMR metabolomics,X23424.Total Lipids in VLDL,DLL4,Delta-like protein 4,39638,0.0287453160828828,0.00911885955793162,0.0108723513493368,0.0466182808164288,0.00162427270148577
NMR metabolomics,X23424.Total Lipids in VLDL,IL36G,Interleukin-36 gamma,39624,0.02188626523421,0.00694895387257926,0.00826631564395462,0.0355062148244653,0.00163943809251068
NMR metabolomics,X23424.Total Lipids in VLDL,CTRL,Chymotrypsin-like protease CTRL-1,39929,-0.0231402426833669,0.00735148409081234,-0.0375491515013591,-0.00873133386537466,0.00164989135894732
NMR metabolomics,X23424.Total Lipids in VLDL,NDRG1,Protein NDRG1,41839,0.0213399473620691,0.0068119186507857,0.00798858680652918,0.0346913079176091,0.00173562409921071
NMR metabolomics,X23424.Total Lipids in VLDL,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,42072,0.00866600918547573,0.00277220885881527,0.0032324798221978,0.0140995385487537,0.00177559953886523
NMR metabolomics,X23424.Total Lipids in VLDL,SNX18,Sorting nexin-18,39930,0.014098330479909,0.00452082415839046,0.00523751512946371,0.0229591458303543,0.00182210509852083
NMR metabolomics,X23424.Total Lipids in VLDL,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,42122,0.0189322675636987,0.00607233125944668,0.0070304982951832,0.0308340368322142,0.00182593426786271
NMR metabolomics,X23424.Total Lipids in VLDL,AHNAK2,Protein AHNAK2,39638,0.0100248865587816,0.00322116441786894,0.00371140429975845,0.0163383688178047,0.00186176987846176
NMR metabolomics,X23424.Total Lipids in VLDL,EPHX2,Bifunctional epoxide hydrolase 2,41900,0.0195727859139769,0.00628961664766867,0.00724513728454628,0.0319004345434075,0.00186268372243469
NMR metabolomics,X23424.Total Lipids in VLDL,PDRG1,p53 and DNA damage-regulated protein 1,39649,0.0161952970133281,0.00521854696496554,0.00596694496199565,0.0264236490646605,0.00191786595440989
NMR metabolomics,X23424.Total Lipids in VLDL,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",39730,-0.019890496351292,0.00641212690008566,-0.0324582650754599,-0.00732272762712405,0.00192690895478935
NMR metabolomics,X23424.Total Lipids in VLDL,IL17RA,Interleukin-17 receptor A,42137,0.0141790944829429,0.00457901753787681,0.00520422010870435,0.0231539688571814,0.00196195942625452
NMR metabolomics,X23424.Total Lipids in VLDL,CELA2A,Chymotrypsin-like elastase family member 2A,39966,0.0205527004993324,0.00664721536113535,0.00752415839150711,0.0335812426071577,0.00199343588111263
NMR metabolomics,X23424.Total Lipids in VLDL,PLA2G1B,Phospholipase A2,42299,-0.0142078924476024,0.00459806989182211,-0.0232201094355737,-0.00519567545963107,0.00200578628700552
NMR metabolomics,X23424.Total Lipids in VLDL,SIGLEC6,Sialic acid-binding Ig-like lectin 6,42262,0.0106778931758194,0.00345620770196238,0.0039037260799731,0.0174520602716656,0.00200908136756625
NMR metabolomics,X23424.Total Lipids in VLDL,CLSTN1,Calsyntenin-1,41839,0.0161243323632974,0.00522894473790316,0.00587560067700725,0.0263730640495876,0.00204886032565126
NMR metabolomics,X23424.Total Lipids in VLDL,IL4R,Interleukin-4 receptor subunit alpha,42119,-0.0118651058303526,0.00386411507284597,-0.0194387713731307,-0.0042914402875745,0.00214061513258458
NMR metabolomics,X23424.Total Lipids in VLDL,PON1,Serum paraoxonase/arylesterase 1,39990,-0.00858635024383831,0.00280117730459744,-0.0140766577608493,-0.00309604272682732,0.00217986296435598
NMR metabolomics,X23424.Total Lipids in VLDL,CGA,Glycoprotein hormones alpha chain,42137,-0.0195638084171723,0.00638434995655469,-0.0320771343320195,-0.00705048250232509,0.00218581075129823
NMR metabolomics,X23424.Total Lipids in VLDL,S100A16,Protein S100-A16,41814,-0.0192175520141374,0.00628148201236268,-0.0315292567583682,-0.00690584726990652,0.00222226688931653
NMR metabolomics,X23424.Total Lipids in VLDL,PREB,Prolactin regulatory element-binding protein,41913,0.0089508405095934,0.00292722367090196,0.00321348211462556,0.0146881989045612,0.00223416872431082
NMR metabolomics,X23424.Total Lipids in VLDL,TERF1,Telomeric repeat-binding factor 1,39657,-0.00918548766434208,0.00300691403157905,-0.015079039166237,-0.00329193616244714,0.00225755160228145
NMR metabolomics,X23424.Total Lipids in VLDL,NINJ1,Ninjurin-1,41843,0.0170725400539684,0.00560631280510852,0.00608416695595568,0.0280609131519811,0.00232955388613925
NMR metabolomics,X23424.Total Lipids in VLDL,MPO,Myeloperoxidase,42137,0.0141302094201629,0.00464188402756864,0.00503211672612837,0.0232283021141974,0.00233850593516028
NMR metabolomics,X23424.Total Lipids in VLDL,ALCAM,CD166 antigen,42310,0.00618009248914561,0.00203109174698754,0.00219915266505003,0.0101610323132412,0.00234875176111038
NMR metabolomics,X23424.Total Lipids in VLDL,PCDHB15,Protocadherin beta-15,39919,-0.0125135245812986,0.00411573430666588,-0.0205803638223638,-0.00444668534023352,0.0023679539533785
NMR metabolomics,X23424.Total Lipids in VLDL,RANBP2,E3 SUMO-protein ligase RanBP2,39586,-0.0104465298518021,0.00343776774529108,-0.0171845546325726,-0.00370850507103157,0.00238117258069101
NMR metabolomics,X23424.Total Lipids in VLDL,CEP164,Centrosomal protein of 164 kDa,41913,0.0194783516962169,0.00642494155801882,0.00688546624250001,0.0320712371499338,0.0024366641433989
NMR metabolomics,X23424.Total Lipids in VLDL,CD248,Endosialin,39966,-0.0126428759654322,0.00418533662014459,-0.0208461357409156,-0.00443961618994885,0.00252705908900719
NMR metabolomics,X23424.Total Lipids in VLDL,AOC1,Amiloride-sensitive amine oxidase [copper-containing],41913,0.0167459396658388,0.00555948884932665,0.00584934152115857,0.027642537810519,0.0025990303442949
NMR metabolomics,X23424.Total Lipids in VLDL,SOX9,Transcription factor SOX-9,39649,0.00859090337727818,0.00285553659956721,0.00299405164212645,0.0141877551124299,0.00263125796366429
NMR metabolomics,X23424.Total Lipids in VLDL,CDH17,Cadherin-17,42145,-0.0211020704051255,0.00703499394968106,-0.0348906585465004,-0.00731348226375064,0.00270838108581127
NMR metabolomics,X23424.Total Lipids in VLDL,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,42185,0.0134581638920952,0.00450711207556413,0.00462422422398954,0.0222921035602009,0.00283171468771655
NMR metabolomics,X23424.Total Lipids in VLDL,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,42310,0.0215823144205938,0.00723208914625676,0.00740741969393053,0.035757209147257,0.00284781605565735
NMR metabolomics,X23424.Total Lipids in VLDL,LAYN,Layilin,41997,-0.0110021196617895,0.0036948665888906,-0.0182440581760151,-0.00376018114756393,0.00290961507199449
NMR metabolomics,X23424.Total Lipids in VLDL,BLVRB,Flavin reductase,42137,0.019497737551476,0.00657511906180166,0.00661050419034477,0.0323849709126073,0.00302834958269746
NMR metabolomics,X23424.Total Lipids in VLDL,DCTPP1,dCTP pyrophosphatase 1,42145,0.00966559696414789,0.00326619258991573,0.00326385948791307,0.0160673344403827,0.00308886654079576
NMR metabolomics,X23424.Total Lipids in VLDL,KIF20B,Kinesin-like protein KIF20B,39586,0.0228702491104539,0.00772892941109439,0.00772154746470892,0.0380189507561989,0.00309252364427356
NMR metabolomics,X23424.Total Lipids in VLDL,CD59,CD59 glycoprotein,41638,0.00719876691991011,0.00243590716140724,0.00242438888355193,0.0119731449562683,0.00312952850192556
NMR metabolomics,X23424.Total Lipids in VLDL,LY9,T-lymphocyte surface antigen Ly-9,41960,0.00925937047766638,0.0031360191154132,0.00311277301145651,0.0154059679438763,0.00315671140943187
NMR metabolomics,X23424.Total Lipids in VLDL,SELL,L-selectin,39979,0.00710742906761649,0.00241042851097402,0.00238298918610741,0.0118318689491256,0.0031984881413497
NMR metabolomics,X23424.Total Lipids in VLDL,LMOD1,Leiomodin-1,39934,-0.0105365539833486,0.00358402758355185,-0.0175612480471102,-0.00351185991958696,0.00329019212086939
NMR metabolomics,X23424.Total Lipids in VLDL,SEMA6C,Semaphorin-6C,39657,0.00783691708595385,0.00266875589297031,0.00260615553573203,0.0130676786361757,0.00332576628903798
NMR metabolomics,X23424.Total Lipids in VLDL,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,42016,0.0210725924093547,0.00718702677398373,0.00698601993234656,0.0351591648863628,0.00337320868258845
NMR metabolomics,X23424.Total Lipids in VLDL,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,39930,0.0152769781667943,0.00521605705295382,0.00505350634300479,0.0255004499905838,0.00340911220011713
NMR metabolomics,X23424.Total Lipids in VLDL,HCG22,Protein PBMUCL2,39575,-0.0175814015005792,0.00600463457658759,-0.0293504852706909,-0.00581231773046755,0.00341881835352872
NMR metabolomics,X23424.Total Lipids in VLDL,EIF5,Eukaryotic translation initiation factor 5,39575,0.012880627272382,0.00439978042962433,0.00425705763031834,0.0215041969144457,0.00342333178697595
NMR metabolomics,X23424.Total Lipids in VLDL,CPTP,Ceramide-1-phosphate transfer protein,39575,-0.0119187027218026,0.00407218980103739,-0.0199001947318359,-0.00393721071176928,0.00343112738374116
NMR metabolomics,X23424.Total Lipids in VLDL,NCAM1,Neural cell adhesion molecule 1,42217,0.00980549359668486,0.00337625905994427,0.00318802583919409,0.0164229613541756,0.00368728233192271
NMR metabolomics,X23424.Total Lipids in VLDL,CTHRC1,Collagen triple helix repeat-containing protein 1,39966,0.00852498986642218,0.00293959106542372,0.00276339137819169,0.0142865883546527,0.00373806323343688
NMR metabolomics,X23424.Total Lipids in VLDL,ARG1,Arginase-1,42015,0.0151244347196347,0.00521632375271465,0.00490044016431401,0.0253484292749554,0.00374432343266909
NMR metabolomics,X23424.Total Lipids in VLDL,NLGN2,Neuroligin-2,39586,-0.0139729018037216,0.00483353656595703,-0.0234466334729974,-0.00449917013444586,0.0038498656736742
NMR metabolomics,X23424.Total Lipids in VLDL,MERTK,Tyrosine-protein kinase Mer,42296,0.00735426952317193,0.002546255510903,0.00236360872180205,0.0123449303245418,0.00387975926847929
NMR metabolomics,X23424.Total Lipids in VLDL,GZMH,Granzyme H,41900,0.0234234671372908,0.00812146049126504,0.00750540457441132,0.0393415297001703,0.00393108267927954
NMR metabolomics,X23424.Total Lipids in VLDL,S100A14,Protein S100-A14,39934,0.0154270154111309,0.00535035945729797,0.00494031087482693,0.025913719947435,0.00394197117092713
NMR metabolomics,X23424.Total Lipids in VLDL,PRDX2,Peroxiredoxin-2,39819,0.0179865952301455,0.00623906921281866,0.00575801957302092,0.0302151708872701,0.00394784564561704
NMR metabolomics,X23424.Total Lipids in VLDL,CST7,Cystatin-F,42148,0.0279947048233684,0.00974119690502187,0.00890195888952551,0.0470874507572112,0.00406136611106179
NMR metabolomics,X23424.Total Lipids in VLDL,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,42016,0.0311428869441704,0.0108481725869901,0.00988046867366982,0.0524053052146709,0.00410080640334059
NMR metabolomics,X23424.Total Lipids in VLDL,TOP1,DNA topoisomerase 1,39930,0.0357906402782613,0.0124680476418622,0.0113532669002114,0.0602280136563111,0.00410466700848394
NMR metabolomics,X23424.Total Lipids in VLDL,NTF3,Neurotrophin-3,42119,0.010186711807793,0.00355178649464765,0.00322521027828359,0.0171482133373024,0.00413645372889986
NMR metabolomics,X23424.Total Lipids in VLDL,SYT1,Synaptotagmin-1,39929,0.0118720040798786,0.00414024528963123,0.00375712331220137,0.0199868848475558,0.00414539377145297
NMR metabolomics,X23424.Total Lipids in VLDL,IL15,Interleukin-15,42119,0.00974365275948161,0.00339851528099945,0.00308256280872269,0.0164047427102405,0.00414981078240189
NMR metabolomics,X23424.Total Lipids in VLDL,ITGAV,Integrin alpha-V,42262,0.00489308505459929,0.00171442419611919,0.00153281363020566,0.00825335647899291,0.0043228068977033
NMR metabolomics,X23424.Total Lipids in VLDL,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,42310,0.0080941997578604,0.00283614607600276,0.00253535344889499,0.0136530460668258,0.00432449629411896
NMR metabolomics,X23424.Total Lipids in VLDL,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,39958,0.0220572227354561,0.00773650722243607,0.00689366857948139,0.0372207768914308,0.00436527033684695
NMR metabolomics,X23424.Total Lipids in VLDL,LYPD8,Ly6/PLAUR domain-containing protein 8,41843,0.0153233043229107,0.00538251240983119,0.00477357999964159,0.0258730286461799,0.0044219501180651
NMR metabolomics,X23424.Total Lipids in VLDL,CD300E,CMRF35-like molecule 2,42232,0.0122683975361396,0.00431075383420143,0.0038193200211048,0.0207174750511744,0.00443385049916794
NMR metabolomics,X23424.Total Lipids in VLDL,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",39929,0.016457868022531,0.00578501690205107,0.0051192348945109,0.0277965011505511,0.00445032487078767
NMR metabolomics,X23424.Total Lipids in VLDL,OSBPL2,Oxysterol-binding protein-related protein 2,39929,0.0112455775198406,0.00397007723477238,0.0034642261396867,0.0190269288999944,0.00462549210596971
NMR metabolomics,X23424.Total Lipids in VLDL,SERPINA11,Serpin A11,42310,-0.012203454691564,0.00431058174502033,-0.0206521949118039,-0.0037547144713242,0.00464635964367419
NMR metabolomics,X23424.Total Lipids in VLDL,ARTN,Artemin,41913,0.0131953920442715,0.00466655822766801,0.00404893791804219,0.0223418461705008,0.00469610668839106
NMR metabolomics,X23424.Total Lipids in VLDL,STX5,Syntaxin-5,39657,0.0116249080382299,0.00411358810596059,0.00356227535054713,0.0196875407259126,0.0047221081831688
NMR metabolomics,X23424.Total Lipids in VLDL,CLMP,CXADR-like membrane protein,42262,0.00642466156195077,0.00228301879676051,0.00194994472030018,0.0108993784036014,0.00489826971339748
NMR metabolomics,X23424.Total Lipids in VLDL,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,39979,-0.00563233005531623,0.00200425989184668,-0.00956067944333572,-0.00170398066729674,0.00495984246254259
NMR metabolomics,X23424.Total Lipids in VLDL,INHBB,Inhibin beta B chain,39736,0.0151450382037035,0.00540281122328141,0.00455552820607196,0.0257345482013351,0.00506893303899188
NMR metabolomics,X23424.Total Lipids in VLDL,GUK1,Guanylate kinase,39575,-0.0116203935603561,0.00416128241605938,-0.0197765070958324,-0.00346428002487969,0.00523924972336984
NMR metabolomics,X23424.Total Lipids in VLDL,RAD51,DNA repair protein RAD51 homolog 1,39757,0.0151505797904573,0.00542804297745916,0.0045116155546373,0.0257895440262772,0.00526074560239895
NMR metabolomics,X23424.Total Lipids in VLDL,CCAR2,Cell cycle and apoptosis regulator protein 2,39929,0.0160477145584336,0.00575275569904056,0.00477231338831412,0.0273231157285531,0.00528662362277984
NMR metabolomics,X23424.Total Lipids in VLDL,SLURP1,Secreted Ly-6/uPAR-related protein 1,39908,0.0104827558308632,0.00375982346720876,0.00311350183513407,0.0178520098265924,0.00531070658390026
NMR metabolomics,X23424.Total Lipids in VLDL,BMP4,Bone morphogenetic protein 4,41992,-0.0135792505621047,0.00488672614497868,-0.0231572338062629,-0.00400126731794649,0.00546355702496094
NMR metabolomics,X23424.Total Lipids in VLDL,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,41900,0.0102275577739787,0.00368072948631389,0.00301332798080347,0.0174417875671539,0.00546573504729767
NMR metabolomics,X23424.Total Lipids in VLDL,SPON1,Spondin-1,42144,0.00934661731973373,0.00336540791534387,0.00275041780565974,0.0159428168338077,0.00548944462715646
NMR metabolomics,X23424.Total Lipids in VLDL,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",39649,-0.0160788492833466,0.00580535137347635,-0.0274573379753602,-0.00470036059133292,0.00562084863607141
NMR metabolomics,X23424.Total Lipids in VLDL,CDH6,Cadherin-6,42145,-0.0111128954049451,0.00401410608646255,-0.0189805433344117,-0.0032452474754785,0.00563983031559453
NMR metabolomics,X23424.Total Lipids in VLDL,GSAP,Gamma-secretase-activating protein,41843,0.024037465371075,0.00869423518992368,0.00699676439882459,0.0410781663433254,0.00570436616023102
NMR metabolomics,X23424.Total Lipids in VLDL,TTN,Titin,39575,-0.0197809216845589,0.00715975218269806,-0.0338140359626471,-0.00574780740647072,0.00574043167909374
NMR metabolomics,X23424.Total Lipids in VLDL,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,39635,0.0111168419119772,0.00403901355931545,0.0032003753357189,0.0190333084882355,0.00592630875284526
NMR metabolomics,X23424.Total Lipids in VLDL,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,39539,-0.0152965136463674,0.00556400166016755,-0.0262019569002958,-0.00439107039243903,0.00598402703647871
NMR metabolomics,X23424.Total Lipids in VLDL,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,39638,0.0102853421009162,0.00374254104936394,0.00294996164416293,0.0176207225576696,0.0060016342372402
NMR metabolomics,X23424.Total Lipids in VLDL,CSRP3,Cysteine and glycine-rich protein 3,39575,-0.0287304280848397,0.0104629024064788,-0.0492377168015382,-0.00822313936814126,0.00604373823717493
NMR metabolomics,X23424.Total Lipids in VLDL,DPEP1,Dipeptidase 1,41997,-0.0129851790862329,0.00474168881240522,-0.0222788891585471,-0.00369146901391862,0.00617991662433257
NMR metabolomics,X23424.Total Lipids in VLDL,CD109,CD109 antigen,42137,-0.00963925766437362,0.00352146251047642,-0.0165413241849074,-0.00273719114383983,0.00620288794656659
NMR metabolomics,X23424.Total Lipids in VLDL,OLFM4,Olfactomedin-4,39347,0.0350700706219872,0.0128213282221509,0.00994026730657148,0.0601998739374028,0.00624272818966159
NMR metabolomics,X23424.Total Lipids in VLDL,RNF31,E3 ubiquitin-protein ligase RNF31,39657,0.0102631526529641,0.00375665507567944,0.00290010870463245,0.0176261966012958,0.00630525487801516
NMR metabolomics,X23424.Total Lipids in VLDL,BATF,Basic leucine zipper transcriptional factor ATF-like,39649,0.0228530116846398,0.00836604575616304,0.0064555620025602,0.0392504613667193,0.00631203348192892
NMR metabolomics,X23424.Total Lipids in VLDL,LPCAT2,Lysophosphatidylcholine acyltransferase 2,42070,0.0115395302431202,0.00422610328537049,0.00325636780379408,0.0198226926824464,0.00633135172902521
NMR metabolomics,X23424.Total Lipids in VLDL,FAM171B,Protein FAM171B,39919,0.00748371982007672,0.00274297184351653,0.00210749500678431,0.0128599446333691,0.00637550092725236
NMR metabolomics,X23424.Total Lipids in VLDL,HRAS,GTPase Hras,39750,0.0278890856520486,0.0102442314443948,0.00781039202103482,0.0479677792830624,0.00649067447410667
NMR metabolomics,X23424.Total Lipids in VLDL,SPINK1,Serine protease inhibitor Kazal-type 1,42137,-0.0118104157159198,0.00435734436777664,-0.020350810676762,-0.00327002075507759,0.00672742475715563
NMR metabolomics,X23424.Total Lipids in VLDL,TGFBR3,Transforming growth factor beta receptor type 3,42310,-0.00838759199388973,0.00309898210132477,-0.0144615969124863,-0.00231358707529318,0.00680677249261059
NMR metabolomics,X23424.Total Lipids in VLDL,LRRC25,Leucine-rich repeat-containing protein 25,42070,0.0108910211876573,0.00405906380607062,0.00293525612775888,0.0188467862475557,0.0073024346711183
NMR metabolomics,X23424.Total Lipids in VLDL,PLA2G2A,"Phospholipase A2, membrane associated",42135,-0.0146764229940686,0.00547155883433229,-0.0254006783093599,-0.00395216767877733,0.00732041991618888
NMR metabolomics,X23424.Total Lipids in VLDL,DCUN1D2,DCN1-like protein 2,39560,-0.0221401621854224,0.00825868504443273,-0.0383271848725105,-0.00595313949833421,0.0073548873970365
NMR metabolomics,X23424.Total Lipids in VLDL,TNFSF8,Tumor necrosis factor ligand superfamily member 8,39966,0.010223116597469,0.00381665841016474,0.00274246611354614,0.0177037670813919,0.00740477039338857
NMR metabolomics,X23424.Total Lipids in VLDL,CEP290,Centrosomal protein of 290 kDa,39757,0.0146574964217583,0.0054823259486924,0.00391213756232117,0.0254028552811954,0.00751532028246534
NMR metabolomics,X23424.Total Lipids in VLDL,GFRA2,GDNF family receptor alpha-2,42070,0.00573865178683898,0.00215398667550278,0.00151683790285352,0.00996046567082444,0.00772635034135864
NMR metabolomics,X23424.Total Lipids in VLDL,SOD3,Extracellular superoxide dismutase,39990,-0.0167080387106907,0.00627638760807211,-0.029009758422512,-0.00440631899886934,0.00777760930965724
NMR metabolomics,X23424.Total Lipids in VLDL,CRTAM,Cytotoxic and regulatory T-cell molecule,42016,-0.0140910482653389,0.00529370729117214,-0.0244667145560363,-0.00371538197464151,0.00778053973227838
NMR metabolomics,X23424.Total Lipids in VLDL,KIAA1549L,UPF0606 protein KIAA1549L,39757,-0.00752515212597691,0.00282707699005468,-0.0130662230264841,-0.00198408122546974,0.00778322703305293
NMR metabolomics,X23424.Total Lipids in VLDL,IGLC2,Immunoglobulin lambda constant 2,39963,-0.00702359463509085,0.00264843420612619,-0.0122145256790982,-0.0018326635910835,0.00801323879295049
NMR metabolomics,X23424.Total Lipids in VLDL,NECTIN4,Nectin-4,42181,-0.00919234016986284,0.0034676391362888,-0.0159889128769889,-0.0023957674627368,0.00803724055886399
NMR metabolomics,X23424.Total Lipids in VLDL,GPR101,Probable G-protein coupled receptor 101,39586,-0.0159160908095505,0.00600804717473196,-0.0276918632720251,-0.00414031834707585,0.00808150271366374
NMR metabolomics,X23424.Total Lipids in VLDL,BTN2A1,Butyrophilin subfamily 2 member A1,42185,0.00743917500953503,0.00280876011911775,0.00193400517606424,0.0129443448430058,0.0080928495682847
NMR metabolomics,X23424.Total Lipids in VLDL,LEG1,Protein LEG1 homolog,39398,-0.01922194222974,0.00730865305040153,-0.033546902208527,-0.00489698225095299,0.00854996297410059
NMR metabolomics,X23424.Total Lipids in VLDL,VEGFD,Vascular endothelial growth factor D,42275,-0.0104490684687807,0.00398273588576227,-0.0182552308048747,-0.00264290613268662,0.00871048992334734
NMR metabolomics,X23424.Total Lipids in VLDL,TGFBR2,TGF-beta receptor type-2,42181,0.00923391938277609,0.00353368068657771,0.00230790523708378,0.0161599335284684,0.00898195891684968
NMR metabolomics,X23424.Total Lipids in VLDL,ENDOU,Poly(U)-specific endoribonuclease,39090,0.0152743861584553,0.00584888668360015,0.00381056825859899,0.0267382040583116,0.00902735001981459
NMR metabolomics,X23424.Total Lipids in VLDL,CPVL,Probable serine carboxypeptidase CPVL,42223,0.0110595018720322,0.00423584390809213,0.0027572478121716,0.0193617559318927,0.00903946683942273
NMR metabolomics,X23424.Total Lipids in VLDL,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,41619,0.0102687988447724,0.00393604850178822,0.00255414378126752,0.0179834539082773,0.00909347863097176
NMR metabolomics,X23424.Total Lipids in VLDL,RNASET2,Ribonuclease T2,42258,0.00720814801648654,0.00276654389084733,0.00178572199042577,0.0126305740425473,0.00918477220848531
NMR metabolomics,X23424.Total Lipids in VLDL,TSC1,Hamartin,39657,0.0199103115891444,0.00765303025529538,0.00491037228876541,0.0349102508895233,0.00929070096615813
NMR metabolomics,X23424.Total Lipids in VLDL,CALB1,Calbindin,42070,0.0121062064398413,0.00466888891213743,0.00295518417205193,0.0212572287076307,0.00952588151310914
NMR metabolomics,X23424.Total Lipids in VLDL,CSF1R,Macrophage colony-stimulating factor 1 receptor,39990,0.0109296166216001,0.0042175328423213,0.00266325225065035,0.0191959809925499,0.00956883516156593
NMR metabolomics,X23424.Total Lipids in VLDL,DPP7,Dipeptidyl peptidase 2,42054,0.016777661076941,0.00648455113020795,0.00406794086173342,0.0294873812921486,0.00968273283672093
NMR metabolomics,X23424.Total Lipids in VLDL,PLB1,"Phospholipase B1, membrane-associated",39929,0.0158536771018657,0.00613232552482394,0.00383431907321078,0.0278730351305206,0.00974283643162808
NMR metabolomics,X23424.Total Lipids in VLDL,FRMD7,FERM domain-containing protein 7,39649,0.00906435572184705,0.00351238774069123,0.00218007575009224,0.0159486356936019,0.0098733148587775
NMR metabolomics,X23424.Total Lipids in VLDL,APOBR,Apolipoprotein B receptor,39638,-0.0114574310968576,0.00444166023908011,-0.0201630851654546,-0.00275177702826057,0.00990607160606625
NMR metabolomics,X23424.Total Lipids in VLDL,MFAP4,Microfibril-associated glycoprotein 4,39736,-0.00877218665492727,0.00341463696067226,-0.0154648750978449,-0.00207949821200964,0.010212284603835
NMR metabolomics,X23424.Total Lipids in VLDL,PNMA2,Paraneoplastic antigen Ma2,39586,0.0117949007055578,0.00460039626346395,0.00277812402916848,0.0208116773819472,0.0103638747005069
NMR metabolomics,X23424.Total Lipids in VLDL,SCP2,Non-specific lipid-transfer protein,41843,0.0195884758077352,0.00766019249119531,0.00457449852499237,0.034602453090478,0.0105635636231971
NMR metabolomics,X23424.Total Lipids in VLDL,GPR158,Probable G-protein coupled receptor 158,39934,0.00912070110096852,0.00358234492763014,0.00209930504281345,0.0161420971591236,0.0109091941952401
NMR metabolomics,X23424.Total Lipids in VLDL,DNPEP,Aspartyl aminopeptidase,39929,0.0149393264413225,0.00588461284509228,0.00340548526494159,0.0264731676177033,0.0111394616798841
NMR metabolomics,X23424.Total Lipids in VLDL,PRKCQ,Protein kinase C theta type,41913,0.0112078076256933,0.00441561567213464,0.00255320090830937,0.0198624143430772,0.0111530627716465
NMR metabolomics,X23424.Total Lipids in VLDL,THY1,Thy-1 membrane glycoprotein,42249,0.00765209066093451,0.00301544196647332,0.0017418244066468,0.0135623569152222,0.0111714639870583
NMR metabolomics,X23424.Total Lipids in VLDL,LAMTOR5,Ragulator complex protein LAMTOR5,39919,0.0106876223396975,0.00421764574823715,0.00242103667315269,0.0189542080062423,0.0112894180404715
NMR metabolomics,X23424.Total Lipids in VLDL,CHEK2,Serine/threonine-protein kinase Chk2,41900,0.00864574045072166,0.00341615697188392,0.00195007278582918,0.0153414081156141,0.0113904638102291
NMR metabolomics,X23424.Total Lipids in VLDL,MYO6,Unconventional myosin-VI,39934,0.00977836859685773,0.003866145515599,0.00220072338628368,0.0173560138074318,0.0114447756928178
NMR metabolomics,X23424.Total Lipids in VLDL,ATXN10,Ataxin-10,41839,0.0190767506759561,0.00756913715019223,0.00424124186157936,0.0339122594903329,0.0117360242768299
NMR metabolomics,X23424.Total Lipids in VLDL,ATF2,Cyclic AMP-dependent transcription factor ATF-2,41839,0.0178300892434959,0.00708404426741206,0.00394536247936822,0.0317148160076235,0.0118497332776277
NMR metabolomics,X23424.Total Lipids in VLDL,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,39930,-0.0188021354370959,0.0074726454028241,-0.0334485204266311,-0.00415575044756067,0.0118788998892837
NMR metabolomics,X23424.Total Lipids in VLDL,CKAP4,Cytoskeleton-associated protein 4,42247,0.00736186758943066,0.00292743657254615,0.00162409190724021,0.0130996432716211,0.0119219686105067
NMR metabolomics,X23424.Total Lipids in VLDL,CAPS,Calcyphosin,39929,0.0246819406562471,0.00981881793645082,0.00543705750080347,0.0439268238116907,0.0119596512658863
NMR metabolomics,X23424.Total Lipids in VLDL,GPC1,Glypican-1,42262,0.00765037485499964,0.00304856137205128,0.00167519456577914,0.0136255551442201,0.0121015819917075
NMR metabolomics,X23424.Total Lipids in VLDL,JCHAIN,Immunoglobulin J chain,41913,-0.0157951399720371,0.0063274944455755,-0.0281970290853651,-0.00339325085870914,0.0125626697231319
NMR metabolomics,X23424.Total Lipids in VLDL,RAB39B,Ras-related protein Rab-39B,39575,0.023796389960371,0.00954635205189947,0.00508553993864802,0.042507239982094,0.012691475655326
NMR metabolomics,X23424.Total Lipids in VLDL,RAC3,Ras-related C3 botulinum toxin substrate 3,39649,0.0177960923110805,0.00714294822211862,0.00379591379572797,0.031796270826433,0.012737874591684
NMR metabolomics,X23424.Total Lipids in VLDL,BOC,Brother of CDO,41900,-0.00597478641412437,0.00239955958811898,-0.0106779232068376,-0.00127164962141117,0.0127881769852157
NMR metabolomics,X23424.Total Lipids in VLDL,NOTCH2,Neurogenic locus notch homolog protein 2,39966,0.00565461982634417,0.00227398929490662,0.00119760080832721,0.0101116388443611,0.0129093929525327
NMR metabolomics,X23424.Total Lipids in VLDL,SIGLEC10,Sialic acid-binding Ig-like lectin 10,42119,0.00884278535204385,0.00356630354078116,0.00185283041211278,0.0158327402919749,0.0131673618737444
NMR metabolomics,X23424.Total Lipids in VLDL,AMIGO1,Amphoterin-induced protein 1,39649,0.0129821215494884,0.00524223054011151,0.00270734969086982,0.023256893408107,0.0132844828324049
NMR metabolomics,X23424.Total Lipids in VLDL,CDK1,Cyclin-dependent kinase 1,39560,0.00928439307534928,0.00377576032337216,0.00188390284153983,0.0166848833091587,0.0139498766259971
NMR metabolomics,X23424.Total Lipids in VLDL,CLEC4D,C-type lectin domain family 4 member D,42119,0.0156409216996501,0.00638633030924803,0.00312371429352391,0.0281581291057762,0.0143329750514728
NMR metabolomics,X23424.Total Lipids in VLDL,PDCD1,Programmed cell death protein 1,42232,0.0105828142311292,0.00432443825855362,0.00210691524436412,0.0190587132178943,0.0144091720275124
NMR metabolomics,X23424.Total Lipids in VLDL,CXCL14,C-X-C motif chemokine 14,41913,0.0143353497608897,0.00590186945271257,0.0027676856335731,0.0259030138882064,0.0151557387098833
NMR metabolomics,X23424.Total Lipids in VLDL,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",39586,0.00796368856776538,0.00328050712118865,0.00153389461023563,0.0143934825252951,0.0152159568843102
NMR metabolomics,X23424.Total Lipids in VLDL,SERPINB5,Serpin B5,41900,0.0121971180678166,0.00502533216194916,0.00234746703039626,0.022046769105237,0.0152321288056816
NMR metabolomics,X23424.Total Lipids in VLDL,RPS10,40S ribosomal protein S10,39575,-0.0104594253525142,0.00431719545447524,-0.0189211284432857,-0.00199772226174274,0.0154201891043641
NMR metabolomics,X23424.Total Lipids in VLDL,UPK3BL1,Uroplakin-3b-like protein 1,39738,-0.0132217305350578,0.00546570731912488,-0.0239345168805426,-0.00250894418957301,0.0155777144667592
NMR metabolomics,X23424.Total Lipids in VLDL,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,39575,-0.00518199971921425,0.00215270469571999,-0.00940130092282543,-0.000962698515603071,0.0160915838197909
NMR metabolomics,X23424.Total Lipids in VLDL,SLC13A1,Solute carrier family 13 member 1,39919,0.014921184103976,0.00620429105434159,0.00276077363746648,0.0270815945704855,0.0161893855845044
NMR metabolomics,X23424.Total Lipids in VLDL,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",41913,0.028720356965503,0.0119574016806927,0.00528384967134535,0.0521568642596607,0.0163242515024421
NMR metabolomics,X23424.Total Lipids in VLDL,CRTAC1,Cartilage acidic protein 1,42310,0.00763173059294163,0.00319563600288008,0.00136828402729667,0.0138951771585866,0.0169458359744505
NMR metabolomics,X23424.Total Lipids in VLDL,LIFR,Leukemia inhibitory factor receptor,42119,-0.00591201527433196,0.00247762711036368,-0.0107681644106448,-0.00105586613801915,0.0170390081049287
NMR metabolomics,X23424.Total Lipids in VLDL,PRG3,Proteoglycan 3,39966,-0.0122089328286553,0.00514378864582251,-0.0222907585744674,-0.00212710708284317,0.0176355228774404
NMR metabolomics,X23424.Total Lipids in VLDL,CASP1,Caspase-1,41839,0.0168460762277387,0.00710986127277825,0.00291074813309332,0.030781404322384,0.0178314293118015
NMR metabolomics,X23424.Total Lipids in VLDL,ART5,Ecto-ADP-ribosyltransferase 5,39586,-0.0151804097957207,0.00640853538534667,-0.0277411391510002,-0.00261968044044128,0.0178640684231791
NMR metabolomics,X23424.Total Lipids in VLDL,CLEC1A,C-type lectin domain family 1 member A,41900,-0.00831615670672424,0.00351737642309119,-0.015210214495983,-0.0014220989174655,0.0180781337150095
NMR metabolomics,X23424.Total Lipids in VLDL,CRHR1,Corticotropin-releasing factor receptor 1,41900,0.0142142623940333,0.00602009142939779,0.00241488319241362,0.026013641595653,0.0182333228666504
NMR metabolomics,X23424.Total Lipids in VLDL,MAEA,E3 ubiquitin-protein transferase MAEA,41843,0.00949859348425178,0.00403047530604699,0.00159886188439968,0.0173983250841039,0.0184529551292844
NMR metabolomics,X23424.Total Lipids in VLDL,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",39934,0.0163601170272461,0.00696219145775978,0.00271422177003693,0.0300060122844553,0.0187979528987264
NMR metabolomics,X23424.Total Lipids in VLDL,DDX39A,ATP-dependent RNA helicase DDX39A,39657,0.00596729848941768,0.00253960430584874,0.000989674049954156,0.0109449229288812,0.018806229601535
NMR metabolomics,X23424.Total Lipids in VLDL,VSTM1,V-set and transmembrane domain-containing protein 1,41839,0.0121463534816607,0.00519001755045893,0.00197391908276115,0.0223187878805602,0.0192814808265365
NMR metabolomics,X23424.Total Lipids in VLDL,RALB,Ras-related protein Ral-B,39657,0.00714849097819814,0.00306712374717212,0.00113692843374077,0.0131600535226555,0.0197880077463759
NMR metabolomics,X23424.Total Lipids in VLDL,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,42016,-0.00694138004930726,0.00297916030934958,-0.0127805342556324,-0.00110222584298209,0.0198220322451061
NMR metabolomics,X23424.Total Lipids in VLDL,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,41843,0.0297107202885527,0.0127744828747597,0.00467273385402363,0.0547487067230818,0.0200449627060309
NMR metabolomics,X23424.Total Lipids in VLDL,KIAA0319,Dyslexia-associated protein KIAA0319,39929,0.0073202187845758,0.00316476048208556,0.00111728823968811,0.0135231493294635,0.0207382406067288
NMR metabolomics,X23424.Total Lipids in VLDL,FABP1,"Fatty acid-binding protein, liver",42123,-0.0226941062516824,0.00981170373088559,-0.0419250455642182,-0.00346316693914666,0.0207396126483785
NMR metabolomics,X23424.Total Lipids in VLDL,PGM2,Phosphoglucomutase-2,39649,0.0145089770320082,0.00627307074828803,0.00221375836536365,0.0268041956986527,0.0207464866926933
NMR metabolomics,X23424.Total Lipids in VLDL,CST6,Cystatin-M,41864,0.0118764079787106,0.00513631094568565,0.00180923852516671,0.0219435774322545,0.0207794351303781
NMR metabolomics,X23424.Total Lipids in VLDL,FLT1,Vascular endothelial growth factor receptor 1,42042,0.00517113449437949,0.00224344531662786,0.000773981673788882,0.00956828731497009,0.0211819059804561
NMR metabolomics,X23424.Total Lipids in VLDL,ALPP,"Alkaline phosphatase, placental type",42070,0.0247460005206869,0.0107531259296068,0.00366987369865749,0.0458221273427163,0.0213907545502352
NMR metabolomics,X23424.Total Lipids in VLDL,PLXDC2,Plexin domain-containing protein 2,39929,0.00651455787540354,0.00283303144564212,0.000961816241944996,0.0120672995088621,0.021494621205828
NMR metabolomics,X23424.Total Lipids in VLDL,C1GALT1C1,C1GALT1-specific chaperone 1,39575,0.00773213900715499,0.00337468453769446,0.00111775731327384,0.0143465207010361,0.0219696486968759
NMR metabolomics,X23424.Total Lipids in VLDL,MTR,Methionine synthase,39575,0.0154403259510163,0.00675480713277055,0.002200903970786,0.0286797479312465,0.0222833066389522
NMR metabolomics,X23424.Total Lipids in VLDL,CD5L,CD5 antigen-like,39925,0.0113572588509283,0.00496867698465182,0.00161865196101077,0.0210958657408459,0.0222860331912265
NMR metabolomics,X23424.Total Lipids in VLDL,AIF1L,Allograft inflammatory factor 1-like,39638,0.0133558936472626,0.00586859912835617,0.00185343935568456,0.0248583479388407,0.0228756715721975
NMR metabolomics,X23424.Total Lipids in VLDL,LMNB2,Lamin-B2,39929,0.00671331031358422,0.00296492458247831,0.000902058131926731,0.0125245624952417,0.023577981380673
NMR metabolomics,X23424.Total Lipids in VLDL,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,42249,0.016339429895798,0.00723815458651569,0.00215264690622728,0.0305262128853688,0.023998658134524
NMR metabolomics,X23424.Total Lipids in VLDL,IL1A,Interleukin-1 alpha,41913,0.0134867956483753,0.00597466565495522,0.00177645096466304,0.0251971403320875,0.0240035592958683
NMR metabolomics,X23424.Total Lipids in VLDL,NEB,Nebulin,39575,-0.00926029348480302,0.00411559282376207,-0.0173268554193767,-0.00119373155022937,0.024465437608635
NMR metabolomics,X23424.Total Lipids in VLDL,SRPX,Sushi repeat-containing protein SRPX,39958,-0.00895559128017755,0.00398431169349638,-0.0167648421994305,-0.00114634036092465,0.024613570634857
NMR metabolomics,X23424.Total Lipids in VLDL,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,42137,-0.00675118689066094,0.00300772814630704,-0.0126463340574227,-0.000856039723899135,0.0248090462751928
NMR metabolomics,X23424.Total Lipids in VLDL,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,39638,-0.00926748823446515,0.00412926328434956,-0.0173608442717903,-0.00117413219714001,0.0248299934665354
NMR metabolomics,X23424.Total Lipids in VLDL,C9orf40,Uncharacterized protein C9orf40,39930,0.0180001562664284,0.00803803730111821,0.00224560315623665,0.03375470937662,0.0251510407464781
NMR metabolomics,X23424.Total Lipids in VLDL,RNASE10,Inactive ribonuclease-like protein 10,39638,-0.0109646629513189,0.00489775373239731,-0.0205642602668176,-0.00136506563582019,0.0251944716140109
NMR metabolomics,X23424.Total Lipids in VLDL,RYR1,Ryanodine receptor 1,39575,-0.00778833923464639,0.00349094449344708,-0.0146305904418027,-0.000946088027490108,0.0257004543505759
NMR metabolomics,X23424.Total Lipids in VLDL,BAMBI,BMP and activin membrane-bound inhibitor homolog,41843,0.00685114699507767,0.00307308335395561,0.000827903621324679,0.0128743903688307,0.0258036831762783
NMR metabolomics,X23424.Total Lipids in VLDL,B2M,Beta-2-microglobulin,39979,0.00702151605895206,0.00315050959506995,0.000846517252614957,0.0131965148652892,0.0258538494220749
NMR metabolomics,X23424.Total Lipids in VLDL,UBE2B,Ubiquitin-conjugating enzyme E2 B,39919,0.00666264740855414,0.002991126076717,0.000800040298188813,0.0125252545189195,0.0259353771494964
NMR metabolomics,X23424.Total Lipids in VLDL,PSMD1,26S proteasome non-ATPase regulatory subunit 1,39934,0.0113327174819142,0.00509089027819176,0.00135457253665832,0.02131086242717,0.0260285608877053
NMR metabolomics,X23424.Total Lipids in VLDL,ULBP2,UL16-binding protein 2,42016,0.00904352016730441,0.0040630420543997,0.001079957740681,0.0170070825939278,0.0260441123026117
NMR metabolomics,X23424.Total Lipids in VLDL,KIAA1549,UPF0606 protein KIAA1549,39757,0.0157368791852527,0.00707515339629455,0.0018695785285154,0.02960417984199,0.0261518549034117
NMR metabolomics,X23424.Total Lipids in VLDL,HYAL1,Hyaluronidase-1,42077,-0.00528985058472867,0.00238136043768423,-0.00995731704258977,-0.000622384126867574,0.0263433730667077
NMR metabolomics,X23424.Total Lipids in VLDL,SLITRK1,SLIT and NTRK-like protein 1,39657,0.00746664131601525,0.00336160955838869,0.000877886581573411,0.0140553960504571,0.0263609362574734
NMR metabolomics,X23424.Total Lipids in VLDL,PPM1B,Protein phosphatase 1B,39657,0.014150346478275,0.00638047908956946,0.00164460746271886,0.0266560854938312,0.0265917142523693
NMR metabolomics,X23424.Total Lipids in VLDL,IL10RA,Interleukin-10 receptor subunit alpha,41913,0.0128272125971591,0.00578613088340349,0.00148639606568821,0.0241680291286299,0.0266474771953274
NMR metabolomics,X23424.Total Lipids in VLDL,KLK3,Prostate-specific antigen,39966,0.0261841114082382,0.0118376929183581,0.00298223328825622,0.0493859895282201,0.0269915303092044
NMR metabolomics,X23424.Total Lipids in VLDL,IMPG1,Interphotoreceptor matrix proteoglycan 1,39586,-0.00691565046811263,0.0031339595870492,-0.0130582112587291,-0.000773089677496201,0.0273569303966188
NMR metabolomics,X23424.Total Lipids in VLDL,HSP90B1,Endoplasmin,41774,0.0144517574015717,0.00655919855349269,0.00159572823672603,0.0273077865664174,0.0275921942977855
NMR metabolomics,X23424.Total Lipids in VLDL,ID4,DNA-binding protein inhibitor ID-4,39757,-0.00955157850438054,0.00433977818811984,-0.0180575437530954,-0.00104561325566564,0.027760890783375
NMR metabolomics,X23424.Total Lipids in VLDL,NEDD9,Enhancer of filamentation 1,39657,0.00770695431581737,0.00350213747516358,0.000842764864496748,0.014571143767138,0.027781906233334
NMR metabolomics,X23424.Total Lipids in VLDL,SCN2B,Sodium channel subunit beta-2,39649,-0.00641131567501179,0.00291541911001108,-0.0121255371306335,-0.000697094219390067,0.0278910311296581
NMR metabolomics,X23424.Total Lipids in VLDL,FABP3,"Fatty acid-binding protein, heart",39958,0.0123374272957251,0.00562121755867281,0.00131984088072642,0.0233550137107238,0.0281983850992564
NMR metabolomics,X23424.Total Lipids in VLDL,TP53INP1,Tumor protein p53-inducible nuclear protein 1,41900,0.00667042236530361,0.00303946670828626,0.000713067617062551,0.0126277771135447,0.028209324880293
NMR metabolomics,X23424.Total Lipids in VLDL,CCL21,C-C motif chemokine 21,42185,0.00857797464180707,0.00394928695986252,0.000837372200476522,0.0163185770831376,0.0298705453847026
NMR metabolomics,X23424.Total Lipids in VLDL,HEBP1,Heme-binding protein 1,41900,-0.0116229310512049,0.00536861835498909,-0.0221454230269836,-0.00110043907542634,0.0304072326675598
NMR metabolomics,X23424.Total Lipids in VLDL,KRT14,"Keratin, type I cytoskeletal 14",41482,0.00666767190971517,0.00308161975428717,0.00062769719131232,0.012707646628118,0.0305064208682834
NMR metabolomics,X23424.Total Lipids in VLDL,SEZ6L,Seizure 6-like protein,42181,0.00614137451956204,0.00283920569306502,0.0005765313611546,0.0117062176779695,0.0305538945255521
NMR metabolomics,X23424.Total Lipids in VLDL,ADAMTSL5,ADAMTS-like protein 5,39958,-0.0089661391683363,0.00414762674767502,-0.0170954875937793,-0.000836790742893256,0.0306581402769343
NMR metabolomics,X23424.Total Lipids in VLDL,NMRK2,Nicotinamide riboside kinase 2,39560,-0.00871744061309227,0.00404227814108543,-0.0166403057696197,-0.000794575456564828,0.0310611572744778
NMR metabolomics,X23424.Total Lipids in VLDL,GM2A,Ganglioside GM2 activator,39733,0.00855551426726422,0.00398198224285097,0.000750829071276311,0.0163601994632521,0.0316910666077542
NMR metabolomics,X23424.Total Lipids in VLDL,MYH7B,Myosin-7B,39560,-0.00951696965364714,0.00443887349660925,-0.0182171617070013,-0.000816777600293016,0.0320543704829765
NMR metabolomics,X23424.Total Lipids in VLDL,SHPK,Sedoheptulokinase,39757,-0.00881944848206386,0.00413230975467835,-0.0169187756012334,-0.00072012136289429,0.0328427434059576
NMR metabolomics,X23424.Total Lipids in VLDL,LTO1,Protein LTO1 homolog,41913,0.00909706106585177,0.00426456302722353,0.000738517532493637,0.0174556045992099,0.0329285714572965
NMR metabolomics,X23424.Total Lipids in VLDL,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,39930,-0.00667492434056011,0.00313969510633898,-0.0128287267489845,-0.000521121932135705,0.0335266112281796
NMR metabolomics,X23424.Total Lipids in VLDL,CPLX2,Complexin-2,39560,-0.0067305476382999,0.00317267301520343,-0.0129489867480986,-0.000512108528501179,0.0339094995998651
NMR metabolomics,X23424.Total Lipids in VLDL,MET,Hepatocyte growth factor receptor,42158,-0.00418509624434967,0.00198007598554502,-0.00806604517601791,-0.000304147312681427,0.0345673314786187
NMR metabolomics,X23424.Total Lipids in VLDL,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",41839,0.0114034263341358,0.00541476017439829,0.000790496392315123,0.0220163562759564,0.0352240695368953
NMR metabolomics,X23424.Total Lipids in VLDL,MYBPC2,"Myosin-binding protein C, fast-type",39638,-0.0191501987649028,0.00910065311611202,-0.0369874788724823,-0.00131291865732322,0.0353777682862288
NMR metabolomics,X23424.Total Lipids in VLDL,DBH,Dopamine beta-hydroxylase,39978,0.0247905680096892,0.0117818638286306,0.00169811490557325,0.0478830211138051,0.0353890299299248
NMR metabolomics,X23424.Total Lipids in VLDL,CD7,T-cell antigen CD7,39636,0.00972369118169499,0.00463134269145183,0.000646259506449408,0.0188011228569406,0.0357919383289969
NMR metabolomics,X23424.Total Lipids in VLDL,TLR4,Toll-like receptor 4,39657,0.00616110206760121,0.00293626631313193,0.000406020093862634,0.0119161840413398,0.0359032539200388
NMR metabolomics,X23424.Total Lipids in VLDL,LELP1,Late cornified envelope-like proline-rich protein 1,39586,-0.0153193176423308,0.00731530139513063,-0.0296573083767868,-0.000981326907874778,0.0362697295888302
NMR metabolomics,X23424.Total Lipids in VLDL,CLSPN,Claspin,41820,0.00765394443880559,0.0036688818840781,0.000462935946012513,0.0148449529315987,0.0369815296204683
NMR metabolomics,X23424.Total Lipids in VLDL,IFNGR1,Interferon gamma receptor 1,42185,0.00464229399012659,0.00223198591579277,0.000267601595172759,0.00901698638508041,0.0375539645929744
NMR metabolomics,X23424.Total Lipids in VLDL,FCRLB,Fc receptor-like B,41843,0.0132179755279877,0.00636243937974379,0.000747594343689871,0.0256883567122855,0.037774546944675
NMR metabolomics,X23424.Total Lipids in VLDL,CLSTN2,Calsyntenin-2,42296,-0.00857073356774515,0.0041319444651044,-0.0166693447193498,-0.000472122416140516,0.0380736624837683
NMR metabolomics,X23424.Total Lipids in VLDL,ICAM2,Intercellular adhesion molecule 2,42310,-0.00700855343315381,0.00337904526287456,-0.0136314821483879,-0.000385624717919664,0.0380865654458674
NMR metabolomics,X23424.Total Lipids in VLDL,TIMP2,Metalloproteinase inhibitor 2,39958,-0.00610977790598608,0.00294996705764513,-0.0118917133389705,-0.000327842473001631,0.0383687788078761
NMR metabolomics,X23424.Total Lipids in VLDL,KLK11,Kallikrein-11,42062,0.00688724663096626,0.00332705629374586,0.000366216295224378,0.0134082769667081,0.0384646116493745
NMR metabolomics,X23424.Total Lipids in VLDL,TDGF1,Teratocarcinoma-derived growth factor 1,41839,0.0317284231063773,0.0153501626864765,0.0016421042408834,0.0618147419718711,0.0387557766187425
NMR metabolomics,X23424.Total Lipids in VLDL,AMBN,Ameloblastin,41913,-0.00583664138428062,0.00282457744604248,-0.0113728131785239,-0.00030046959003736,0.0388122068420372
NMR metabolomics,X23424.Total Lipids in VLDL,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,41843,0.00752813946467804,0.00364446904271225,0.000384980140962035,0.0146712987883941,0.0388824519838034
NMR metabolomics,X23424.Total Lipids in VLDL,EP300,Histone acetyltransferase p300,39657,0.0065607588346775,0.00318477157914226,0.000318606539558675,0.0128029111297963,0.0394180060389857
NMR metabolomics,X23424.Total Lipids in VLDL,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,39649,-0.00667827029665633,0.00324280104516545,-0.0130341603451806,-0.000322380248132045,0.0394779604285962
NMR metabolomics,X23424.Total Lipids in VLDL,UNG,Uracil-DNA glycosylase,39919,0.00746862898980846,0.00363908134653073,0.000336029550608231,0.0146012284290087,0.0401596633996216
NMR metabolomics,X23424.Total Lipids in VLDL,FGF9,Fibroblast growth factor 9,39539,0.00873980131664889,0.00426427850814728,0.000381815440680219,0.0170977871926176,0.0404333202115269
NMR metabolomics,X23424.Total Lipids in VLDL,MRPS16,"28S ribosomal protein S16, mitochondrial",39657,0.0062188043376019,0.00304459683816391,0.000251394534800631,0.0121862141404032,0.0411186200368722
NMR metabolomics,X23424.Total Lipids in VLDL,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",39657,0.0131384448609738,0.00644363723850377,0.00050891587350646,0.0257679738484412,0.0414757959553156
NMR metabolomics,X23424.Total Lipids in VLDL,NGF,Beta-nerve growth factor,42016,0.00256069034141815,0.00125725849205915,9.64636969822148e-05,0.00502491698585408,0.0416971571330894
NMR metabolomics,X23424.Total Lipids in VLDL,PZP,Pregnancy zone protein,39979,0.00694679817444667,0.00343543318010624,0.000213349141438441,0.0136802472074549,0.0431891115531031
NMR metabolomics,X23424.Total Lipids in VLDL,CXCL9,C-X-C motif chemokine 9,42185,0.0135525440751966,0.00670444303986947,0.000411835717052453,0.0266932524333408,0.0432551226231825
NMR metabolomics,X23424.Total Lipids in VLDL,MNAT1,CDK-activating kinase assembly factor MAT1,39757,0.00942043163308897,0.00466557678181303,0.000275901140735443,0.0185649621254425,0.043497008339146
NMR metabolomics,X23424.Total Lipids in VLDL,IL4,Interleukin-4,41913,0.0196375757756436,0.00974515965555034,0.000537062850764877,0.0387380887005222,0.0439131098823214
NMR metabolomics,X23424.Total Lipids in VLDL,TXNL1,Thioredoxin-like protein 1,39570,0.0211917899342791,0.0105187383965495,0.000575062677042174,0.041808517191516,0.0439635594696496
NMR metabolomics,X23424.Total Lipids in VLDL,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,39757,0.0107222555336308,0.00533044134545216,0.00027459049654455,0.021169920570717,0.0442952303573984
NMR metabolomics,X23424.Total Lipids in VLDL,TNXB,Tenascin-X,42137,0.005383911917895,0.00269836419735922,9.51180910709276e-05,0.0106727057447191,0.046035598547205
NMR metabolomics,X23424.Total Lipids in VLDL,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,39638,-0.0052829957572964,0.00264940051641952,-0.0104758207694787,-9.01707451141376e-05,0.0461728553582139
NMR metabolomics,X23424.Total Lipids in VLDL,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,41839,0.00922822690753217,0.00463088072047676,0.000151700695397725,0.0183047531196666,0.0463083927538798
NMR metabolomics,X23424.Total Lipids in VLDL,EIF5A,Eukaryotic translation initiation factor 5A-1,41913,0.00635475361686368,0.00319114139834264,0.000100116476112094,0.0126093907576153,0.0464602678005238
NMR metabolomics,X23424.Total Lipids in VLDL,CA8,Carbonic anhydrase-related protein,39657,0.00546401628229227,0.00275551736940698,6.3202238254588e-05,0.0108648303263299,0.0473992140300624
NMR metabolomics,X23424.Total Lipids in VLDL,SPARCL1,SPARC-like protein 1,42169,-0.00559263660467999,0.00282162197317769,-0.0111230156721083,-6.22575372517167e-05,0.0474921698574965
NMR metabolomics,X23424.Total Lipids in VLDL,CA3,Carbonic anhydrase 3,42287,-0.0120184602829249,0.00606940835943288,-0.0239145006674133,-0.00012241989843648,0.0477044247892501
NMR metabolomics,X23424.Total Lipids in VLDL,PSMD5,26S proteasome non-ATPase regulatory subunit 5,39649,-0.0110448761526298,0.00559104264513138,-0.0220033197370873,-8.64325681723e-05,0.0482409156501355
NMR metabolomics,X23424.Total Lipids in VLDL,AGBL2,Cytosolic carboxypeptidase 2,39586,0.0187390533662128,0.00950567423919385,0.000107931857392819,0.0373701748750327,0.048708401332066
NMR metabolomics,X23424.Total Lipids in VLDL,REXO2,"Oligoribonuclease, mitochondrial",39575,-0.00942982286437931,0.00481516066932028,-0.0188675377762471,7.89204748844786e-06,0.0502129604716941
NMR metabolomics,X23424.Total Lipids in VLDL,ATP6V1D,V-type proton ATPase subunit D,42070,0.00524028278396169,0.00267813015816223,-8.85232603628407e-06,0.0104894178939597,0.0504040163465892
NMR metabolomics,X23424.Total Lipids in VLDL,PI3,Elafin,41966,0.0113373144981713,0.00580022442333409,-3.11253715635611e-05,0.0227057543679061,0.0506471304399951
NMR metabolomics,X23424.Total Lipids in VLDL,MANSC4,MANSC domain-containing protein 4,39575,0.0137367599915681,0.00702782892687729,-3.77847051113919e-05,0.0275113046882476,0.0506528713737895
NMR metabolomics,X23424.Total Lipids in VLDL,ENOPH1,Enolase-phosphatase E1,39919,0.0107143624754511,0.00550832928789926,-8.19629288314073e-05,0.0215106878797337,0.0517852439727398
NMR metabolomics,X23424.Total Lipids in VLDL,RBP7,Retinoid-binding protein 7,39930,0.0125472664937605,0.00645632283115661,-0.000107126255306454,0.0252016592428275,0.0519916673678073
NMR metabolomics,X23424.Total Lipids in VLDL,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,42181,0.00916650245576064,0.00471720614875821,-7.92215958054579e-05,0.0184122265073267,0.0520119290755123
NMR metabolomics,X23424.Total Lipids in VLDL,PEAR1,Platelet endothelial aggregation receptor 1,42310,0.00457222587287405,0.00235841200416447,-5.02616552883048e-05,0.00919471340103641,0.0525597949023217
NMR metabolomics,X23424.Total Lipids in VLDL,CD3E,T-cell surface glycoprotein CD3 epsilon chain,39757,0.00696568285055485,0.00359510962510456,-8.07320146500885e-05,0.0140120977157598,0.0527040925854588
NMR metabolomics,X23424.Total Lipids in VLDL,YY1,Transcriptional repressor protein YY1,39657,0.00557992124159298,0.00288521967360356,-7.51093186699995e-05,0.011234951801856,0.0531426042411183
NMR metabolomics,X23424.Total Lipids in VLDL,DHODH,Dihydroorotate dehydrogenase,39575,0.00926513563008697,0.00480404008810813,-0.000150782942604961,0.0186810542027789,0.0538046459851748
NMR metabolomics,X23424.Total Lipids in VLDL,HTR1B,5-hydroxytryptamine receptor 1B,39586,-0.00870717790927684,0.00451889777406901,-0.0175642175464521,0.000149861727898409,0.0540257499012909
NMR metabolomics,X23424.Total Lipids in VLDL,PPT1,Palmitoyl-protein thioesterase 1,39649,0.0153933607664968,0.00800335622453228,-0.000293217433586498,0.03107993896658,0.054460120243336
NMR metabolomics,X23424.Total Lipids in VLDL,ITGB5,Integrin beta-5,42181,0.00762266981784156,0.00396401586723529,-0.00014680128193961,0.0153921409176227,0.0545051400975385
NMR metabolomics,X23424.Total Lipids in VLDL,THBS2,Thrombospondin-2,42137,0.00766637163699401,0.00398718073838365,-0.000148502610237944,0.015481245884226,0.0545317845204799
NMR metabolomics,X23424.Total Lipids in VLDL,GBP2,Guanylate-binding protein 2,41913,0.0120367596067247,0.00626192751792662,-0.000236618328411474,0.0243101375418609,0.0546002550057071
NMR metabolomics,X23424.Total Lipids in VLDL,GBA,Lysosomal acid glucosylceramidase,39649,0.0109815524070404,0.00573108045213186,-0.000251365279138086,0.0222144700932188,0.0553730542242579
NMR metabolomics,X23424.Total Lipids in VLDL,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,39560,-0.0161234970583785,0.00844624017796939,-0.0326781278071985,0.000431133690441492,0.0562939158845592
NMR metabolomics,X23424.Total Lipids in VLDL,MUCL3,Mucin-like protein 3,39560,-0.00841762468675882,0.00441043903604165,-0.0170620851974004,0.000226835823882802,0.0563438837823312
NMR metabolomics,X23424.Total Lipids in VLDL,NME1,Nucleoside diphosphate kinase A,39657,-0.00431682244066734,0.0022693918022674,-0.00876483037311144,0.00013118549177676,0.0571718148164922
NMR metabolomics,X23424.Total Lipids in VLDL,RNASE1,Ribonuclease pancreatic,39990,0.0048573177450057,0.00255494390714884,-0.000150372313006025,0.00986500780301742,0.0573082928448179
NMR metabolomics,X23424.Total Lipids in VLDL,SIGLEC15,Sialic acid-binding Ig-like lectin 15,41839,0.0148110975389285,0.00780837384373097,-0.000493315194784219,0.0301155102726412,0.0578731407857749
NMR metabolomics,X23424.Total Lipids in VLDL,TFF1,Trefoil factor 1,42084,-0.0157542072634977,0.00830733265329139,-0.0320365792639488,0.000528164736953447,0.0579256368541226
NMR metabolomics,X23424.Total Lipids in VLDL,CCL28,C-C motif chemokine 28,42075,0.0115255559348372,0.00607947606059323,-0.000390217143925568,0.0234413290135999,0.0580060166123997
NMR metabolomics,X23424.Total Lipids in VLDL,GKN1,Gastrokine-1,41538,0.00553818287195875,0.00292782209571289,-0.000200348435638504,0.011276714179556,0.0585704986712922
NMR metabolomics,X23424.Total Lipids in VLDL,LY96,Lymphocyte antigen 96,42016,-0.00712432140073839,0.00377281832439999,-0.0145190453165624,0.000270402515085601,0.059003382230544
NMR metabolomics,X23424.Total Lipids in VLDL,AREG,Amphiregulin,42070,-0.00760960953707309,0.00404074419829135,-0.0155294681657241,0.00031024909157796,0.0596921119331828
NMR metabolomics,X23424.Total Lipids in VLDL,IL5,Interleukin-5,41913,0.0268211758118441,0.0142635176510195,-0.00113531878415403,0.0547776704078422,0.0600748501051951
NMR metabolomics,X23424.Total Lipids in VLDL,CDKL5,Cyclin-dependent kinase-like 5,39586,-0.0101305943315551,0.00540329619762859,-0.0207210548789072,0.000459866215796887,0.0608341545261443
NMR metabolomics,X23424.Total Lipids in VLDL,ARMCX2,Armadillo repeat-containing X-linked protein 2,39586,-0.0111279221072382,0.00594155870988164,-0.0227733771786062,0.000517532964129862,0.061109269891038
NMR metabolomics,X23424.Total Lipids in VLDL,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,42296,0.00766339364719334,0.00409942296361873,-0.000371475361499375,0.0156982626558861,0.0615908011115878
NMR metabolomics,X23424.Total Lipids in VLDL,GFRAL,GDNF family receptor alpha-like,39574,-0.0122219392003479,0.00654112678229407,-0.0250425476936443,0.000598669292948505,0.0617223591341851
NMR metabolomics,X23424.Total Lipids in VLDL,RAB6B,Ras-related protein Rab-6B,41839,0.00912387744034496,0.00488795589458801,-0.000456516113047549,0.0187042709937375,0.0619790146559416
NMR metabolomics,X23424.Total Lipids in VLDL,ATP1B4,Protein ATP1B4,39560,-0.00808738249782933,0.00433466170808678,-0.0165833194456794,0.000408554450020752,0.0621034510710183
NMR metabolomics,X23424.Total Lipids in VLDL,COL5A1,Collagen alpha-1(V) chain,39736,-0.00789874138618716,0.00424572409238389,-0.0162203606072596,0.000422877834885265,0.0628554198649532
NMR metabolomics,X23424.Total Lipids in VLDL,MKI67,Proliferation marker protein Ki-67,39657,0.00782774724401115,0.00420996019477674,-0.000423774737751263,0.0160792692257736,0.0630055088521504
NMR metabolomics,X23424.Total Lipids in VLDL,S100G,Protein S100-G,39934,-0.00939695698074408,0.00505467026177961,-0.0193041106938321,0.000510196732343954,0.0630439243449574
NMR metabolomics,X23424.Total Lipids in VLDL,PRR5,Proline-rich protein 5,39657,0.00905814096618688,0.00488069013895605,-0.000508011706166978,0.0186242936385407,0.0634924102292366
NMR metabolomics,X23424.Total Lipids in VLDL,TIE1,Tyrosine-protein kinase receptor Tie-1,42310,0.00777753564571607,0.00420822897288964,-0.000470593141147613,0.0160256644325798,0.0645988251344697
NMR metabolomics,X23424.Total Lipids in VLDL,ADGRE5,Adhesion G protein-coupled receptor E5,42248,-0.00594561242507231,0.00321710284069705,-0.0122511339928385,0.0003599091426939,0.0646056913200873
NMR metabolomics,X23424.Total Lipids in VLDL,FDX2,"Ferredoxin-2, mitochondrial",39575,0.0105481798573364,0.00570869084284656,-0.000640854194642907,0.0217372139093156,0.0646667676592077
NMR metabolomics,X23424.Total Lipids in VLDL,EPN1,Epsin-1,39757,0.00825725739417783,0.00447267557753628,-0.000509186737793276,0.0170237015261489,0.0648960114653444
NMR metabolomics,X23424.Total Lipids in VLDL,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,39586,-0.00599980811714426,0.00326017848095853,-0.012389757939823,0.000390141705534457,0.0657465860167782
NMR metabolomics,X23424.Total Lipids in VLDL,BRK1,Protein BRICK1,41839,0.00860122933870521,0.0046876251495925,-0.000586515954496093,0.0177889746319065,0.0665459049081206
NMR metabolomics,X23424.Total Lipids in VLDL,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,41843,0.0238882102609561,0.0130341907580643,-0.00165880362484997,0.0494352241467622,0.06686451208195
NMR metabolomics,X23424.Total Lipids in VLDL,HSBP1,Heat shock factor-binding protein 1,39638,0.0182036958839419,0.00995668275246498,-0.00131140231088946,0.0377187940787733,0.0675331289090406
NMR metabolomics,X23424.Total Lipids in VLDL,REG4,Regenerating islet-derived protein 4,42144,0.00961591623850363,0.00526214367072401,-0.000697885356115435,0.0199297178331227,0.067665213453913
NMR metabolomics,X23424.Total Lipids in VLDL,SCN2A,Sodium channel protein type 2 subunit alpha,39586,0.00915900669321477,0.00501577174283739,-0.000671905922746519,0.0189899193091761,0.0678711594048786
NMR metabolomics,X23424.Total Lipids in VLDL,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,39586,0.0116672232627434,0.00639611165578377,-0.000869155582592764,0.0242036021080796,0.0681623110063852
NMR metabolomics,X23424.Total Lipids in VLDL,IL13RA2,Interleukin-13 receptor subunit alpha-2,39586,-0.0055351189069057,0.00304186255827853,-0.0114971695211316,0.000426931707320204,0.0688398409753075
NMR metabolomics,X23424.Total Lipids in VLDL,PCDH17,Protocadherin-17,42145,0.00700811250708061,0.00386400197420142,-0.000565331362354169,0.0145815563765154,0.069747155585071
NMR metabolomics,X23424.Total Lipids in VLDL,TEX101,Testis-expressed protein 101,39649,0.0115005593211654,0.00636617187707044,-0.000977137557892641,0.0239782562002235,0.0708657587773719
NMR metabolomics,X23424.Total Lipids in VLDL,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",39586,-0.0102497398651833,0.00567829349869794,-0.0213791951226313,0.000879715392264661,0.0710904737667303
NMR metabolomics,X23424.Total Lipids in VLDL,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",39929,-0.00468129279086175,0.00262124875690773,-0.0098189403544009,0.000456354772677389,0.0741419024084774
NMR metabolomics,X23424.Total Lipids in VLDL,ADGRE1,Adhesion G protein-coupled receptor E1,39930,0.0100494922161878,0.00562946077976617,-0.000984250912153931,0.0210832353445294,0.0742619953604871
NMR metabolomics,X23424.Total Lipids in VLDL,TPSG1,Tryptase gamma,39657,0.0048262605829169,0.00271024657133155,-0.000485822696892945,0.0101383438627267,0.0749814119944741
NMR metabolomics,X23424.Total Lipids in VLDL,SAG,S-arrestin,39586,-0.0095976259037441,0.00540711821539902,-0.0201955776059262,0.00100032579843797,0.0759258423368101
NMR metabolomics,X23424.Total Lipids in VLDL,PTK7,Inactive tyrosine-protein kinase 7,41839,0.00699328124251896,0.00395007414990466,-0.000748864091294164,0.0147354265763321,0.0766805897906538
NMR metabolomics,X23424.Total Lipids in VLDL,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,39575,0.010242359892984,0.00578611602610964,-0.00109842751819085,0.0215831473041589,0.0767279964016784
NMR metabolomics,X23424.Total Lipids in VLDL,PGLYRP4,Peptidoglycan recognition protein 4,39575,0.010726462840338,0.00608481162834302,-0.00119976795121427,0.0226526936318904,0.0779577043983229
NMR metabolomics,X23424.Total Lipids in VLDL,PMCH,Pro-MCH,39575,-0.0150238033229785,0.00853342123222558,-0.0317493089381406,0.00170170229218368,0.0783367180465476
NMR metabolomics,X23424.Total Lipids in VLDL,AKR1B10,Aldo-keto reductase family 1 member B10,39649,0.0117732539461083,0.00669336041861438,-0.00134573247437591,0.0248922403665924,0.0786144997046813
NMR metabolomics,X23424.Total Lipids in VLDL,SCARB1,Scavenger receptor class B member 1,41839,0.010077970778352,0.00573385727101771,-0.00116038947284273,0.0213163310295467,0.078834448528936
NMR metabolomics,X23424.Total Lipids in VLDL,AIDA,"Axin interactor, dorsalization-associated protein",39649,0.0155592963368291,0.00885433181612773,-0.0017951940227812,0.0329137866964395,0.0789024799491292
NMR metabolomics,X23424.Total Lipids in VLDL,TXNDC15,Thioredoxin domain-containing protein 15,42181,0.00500012238013984,0.00285014364402321,-0.000586159162145652,0.0105864039224253,0.0793947336160648
NMR metabolomics,X23424.Total Lipids in VLDL,MELTF,Melanotransferrin,39958,0.00545297381568377,0.00310969832500517,-0.000642034901326364,0.0115479825326939,0.0795366944587596
NMR metabolomics,X23424.Total Lipids in VLDL,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,41701,-0.0151832328708863,0.00870707589155907,-0.032249101618342,0.00188263587656951,0.0812207525899627
NMR metabolomics,X23424.Total Lipids in VLDL,OGN,Mimecan,42137,0.0077721203237277,0.00446409434808295,-0.000977504598514893,0.0165217452459703,0.0817011117545685
NMR metabolomics,X23424.Total Lipids in VLDL,GSN,Gelsolin,39943,0.0033854376171071,0.0019583676753661,-0.000452963026610456,0.00722383826082465,0.0838893343351665
NMR metabolomics,X23424.Total Lipids in VLDL,GPHA2,Glycoprotein hormone alpha-2,39930,-0.00779338998614925,0.00451208297870056,-0.0166370726244024,0.00105029265210385,0.0841542194181119
NMR metabolomics,X23424.Total Lipids in VLDL,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",39575,-0.0119753861232292,0.0069400087256832,-0.0255778032255682,0.00162703097910992,0.0844551469496959
NMR metabolomics,X23424.Total Lipids in VLDL,EDNRB,Endothelin receptor type B,39657,0.00776230295675442,0.00453308754002043,-0.00112254862168562,0.0166471545351945,0.0868573613801534
NMR metabolomics,X23424.Total Lipids in VLDL,ABO,Histo-blood group ABO system transferase,39990,0.025620116138169,0.0149838103289051,-0.0037481521064851,0.0549883843828231,0.0873202574913044
NMR metabolomics,X23424.Total Lipids in VLDL,FSHB,Follitropin subunit beta,39638,-0.00723654152526355,0.00424328807706237,-0.0155533861563058,0.0010803031057787,0.0881463136374468
NMR metabolomics,X23424.Total Lipids in VLDL,DEFB118,Beta-defensin 118,39586,0.0100475024501126,0.00589335139252944,-0.00150346627924514,0.0215984711794703,0.0882436389080834
NMR metabolomics,X23424.Total Lipids in VLDL,CD82,CD82 antigen,39757,-0.00730147027433724,0.00428441181295675,-0.0156989174277325,0.00109597687905799,0.0883726343236834
NMR metabolomics,X23424.Total Lipids in VLDL,CD3D,T-cell surface glycoprotein CD3 delta chain,39586,-0.00606052188267002,0.00356987764785393,-0.0130574820724637,0.000936438307123674,0.0895958615799256
NMR metabolomics,X23424.Total Lipids in VLDL,CCDC50,Coiled-coil domain-containing protein 50,39934,0.0130381018806254,0.00768510792439138,-0.00202470965118169,0.0281009134124325,0.0898109023708645
NMR metabolomics,X23424.Total Lipids in VLDL,FH,"Fumarate hydratase, mitochondrial",39586,0.0144311814191511,0.00850996887794343,-0.00224835758161806,0.0311107204199202,0.0899526265257948
NMR metabolomics,X23424.Total Lipids in VLDL,EPHA4,Ephrin type-A receptor 4,39736,0.00508657713421104,0.00302284066684538,-0.000838190572805903,0.011011344841228,0.0924584505899446
NMR metabolomics,X23424.Total Lipids in VLDL,CTRC,Chymotrypsin-C,42122,0.0113432100158708,0.00674364686788461,-0.00187433784518299,0.0245607578769247,0.0925805439149251
NMR metabolomics,X23424.Total Lipids in VLDL,TLR1,Toll-like receptor 1,39657,0.00461682505960826,0.00276843339639534,-0.000809304397326602,0.0100429545165431,0.0954101644246537
NMR metabolomics,X23424.Total Lipids in VLDL,REG3G,Regenerating islet-derived protein 3-gamma,39919,0.00682754454187332,0.00410086424260113,-0.00121014937362491,0.0148652384573715,0.0959596222983607
NMR metabolomics,X23424.Total Lipids in VLDL,IGFL4,Insulin growth factor-like family member 4,39657,0.0122908129064401,0.00739409582097799,-0.0022016149026768,0.0267832407155569,0.0964916240318927
NMR metabolomics,X23424.Total Lipids in VLDL,BCL2L15,Bcl-2-like protein 15,39657,0.00973097445825319,0.00585703039895208,-0.00174880512369289,0.0212107540401993,0.0966579184954452
NMR metabolomics,X23424.Total Lipids in VLDL,TPSAB1,Tryptase alpha/beta-1,42281,0.00893220134518718,0.00537739540040524,-0.00160749363960708,0.0194718963299814,0.0967233792585047
NMR metabolomics,X23424.Total Lipids in VLDL,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,39919,0.00805540627085892,0.00487005059856619,-0.00148989290233081,0.0176007054440487,0.0981409488523811
NMR metabolomics,X23424.Total Lipids in VLDL,WIF1,Wnt inhibitory factor 1,42262,-0.00574167154376239,0.00347199802465946,-0.0125467876720949,0.00106344458457015,0.0982097934388288
NMR metabolomics,X23424.Total Lipids in VLDL,CFD,Complement factor D,39979,0.00346005480654549,0.00209583913785703,-0.000647789903654299,0.00756789951674528,0.0987832812688994
NMR metabolomics,X23424.Total Lipids in VLDL,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,39586,0.0100179744080172,0.00607559262124668,-0.00189018712962631,0.0219261359456607,0.0991990851014054
NMR metabolomics,X23424.Total Lipids in VLDL,EVI2B,Protein EVI2B,39560,-0.00681582550135091,0.00413578891456577,-0.0149219717738998,0.00129032077119799,0.0993790840076398
NMR metabolomics,X23424.Total Lipids in VLDL,CLEC4C,C-type lectin domain family 4 member C,42119,0.0082268634813949,0.00500409381012942,-0.00158116038645876,0.0180348873492486,0.100193954015768
NMR metabolomics,X23424.Total Lipids in VLDL,KIRREL1,Kin of IRRE-like protein 1,39586,-0.00948199522326992,0.00577225249939618,-0.0207956101220864,0.00183161967554659,0.100476648616998
NMR metabolomics,X23424.Total Lipids in VLDL,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,42248,0.00586061627113876,0.00357164573478317,-0.00113980936903626,0.0128610419113138,0.100846869104759
NMR metabolomics,X23424.Total Lipids in VLDL,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,42016,0.00573952000115726,0.00349871994464832,-0.00111797109035346,0.012597011092668,0.10093241485128
NMR metabolomics,X23424.Total Lipids in VLDL,RAP1A,Ras-related protein Rap-1A,39657,-0.0116935918124262,0.00715375628666161,-0.025714954134283,0.00232777050943055,0.102159583019155
NMR metabolomics,X23424.Total Lipids in VLDL,ATP5PO,"ATP synthase subunit O, mitochondrial",41839,0.00702752908553256,0.00430191225560697,-0.00140421893545709,0.0154592771065222,0.102370298524714
NMR metabolomics,X23424.Total Lipids in VLDL,LY6D,Lymphocyte antigen 6D,42041,0.00668917884390619,0.00410118205093487,-0.00134913797592616,0.0147274956637385,0.102905983814078
NMR metabolomics,X23424.Total Lipids in VLDL,GGT5,Glutathione hydrolase 5 proenzyme,42016,0.00402971611327956,0.0024715759365647,-0.000814572722387255,0.00887400494894637,0.103035442242315
NMR metabolomics,X23424.Total Lipids in VLDL,TCL1B,T-cell leukemia/lymphoma protein 1B,41900,0.0127816984852297,0.00784366327984486,-0.00259188154326621,0.0281552785137256,0.103218784152176
NMR metabolomics,X23424.Total Lipids in VLDL,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,39560,0.00911394920498427,0.00560700507654925,-0.00187578074505227,0.0201036791550208,0.104093835943972
NMR metabolomics,X23424.Total Lipids in VLDL,S100A3,Protein S100-A3,39919,0.00716103949872929,0.00441084114813965,-0.00148420915162441,0.015806288149083,0.104508526185257
NMR metabolomics,X23424.Total Lipids in VLDL,RGMA,Repulsive guidance molecule A,42249,-0.00537279695634928,0.00331860786588948,-0.0118772683734927,0.0011316744607941,0.105472259198796
NMR metabolomics,X23424.Total Lipids in VLDL,CLEC11A,C-type lectin domain family 11 member A,42118,-0.00809489907533356,0.0050098758098945,-0.0179142556627268,0.00172445751205965,0.106163412606124
NMR metabolomics,X23424.Total Lipids in VLDL,CD160,CD160 antigen,42296,-0.00807671615307911,0.00500009912490249,-0.017876910437888,0.00172347813172976,0.106266351718783
NMR metabolomics,X23424.Total Lipids in VLDL,CUZD1,CUB and zona pellucida-like domain-containing protein 1,39649,0.00666633279415699,0.00412915979426824,-0.00142682040260876,0.0147594859909227,0.106457843232482
NMR metabolomics,X23424.Total Lipids in VLDL,SLC28A1,Sodium/nucleoside cotransporter 1,39560,0.00993439976976564,0.00615850509635734,-0.00213627021909474,0.022005069758626,0.106747510747935
NMR metabolomics,X23424.Total Lipids in VLDL,CLEC7A,C-type lectin domain family 7 member A,42296,-0.00985032572424412,0.00614007572947101,-0.0218848741540073,0.00218422270551906,0.108678094902236
NMR metabolomics,X23424.Total Lipids in VLDL,SHISA5,Protein shisa-5,39966,0.00429654138799349,0.00268369997632374,-0.000963510565601043,0.00955659334158801,0.109409849979915
NMR metabolomics,X23424.Total Lipids in VLDL,SH3GL3,Endophilin-A3,39690,0.0140933081386533,0.00881106603483377,-0.00317638128962087,0.0313629975669275,0.109737832710609
NMR metabolomics,X23424.Total Lipids in VLDL,THAP12,52 kDa repressor of the inhibitor of the protein kinase,39539,0.0143010588375379,0.00894115921449299,-0.00322361322286839,0.0318257308979441,0.109746506439156
NMR metabolomics,X23424.Total Lipids in VLDL,STOML2,"Stomatin-like protein 2, mitochondrial",39560,0.0157023071091985,0.00985087138268182,-0.00360540080085784,0.0350100150192549,0.11096445797299
NMR metabolomics,X23424.Total Lipids in VLDL,HMCN2,Hemicentin-2,39721,-0.00953778439344417,0.00600254163521811,-0.0213027659984717,0.00222719721158333,0.112098383050737
NMR metabolomics,X23424.Total Lipids in VLDL,CD2,T-cell surface antigen CD2,39575,-0.00638859454509765,0.00402428597491683,-0.0142761950559346,0.00149900596573935,0.112425973254334
NMR metabolomics,X23424.Total Lipids in VLDL,CAPN3,Calpain-3,39919,-0.00637660650874557,0.00403108999984096,-0.0142775429084338,0.00152432989094271,0.113710239612682
NMR metabolomics,X23424.Total Lipids in VLDL,MFAP3,Microfibril-associated glycoprotein 3,41900,0.0077798118344207,0.00493642483273755,-0.00189558083774491,0.0174552045065863,0.115049293180816
NMR metabolomics,X23424.Total Lipids in VLDL,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",39575,-0.0135970379870924,0.00866416691403665,-0.0305788051386042,0.00338472916441947,0.116597181118814
NMR metabolomics,X23424.Total Lipids in VLDL,IDI2,Isopentenyl-diphosphate delta-isomerase 2,41839,-0.00793437611254271,0.00506124453135015,-0.017854415393989,0.00198566316890358,0.116981378636252
NMR metabolomics,X23424.Total Lipids in VLDL,DOC2B,Double C2-like domain-containing protein beta,39649,0.00591964755160784,0.00379350045851667,-0.00151561334708484,0.0133549084503005,0.118677251846236
NMR metabolomics,X23424.Total Lipids in VLDL,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",39657,0.00552196866569503,0.00355261757759587,-0.00144116178639288,0.0124850991177829,0.120132423031604
NMR metabolomics,X23424.Total Lipids in VLDL,OPTC,Opticin,42070,-0.00724580270579646,0.00468337069140787,-0.0164252092609559,0.00193360384936297,0.121854394635142
NMR metabolomics,X23424.Total Lipids in VLDL,DNAJA1,DnaJ homolog subfamily A member 1,39560,-0.00747259255552989,0.0048468710526724,-0.0169724598187678,0.00202727470770803,0.123166782285721
NMR metabolomics,X23424.Total Lipids in VLDL,AGR2,Anterior gradient protein 2 homolog,41740,0.0158973241929887,0.010352138380941,-0.00439286703365572,0.036187515419633,0.124646830273395
NMR metabolomics,X23424.Total Lipids in VLDL,GPA33,Cell surface A33 antigen,42070,0.0211748118879839,0.0138010613433988,-0.00587526834507771,0.0482248921210455,0.12498214073839
NMR metabolomics,X23424.Total Lipids in VLDL,OTOA,Otoancorin,39586,-0.00831169883265219,0.005434112410572,-0.0189625591573733,0.00233916149206893,0.126159124065451
NMR metabolomics,X23424.Total Lipids in VLDL,PALM3,Paralemmin-3,39575,0.0119742208287131,0.00784277894217337,-0.00339762589794669,0.0273460675553729,0.126843820175945
NMR metabolomics,X23424.Total Lipids in VLDL,GH2,Growth hormone variant,41843,0.0255183178095968,0.0167320355202153,-0.00727647181002527,0.0583131074292189,0.127253708182798
NMR metabolomics,X23424.Total Lipids in VLDL,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,39919,-0.0139802532262872,0.00921536793743399,-0.0320423743836579,0.00408186793108339,0.129279814848173
NMR metabolomics,X23424.Total Lipids in VLDL,FHIP2A,FHF complex subunit HOOK interacting protein 2A,39575,0.007242230225847,0.00479359629431204,-0.0021532185110046,0.0166376789626986,0.130864751799891
NMR metabolomics,X23424.Total Lipids in VLDL,POF1B,Protein POF1B,39657,-0.00705438976525012,0.00470116306535321,-0.0162686693733424,0.00215988984284216,0.133497267589333
NMR metabolomics,X23424.Total Lipids in VLDL,GUCY2C,Heat-stable enterotoxin receptor,39757,-0.0126747123789756,0.00846610846444003,-0.0292682849692781,0.00391886021132683,0.134392411896909
NMR metabolomics,X23424.Total Lipids in VLDL,SUMF1,Formylglycine-generating enzyme,39657,0.0102198064244532,0.00683452416200584,-0.00317586093307826,0.0236154737819846,0.134859267180442
NMR metabolomics,X23424.Total Lipids in VLDL,IZUMO1,Izumo sperm-egg fusion protein 1,39560,-0.00754820294848127,0.00505993941779757,-0.0174656842073645,0.00236927831040197,0.135791491057561
NMR metabolomics,X23424.Total Lipids in VLDL,MMP8,Neutrophil collagenase,42224,0.0109982204472901,0.00738422966602396,-0.00347486969811682,0.0254713105926971,0.136399913844919
NMR metabolomics,X23424.Total Lipids in VLDL,CHRM1,Muscarinic acetylcholine receptor M1,39649,-0.0055333553287272,0.00374174270583568,-0.0128671710321651,0.00180046037471073,0.139217551952711
NMR metabolomics,X23424.Total Lipids in VLDL,VCPKMT,Protein-lysine methyltransferase METTL21D,39560,0.0127148371296643,0.00866738460082396,-0.00427323668795069,0.0297029109472792,0.142411529746954
NMR metabolomics,X23424.Total Lipids in VLDL,KLRK1,NKG2-D type II integral membrane protein,39929,0.00714197294323734,0.00487132001688295,-0.00240581428985325,0.0166897601763279,0.142641493848538
NMR metabolomics,X23424.Total Lipids in VLDL,CTSB,Cathepsin B,42153,-0.00767362454177504,0.0052377473907385,-0.0179396094276225,0.00259236034407243,0.142927206072372
NMR metabolomics,X23424.Total Lipids in VLDL,ADGRE2,Adhesion G protein-coupled receptor E2,42185,-0.00433814116871856,0.00296211748489915,-0.0101438914391209,0.00146760910168377,0.143069452221894
NMR metabolomics,X23424.Total Lipids in VLDL,SOD2,"Superoxide dismutase [Mn], mitochondrial",42137,0.00575719752095669,0.00393114560477868,-0.00194784786440954,0.0134622429063229,0.143078189300736
NMR metabolomics,X23424.Total Lipids in VLDL,DDX1,ATP-dependent RNA helicase DDX1,39930,0.00728220620844389,0.00497982923450165,-0.00247825909117934,0.0170426715080671,0.143675648765728
NMR metabolomics,X23424.Total Lipids in VLDL,SLC44A4,Choline transporter-like protein 4,39649,-0.0103901023029583,0.00711238756921065,-0.0243303819386112,0.00355017733269454,0.144086168005111
NMR metabolomics,X23424.Total Lipids in VLDL,RBM25,RNA-binding protein 25,39560,-0.00706992930972579,0.0048463775101877,-0.0165688292296937,0.0024289706102421,0.144646899373821
NMR metabolomics,X23424.Total Lipids in VLDL,ADGRV1,Adhesion G-protein coupled receptor V1,39586,-0.0104246242232941,0.00716850305527123,-0.0244748902116258,0.00362564176503746,0.145912199356401
NMR metabolomics,X23424.Total Lipids in VLDL,FZD8,Frizzled-8,39586,0.00645990715058854,0.00445366008977246,-0.00226926662536549,0.0151890809265426,0.146955622918179
NMR metabolomics,X23424.Total Lipids in VLDL,PNLIPRP2,Pancreatic lipase-related protein 2,42123,0.0447976175706358,0.0309041929769987,-0.0157746006642816,0.105369835805553,0.147203222589738
NMR metabolomics,X23424.Total Lipids in VLDL,CSPG5,Chondroitin sulfate proteoglycan 5,39586,-0.00748038371898768,0.00516945230967734,-0.0176125102459553,0.00265174280797991,0.147915366213502
NMR metabolomics,X23424.Total Lipids in VLDL,PILRA,Paired immunoglobulin-like type 2 receptor alpha,42137,0.00636837098729926,0.00440193790771305,-0.00225942731181832,0.0149961692864168,0.147998554225985
NMR metabolomics,X23424.Total Lipids in VLDL,PLAUR,Urokinase plasminogen activator surface receptor,42040,-0.00423571005805334,0.00293848499304914,-0.00999514064442965,0.00152372052832297,0.149477926304211
NMR metabolomics,X23424.Total Lipids in VLDL,CSF2RB,Cytokine receptor common subunit beta,39657,-0.00632360445424068,0.00440011153468436,-0.014947823062222,0.00230061415374068,0.150704695263233
NMR metabolomics,X23424.Total Lipids in VLDL,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,39560,0.00872324439635503,0.00608452805683522,-0.00320243059504201,0.0206489193877521,0.151693151303507
NMR metabolomics,X23424.Total Lipids in VLDL,AXL,Tyrosine-protein kinase receptor UFO,42217,-0.00402564116573812,0.00281140555408481,-0.00953599605174434,0.0014847137202681,0.152196458192894
NMR metabolomics,X23424.Total Lipids in VLDL,STX1B,Syntaxin-1B,39649,0.00591072061783289,0.00415044135970629,-0.00222414444719144,0.0140455856828572,0.154440391561693
NMR metabolomics,X23424.Total Lipids in VLDL,NUP50,Nuclear pore complex protein Nup50,39575,-0.00465886254324443,0.0032801953991648,-0.0110880455256074,0.00177032043911858,0.155548677351327
NMR metabolomics,X23424.Total Lipids in VLDL,EPHA10,Ephrin type-A receptor 10,41839,0.00962061718851542,0.00678630766536888,-0.0036805458356076,0.0229217802126384,0.156316159394388
NMR metabolomics,X23424.Total Lipids in VLDL,CD177,CD177 antigen,42123,-0.0188278912695124,0.0132950446422723,-0.0448861787683661,0.00723039622934124,0.156752118328199
NMR metabolomics,X23424.Total Lipids in VLDL,FGF7,Fibroblast growth factor 7,39560,-0.0113609723553021,0.00804460467260589,-0.0271283975136097,0.00440645280300541,0.157905508648412
NMR metabolomics,X23424.Total Lipids in VLDL,CCNE1,G1/S-specific cyclin-E1,39657,0.0133757263258475,0.00947612508138766,-0.00519747883367232,0.0319489314853673,0.158119908364865
NMR metabolomics,X23424.Total Lipids in VLDL,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",39934,-0.00611446974097762,0.00433300536629922,-0.0146071602589241,0.00237822077696885,0.158231292598345
NMR metabolomics,X23424.Total Lipids in VLDL,CDH23,Cadherin-23,39929,-0.0039014953088481,0.00276660878923469,-0.00932404853574809,0.00152105791805189,0.158505572339355
NMR metabolomics,X23424.Total Lipids in VLDL,RICTOR,Rapamycin-insensitive companion of mTOR,39657,-0.00666382458658716,0.00474540923576156,-0.0159648266886798,0.0026371775155055,0.16026725718878
NMR metabolomics,X23424.Total Lipids in VLDL,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",42224,-0.00984811926720715,0.00706456050452211,-0.0236946578560705,0.00399841932165619,0.163335127756783
NMR metabolomics,X23424.Total Lipids in VLDL,MORF4L2,Mortality factor 4-like protein 2,39560,-0.0054442303243825,0.00390915469002505,-0.0131061735168316,0.0022177128680666,0.163742602991574
NMR metabolomics,X23424.Total Lipids in VLDL,NXPE4,NXPE family member 4,39575,-0.00459574759345342,0.00330876541446808,-0.0110809278058108,0.00188943261890401,0.164872656881854
NMR metabolomics,X23424.Total Lipids in VLDL,PPIE,Peptidyl-prolyl cis-trans isomerase E,39757,-0.00877870880190015,0.00634790917826088,-0.0212206107912915,0.00366319318749116,0.166714259076143
NMR metabolomics,X23424.Total Lipids in VLDL,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",39934,0.00999546829627707,0.0072326427597029,-0.00418051151274062,0.0241714481052948,0.167000804838406
NMR metabolomics,X23424.Total Lipids in VLDL,H2AP,Huntingtin-interacting protein M,39560,-0.00720018638155951,0.00521460414156099,-0.0174208104990191,0.00302043773590004,0.167376818095815
NMR metabolomics,X23424.Total Lipids in VLDL,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,39919,-0.00627806007040808,0.0045539202673896,-0.0152037437944917,0.00264762365367554,0.168043627855902
NMR metabolomics,X23424.Total Lipids in VLDL,HIP1,Huntingtin-interacting protein 1,39575,0.00466999997571641,0.00340709024481371,-0.00200789690411846,0.0113478968555513,0.170505553199461
NMR metabolomics,X23424.Total Lipids in VLDL,MYH4,Myosin-4,39575,-0.00646142932998596,0.00473865250492718,-0.0157491882396432,0.0028263295796713,0.172734566674853
NMR metabolomics,X23424.Total Lipids in VLDL,MED21,Mediator of RNA polymerase II transcription subunit 21,39575,0.00687650790427919,0.00505042821085672,-0.00302233138899998,0.0167753471975584,0.173361805223745
NMR metabolomics,X23424.Total Lipids in VLDL,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,41662,0.0087545908694102,0.00643219636045217,-0.00385251399707605,0.0213616957358964,0.173518912146667
NMR metabolomics,X23424.Total Lipids in VLDL,LCN15,Lipocalin-15,39934,-0.00852922499671036,0.00626708984997031,-0.0208127211026522,0.00375427110923145,0.1735550841824
NMR metabolomics,X23424.Total Lipids in VLDL,WASL,Neural Wiskott-Aldrich syndrome protein,39657,-0.00827149796548548,0.00608589890412892,-0.0201998598175782,0.0036568638866072,0.174134670000397
NMR metabolomics,X23424.Total Lipids in VLDL,SIRPB1,Signal-regulatory protein beta-1,42100,0.00668930354089331,0.00492981493764022,-0.00297313373688151,0.0163517408186681,0.174833246850934
NMR metabolomics,X23424.Total Lipids in VLDL,PGR,Progesterone receptor,39657,0.014051448261944,0.0103669667215853,-0.00626780651236309,0.0343707030362512,0.175315944152189
NMR metabolomics,X23424.Total Lipids in VLDL,DDA1,DET1- and DDB1-associated protein 1,39575,0.00547924407501682,0.00404996335296523,-0.00245868409679502,0.0134171722468287,0.176111609755059
NMR metabolomics,X23424.Total Lipids in VLDL,TLR2,Toll-like receptor 2,39757,-0.00322230005304574,0.00239327742647436,-0.00791312380893548,0.00146852370284401,0.178202071283725
NMR metabolomics,X23424.Total Lipids in VLDL,PFDN4,Prefoldin subunit 4,39560,-0.00733561020751234,0.00546301220036957,-0.0180431141202367,0.00337189370521201,0.179371818576479
NMR metabolomics,X23424.Total Lipids in VLDL,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,39757,0.00955263626484715,0.0071306639244275,-0.00442346502703075,0.023528737556725,0.180384514809498
NMR metabolomics,X23424.Total Lipids in VLDL,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,41900,0.00380780848994989,0.0028464252648512,-0.00177118502915846,0.00938680200905824,0.181000465153252
NMR metabolomics,X23424.Total Lipids in VLDL,CD209,CD209 antigen,42171,-0.0053360061685244,0.004025711248339,-0.0132264002152688,0.00255438787822005,0.185033782261043
NMR metabolomics,X23424.Total Lipids in VLDL,PRRT3,Proline-rich transmembrane protein 3,39638,0.00529763725742891,0.00400438023065773,-0.00255094799466024,0.0131462225095181,0.185875887545023
NMR metabolomics,X23424.Total Lipids in VLDL,TUBB3,Tubulin beta-3 chain,39586,-0.00391146371717337,0.00296024843036594,-0.00971355064069061,0.00189062320634387,0.186419023604002
NMR metabolomics,X23424.Total Lipids in VLDL,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",39575,-0.00838829311609422,0.00636490761696163,-0.020863512045339,0.00408692581315056,0.187565612933996
NMR metabolomics,X23424.Total Lipids in VLDL,FOS,Proto-oncogene c-Fos,39539,-0.0049219960575276,0.00373640530624628,-0.0122453504577703,0.0024013583427151,0.187763044554763
NMR metabolomics,X23424.Total Lipids in VLDL,CNTN2,Contactin-2,42262,0.00598140486278431,0.00454107890608253,-0.00291910979313745,0.0148819195187061,0.187801379603251
NMR metabolomics,X23424.Total Lipids in VLDL,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",42070,0.00469851053190436,0.00357096183366101,-0.00230057466207122,0.0116975957258799,0.188278713598547
NMR metabolomics,X23424.Total Lipids in VLDL,DCUN1D1,DCN1-like protein 1,39586,-0.0102256225313632,0.00779730443402042,-0.0255083392220433,0.00505709415931679,0.189739780815436
NMR metabolomics,X23424.Total Lipids in VLDL,DUOX2,Dual oxidase 2,41900,0.00941438923241305,0.00725518351174058,-0.0048057704505985,0.0236345489154246,0.194444336799694
NMR metabolomics,X23424.Total Lipids in VLDL,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",39649,0.0103154231499875,0.00798021608305994,-0.00532580037281002,0.0259566466727849,0.196167977667121
NMR metabolomics,X23424.Total Lipids in VLDL,ENG,Endoglin,42310,0.00230158163752656,0.00178365168932084,-0.00119437567354229,0.00579753894859541,0.196941843224038
NMR metabolomics,X23424.Total Lipids in VLDL,ADGRB3,Adhesion G protein-coupled receptor B3,41992,-0.00447331416605499,0.00348344707811925,-0.0113008704391687,0.00235424210705875,0.199107111728061
NMR metabolomics,X23424.Total Lipids in VLDL,CSF1,Macrophage colony-stimulating factor 1,42185,0.00357380786570018,0.00278598103880227,-0.00188671497035227,0.00903433070175263,0.19959015418182
NMR metabolomics,X23424.Total Lipids in VLDL,DCN,Decorin,41900,-0.00303316259555185,0.00237459742405978,-0.00768737354670902,0.00162104835560532,0.201505378482136
NMR metabolomics,X23424.Total Lipids in VLDL,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,39657,0.00446933876664392,0.00350048170092431,-0.00239160536716773,0.0113302829004556,0.201707372840467
NMR metabolomics,X23424.Total Lipids in VLDL,FSTL3,Follistatin-related protein 3,42084,0.0043069411196089,0.00337771607699051,-0.00231338239129249,0.0109272646305103,0.202294210472294
NMR metabolomics,X23424.Total Lipids in VLDL,GABARAP,Gamma-aminobutyric acid receptor-associated protein,39919,0.00629780408446721,0.00499500243544487,-0.00349240068900474,0.0160880088579392,0.207399325050773
NMR metabolomics,X23424.Total Lipids in VLDL,IL18RAP,Interleukin-18 receptor accessory protein,41936,0.0219830381280239,0.0174568761291569,-0.0122324390851236,0.0561985153411714,0.207952430245446
NMR metabolomics,X23424.Total Lipids in VLDL,PSMA1,Proteasome subunit alpha type-1,41843,0.00601386790059122,0.00477902463059527,-0.00335302037537551,0.015380756176558,0.208273604827632
NMR metabolomics,X23424.Total Lipids in VLDL,RTKN2,Rhotekin-2,39575,-0.00662577755188692,0.00526626303119902,-0.016947653093037,0.00369609798926316,0.208362307627234
NMR metabolomics,X23424.Total Lipids in VLDL,HEPACAM2,HEPACAM family member 2,39929,0.0056764690908542,0.00451687855813382,-0.00317661288308809,0.0145295510647965,0.208879552947155
NMR metabolomics,X23424.Total Lipids in VLDL,APOA4,Apolipoprotein A-IV,39979,0.00444407741226382,0.00356170144314756,-0.00253685741630541,0.011425012240833,0.212151958312675
NMR metabolomics,X23424.Total Lipids in VLDL,ITGB2,Integrin beta-2,42079,-0.0036975202913003,0.00296590676491255,-0.00951069755052889,0.00211565696792829,0.212538541371812
NMR metabolomics,X23424.Total Lipids in VLDL,MYL4,Myosin light chain 4,39638,-0.00664706097937292,0.00533323516578543,-0.0171002019043124,0.00380607994556652,0.212663525718033
NMR metabolomics,X23424.Total Lipids in VLDL,SMC3,Structural maintenance of chromosomes protein 3,39560,0.0067163372405718,0.0053948785533588,-0.00385762472401144,0.017290299205155,0.213177893814467
NMR metabolomics,X23424.Total Lipids in VLDL,IL3RA,Interleukin-3 receptor subunit alpha,41913,0.00403530334117352,0.00324515262357525,-0.00232519580103397,0.010395802483381,0.213710524583014
NMR metabolomics,X23424.Total Lipids in VLDL,HBQ1,Hemoglobin subunit theta-1,42262,-0.00787097053945077,0.00634311455782926,-0.0203034750727961,0.00456153399389459,0.214675667543499
NMR metabolomics,X23424.Total Lipids in VLDL,CLEC12A,C-type lectin domain family 12 member A,39657,0.00261843110452429,0.0021110166957968,-0.00151916161923744,0.00675602382828602,0.214866760885792
NMR metabolomics,X23424.Total Lipids in VLDL,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,39649,-0.00608226413085553,0.00491060823008989,-0.0157070562618317,0.00354252800012065,0.215521129907715
NMR metabolomics,X23424.Total Lipids in VLDL,MRPL24,"39S ribosomal protein L24, mitochondrial",39575,0.00496208884939954,0.00400926547167105,-0.00289607147507571,0.0128202491738748,0.215870359646487
NMR metabolomics,X23424.Total Lipids in VLDL,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,42249,0.00594919239869048,0.00481797822545141,-0.00349404492319428,0.0153924297205752,0.21692984404957
NMR metabolomics,X23424.Total Lipids in VLDL,ARHGEF5,Rho guanine nucleotide exchange factor 5,39586,-0.00965380882046601,0.00783221913589499,-0.0250049583268202,0.00569734068588817,0.217760205787313
NMR metabolomics,X23424.Total Lipids in VLDL,TNPO1,Transportin-1,39757,0.00450220063075904,0.00366872553522934,-0.00268850141829046,0.0116929026798085,0.219779401350515
NMR metabolomics,X23424.Total Lipids in VLDL,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",39757,0.00877433816575204,0.00715393958827558,-0.0052473834272681,0.0227960597587722,0.220034815405848
NMR metabolomics,X23424.Total Lipids in VLDL,KCNIP4,Kv channel-interacting protein 4,41839,0.00643820307695459,0.0052564690438505,-0.00386447624899238,0.0167408824029016,0.220666656312868
NMR metabolomics,X23424.Total Lipids in VLDL,EPHA2,Ephrin type-A receptor 2,41614,-0.0040812911468204,0.00333494364978922,-0.0106177807004073,0.00245519840676647,0.22105129886747
NMR metabolomics,X23424.Total Lipids in VLDL,ACRV1,Acrosomal protein SP-10,39657,0.0134159516848895,0.0109956326992165,-0.0081354884055749,0.034967391775354,0.222446777757103
NMR metabolomics,X23424.Total Lipids in VLDL,USP28,Ubiquitin carboxyl-terminal hydrolase 28,39929,0.00457883896695778,0.00377143657008449,-0.00281317671040783,0.0119708546443234,0.224741142050334
NMR metabolomics,X23424.Total Lipids in VLDL,TGM2,Protein-glutamine gamma-glutamyltransferase 2,42120,0.00912421435349932,0.00754406995653324,-0.00566216276130582,0.0239105914683045,0.22650917520917
NMR metabolomics,X23424.Total Lipids in VLDL,NOS2,"Nitric oxide synthase, inducible",39575,-0.00502764190338976,0.00416903855501983,-0.0131989574712286,0.00314367366444911,0.227863705022425
NMR metabolomics,X23424.Total Lipids in VLDL,HDAC8,Histone deacetylase 8,39657,0.00748976867382426,0.00622834133513238,-0.0047177803430352,0.0196973176906837,0.229183915608106
NMR metabolomics,X23424.Total Lipids in VLDL,VSTM2B,V-set and transmembrane domain-containing protein 2B,39757,0.00509725436527628,0.00424614000358541,-0.00322518004175113,0.0134196887723037,0.229992337990882
NMR metabolomics,X23424.Total Lipids in VLDL,PDCD1LG2,Programmed cell death 1 ligand 2,42070,-0.00392568298948005,0.0032718743793013,-0.0103385567729106,0.00248719079395049,0.230227665891311
NMR metabolomics,X23424.Total Lipids in VLDL,ZNF174,Zinc finger protein 174,39657,0.00456088670164499,0.00380415074190278,-0.00289524875248447,0.0120170221557744,0.230583286402347
NMR metabolomics,X23424.Total Lipids in VLDL,RELB,Transcription factor RelB,39657,0.00580617051658684,0.00485244311359542,-0.00370461798606018,0.0153169590192339,0.231509285225613
NMR metabolomics,X23424.Total Lipids in VLDL,CALCB,Calcitonin gene-related peptide 2,39929,0.00501561570318595,0.00419977210123612,-0.00321593761523685,0.0132471690216087,0.232401667276237
NMR metabolomics,X23424.Total Lipids in VLDL,CTAG1A_CTAG1B,Cancer/testis antigen 1,39735,-0.00622223224892388,0.0052153573721856,-0.0164443326984077,0.00399986820055989,0.232871447302506
NMR metabolomics,X23424.Total Lipids in VLDL,GRIK2,"Glutamate receptor ionotropic, kainate 2",39934,0.0051306816670472,0.00430368062725564,-0.00330453236237385,0.0135658956964683,0.233222948447836
NMR metabolomics,X23424.Total Lipids in VLDL,PGA4,Pepsin A-4,39990,0.00921991907010918,0.00774876265335089,-0.00596765573045856,0.0244074938706769,0.23412742354305
NMR metabolomics,X23424.Total Lipids in VLDL,DRAXIN,Draxin,42016,0.00520050707112391,0.00439031337168819,-0.00340450713738494,0.0138055212796328,0.236219881245606
NMR metabolomics,X23424.Total Lipids in VLDL,ARNT,Aryl hydrocarbon receptor nuclear translocator,41913,0.00451791729117481,0.00382245738815581,-0.00297409918961058,0.0120099337719602,0.237250411561436
NMR metabolomics,X23424.Total Lipids in VLDL,IL18BP,Interleukin-18-binding protein,42217,0.00381670365439934,0.0032386278531454,-0.00253100693776565,0.0101644142465643,0.238620296179518
NMR metabolomics,X23424.Total Lipids in VLDL,KLK14,Kallikrein-14,42262,-0.00563110481046008,0.00477915341464754,-0.0149982455031693,0.0037360358822491,0.238711864495944
NMR metabolomics,X23424.Total Lipids in VLDL,MSMB,Beta-microseminoprotein,42103,-0.00848969379329094,0.00720634439417153,-0.0226141288058671,0.00563474121928527,0.238783064700991
NMR metabolomics,X23424.Total Lipids in VLDL,KRT8,"Keratin, type II cytoskeletal 8",39586,0.0101596229639631,0.00867699443677034,-0.00684728613210674,0.027166532060033,0.241676872033512
NMR metabolomics,X23424.Total Lipids in VLDL,NRXN3,Neurexin-3,39649,0.00433621631071083,0.00371732816198974,-0.00294974688678905,0.0116221795082107,0.243442632999031
NMR metabolomics,X23424.Total Lipids in VLDL,EXOSC10,Exosome component 10,39575,-0.00703023798389356,0.00602858362818134,-0.018846261895129,0.00478578592734187,0.243578796760327
NMR metabolomics,X23424.Total Lipids in VLDL,MRC1,Macrophage mannose receptor 1,39990,0.0034242603028927,0.0029373465192952,-0.00233293887492588,0.00918145948071128,0.243733257753456
NMR metabolomics,X23424.Total Lipids in VLDL,PCNA,Proliferating cell nuclear antigen,39560,0.00776662621425922,0.00667378441449187,-0.00531399123814484,0.0208472436666633,0.244550090631336
NMR metabolomics,X23424.Total Lipids in VLDL,BEX3,Protein BEX3,39560,-0.00562629561601414,0.00484170689221802,-0.0151160411247615,0.00386344989273318,0.245241288358896
NMR metabolomics,X23424.Total Lipids in VLDL,LRP1,Prolow-density lipoprotein receptor-related protein 1,42070,0.00320563243889646,0.00276108865427218,-0.00220610132347701,0.00861736620126992,0.245661220059638
NMR metabolomics,X23424.Total Lipids in VLDL,MAPK13,Mitogen-activated protein kinase 13,39560,0.00521399032766553,0.00451635522786149,-0.003638065918943,0.0140660465742741,0.248333273179771
NMR metabolomics,X23424.Total Lipids in VLDL,TYRO3,Tyrosine-protein kinase receptor TYRO3,42145,0.00336591026151889,0.00292135131221839,-0.00235993831042915,0.00909175883346694,0.249269177972191
NMR metabolomics,X23424.Total Lipids in VLDL,CASQ2,Calsequestrin-2,39575,0.0056578793981366,0.0049210285230787,-0.00398733650709765,0.0153030953033709,0.250278031097604
NMR metabolomics,X23424.Total Lipids in VLDL,COPE,Coatomer subunit epsilon,41839,0.00549597979230839,0.00478815802291201,-0.00388880993259915,0.0148807695172159,0.251060493670622
NMR metabolomics,X23424.Total Lipids in VLDL,IGFBP7,Insulin-like growth factor-binding protein 7,42310,0.00367918983129295,0.0032088009356578,-0.00261006000259634,0.00996843966518224,0.251569734358894
NMR metabolomics,X23424.Total Lipids in VLDL,PDIA2,Protein disulfide-isomerase A2,39560,0.00472312253076911,0.00413686647096341,-0.00338513575231917,0.0128313808138574,0.253597444204983
NMR metabolomics,X23424.Total Lipids in VLDL,DUSP29,Dual specificity phosphatase 29,39649,-0.0079307343445804,0.00696140584633281,-0.0215750898033927,0.0057136211142319,0.254626425389695
NMR metabolomics,X23424.Total Lipids in VLDL,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,39575,-0.00464560240061089,0.00408389387032404,-0.012650034386446,0.00335882958522423,0.255336447103781
NMR metabolomics,X23424.Total Lipids in VLDL,ACTN4,Alpha-actinin-4,41913,0.00370547590466004,0.00325750316873947,-0.00267923030606932,0.0100901821153894,0.255341325195313
NMR metabolomics,X23424.Total Lipids in VLDL,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",39657,0.00329315894633622,0.00289526648611834,-0.00238156336645572,0.00896788125912817,0.255383798378473
NMR metabolomics,X23424.Total Lipids in VLDL,GAD2,Glutamate decarboxylase 2,39657,-0.00533048303129748,0.00468667492676864,-0.014516365887764,0.00385539982516905,0.255408327580536
NMR metabolomics,X23424.Total Lipids in VLDL,CRISP2,Cysteine-rich secretory protein 2,42262,0.00622748311835418,0.00547873777691933,-0.0045108429244077,0.0169658091611161,0.255698777816618
NMR metabolomics,X23424.Total Lipids in VLDL,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,42119,0.00998492642449146,0.00878613240523656,-0.00723589308977221,0.0272057459387551,0.255791935293061
NMR metabolomics,X23424.Total Lipids in VLDL,AMY2B,Alpha-amylase 2B,41300,-0.00588132795294294,0.00517685635500657,-0.0160279664087558,0.00426531050286995,0.255944118996616
NMR metabolomics,X23424.Total Lipids in VLDL,ANXA10,Annexin A10,41839,-0.00957339249148535,0.00843814746571109,-0.0261121615242791,0.00696537654130839,0.256589805487427
NMR metabolomics,X23424.Total Lipids in VLDL,HTR1A,5-hydroxytryptamine receptor 1A,39586,-0.00844995642183419,0.00748364918553139,-0.0231179088254757,0.00621799598180732,0.258870829616645
NMR metabolomics,X23424.Total Lipids in VLDL,TEX33,Testis-expressed protein 33,39757,-0.00449963417837777,0.00398795082644457,-0.0123160177982091,0.00331674944145358,0.259214407378543
NMR metabolomics,X23424.Total Lipids in VLDL,NPHS2,Podocin,39657,-0.0118877114868204,0.0105407174408634,-0.0325475176709127,0.00877209469727177,0.259433258814801
NMR metabolomics,X23424.Total Lipids in VLDL,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",39657,0.00579135699864442,0.0051381193083964,-0.00427935684581253,0.0158620708431014,0.259709628797923
NMR metabolomics,X23424.Total Lipids in VLDL,RGS8,Regulator of G-protein signaling 8,41913,-0.00741570472073006,0.00659835580411483,-0.0203484820967951,0.005517072655335,0.261087763935708
NMR metabolomics,X23424.Total Lipids in VLDL,PILRB,Paired immunoglobulin-like type 2 receptor beta,42145,0.00666127352224821,0.00595455866010621,-0.00500966145155995,0.0183322084960564,0.263294523851974
NMR metabolomics,X23424.Total Lipids in VLDL,RBM19,Probable RNA-binding protein 19,39575,-0.00553295461302203,0.0049732259011896,-0.0152804773793536,0.00421456815330959,0.265926792196253
NMR metabolomics,X23424.Total Lipids in VLDL,ENPEP,Glutamyl aminopeptidase,39575,0.00486754820976771,0.00438862939176945,-0.00373416539810041,0.0134692618176358,0.267399617165113
NMR metabolomics,X23424.Total Lipids in VLDL,PRTN3,Myeloblastin,41800,-0.00551114246930564,0.00496946321410674,-0.0152512903689549,0.00422900543034358,0.267449712323138
NMR metabolomics,X23424.Total Lipids in VLDL,CD33,Myeloid cell surface antigen CD33,42181,0.00908192063404085,0.00819750704953928,-0.00698519318305614,0.0251490344511378,0.267929759324148
NMR metabolomics,X23424.Total Lipids in VLDL,TEF,Thyrotroph embryonic factor,39575,0.00488661792461245,0.00442916100081878,-0.00379453763699235,0.0135677734862173,0.269928488234946
NMR metabolomics,X23424.Total Lipids in VLDL,TFAP2A,Transcription factor AP-2-alpha,39586,0.00676809174325781,0.00615462891526707,-0.00529498093066565,0.0188311644171813,0.271497834064246
NMR metabolomics,X23424.Total Lipids in VLDL,CD200,OX-2 membrane glycoprotein,42119,-0.0030810211469276,0.00280661353788051,-0.0085819836811734,0.00241994138731819,0.272323707452988
NMR metabolomics,X23424.Total Lipids in VLDL,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,39649,0.00571610910121877,0.00521258435330297,-0.00450055623125504,0.0159327744336926,0.272841101623189
NMR metabolomics,X23424.Total Lipids in VLDL,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,39575,-0.00648491343616681,0.00592895459862815,-0.018105664449478,0.00513583757714436,0.274079813484891
NMR metabolomics,X23424.Total Lipids in VLDL,CRNN,Cornulin,41749,0.00759813164851869,0.00695337377498869,-0.00603048095045914,0.0212267442474965,0.274534181922927
NMR metabolomics,X23424.Total Lipids in VLDL,MYOM1,Myomesin-1,39586,0.00546301693811126,0.00506466166439258,-0.00446371992409819,0.0153897538003207,0.280765736102835
NMR metabolomics,X23424.Total Lipids in VLDL,KCNH2,Potassium voltage-gated channel subfamily H member 2,39649,0.00857126984760182,0.00797327980565537,-0.0070563585714827,0.0241988982666864,0.282398536085827
NMR metabolomics,X23424.Total Lipids in VLDL,IL36A,Interleukin-36 alpha,39657,-0.00631399442999432,0.00594260510851106,-0.017961500442676,0.00533351158268736,0.288033756919058
NMR metabolomics,X23424.Total Lipids in VLDL,ALMS1,Alstrom syndrome protein 1,39757,-0.00484114102251796,0.00459159822799366,-0.0138406735493855,0.00415839150434961,0.291746590002559
NMR metabolomics,X23424.Total Lipids in VLDL,GFRA3,GDNF family receptor alpha-3,41989,0.00300992723643757,0.00287120630257546,-0.00261763711661032,0.00863749158948547,0.294512647988351
NMR metabolomics,X23424.Total Lipids in VLDL,ZP4,Zona pellucida sperm-binding protein 4,39560,0.00336871102261562,0.00322948161098005,-0.00296107293490528,0.00969849498013651,0.296919430730997
NMR metabolomics,X23424.Total Lipids in VLDL,MYOC,Myocilin,42137,-0.00475862188992565,0.00461684545662705,-0.0138076389849147,0.00429039520506337,0.302695948567401
NMR metabolomics,X23424.Total Lipids in VLDL,DNAJA4,DnaJ homolog subfamily A member 4,39929,0.00731554073017817,0.00714365706677804,-0.00668602712070678,0.0213171085810631,0.305828320654725
NMR metabolomics,X23424.Total Lipids in VLDL,TJP3,Tight junction protein ZO-3,39586,-0.00439526250576024,0.00430188437919717,-0.0128269558889867,0.00403643087746621,0.306942411331042
NMR metabolomics,X23424.Total Lipids in VLDL,PGLYRP1,Peptidoglycan recognition protein 1,42248,-0.0044082800963924,0.00433003713600688,-0.0128951528829659,0.00407859269018108,0.308662826486006
NMR metabolomics,X23424.Total Lipids in VLDL,TG,Thyroglobulin,39919,-0.011018371267393,0.0108244245475686,-0.0322342433806275,0.0101975008458415,0.308738916658307
NMR metabolomics,X23424.Total Lipids in VLDL,PRL,Prolactin,42249,0.00762377963723896,0.00759323430536459,-0.00725895960127563,0.0225065188757536,0.315385469326788
NMR metabolomics,X23424.Total Lipids in VLDL,PFDN6,Prefoldin subunit 6,39649,0.00670695817045809,0.00670339226097714,-0.0064316906610571,0.0198456070019733,0.317075051731533
NMR metabolomics,X23424.Total Lipids in VLDL,SUSD5,Sushi domain-containing protein 5,39695,-0.00356153417877076,0.00356381218359983,-0.0105466060586264,0.00342353770108491,0.317641738838333
NMR metabolomics,X23424.Total Lipids in VLDL,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,39575,-0.00350675420548616,0.0035184606582256,-0.0104029370956083,0.00338942868463602,0.318945306596465
NMR metabolomics,X23424.Total Lipids in VLDL,TMPRSS11B,Transmembrane protease serine 11B,39586,0.00780927683748366,0.00785089121044925,-0.00757846993499687,0.0231970236099642,0.319904390412744
NMR metabolomics,X23424.Total Lipids in VLDL,CHP1,Calcineurin B homologous protein 1,39586,0.00759054826359708,0.00763340059111485,-0.00737091689498802,0.0225520134221822,0.320056781244307
NMR metabolomics,X23424.Total Lipids in VLDL,CTNNA1,Catenin alpha-1,39586,-0.00347570038586772,0.00349759001291969,-0.0103309768111903,0.00337957603945488,0.320370614094375
NMR metabolomics,X23424.Total Lipids in VLDL,FBLN2,Fibulin-2,39966,-0.00330033344869176,0.00332225631891304,-0.00981195583376133,0.0032112889363778,0.320535619524955
NMR metabolomics,X23424.Total Lipids in VLDL,GBP6,Guanylate-binding protein 6,39575,-0.00458844122924411,0.00462426284988169,-0.0136519964150122,0.004475113956524,0.32109573148391
NMR metabolomics,X23424.Total Lipids in VLDL,KLHL41,Kelch-like protein 41,39934,-0.005327188504626,0.00542040772063212,-0.015951187637065,0.00529681062781296,0.325725788919885
NMR metabolomics,X23424.Total Lipids in VLDL,KIRREL2,Kin of IRRE-like protein 2,41839,0.00403993287552093,0.00411471208956003,-0.00402490282001673,0.0121047685710586,0.326203331335695
NMR metabolomics,X23424.Total Lipids in VLDL,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,39649,-0.00423121201899175,0.00432019520232497,-0.0126987946155487,0.0042363705775652,0.327402353144467
NMR metabolomics,X23424.Total Lipids in VLDL,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,42016,0.00305064790895193,0.00311540488677299,-0.00305554566912313,0.00915684148702699,0.327491936822075
NMR metabolomics,X23424.Total Lipids in VLDL,SEMA3G,Semaphorin-3G,39736,0.00460872315600751,0.00471077494186176,-0.00462439573004155,0.0138418420420566,0.327929166545963
NMR metabolomics,X23424.Total Lipids in VLDL,HIF1A,Hypoxia-inducible factor 1-alpha,39657,0.00632445142126301,0.00647694237687378,-0.0063703556374096,0.0190192584799356,0.328859738058131
NMR metabolomics,X23424.Total Lipids in VLDL,CEND1,Cell cycle exit and neuronal differentiation protein 1,39586,0.00610486772984632,0.00626572934030474,-0.00617596177715098,0.0183856972368436,0.329915777192677
NMR metabolomics,X23424.Total Lipids in VLDL,HDDC2,5'-deoxynucleotidase HDDC2,39930,-0.00440999400441561,0.00452630189475697,-0.0132815457181393,0.00446155770930805,0.329926423805796
NMR metabolomics,X23424.Total Lipids in VLDL,IL20RA,Interleukin-20 receptor subunit alpha,41913,0.00445932497317559,0.0045785453927824,-0.00451462399667791,0.0134332739430291,0.330093564766889
NMR metabolomics,X23424.Total Lipids in VLDL,SSB,Lupus La protein,41839,0.0059108246681403,0.00607661983732139,-0.00599935021300962,0.0178209995492902,0.330712297587478
NMR metabolomics,X23424.Total Lipids in VLDL,SPINK5,Serine protease inhibitor Kazal-type 5,42137,-0.00355792343124682,0.00366217300180283,-0.0107357825147804,0.00361993565228672,0.331300081964456
NMR metabolomics,X23424.Total Lipids in VLDL,WNT9A,Protein Wnt-9a,41913,-0.00292077466586856,0.00300943224611995,-0.00881926186826366,0.00297771253652653,0.331794980306399
NMR metabolomics,X23424.Total Lipids in VLDL,AMY2A,Pancreatic alpha-amylase,41665,-0.00487378104971337,0.00505093070223642,-0.0147736052260968,0.00502604312667002,0.334599073892797
NMR metabolomics,X23424.Total Lipids in VLDL,KIT,Mast/stem cell growth factor receptor Kit,42199,-0.00289572428085473,0.00300274753814504,-0.00878110945561901,0.00298966089390955,0.334883507599361
NMR metabolomics,X23424.Total Lipids in VLDL,CREB3,Cyclic AMP-responsive element-binding protein 3,39560,0.00560533886337593,0.00581279269531903,-0.00578773481944938,0.0169984125462012,0.334911395991044
NMR metabolomics,X23424.Total Lipids in VLDL,RNASE6,Ribonuclease K6,39937,0.00321471139425876,0.00333622874994675,-0.00332429695563687,0.0097537197441544,0.335278879760236
NMR metabolomics,X23424.Total Lipids in VLDL,IL12RB2,Interleukin-12 receptor subunit beta-2,39657,-0.00408473679035626,0.00427941809172479,-0.0124723962501368,0.00430292266942433,0.339847666475237
NMR metabolomics,X23424.Total Lipids in VLDL,RSPO3,R-spondin-3,42262,0.0027557512193166,0.00289923335988201,-0.00292674616605214,0.00843824860468534,0.341869828426416
NMR metabolomics,X23424.Total Lipids in VLDL,IL24,Interleukin-24,41913,-0.004705431136776,0.00497941357164283,-0.0144650817371959,0.00505421946364394,0.344687784624856
NMR metabolomics,X23424.Total Lipids in VLDL,ADRA2A,Alpha-2A adrenergic receptor,39575,-0.00677084190039919,0.00718638019754161,-0.0208561470875807,0.00731446328678235,0.34612278221629
NMR metabolomics,X23424.Total Lipids in VLDL,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,39934,0.00249952901598173,0.00265363798636502,-0.0027016014372937,0.00770065946925717,0.346250911576509
NMR metabolomics,X23424.Total Lipids in VLDL,RETN,Resistin,42105,-0.00416749418527967,0.00443516661477292,-0.0128604207502346,0.00452543237967527,0.347415096907429
NMR metabolomics,X23424.Total Lipids in VLDL,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,41900,0.0046949653951724,0.00501905564983212,-0.00514238367849856,0.0145323144688434,0.349584734969185
NMR metabolomics,X23424.Total Lipids in VLDL,STEAP4,Metalloreductase STEAP4,39586,0.00700630819435995,0.0075295260891977,-0.00775156294046754,0.0217641793291874,0.352126925289382
NMR metabolomics,X23424.Total Lipids in VLDL,THRAP3,Thyroid hormone receptor-associated protein 3,39575,-0.0101525930891523,0.010957461784636,-0.0316292181870388,0.0113240320087342,0.354182643726495
NMR metabolomics,X23424.Total Lipids in VLDL,ELAVL4,ELAV-like protein 4,39586,0.00784008505869924,0.00847818543871504,-0.00877715840118224,0.0244573285185807,0.355123451099908
NMR metabolomics,X23424.Total Lipids in VLDL,TRPV3,Transient receptor potential cation channel subfamily V member 3,39575,-0.0047565405762558,0.00514829431588177,-0.0148471974353841,0.00533411628287247,0.355555513493625
NMR metabolomics,X23424.Total Lipids in VLDL,COMMD9,COMM domain-containing protein 9,39919,0.00379957728195721,0.00411914963741611,-0.00427395600737836,0.0118731105712928,0.356330306975799
NMR metabolomics,X23424.Total Lipids in VLDL,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,39757,-0.00625387861837756,0.00679418259869179,-0.0195704765118135,0.00706271927505834,0.357344232197894
NMR metabolomics,X23424.Total Lipids in VLDL,DEFA1_DEFA1B,Neutrophil defensin 1,41879,0.00507637665114708,0.00552831980288547,-0.00575913016250844,0.0159118834648026,0.358504960060998
NMR metabolomics,X23424.Total Lipids in VLDL,FLT3,Receptor-type tyrosine-protein kinase FLT3,41843,0.00285964871751352,0.00312090559389119,-0.00325732624651322,0.00897662368154026,0.359532482575148
NMR metabolomics,X23424.Total Lipids in VLDL,SLC51B,Organic solute transporter subunit beta,39575,-0.00685880631333231,0.00750347534734834,-0.0215656179941351,0.00784800536747044,0.360692821157729
NMR metabolomics,X23424.Total Lipids in VLDL,VTCN1,V-set domain-containing T-cell activation inhibitor 1,41843,-0.00299003557647294,0.0032827138129844,-0.00942415464992236,0.00344408349697648,0.362394892684361
NMR metabolomics,X23424.Total Lipids in VLDL,MAPT,Microtubule-associated protein tau,41839,0.0049607091762805,0.00545348589546349,-0.00572812317882794,0.0156495415313889,0.36302893025577
NMR metabolomics,X23424.Total Lipids in VLDL,PI16,Peptidase inhibitor 16,39990,0.00226886575829117,0.00249558247087527,-0.00262247588462436,0.00716020740120671,0.363288718752773
NMR metabolomics,X23424.Total Lipids in VLDL,LAMA1,Laminin subunit alpha-1,39575,-0.00483317906370429,0.00534532049916624,-0.0153100072420701,0.00564364911466154,0.365915130985815
NMR metabolomics,X23424.Total Lipids in VLDL,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,39586,0.00697675916100422,0.00772876704798962,-0.00817162425305544,0.0221251425750639,0.366704848951357
NMR metabolomics,X23424.Total Lipids in VLDL,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",41839,0.00472838280826085,0.00525646230086474,-0.00557428330143403,0.0150310489179557,0.368383009281226
NMR metabolomics,X23424.Total Lipids in VLDL,MRPL52,"39S ribosomal protein L52, mitochondrial",39541,0.00247424574878512,0.0027522613582635,-0.00292018651341133,0.00786867801098158,0.368679646470821
NMR metabolomics,X23424.Total Lipids in VLDL,FSTL1,Follistatin-related protein 1,39638,-0.0021599984671954,0.00240509263329927,-0.00687398002846197,0.00255398309407116,0.369155203023918
NMR metabolomics,X23424.Total Lipids in VLDL,DOCK9,Dedicator of cytokinesis protein 9,39586,0.010901085170505,0.0121532903186142,-0.012919363853979,0.0347215341949889,0.369756848000812
NMR metabolomics,X23424.Total Lipids in VLDL,TPPP2,Tubulin polymerization-promoting protein family member 2,39757,-0.00705574622918007,0.00788547672981976,-0.0225112806196268,0.00839978816126666,0.370925405327836
NMR metabolomics,X23424.Total Lipids in VLDL,TNNI3,"Troponin I, cardiac muscle",41900,0.00773983966378796,0.00866747741103386,-0.0092484160618384,0.0247280953894143,0.371886777885296
NMR metabolomics,X23424.Total Lipids in VLDL,DENND2B,DENN domain-containing protein 2B,39575,-0.00446261988267431,0.00506741045165258,-0.0143947443679134,0.00546950460256475,0.378526050833762
NMR metabolomics,X23424.Total Lipids in VLDL,CLGN,Calmegin,39649,0.00415219525077335,0.00472190043596666,-0.00510272960372131,0.013407120105268,0.379231563620558
NMR metabolomics,X23424.Total Lipids in VLDL,TMEM132A,Transmembrane protein 132A,39638,0.00570659992437513,0.00649241737522068,-0.00701853813105741,0.0184317379798077,0.379440030996661
NMR metabolomics,X23424.Total Lipids in VLDL,DDX53,Probable ATP-dependent RNA helicase DDX53,39649,0.00326308223323962,0.00374365108253109,-0.00407447388852132,0.0106006383550006,0.3834286672999
NMR metabolomics,X23424.Total Lipids in VLDL,GJA8,Gap junction alpha-8 protein,39560,-0.00562005881957816,0.00645962577837327,-0.0182809253451898,0.00704080770603345,0.384303858575661
NMR metabolomics,X23424.Total Lipids in VLDL,PTTG1,Securin,39757,0.00371910853419111,0.00430327138243188,-0.00471530337537537,0.0121535204437576,0.38746835396474
NMR metabolomics,X23424.Total Lipids in VLDL,SCN3A,Sodium channel protein type 3 subunit alpha,39649,-0.00325026193079402,0.00379449692325929,-0.0106874759003822,0.00418695203879418,0.391699734477679
NMR metabolomics,X23424.Total Lipids in VLDL,PSMC3,26S proteasome regulatory subunit 6A,39560,-0.00269845007402509,0.00315220722290338,-0.00887677623091571,0.00347987608286553,0.391988297620613
NMR metabolomics,X23424.Total Lipids in VLDL,TNR,Tenascin-R,42016,0.00370043235696541,0.00432277648901816,-0.00477220956151017,0.012173074275441,0.391995706507599
NMR metabolomics,X23424.Total Lipids in VLDL,VSIG2,V-set and immunoglobulin domain-containing protein 2,39919,0.00548677834685496,0.00641088550224856,-0.00707855723755222,0.0180521139312621,0.392096973532413
NMR metabolomics,X23424.Total Lipids in VLDL,SLC39A14,Zinc transporter ZIP14,41839,-0.00297337410527187,0.00348180072601003,-0.00979770352825153,0.00385095531770779,0.39313376289212
NMR metabolomics,X23424.Total Lipids in VLDL,BSND,Barttin,39560,0.00296529794640852,0.00347333072543124,-0.0038424302754367,0.00977302616825375,0.393271462075789
NMR metabolomics,X23424.Total Lipids in VLDL,FBN2,Fibrillin-2,39649,0.00527497402928053,0.00621022361039257,-0.0068970642470889,0.01744701230565,0.39567625230797
NMR metabolomics,X23424.Total Lipids in VLDL,OLR1,Oxidized low-density lipoprotein receptor 1,42017,0.00511328276732803,0.0060456825862138,-0.00673625510165102,0.0169628206363071,0.39769376557404
NMR metabolomics,X23424.Total Lipids in VLDL,LYPLA2,Acyl-protein thioesterase 2,39586,0.00950183965429661,0.011237164583933,-0.012523002930212,0.0315266822388052,0.397809573233382
NMR metabolomics,X23424.Total Lipids in VLDL,RBP1,Retinol-binding protein 1,39649,0.00613416933136691,0.00726078215871129,-0.00809696369970722,0.020365302362441,0.39822076779394
NMR metabolomics,X23424.Total Lipids in VLDL,AKAP12,A-kinase anchor protein 12,39736,0.0018549648278916,0.00219956317978859,-0.00245617900449403,0.00616610866027723,0.399060189658856
NMR metabolomics,X23424.Total Lipids in VLDL,BTNL10,Butyrophilin-like protein 10,39560,-0.00345812606579264,0.00412818446464102,-0.011549367616489,0.00463311548490376,0.402224836548796
NMR metabolomics,X23424.Total Lipids in VLDL,GIPC2,PDZ domain-containing protein GIPC2,39929,-0.00263516323469063,0.00315612627388166,-0.00882117073149869,0.00355084426211743,0.403771388039302
NMR metabolomics,X23424.Total Lipids in VLDL,COL4A4,Collagen alpha-4(IV) chain,39743,-0.00462540006954243,0.00554149256597208,-0.0154867254988477,0.00623592535976284,0.403913049920977
NMR metabolomics,X23424.Total Lipids in VLDL,CLNS1A,Methylosome subunit pICln,39649,-0.00289498961130026,0.00347214991587346,-0.00970040344641224,0.00391042422381171,0.404426164468556
NMR metabolomics,X23424.Total Lipids in VLDL,FDX1,"Adrenodoxin, mitochondrial",39575,0.00542806670859063,0.00651421567549791,-0.00733979601538528,0.0181959294325665,0.404713529527447
NMR metabolomics,X23424.Total Lipids in VLDL,POLR2A,DNA-directed RNA polymerase II subunit RPB1,39657,0.00256575782153348,0.00309028883497724,-0.00349120829502191,0.00862272393808887,0.406407051193125
NMR metabolomics,X23424.Total Lipids in VLDL,MAG,Myelin-associated glycoprotein,39649,0.0041688922261849,0.00502874455441438,-0.0056874471004673,0.0140252315528371,0.407115227598688
NMR metabolomics,X23424.Total Lipids in VLDL,PSAPL1,Proactivator polypeptide-like 1,39930,0.00428780537659656,0.00519803927863085,-0.0059003516095199,0.014475962362713,0.409451983170837
NMR metabolomics,X23424.Total Lipids in VLDL,TSPAN7,Tetraspanin-7,39586,-0.00829692050011137,0.010090011631352,-0.0280733432975613,0.0114795022973386,0.410929440253907
NMR metabolomics,X23424.Total Lipids in VLDL,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,39757,0.00379643655833845,0.00462198383259854,-0.00526265175355469,0.0128555248702316,0.411443524831679
NMR metabolomics,X23424.Total Lipids in VLDL,IL19,Interleukin-19,41756,-0.00621016958006989,0.00757170681647803,-0.0210507149403668,0.00863037578022705,0.412127827848172
NMR metabolomics,X23424.Total Lipids in VLDL,EDDM3B,Epididymal secretory protein E3-beta,39919,0.00520524329685136,0.00634849320045107,-0.00723780337603274,0.0176482899697354,0.412280168883742
NMR metabolomics,X23424.Total Lipids in VLDL,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,39757,-0.00314638794253893,0.00384193609566008,-0.0106765826900327,0.00438380680495483,0.412827328069877
NMR metabolomics,X23424.Total Lipids in VLDL,ISM2,Isthmin-2,39966,0.00366795669705938,0.00448826790916908,-0.00512904840491201,0.0124649617990308,0.41381291974906
NMR metabolomics,X23424.Total Lipids in VLDL,TYMP,Thymidine phosphorylase,42070,0.0056002193041051,0.00686161852991267,-0.00784855301452374,0.0190489916227339,0.414419669612152
NMR metabolomics,X23424.Total Lipids in VLDL,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,39586,0.00547518442485666,0.00672270952847005,-0.00770132625094463,0.018651695100658,0.415415621113442
NMR metabolomics,X23424.Total Lipids in VLDL,SHH,Sonic hedgehog protein,39657,-0.00358433321353506,0.00441326878096021,-0.0122343400242171,0.00506567359714695,0.416710443779857
NMR metabolomics,X23424.Total Lipids in VLDL,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",39560,-0.00452066802665285,0.00558179994619843,-0.0154609959212018,0.00641965986789608,0.418018504484519
NMR metabolomics,X23424.Total Lipids in VLDL,CD70,CD70 antigen,42119,0.00368614038525931,0.00456219331767493,-0.00525575851738356,0.0126280392879022,0.41911890798112
NMR metabolomics,X23424.Total Lipids in VLDL,LPO,Lactoperoxidase,41647,-0.00513332486445616,0.00635393923672145,-0.0175870457684302,0.00732039603951789,0.41916493234203
NMR metabolomics,X23424.Total Lipids in VLDL,EFNA1,Ephrin-A1,42113,0.00244823367876582,0.00303981616887431,-0.00350980601222782,0.00840627336975946,0.420609565206511
NMR metabolomics,X23424.Total Lipids in VLDL,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,39713,0.00408545052503081,0.00508515601566091,-0.00588145526566458,0.0140523563157262,0.421756647015582
NMR metabolomics,X23424.Total Lipids in VLDL,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",39575,-0.00353605341831924,0.00440679815390896,-0.0121733777999808,0.00510127096334232,0.422333925220488
NMR metabolomics,X23424.Total Lipids in VLDL,UGDH,UDP-glucose 6-dehydrogenase,39575,0.00821690031588253,0.0103204899069982,-0.0120112599018339,0.028445060533599,0.42594843306592
NMR metabolomics,X23424.Total Lipids in VLDL,TNN,Tenascin-N,39966,0.00355360329119926,0.00447002511389669,-0.00520764593203826,0.0123148525144368,0.42663877868112
NMR metabolomics,X23424.Total Lipids in VLDL,CHGB,Secretogranin-1,42210,0.00346646870006528,0.00436200188147452,-0.00508305498762477,0.0120159923877553,0.426803783082119
NMR metabolomics,X23424.Total Lipids in VLDL,OFD1,Oral-facial-digital syndrome 1 protein,39757,-0.00543192583085978,0.00683964822203611,-0.0188376363460506,0.00797378468433099,0.42710634940598
NMR metabolomics,X23424.Total Lipids in VLDL,SCG3,Secretogranin-3,42144,-0.00272662125693394,0.00343492585681486,-0.00945907593629107,0.00400583342242318,0.427329659141544
NMR metabolomics,X23424.Total Lipids in VLDL,CDH4,Cadherin-4,39586,0.00379144065907271,0.00481140824204319,-0.00563891949533195,0.0132218008134774,0.430707511979039
NMR metabolomics,X23424.Total Lipids in VLDL,UNC5D,Netrin receptor UNC5D,39657,0.00212389315370118,0.00270133850154404,-0.00317073030932513,0.00741851661672749,0.431745312921376
NMR metabolomics,X23424.Total Lipids in VLDL,MORF4L1,Mortality factor 4-like protein 1,39757,-0.00320025694449422,0.00407469891381725,-0.011186666815576,0.0047861529265876,0.432237424555571
NMR metabolomics,X23424.Total Lipids in VLDL,REST,RE1-silencing transcription factor,39560,-0.00276037896042617,0.0035433939281363,-0.00970543105957332,0.00418467313872099,0.435984050937204
NMR metabolomics,X23424.Total Lipids in VLDL,CBX2,Chromobox protein homolog 2,39575,-0.0031801745343962,0.00408229286264897,-0.0111814685451882,0.00482111947639579,0.435986641940256
NMR metabolomics,X23424.Total Lipids in VLDL,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,39649,-0.00364575171747016,0.00469623816477552,-0.0128503785204302,0.00555887508548985,0.437580693408168
NMR metabolomics,X23424.Total Lipids in VLDL,HNF1A,Hepatocyte nuclear factor 1-alpha,39649,0.00558996679477836,0.00722227469315452,-0.00856569160380451,0.0197456251933612,0.438953395654081
NMR metabolomics,X23424.Total Lipids in VLDL,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,41843,-0.00623861191533852,0.00808569000857929,-0.0220865643321539,0.0096093405014769,0.440387599070554
NMR metabolomics,X23424.Total Lipids in VLDL,PRC1,Protein regulator of cytokinesis 1,39919,0.00349343211765598,0.00455750911884169,-0.00543928575527374,0.0124261499905857,0.443381607145667
NMR metabolomics,X23424.Total Lipids in VLDL,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,39966,-0.0109496241068876,0.0143336784973914,-0.0390436339617748,0.0171443857479996,0.444937409772821
NMR metabolomics,X23424.Total Lipids in VLDL,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,39586,-0.00485746763654967,0.00636373729916555,-0.0173303927429141,0.0076154574698148,0.445298367008476
NMR metabolomics,X23424.Total Lipids in VLDL,CDC123,Cell division cycle protein 123 homolog,39560,0.00494337945841473,0.0064976938391064,-0.00779210046623382,0.0176788593830633,0.446798970615867
NMR metabolomics,X23424.Total Lipids in VLDL,CA11,Carbonic anhydrase-related protein 11,41843,-0.00239571496263041,0.00315041333833228,-0.00857052510576167,0.00377909518050085,0.447002382033113
NMR metabolomics,X23424.Total Lipids in VLDL,MRPL28,"39S ribosomal protein L28, mitochondrial",39934,-0.00284721218387462,0.00374440420449052,-0.010186244424676,0.00449182005692679,0.447036570875283
NMR metabolomics,X23424.Total Lipids in VLDL,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,39586,-0.00461746827459447,0.00608435323137633,-0.0165428006080921,0.00730786405890312,0.447923487991642
NMR metabolomics,X23424.Total Lipids in VLDL,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,39560,0.00208579409131936,0.00276069946654246,-0.00332517686310387,0.00749676504574258,0.449946661903116
NMR metabolomics,X23424.Total Lipids in VLDL,CLEC6A,C-type lectin domain family 6 member A,41843,0.00367623098230891,0.00489209963186394,-0.00591228429614441,0.0132647462607622,0.452387522530319
NMR metabolomics,X23424.Total Lipids in VLDL,FOLR3,Folate receptor gamma,42132,-0.0148523696588264,0.0198091004147368,-0.0536782064717105,0.0239734671540576,0.453403220173851
NMR metabolomics,X23424.Total Lipids in VLDL,GID8,Glucose-induced degradation protein 8 homolog,39934,0.00261871105725979,0.00351110196102903,-0.00426304878635712,0.00950047090087669,0.455781129334467
NMR metabolomics,X23424.Total Lipids in VLDL,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,39575,-0.00508696992488763,0.00682285461944818,-0.0184597649790061,0.00828582512923081,0.455938377313912
NMR metabolomics,X23424.Total Lipids in VLDL,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,39586,-0.0044019693463521,0.00591030408482502,-0.0159861653526091,0.00718222665990494,0.456411138156137
NMR metabolomics,X23424.Total Lipids in VLDL,DIPK1C,Divergent protein kinase domain 1C,39649,0.00322958529191026,0.00434327404152324,-0.00528323182947528,0.0117424024132958,0.457144525472548
NMR metabolomics,X23424.Total Lipids in VLDL,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",39586,-0.00411574439999206,0.00554886658555184,-0.0149915229076737,0.00676003410768955,0.458268587790817
NMR metabolomics,X23424.Total Lipids in VLDL,OSTN,Osteocrin,39649,0.00310144041046619,0.00418250455158683,-0.00509626851064399,0.0112991493315764,0.458389675697474
NMR metabolomics,X23424.Total Lipids in VLDL,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,39575,-0.00276558041733769,0.00376897367994147,-0.010152768830023,0.00462160799534758,0.463101270100733
NMR metabolomics,X23424.Total Lipids in VLDL,SOX2,Transcription factor SOX-2,39915,0.00186144758148182,0.00253735313868302,-0.0031117645703369,0.00683465973330053,0.463196871872842
NMR metabolomics,X23424.Total Lipids in VLDL,ESR1,Estrogen receptor,39657,0.00430207479635261,0.00591270442898336,-0.00728682588445478,0.01589097547716,0.466874813097587
NMR metabolomics,X23424.Total Lipids in VLDL,OMP,Olfactory marker protein,39586,-0.00359504751562086,0.00495914579361658,-0.0133149732711094,0.00612487823986764,0.468508688317923
NMR metabolomics,X23424.Total Lipids in VLDL,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,39990,-0.00276240983631399,0.00381151757617983,-0.0102329842856265,0.00470816461299847,0.46861829455416
NMR metabolomics,X23424.Total Lipids in VLDL,FCAR,Immunoglobulin alpha Fc receptor,42119,0.003641963023284,0.0050277493369055,-0.00621242567705078,0.0134963517236188,0.468849654247633
NMR metabolomics,X23424.Total Lipids in VLDL,ANK2,Ankyrin-2,39575,-0.0052050955030734,0.00722886114343784,-0.0193736633442116,0.00896347233806477,0.47151345941512
NMR metabolomics,X23424.Total Lipids in VLDL,MAPRE3,Microtubule-associated protein RP/EB family member 3,39560,-0.0109173973749333,0.0151880338864667,-0.040685943792408,0.0188511490425414,0.472269800388282
NMR metabolomics,X23424.Total Lipids in VLDL,LRP2BP,LRP2-binding protein,39649,-0.00574774756727174,0.0080321536896012,-0.0214907687988901,0.00999527366434661,0.474258232928459
NMR metabolomics,X23424.Total Lipids in VLDL,SPINK8,Serine protease inhibitor Kazal-type 8,39575,-0.0026425900623591,0.00369822853239078,-0.00989111798584503,0.00460593786112683,0.474898860336668
NMR metabolomics,X23424.Total Lipids in VLDL,DLGAP5,Disks large-associated protein 5,39934,0.00362298285148787,0.00510672363008655,-0.00638619546348177,0.0136321611664575,0.478057704006029
NMR metabolomics,X23424.Total Lipids in VLDL,GLI2,Zinc finger protein GLI2,39657,-0.00242270111951568,0.00343369291804698,-0.00915273923888777,0.0043073369998564,0.480472187898845
NMR metabolomics,X23424.Total Lipids in VLDL,MAMDC2,MAM domain-containing protein 2,39958,-0.00258389996160691,0.0036780276505675,-0.00979283415671922,0.0046250342335054,0.482367300757499
NMR metabolomics,X23424.Total Lipids in VLDL,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,39575,0.00358652600696655,0.00511804789003522,-0.00644484785750247,0.0136178998714356,0.48346732318802
NMR metabolomics,X23424.Total Lipids in VLDL,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,42145,-0.00232599621755031,0.00332503328681922,-0.00884306145971598,0.00419106902461535,0.484226180170235
NMR metabolomics,X23424.Total Lipids in VLDL,ZP3,Zona pellucida sperm-binding protein 3,39638,-0.0192680247337104,0.0275769517865141,-0.0733188502352781,0.0347828007678573,0.484754061298257
NMR metabolomics,X23424.Total Lipids in VLDL,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,42179,0.00349604924923557,0.00502572778144229,-0.00635437720239132,0.0133464757008625,0.486672199780013
NMR metabolomics,X23424.Total Lipids in VLDL,CPE,Carboxypeptidase E,42134,-0.00279099208953375,0.00403389440320973,-0.0106974251198248,0.00511544094075733,0.489021255175427
NMR metabolomics,X23424.Total Lipids in VLDL,SHC1,SHC-transforming protein 1,39560,-0.00825764351102389,0.0121101488295168,-0.0319935352168769,0.0154782481948291,0.495330535312126
NMR metabolomics,X23424.Total Lipids in VLDL,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,39966,-0.0018291474742831,0.00269267672617584,-0.00710679385758775,0.00344849890902155,0.496958765162176
NMR metabolomics,X23424.Total Lipids in VLDL,CLEC4M,C-type lectin domain family 4 member M,39945,-0.00348110479505773,0.00512639046766578,-0.0135288301116827,0.0065666205215672,0.497116406940452
NMR metabolomics,X23424.Total Lipids in VLDL,ERCC1,DNA excision repair protein ERCC-1,39560,0.0023493464621416,0.00345992939399795,-0.00443211515009438,0.00913080807437758,0.497142237202223
NMR metabolomics,X23424.Total Lipids in VLDL,NOP56,Nucleolar protein 56,39575,0.00784547300648044,0.0115850626257946,-0.014861249740077,0.0305521957530378,0.498289585365394
NMR metabolomics,X23424.Total Lipids in VLDL,TP53BP1,TP53-binding protein 1,39657,-0.00600951571022351,0.00889596825697154,-0.0234456134938877,0.0114265820734407,0.499351634861949
NMR metabolomics,X23424.Total Lipids in VLDL,IGLON5,IgLON family member 5,39560,-0.00646489203971646,0.00959083505625662,-0.0252629287499794,0.0123331446705465,0.500281169588619
NMR metabolomics,X23424.Total Lipids in VLDL,ECSCR,Endothelial cell-specific chemotaxis regulator,39586,0.00348935565337219,0.00517832480283461,-0.00666016096018365,0.013638872266928,0.500428044473143
NMR metabolomics,X23424.Total Lipids in VLDL,PSCA,Prostate stem cell antigen,39930,0.0180203585170561,0.0268648691148895,-0.0346347849481273,0.0706755019822395,0.50237574812401
NMR metabolomics,X23424.Total Lipids in VLDL,SIGLEC1,Sialoadhesin,42185,-0.00287271202894395,0.00429089839579773,-0.0112828728847075,0.0055374488268196,0.503194564109524
NMR metabolomics,X23424.Total Lipids in VLDL,VNN2,Vascular non-inflammatory molecule 2,42070,0.00322572676381223,0.00488059351778015,-0.00634023653103687,0.0127916900586613,0.508669023086275
NMR metabolomics,X23424.Total Lipids in VLDL,ARG2,"Arginase-2, mitochondrial",39919,-0.0028711591394239,0.00435784222600245,-0.0114125299023887,0.00567021162354091,0.510006265895738
NMR metabolomics,X23424.Total Lipids in VLDL,IL20RB,Interleukin-20 receptor subunit beta,39657,0.00285034608370797,0.00433681916991833,-0.00564981948933194,0.0113505116567479,0.511038058324073
NMR metabolomics,X23424.Total Lipids in VLDL,CDSN,Corneodesmosin,42246,0.00296701647660814,0.0045207143811253,-0.00589358371039744,0.0118276166636137,0.511631991471577
NMR metabolomics,X23424.Total Lipids in VLDL,CORO6,Coronin-6,39586,-0.00264417901599518,0.00403825583424332,-0.0105591604511121,0.00527080241912172,0.512621545145861
NMR metabolomics,X23424.Total Lipids in VLDL,GIPR,Gastric inhibitory polypeptide receptor,39657,0.00302349285999953,0.00467215866135812,-0.00613393811626239,0.0121809238362615,0.517561407345737
NMR metabolomics,X23424.Total Lipids in VLDL,ACTA2,"Actin, aortic smooth muscle",41900,0.00290844172371713,0.00450236094022098,-0.00591618571911599,0.0117330691665503,0.518302503257077
NMR metabolomics,X23424.Total Lipids in VLDL,EPB41L5,Band 4.1-like protein 5,39649,0.00414219363834767,0.00642844342305485,-0.00845755547083983,0.0167419427475352,0.519359241678055
NMR metabolomics,X23424.Total Lipids in VLDL,MN1,Transcriptional activator MN1,39649,-0.00392251985507292,0.00608873928834773,-0.0158564488602345,0.00801140915008863,0.519442724464301
NMR metabolomics,X23424.Total Lipids in VLDL,SEZ6,Seizure protein 6 homolog,39649,0.0020763835006737,0.0032369295254492,-0.00426799836920673,0.00842076537055413,0.521232614847758
NMR metabolomics,X23424.Total Lipids in VLDL,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,42284,0.0025027912506439,0.00395768574274046,-0.00525427280512739,0.0102598553064152,0.527144223222812
NMR metabolomics,X23424.Total Lipids in VLDL,MMP9,Matrix metalloproteinase-9,42125,-0.00388941557350154,0.00617608031833947,-0.0159945329974469,0.00821570185044382,0.528865729710326
NMR metabolomics,X23424.Total Lipids in VLDL,CD164L2,CD164 sialomucin-like 2 protein,39649,-0.00238013428888469,0.00377969688658043,-0.00978834018658233,0.00502807160881295,0.52889366106933
NMR metabolomics,X23424.Total Lipids in VLDL,PLXDC1,Plexin domain-containing protein 1,41843,-0.00205311828649746,0.00332503817848299,-0.00857019311632412,0.00446395654332919,0.53693399909647
NMR metabolomics,X23424.Total Lipids in VLDL,FGF6,Fibroblast growth factor 6,39657,0.00249099122096943,0.00404214677143772,-0.00543161645104851,0.0104135988929874,0.537739236352505
NMR metabolomics,X23424.Total Lipids in VLDL,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,39934,-0.0019027154908703,0.00310158325416511,-0.00798181866903391,0.00417638768729332,0.539580649558857
NMR metabolomics,X23424.Total Lipids in VLDL,PDCL2,Phosducin-like protein 2,39560,-0.00331502555684437,0.00540530002489208,-0.0139094136056329,0.00727936249194411,0.539696217432412
NMR metabolomics,X23424.Total Lipids in VLDL,ANKRA2,Ankyrin repeat family A protein 2,39560,-0.00346892352477786,0.00569727188607155,-0.0146355764214781,0.00769772937192237,0.542620252439829
NMR metabolomics,X23424.Total Lipids in VLDL,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,39575,-0.00297968737396747,0.00489991897742859,-0.0125835285697275,0.00662415382179256,0.543127422738786
NMR metabolomics,X23424.Total Lipids in VLDL,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,42016,-0.00267317934379266,0.00442954220086542,-0.0113550820574889,0.00600872336990355,0.546193731239755
NMR metabolomics,X23424.Total Lipids in VLDL,PAPPA,Pappalysin-1,41913,0.00294540684271596,0.00489853686839549,-0.00665572541933921,0.0125465391047711,0.547661761834282
NMR metabolomics,X23424.Total Lipids in VLDL,ALDH2,"Aldehyde dehydrogenase, mitochondrial",39919,0.00323547249722815,0.00541165939109207,-0.00737137990931231,0.0138423249037686,0.549938184094612
NMR metabolomics,X23424.Total Lipids in VLDL,IL10,Interleukin-10,41913,-0.00464346236752683,0.00794166649977831,-0.0202091287070923,0.0109222039720387,0.558761905876869
NMR metabolomics,X23424.Total Lipids in VLDL,IFNL1,Interferon lambda-1,41839,0.00272625739857389,0.00469222268764687,-0.00647049906921398,0.0119230138663618,0.561239425476584
NMR metabolomics,X23424.Total Lipids in VLDL,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,39919,0.00355101067390168,0.00612798204615471,-0.00845983413656156,0.0155618554843649,0.562280432693796
NMR metabolomics,X23424.Total Lipids in VLDL,COL9A1,Collagen alpha-1(IX) chain,42119,0.0026647569230327,0.00460204255081485,-0.0063552464765644,0.0116847603226298,0.562573266930351
NMR metabolomics,X23424.Total Lipids in VLDL,IL9,Interleukin-9,39757,-0.00334257674832135,0.00580637210728908,-0.0147230660786079,0.00803791258196524,0.564847245357128
NMR metabolomics,X23424.Total Lipids in VLDL,FGF20,Fibroblast growth factor 20,39657,-0.00255221675737457,0.00446488775774107,-0.0113033967625471,0.00619896324779792,0.567591423840408
NMR metabolomics,X23424.Total Lipids in VLDL,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,39757,0.00373050019637862,0.00654798281219983,-0.00910354611553305,0.0165645465082903,0.568880810114558
NMR metabolomics,X23424.Total Lipids in VLDL,TSPAN15,Tetraspanin-15,39575,-0.00294638295897678,0.00520113240146856,-0.0131406024658552,0.0072478365479016,0.571073166598515
NMR metabolomics,X23424.Total Lipids in VLDL,RNF168,E3 ubiquitin-protein ligase RNF168,39657,0.00236469977088141,0.00421981123704034,-0.00590613025371766,0.0106355297954805,0.575231308966563
NMR metabolomics,X23424.Total Lipids in VLDL,BRD2,Bromodomain-containing protein 2,39586,0.00201990159078384,0.00362321811184786,-0.00508160590843797,0.00912140909000565,0.577205230768921
NMR metabolomics,X23424.Total Lipids in VLDL,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,39638,0.00124414091331541,0.0022364823195118,-0.00313936443292772,0.00562764625955855,0.57802140390302
NMR metabolomics,X23424.Total Lipids in VLDL,PODXL2,Podocalyxin-like protein 2,42181,0.00163448693318361,0.00294766469225728,-0.00414293586364066,0.00741190973000788,0.579244243951435
NMR metabolomics,X23424.Total Lipids in VLDL,NTRK3,NT-3 growth factor receptor,42249,-0.00121091945773863,0.00218899814458693,-0.00550135582112901,0.00307951690565174,0.580146260659134
NMR metabolomics,X23424.Total Lipids in VLDL,TPBGL,Trophoblast glycoprotein-like,39649,-0.00231976197997549,0.0042013568478496,-0.0105544214017607,0.00591489744180973,0.580859560759131
NMR metabolomics,X23424.Total Lipids in VLDL,IL13,Interleukin-13,41913,-0.00276192247863327,0.00501831955215495,-0.012597828800857,0.00707398384359044,0.582076228719721
NMR metabolomics,X23424.Total Lipids in VLDL,DKKL1,Dickkopf-like protein 1,42070,-0.00475156361768629,0.0086439191081303,-0.0216936450696217,0.0121905178342491,0.582534168471306
NMR metabolomics,X23424.Total Lipids in VLDL,SAT1,Diamine acetyltransferase 1,39575,-0.00272541909012813,0.00500259183070656,-0.012530499078313,0.00707966089805674,0.585901177456831
NMR metabolomics,X23424.Total Lipids in VLDL,NRN1,Neuritin,39934,0.00195329209005463,0.00359387382269593,-0.00509070060242939,0.00899728478253865,0.586792130357917
NMR metabolomics,X23424.Total Lipids in VLDL,PHLDB2,Pleckstrin homology-like domain family B member 2,39560,0.00513615447660273,0.00947453436094234,-0.0134339328708443,0.0237062418240497,0.58775995633679
NMR metabolomics,X23424.Total Lipids in VLDL,EVPL,Envoplakin,39757,0.00186162150886512,0.00345291392331592,-0.00490608978083407,0.00862933279856432,0.589797518947712
NMR metabolomics,X23424.Total Lipids in VLDL,EFNB2,Ephrin-B2,39649,-0.00318251965983664,0.00598014905996687,-0.0149036118173717,0.00853857249769843,0.594611578736861
NMR metabolomics,X23424.Total Lipids in VLDL,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,39575,0.00277647706233218,0.0052520696977412,-0.00751757954524057,0.0130705336699049,0.597062866404947
NMR metabolomics,X23424.Total Lipids in VLDL,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,39930,0.00939673913588071,0.0177950757000037,-0.0254816092361265,0.0442750875078879,0.597473047340975
NMR metabolomics,X23424.Total Lipids in VLDL,SPRING1,SREBP regulating gene protein,39560,0.00337058175531959,0.00642586829164766,-0.00922412009630983,0.015965283606949,0.599918288936842
NMR metabolomics,X23424.Total Lipids in VLDL,CALY,Neuron-specific vesicular protein calcyon,39575,-0.00210826484557819,0.00401982405251781,-0.00998711998851309,0.00577059029735672,0.599964396148515
NMR metabolomics,X23424.Total Lipids in VLDL,DPEP2,Dipeptidase 2,42070,0.00162322269985634,0.00310461303630128,-0.00446181885129417,0.00770826425100686,0.60109267180759
NMR metabolomics,X23424.Total Lipids in VLDL,GAD1,Glutamate decarboxylase 1,39560,0.0013892979281683,0.0027261189027772,-0.003953895121275,0.00673249097761161,0.610324574187399
NMR metabolomics,X23424.Total Lipids in VLDL,KCNC4,Potassium voltage-gated channel subfamily C member 4,39586,0.0028973784049165,0.00569245270628913,-0.00825982889941019,0.0140545857092432,0.610772299677075
NMR metabolomics,X23424.Total Lipids in VLDL,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",39586,-0.00237076505688573,0.0046864776434147,-0.0115562612379786,0.00681473112420709,0.612955575311636
NMR metabolomics,X23424.Total Lipids in VLDL,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,42179,-0.00300399636822322,0.00597489644404524,-0.0147147933985519,0.00870680066210546,0.6151344145654
NMR metabolomics,X23424.Total Lipids in VLDL,FGF3,Fibroblast growth factor 3,39657,0.00153968985236355,0.0030643205639307,-0.00446637845294063,0.00754575815766773,0.615355976118685
NMR metabolomics,X23424.Total Lipids in VLDL,ATP5F1D,"ATP synthase subunit delta, mitochondrial",39575,0.00257005000316023,0.00513823792252721,-0.0075008963249931,0.0126409963313136,0.616957524367456
NMR metabolomics,X23424.Total Lipids in VLDL,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,42162,-0.00339734644389407,0.00679252112549223,-0.0167106878498588,0.0099159949620707,0.61697063194133
NMR metabolomics,X23424.Total Lipids in VLDL,FZD10,Frizzled-10,39649,0.00305784861265264,0.00616618800147882,-0.00902787987024586,0.0151435770955511,0.619970712526362
NMR metabolomics,X23424.Total Lipids in VLDL,DTX2,Probable E3 ubiquitin-protein ligase DTX2,39649,-0.00303970448635326,0.00616114173986225,-0.0151155422964833,0.00903613332377675,0.621763047053099
NMR metabolomics,X23424.Total Lipids in VLDL,CRYBB2,Beta-crystallin B2,39929,0.00356144271575891,0.00723085432010362,-0.0106110317516442,0.017733917183162,0.622351328381261
NMR metabolomics,X23424.Total Lipids in VLDL,CNTNAP2,Contactin-associated protein-like 2,42119,-0.00217736373312319,0.00443018551897854,-0.0108605273503211,0.00650579988407475,0.62309239492124
NMR metabolomics,X23424.Total Lipids in VLDL,TFRC,Transferrin receptor protein 1,42200,0.00189414089583294,0.00386737087288603,-0.00568590601502367,0.00947418780668956,0.624301146337173
NMR metabolomics,X23424.Total Lipids in VLDL,CDAN1,Codanin-1,39929,0.00110530013148022,0.00226021409351806,-0.00332471949181518,0.00553531975477561,0.624833798313602
NMR metabolomics,X23424.Total Lipids in VLDL,MBL2,Mannose-binding protein C,39826,0.00552683112522286,0.0114172749883024,-0.0168510278518499,0.0279046901022956,0.628341232179763
NMR metabolomics,X23424.Total Lipids in VLDL,HK2,Hexokinase-2,41900,0.00136127174999973,0.00281786503634125,-0.00416174372122911,0.00688428722122858,0.629042474531219
NMR metabolomics,X23424.Total Lipids in VLDL,SEPTIN7,Septin-7,39757,-0.00262570621364338,0.00550197408138568,-0.0134095754131593,0.00815816298587254,0.63320781202917
NMR metabolomics,X23424.Total Lipids in VLDL,PAEP,Glycodelin,42016,-0.00515937273595092,0.0108113626344336,-0.0263496434994408,0.016030898027539,0.633214939618844
NMR metabolomics,X23424.Total Lipids in VLDL,CDH22,Cadherin-22,39757,0.00135849707926786,0.00285045776654726,-0.00422840014316476,0.00694539430170049,0.633664085665552
NMR metabolomics,X23424.Total Lipids in VLDL,NCLN,Nicalin,41913,0.00251431240539442,0.00528822447484067,-0.0078506075652933,0.0128792323760821,0.63447054985915
NMR metabolomics,X23424.Total Lipids in VLDL,SAP18,Histone deacetylase complex subunit SAP18,39757,-0.00352127523653727,0.00747478484057772,-0.0181718535240696,0.0111293030509951,0.637587697321541
NMR metabolomics,X23424.Total Lipids in VLDL,IFNW1,Interferon omega-1,39575,-0.00171570568626841,0.00364925041573859,-0.00886823650111606,0.00543682512857923,0.63825511999838
NMR metabolomics,X23424.Total Lipids in VLDL,HMMR,Hyaluronan mediated motility receptor,39541,0.00232069901939378,0.0050047684816076,-0.00748864720455712,0.0121300452433447,0.642873657778669
NMR metabolomics,X23424.Total Lipids in VLDL,TCN1,Transcobalamin-1,39806,-0.0017038412791162,0.00368574000162782,-0.00892789168230672,0.00552020912407433,0.643890022635745
NMR metabolomics,X23424.Total Lipids in VLDL,CHIT1,Chitotriosidase-1,42207,-0.00743564938306718,0.0161622850860595,-0.0391137281517437,0.0242424293856094,0.645479239330279
NMR metabolomics,X23424.Total Lipids in VLDL,RRP15,RRP15-like protein,39586,0.00429455057086151,0.00943195772954981,-0.0141920865790561,0.0227811877207791,0.648888680284941
NMR metabolomics,X23424.Total Lipids in VLDL,MFAP3L,Microfibrillar-associated protein 3-like,39649,-0.00301628702258304,0.00665947217876676,-0.0160688524929659,0.0100362784477998,0.650606712568862
NMR metabolomics,X23424.Total Lipids in VLDL,TBR1,T-box brain protein 1,39649,0.00223346215679089,0.00495921066758072,-0.00748659075166732,0.0119535150652491,0.652455060804541
NMR metabolomics,X23424.Total Lipids in VLDL,RASA1,Ras GTPase-activating protein 1,41839,0.00149116244105427,0.00336456503046868,-0.00510338501866434,0.00808570990077289,0.657631068008957
NMR metabolomics,X23424.Total Lipids in VLDL,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,42249,-0.00127007637325738,0.00288372856274273,-0.00692218435623314,0.00438203160971837,0.659633729541535
NMR metabolomics,X23424.Total Lipids in VLDL,HDAC9,Histone deacetylase 9,39586,0.00301532272780446,0.00690053138571552,-0.010509718788198,0.0165403642438069,0.662141953095234
NMR metabolomics,X23424.Total Lipids in VLDL,SERPINA3,Alpha-1-antichymotrypsin,39951,-0.000671469569810279,0.00153986373358438,-0.00368960248763567,0.00234666334801511,0.662803097019864
NMR metabolomics,X23424.Total Lipids in VLDL,SUSD4,Sushi domain-containing protein 4,39919,0.00171165490997182,0.00398192230861083,-0.0060929128149054,0.00951622263484904,0.667308263610725
NMR metabolomics,X23424.Total Lipids in VLDL,CLINT1,Clathrin interactor 1,39560,0.00221991763217773,0.00517314175411709,-0.00791944020589178,0.0123592754702472,0.667841654066648
NMR metabolomics,X23424.Total Lipids in VLDL,INSL4,Early placenta insulin-like peptide,39919,-0.00211301497351266,0.00497416523340589,-0.0118623788309882,0.00763634888396288,0.670992079005496
NMR metabolomics,X23424.Total Lipids in VLDL,IKZF2,Zinc finger protein Helios,41843,0.00387356552554313,0.00917621120073811,-0.0141118084279036,0.0218589394789898,0.67293607032737
NMR metabolomics,X23424.Total Lipids in VLDL,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,39586,0.00212513465845141,0.0050528553992372,-0.00777846192405349,0.0120287312409563,0.674069342651481
NMR metabolomics,X23424.Total Lipids in VLDL,CYTH3,Cytohesin-3,39560,0.00315164735536399,0.00756655277979019,-0.0116787960930248,0.0179820908037528,0.67703510174759
NMR metabolomics,X23424.Total Lipids in VLDL,ARID3A,AT-rich interactive domain-containing protein 3A,39586,0.00173280224702055,0.00416619815027042,-0.00643294612750948,0.00989855062155058,0.677477175284601
NMR metabolomics,X23424.Total Lipids in VLDL,SLC34A3,Sodium-dependent phosphate transport protein 2C,39560,0.00207993975427552,0.0050081277379443,-0.00773599061209531,0.0118958701206463,0.677921032846043
NMR metabolomics,X23424.Total Lipids in VLDL,SLAMF1,Signaling lymphocytic activation molecule,41913,-0.00254663560510798,0.00616125892379848,-0.014622703095753,0.00952943188553705,0.679371218473825
NMR metabolomics,X23424.Total Lipids in VLDL,NENF,Neudesin,39919,0.00475599522868838,0.0116150192219372,-0.0180094424463086,0.0275214329036854,0.682202949230531
NMR metabolomics,X23424.Total Lipids in VLDL,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,42129,0.0013805562209997,0.00337717470657203,-0.00523870620388148,0.00799981864588087,0.682700038223951
NMR metabolomics,X23424.Total Lipids in VLDL,RUVBL1,RuvB-like 1,41843,0.00416117975291283,0.0102165679183998,-0.0158632933671508,0.0241856528729765,0.683796284523479
NMR metabolomics,X23424.Total Lipids in VLDL,HBZ,Hemoglobin subunit zeta,39958,-0.00449031689726449,0.0111033352007403,-0.0262528538907155,0.0172722200961865,0.685917729880924
NMR metabolomics,X23424.Total Lipids in VLDL,IL21R,Interleukin-21 receptor,39657,-0.00225987134374696,0.0056011284706859,-0.0132380831462913,0.0087183404587974,0.686612397698375
NMR metabolomics,X23424.Total Lipids in VLDL,CINP,Cyclin-dependent kinase 2-interacting protein,39757,0.00174324429503726,0.00436168442828986,-0.00680565718441086,0.0102921457744854,0.689405573320228
NMR metabolomics,X23424.Total Lipids in VLDL,MORC3,MORC family CW-type zinc finger protein 3,39929,0.001152565736571,0.00290250258899093,-0.00453633933785122,0.00684147081099322,0.691305783870289
NMR metabolomics,X23424.Total Lipids in VLDL,ESPL1,Separin,39560,-0.00219165274432746,0.00552465458743267,-0.0130199757356955,0.00863667024704057,0.691593451133255
NMR metabolomics,X23424.Total Lipids in VLDL,IL3,Interleukin-3,39560,0.00251467749150195,0.00633955766687098,-0.00991085553556518,0.0149402105185691,0.691622602627979
NMR metabolomics,X23424.Total Lipids in VLDL,IL2,Interleukin-2,41913,-0.00130400159214992,0.00330239247785004,-0.007776690848736,0.00516868766443616,0.692948313909093
NMR metabolomics,X23424.Total Lipids in VLDL,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,39934,-0.000983980856346786,0.00249604671012286,-0.0058762324081876,0.00390827069549402,0.693429195786589
NMR metabolomics,X23424.Total Lipids in VLDL,CNGB3,Cyclic nucleotide-gated cation channel beta-3,39586,-0.00217232182069803,0.00556733671209125,-0.0130843017763969,0.00873965813500081,0.696403260628605
NMR metabolomics,X23424.Total Lipids in VLDL,IFNL2,Interferon lambda-2,39586,-0.00233661111023338,0.00605415022079339,-0.0142027455429884,0.00952952332252166,0.69953972540286
NMR metabolomics,X23424.Total Lipids in VLDL,MYL6B,Myosin light chain 6B,39649,0.00359795760509181,0.00943309750859618,-0.0148909135117567,0.0220868287219403,0.702900093202887
NMR metabolomics,X23424.Total Lipids in VLDL,UBQLN3,Ubiquilin-3,39575,0.00221471579064188,0.00581580486967838,-0.00918426175392776,0.0136136933352115,0.703351718969442
NMR metabolomics,X23424.Total Lipids in VLDL,ZCCHC8,Zinc finger CCHC domain-containing protein 8,39575,0.00231478858885373,0.00612112072699946,-0.00968260803606521,0.0143121852137727,0.705315948507893
NMR metabolomics,X23424.Total Lipids in VLDL,KRT6C,"Keratin, type II cytoskeletal 6C",39575,-0.00149239817419688,0.00395215104278213,-0.00923861421804985,0.00625381786965609,0.705722670409225
NMR metabolomics,X23424.Total Lipids in VLDL,ATP2B4,Plasma membrane calcium-transporting ATPase 4,39575,0.00245430016943101,0.00650099035285361,-0.0102876409221621,0.0151962412610241,0.705789213737881
NMR metabolomics,X23424.Total Lipids in VLDL,CYB5A,Cytochrome b5,39560,0.00276175674563503,0.00736910292136002,-0.0116816849802306,0.0172051984715007,0.707834938825242
NMR metabolomics,X23424.Total Lipids in VLDL,SLC1A4,Neutral amino acid transporter A,39649,0.00196053570934813,0.00525186535331885,-0.00833312038315682,0.0122541918018531,0.708930301437689
NMR metabolomics,X23424.Total Lipids in VLDL,NEFL,Neurofilament light polypeptide,41797,0.00181218868383143,0.00488269601585854,-0.00775789550725131,0.0113822728749142,0.71053542147544
NMR metabolomics,X23424.Total Lipids in VLDL,TPRKB,EKC/KEOPS complex subunit TPRKB,39560,-0.00262129723038272,0.00706474697020861,-0.0164682012919916,0.0112256068312261,0.710615594264038
NMR metabolomics,X23424.Total Lipids in VLDL,RLN1,Prorelaxin H1,39934,0.00169148933537881,0.00457989850121944,-0.0072851117270113,0.0106680903977689,0.711889411481795
NMR metabolomics,X23424.Total Lipids in VLDL,PCARE,Photoreceptor cilium actin regulator,39586,-0.00317101611544521,0.00860981190608007,-0.0200462474513621,0.0137042152204717,0.712654709861157
NMR metabolomics,X23424.Total Lipids in VLDL,NLGN1,Neuroligin-1,39649,0.00255621404334682,0.00694394724640166,-0.0110539225596004,0.0161663506462941,0.712789931835389
NMR metabolomics,X23424.Total Lipids in VLDL,BHLHE40,Class E basic helix-loop-helix protein 40,39586,-0.00268642439157198,0.00733316574942151,-0.0170594292604381,0.0116865804772942,0.714119207909109
NMR metabolomics,X23424.Total Lipids in VLDL,SEZ6L2,Seizure 6-like protein 2,42070,-0.000911792153984573,0.00249683086956269,-0.00580558065832745,0.0039819963503583,0.714982942459746
NMR metabolomics,X23424.Total Lipids in VLDL,CLEC2L,C-type lectin domain family 2 member L,39649,-0.00193213510170638,0.00529341500385378,-0.0123072285092598,0.00844295830584703,0.715112945585214
NMR metabolomics,X23424.Total Lipids in VLDL,FOLR1,Folate receptor alpha,42110,0.00109834041632678,0.0030441146281582,-0.00486812425486329,0.00706480508751686,0.718248744648897
NMR metabolomics,X23424.Total Lipids in VLDL,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,39919,0.00373577650812426,0.0103616284817218,-0.0165730153160505,0.024044568332299,0.71845043965576
NMR metabolomics,X23424.Total Lipids in VLDL,LSM8,U6 snRNA-associated Sm-like protein LSm8,39757,-0.00297466713426927,0.00827915320747253,-0.0192018074209154,0.0132524731523769,0.719380420392996
NMR metabolomics,X23424.Total Lipids in VLDL,SMPD3,Sphingomyelin phosphodiesterase 3,39657,-0.00212034175941745,0.00590716309116684,-0.0136983814181044,0.00945769789926955,0.719643708338614
NMR metabolomics,X23424.Total Lipids in VLDL,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,42123,-0.00146490651542292,0.00409377459709701,-0.00948870472573305,0.00655889169488721,0.720470428249303
NMR metabolomics,X23424.Total Lipids in VLDL,BTLA,B- and T-lymphocyte attenuator,39560,0.00315793861517802,0.00886980749460185,-0.0142268840742416,0.0205427613045976,0.721823173665278
NMR metabolomics,X23424.Total Lipids in VLDL,PKLR,Pyruvate kinase PKLR,42143,0.00228931345988153,0.00643029213678652,-0.01031405912822,0.0148926860479831,0.721831033479534
NMR metabolomics,X23424.Total Lipids in VLDL,BTN1A1,Butyrophilin subfamily 1 member A1,39894,0.00140306149703649,0.00395573996415041,-0.00635018883269831,0.0091563118267713,0.722828448938639
NMR metabolomics,X23424.Total Lipids in VLDL,TFF2,Trefoil factor 2,42166,-0.0021252339285399,0.00602909442573932,-0.013942259002989,0.00969179114590916,0.724471512680277
NMR metabolomics,X23424.Total Lipids in VLDL,IL25,Interleukin-25,39510,0.0012471835741939,0.00355632781393533,-0.00572321894111935,0.00821758608950715,0.725824540474567
NMR metabolomics,X23424.Total Lipids in VLDL,PRAME,Melanoma antigen preferentially expressed in tumors,39560,-0.000890348780905893,0.00263038490555015,-0.00604590319578419,0.0042652056339724,0.73500336894107
NMR metabolomics,X23424.Total Lipids in VLDL,DEFB116,Beta-defensin 116,39586,0.00262157553040888,0.00776542559068057,-0.012598658627325,0.0178418096881428,0.735674212427634
NMR metabolomics,X23424.Total Lipids in VLDL,ITGB7,Integrin beta-7,42262,0.00158370300959816,0.00475995200699345,-0.007745802924109,0.0109132089433053,0.739355232022906
NMR metabolomics,X23424.Total Lipids in VLDL,VWC2L,von Willebrand factor C domain-containing protein 2-like,39934,0.00156330913121568,0.00475035247606636,-0.00774738172187439,0.0108739999843058,0.742091255517006
NMR metabolomics,X23424.Total Lipids in VLDL,MATN3,Matrilin-3,41992,0.00110180989985889,0.00340775334951466,-0.00557738666518985,0.00778100646490763,0.746454604736746
NMR metabolomics,X23424.Total Lipids in VLDL,OSCAR,Osteoclast-associated immunoglobulin-like receptor,42144,-0.00114897652843869,0.00358524030008386,-0.00817604751660305,0.00587809445972568,0.74861393257123
NMR metabolomics,X23424.Total Lipids in VLDL,TXK,Tyrosine-protein kinase TXK,39757,-0.00242430622847428,0.00757200933807032,-0.0172654445310921,0.0124168320741435,0.748847861913633
NMR metabolomics,X23424.Total Lipids in VLDL,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,39586,-0.00105766402732239,0.00335349048149936,-0.00763050537106114,0.00551517731641636,0.752470040441714
NMR metabolomics,X23424.Total Lipids in VLDL,TMED1,Transmembrane emp24 domain-containing protein 1,39757,0.00174667545796334,0.00556066583340958,-0.00915222957551945,0.0126455804914461,0.753441358142211
NMR metabolomics,X23424.Total Lipids in VLDL,IL17F,Interleukin-17F,41913,-0.00237400169918223,0.00757859727329017,-0.017228052354831,0.0124800489564665,0.754095029411693
NMR metabolomics,X23424.Total Lipids in VLDL,ATRAID,All-trans retinoic acid-induced differentiation factor,39930,-0.000958178665496933,0.00306678701005157,-0.006969081205198,0.00505272387420414,0.754713953666982
NMR metabolomics,X23424.Total Lipids in VLDL,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,39757,-0.00213600309725968,0.00705733169034032,-0.0159683732103267,0.0116963670158073,0.762151269201782
NMR metabolomics,X23424.Total Lipids in VLDL,IL20,Interleukin-20,41913,0.00143675006973846,0.00481784836138653,-0.00800623271857914,0.0108797328580561,0.765544453326727
NMR metabolomics,X23424.Total Lipids in VLDL,PLIN3,Perilipin-3,42145,-0.00131706654458306,0.00441875644551861,-0.00997782917779954,0.00734369608863342,0.765659869417539
NMR metabolomics,X23424.Total Lipids in VLDL,MLLT1,Protein ENL,39560,-0.00204241720701732,0.00686814488514091,-0.0155039811818935,0.0114191467678589,0.766185572512892
NMR metabolomics,X23424.Total Lipids in VLDL,JUN,Transcription factor AP-1,41913,0.00145012711634899,0.00498552915525088,-0.00832151002794274,0.0112217642606407,0.771157386547256
NMR metabolomics,X23424.Total Lipids in VLDL,ENO1,Alpha-enolase,42119,-0.00235647588918669,0.00812044813680138,-0.0182725542373174,0.013559602458944,0.77167505011355
NMR metabolomics,X23424.Total Lipids in VLDL,GAGE2A,G antigen 2A,39560,-0.00195416250657604,0.00676545113649974,-0.0152144467341155,0.0113061217209634,0.772705934966903
NMR metabolomics,X23424.Total Lipids in VLDL,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,39757,0.00142665953225674,0.00496197240303475,-0.00829880637769136,0.0111521254422048,0.773720575311223
NMR metabolomics,X23424.Total Lipids in VLDL,CNTN1,Contactin-1,42310,-0.000792189679716501,0.00275690550379999,-0.00619572446716448,0.00461134510773148,0.773850660862915
NMR metabolomics,X23424.Total Lipids in VLDL,IL2RG,Cytokine receptor common subunit gamma,39919,0.00105590864041565,0.00367634352307088,-0.00614972466480327,0.00826154194563457,0.773951369075019
NMR metabolomics,X23424.Total Lipids in VLDL,IL2RB,Interleukin-2 receptor subunit beta,41913,-0.00104082400169811,0.00375783449149254,-0.00840617960502349,0.00632453160162727,0.781804053573198
NMR metabolomics,X23424.Total Lipids in VLDL,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,39930,0.000615306765289909,0.00222357895233793,-0.00374290798129243,0.00497352151187225,0.782000852867443
NMR metabolomics,X23424.Total Lipids in VLDL,LYPD1,Ly6/PLAUR domain-containing protein 1,41839,0.00171294563091638,0.0062325219335235,-0.0105027973587897,0.0139286886206224,0.783443540096223
NMR metabolomics,X23424.Total Lipids in VLDL,MSLN,Mesothelin,42048,0.00161131045480182,0.00599776274968857,-0.0101443045345878,0.0133669254441914,0.788201678151237
NMR metabolomics,X23424.Total Lipids in VLDL,SKIV2L,Helicase SKI2W,39575,-0.00109245114389883,0.00409290662406982,-0.00911454812707567,0.00692964583927801,0.789540944087012
NMR metabolomics,X23424.Total Lipids in VLDL,ALPI,Intestinal-type alkaline phosphatase,39657,-0.00345796206999641,0.0129697024632862,-0.0288785788980373,0.0219626547580445,0.789767914416593
NMR metabolomics,X23424.Total Lipids in VLDL,ZNF75D,Zinc finger protein 75D,39757,-0.00168081977331191,0.00632493563959449,-0.0140776936269171,0.0107160540802933,0.790440544412228
NMR metabolomics,X23424.Total Lipids in VLDL,FCRL6,Fc receptor-like protein 6,42119,-0.001844570561743,0.00708371662843509,-0.0157286551534758,0.0120395140299898,0.794562393384756
NMR metabolomics,X23424.Total Lipids in VLDL,IL22,Interleukin-22,39919,0.00188206346791372,0.00727557066826167,-0.0123780550418792,0.0161421819777066,0.795884856859593
NMR metabolomics,X23424.Total Lipids in VLDL,KLK12,Kallikrein-12,41843,0.00355746232090341,0.0137716146321293,-0.0234349023580699,0.0305498269998768,0.796165152788224
NMR metabolomics,X23424.Total Lipids in VLDL,TET2,Methylcytosine dioxygenase TET2,39750,-0.00265037524150488,0.010388406294966,-0.0230116515796382,0.0177109010966284,0.798628801488563
NMR metabolomics,X23424.Total Lipids in VLDL,VASN,Vasorin,41975,0.00071109314116474,0.00282806701180053,-0.0048319182019643,0.00625410448429378,0.801476722500089
NMR metabolomics,X23424.Total Lipids in VLDL,DPP6,Dipeptidyl aminopeptidase-like protein 6,42070,-0.000883684882930646,0.00353320691763455,-0.00780877044149436,0.00604140067563306,0.802507300646771
NMR metabolomics,X23424.Total Lipids in VLDL,RPGR,X-linked retinitis pigmentosa GTPase regulator,39649,0.00104306610607762,0.00418197125754809,-0.00715359755871663,0.00923972977087187,0.803040768043629
NMR metabolomics,X23424.Total Lipids in VLDL,DCDC2C,Doublecortin domain-containing protein 2C,39560,0.00162837300792604,0.00657329958147221,-0.0112552941717595,0.0145120401876116,0.804351549183706
NMR metabolomics,X23424.Total Lipids in VLDL,ERVV_1,,39575,0.00110747503551867,0.00450712914068468,-0.00772649808022331,0.00994144815126064,0.805906458465362
NMR metabolomics,X23424.Total Lipids in VLDL,SPINT3,Kunitz-type protease inhibitor 3,39930,-0.00421117029578211,0.0171708107331701,-0.0378659593327955,0.0294436187412313,0.806265999682847
NMR metabolomics,X23424.Total Lipids in VLDL,COL3A1,Collagen alpha-1(III) chain,39966,0.000596957319042747,0.00243854026712336,-0.00418258160451903,0.00537649624260453,0.806614867941987
NMR metabolomics,X23424.Total Lipids in VLDL,GHRHR,Growth hormone-releasing hormone receptor,41839,0.00136529817861452,0.00558148903705645,-0.00957442033401612,0.0123050166912452,0.80676080374193
NMR metabolomics,X23424.Total Lipids in VLDL,CHL1,Neural cell adhesion molecule L1-like protein,42189,0.000737306068501978,0.00309073600104472,-0.00532053649354568,0.00679514863054963,0.811455378232849
NMR metabolomics,X23424.Total Lipids in VLDL,MMP15,Matrix metalloproteinase-15,39958,0.00119133459438371,0.00502921507245805,-0.00866592694763407,0.0110485961364015,0.81275197876886
NMR metabolomics,X23424.Total Lipids in VLDL,RNF4,E3 ubiquitin-protein ligase RNF4,39757,-0.00157313844226376,0.00675426345166182,-0.0148114948075209,0.0116652179229934,0.815835227356627
NMR metabolomics,X23424.Total Lipids in VLDL,TMPRSS5,Transmembrane protease serine 5,41946,-0.000922954320537296,0.00398142350291072,-0.0087265443862423,0.00688063574516771,0.816685137023918
NMR metabolomics,X23424.Total Lipids in VLDL,IL31,Interleukin-31,39657,-0.00133234106595001,0.00575160159175711,-0.0126054801857939,0.00994079805389393,0.81681651149069
NMR metabolomics,X23424.Total Lipids in VLDL,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,39575,0.00115708700740051,0.00500276843052331,-0.00864833911642518,0.0109625131312262,0.817094339443398
NMR metabolomics,X23424.Total Lipids in VLDL,NPTX2,Neuronal pentraxin-2,39966,0.000798840631768422,0.00353952335770923,-0.00613862514934168,0.00773630641287852,0.821445362405909
NMR metabolomics,X23424.Total Lipids in VLDL,SHD,SH2 domain-containing adapter protein D,39554,0.00192507937047144,0.00853086826042392,-0.0147954224199594,0.0186455811609023,0.821469749089579
NMR metabolomics,X23424.Total Lipids in VLDL,GSTM4,Glutathione S-transferase Mu 4,39575,-0.00174078324208706,0.00772826672608547,-0.0168881860252146,0.0134066195410405,0.821789877754671
NMR metabolomics,X23424.Total Lipids in VLDL,DNLZ,DNL-type zinc finger protein,39586,-0.00194632837227345,0.00873609325551694,-0.0190690711530867,0.0151764144085398,0.823701831925383
NMR metabolomics,X23424.Total Lipids in VLDL,LMOD2,Leiomodin-2,39586,0.00138963873843669,0.00635980911315486,-0.0110755871233468,0.0138548646002202,0.827041112219638
NMR metabolomics,X23424.Total Lipids in VLDL,CSH1,Chorionic somatomammotropin hormone 1,39990,-0.000641253355921244,0.00294717557533392,-0.00641771748357573,0.00513521077173324,0.827758443525896
NMR metabolomics,X23424.Total Lipids in VLDL,TMED10,Transmembrane emp24 domain-containing protein 10,39575,0.00103964319379126,0.00482123352202717,-0.00840997450938199,0.0104892608969645,0.829273610258359
NMR metabolomics,X23424.Total Lipids in VLDL,TAP1,Antigen peptide transporter 1,39757,0.00128512140223454,0.006032922384989,-0.0105394064723439,0.013109649276813,0.831316770659919
NMR metabolomics,X23424.Total Lipids in VLDL,SPINT1,Kunitz-type protease inhibitor 1,42081,0.000587191095652077,0.00275812799631422,-0.0048187397771238,0.00599312196842795,0.831412240997529
NMR metabolomics,X23424.Total Lipids in VLDL,FAM3D,Protein FAM3D,39930,0.0019004124886193,0.00904855371758488,-0.0158347527978471,0.0196355777750857,0.833652800482475
NMR metabolomics,X23424.Total Lipids in VLDL,TPT1,Translationally-controlled tumor protein,41913,0.00137131396217273,0.00661593664500104,-0.0115959218620293,0.0143385497863748,0.835798775734017
NMR metabolomics,X23424.Total Lipids in VLDL,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,39966,-0.000577259682380839,0.00281390118324244,-0.00609250600153602,0.00493798663677434,0.837461978478057
NMR metabolomics,X23424.Total Lipids in VLDL,GAMT,Guanidinoacetate N-methyltransferase,39575,-0.000748798479162863,0.00365894814142951,-0.00792033683636471,0.00642273987803899,0.837850505442466
NMR metabolomics,X23424.Total Lipids in VLDL,CBLN1,Cerebellin-1,39586,0.00193759065732518,0.00958291024055956,-0.0168449134141716,0.0207200947288219,0.839770136826554
NMR metabolomics,X23424.Total Lipids in VLDL,PSMG4,Proteasome assembly chaperone 4,39657,-0.0011611138709107,0.00578822074885874,-0.0125060265386738,0.0101837987968524,0.841015481382415
NMR metabolomics,X23424.Total Lipids in VLDL,TP73,Tumor protein p73,39649,0.000704106218900895,0.00354251150265361,-0.00623921632630017,0.00764742876410196,0.842454887638511
NMR metabolomics,X23424.Total Lipids in VLDL,MAGEA3,Melanoma-associated antigen 3,39757,0.00175892456292174,0.00891042402456222,-0.0157055065252202,0.0192233556510637,0.843517523126668
NMR metabolomics,X23424.Total Lipids in VLDL,TGOLN2,Trans-Golgi network integral membrane protein 2,39990,0.000537687818020801,0.00272856701108551,-0.0048103035237068,0.0058856791597484,0.843785132733191
NMR metabolomics,X23424.Total Lipids in VLDL,SLAMF8,SLAM family member 8,41843,-0.00108544957242664,0.00556044415733626,-0.0119839201208057,0.00981302097595243,0.845232211643533
NMR metabolomics,X23424.Total Lipids in VLDL,SIGLEC5,Sialic acid-binding Ig-like lectin 5,42137,-0.00234325149196658,0.012263279487604,-0.0263792792876704,0.0216927763037372,0.848466801336228
NMR metabolomics,X23424.Total Lipids in VLDL,BCL7A,B-cell CLL/lymphoma 7 protein family member A,39560,0.00126079791044049,0.00664529907379474,-0.0117639882741972,0.0142855840950782,0.849525956141311
NMR metabolomics,X23424.Total Lipids in VLDL,ITGAX,Integrin alpha-X,39757,0.00101138465080344,0.00534038466829425,-0.0094557692990533,0.0114785386006602,0.849795126601639
NMR metabolomics,X23424.Total Lipids in VLDL,PITHD1,PITH domain-containing protein 1,39539,-0.0014932626393103,0.00799368651469493,-0.0171608882081124,0.0141743629294918,0.851816791605452
NMR metabolomics,X23424.Total Lipids in VLDL,NCR1,Natural cytotoxicity triggering receptor 1,42095,0.000732043000571129,0.00395941441123751,-0.0070284092454544,0.00849249524659666,0.853320693987526
NMR metabolomics,X23424.Total Lipids in VLDL,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,42137,-0.000575212009171629,0.00320103023640743,-0.00684923127253019,0.00569880725418693,0.857394001961877
NMR metabolomics,X23424.Total Lipids in VLDL,KHDC3L,KH domain-containing protein 3,39560,-0.00124651757461111,0.00694635054255441,-0.0148613646380178,0.0123683294887955,0.857588259997845
NMR metabolomics,X23424.Total Lipids in VLDL,IL15RA,Interleukin-15 receptor subunit alpha,41913,0.00063493154649495,0.00358369217071462,-0.00638910510810571,0.00765896820109561,0.859375624909861
NMR metabolomics,X23424.Total Lipids in VLDL,GNPDA1,Glucosamine-6-phosphate isomerase 1,39638,0.000603486871122146,0.00348913589103699,-0.00623521947531036,0.00744219321755465,0.862684705055333
NMR metabolomics,X23424.Total Lipids in VLDL,IL33,Interleukin-33,41913,0.000700578176245515,0.00407340754540537,-0.00728330061274901,0.00868445696524004,0.863449392067339
NMR metabolomics,X23424.Total Lipids in VLDL,CDC25A,M-phase inducer phosphatase 1,39560,-0.000712559922760751,0.00414644391979625,-0.00883959000556141,0.0074144701600399,0.863559854418932
NMR metabolomics,X23424.Total Lipids in VLDL,UHRF2,E3 ubiquitin-protein ligase UHRF2,39575,-0.000589540485740965,0.00355707747413764,-0.00756141233505074,0.00638233136356881,0.868366728272563
NMR metabolomics,X23424.Total Lipids in VLDL,TMED4,Transmembrane emp24 domain-containing protein 4,39575,-0.000942142074810703,0.00572965661731945,-0.0121722690447568,0.0102879848951354,0.869393665573695
NMR metabolomics,X23424.Total Lipids in VLDL,CRX,Cone-rod homeobox protein,41900,0.00181709371057011,0.0111012474718021,-0.019941351334162,0.0235755387553022,0.869982605197724
NMR metabolomics,X23424.Total Lipids in VLDL,PALLD,Palladin,39657,0.000634949744976965,0.00394452670962925,-0.00709632260589636,0.00836622209585029,0.87212011346561
NMR metabolomics,X23424.Total Lipids in VLDL,GAL,Galanin peptides,42185,-0.00110453693946029,0.00687200761438776,-0.0145736718636603,0.0123645979847397,0.87230854672701
NMR metabolomics,X23424.Total Lipids in VLDL,CEP350,Centrosome-associated protein 350,39560,0.000570848082483842,0.00378400657068691,-0.0068458047960625,0.00798750096103018,0.880090421255084
NMR metabolomics,X23424.Total Lipids in VLDL,PXDNL,Peroxidasin-like protein,39919,-0.000891025433708984,0.00591294897995752,-0.0124804054344257,0.0106983545670078,0.880222526665012
NMR metabolomics,X23424.Total Lipids in VLDL,KLK1,Kallikrein-1,42016,-0.00197391346139,0.0131889348501751,-0.0278242257677332,0.0238763988449532,0.881031679639925
NMR metabolomics,X23424.Total Lipids in VLDL,PRND,Prion-like protein doppel,39929,0.000754087255800836,0.00505420274904347,-0.00915215013232436,0.010660324643926,0.881398443596778
NMR metabolomics,X23424.Total Lipids in VLDL,MORN4,MORN repeat-containing protein 4,39560,0.00120116771166092,0.00810195655301298,-0.0146786671322445,0.0170810025555664,0.882143072246353
NMR metabolomics,X23424.Total Lipids in VLDL,CNTNAP4,Contactin-associated protein-like 4,39649,-0.0015573084579804,0.010910089177747,-0.0229410832463645,0.0198264663304037,0.88649795890479
NMR metabolomics,X23424.Total Lipids in VLDL,LRP2,Low-density lipoprotein receptor-related protein 2,39649,-0.000531936748763728,0.00379260442748442,-0.0079654414266332,0.00690156792910574,0.888460029521724
NMR metabolomics,X23424.Total Lipids in VLDL,CNTF,Ciliary neurotrophic factor,39586,-0.000500462183507633,0.00357384168593147,-0.00750519188793331,0.00650426752091805,0.888635066890995
NMR metabolomics,X23424.Total Lipids in VLDL,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",39575,0.000687881577020829,0.00522462963471111,-0.00955239250701294,0.0109281556610546,0.895254603331973
NMR metabolomics,X23424.Total Lipids in VLDL,NMI,N-myc-interactor,39875,0.000946454183020769,0.00753227587216361,-0.0138168065264199,0.0157097148924614,0.900008729751858
NMR metabolomics,X23424.Total Lipids in VLDL,KDM3A,Lysine-specific demethylase 3A,39657,-0.00109982290808573,0.00917266654812303,-0.0190782493424069,0.0168786035262354,0.904562799340479
NMR metabolomics,X23424.Total Lipids in VLDL,CD48,CD48 antigen,42166,0.000374389364037014,0.00317232274307737,-0.00584336321239463,0.00659214194046866,0.906055597801647
NMR metabolomics,X23424.Total Lipids in VLDL,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,39934,0.00140986508337553,0.0121845154798215,-0.0224717852570747,0.0252915154238257,0.907884768949783
NMR metabolomics,X23424.Total Lipids in VLDL,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,42016,0.000728515218260122,0.00635082529522868,-0.0117191023603881,0.0131761327969083,0.908675200247808
NMR metabolomics,X23424.Total Lipids in VLDL,CD3G,T-cell surface glycoprotein CD3 gamma chain,39657,-0.00103546639553631,0.0090392958214788,-0.0187524862056348,0.0166815534145621,0.908802572326582
NMR metabolomics,X23424.Total Lipids in VLDL,PLAU,Urokinase-type plasminogen activator,42137,-0.000328116698010048,0.00294821700572082,-0.00610662202922285,0.00545038863320275,0.911385445553764
NMR metabolomics,X23424.Total Lipids in VLDL,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,42119,0.00172147255525841,0.0154835003649588,-0.0286261881600608,0.0320691332705777,0.91147439162855
NMR metabolomics,X23424.Total Lipids in VLDL,SEMA4C,Semaphorin-4C,42070,-0.000317608790105328,0.00287393859268326,-0.00595052843176451,0.00531531085155385,0.912003851839701
NMR metabolomics,X23424.Total Lipids in VLDL,LTBR,Tumor necrosis factor receptor superfamily member 3,42063,0.000331833138194185,0.00306636256989354,-0.00567823749879715,0.00634190377518552,0.913825022732617
NMR metabolomics,X23424.Total Lipids in VLDL,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,39336,-0.000566418354524665,0.00533615173734186,-0.0110252757597147,0.00989243905066537,0.91546742835535
NMR metabolomics,X23424.Total Lipids in VLDL,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",39657,-0.000466184360358804,0.00441656265825978,-0.00912264717054797,0.00819027844983037,0.915938406658195
NMR metabolomics,X23424.Total Lipids in VLDL,UPK3A,Uroplakin-3a,39586,0.00047751852996968,0.00501032502538518,-0.00934271851978527,0.0102977555797246,0.924072803023119
NMR metabolomics,X23424.Total Lipids in VLDL,FGF12,Fibroblast growth factor 12,39657,0.000439045998527143,0.00469016639741247,-0.0087536801404013,0.00963177213745559,0.925420742676542
NMR metabolomics,X23424.Total Lipids in VLDL,FAM171A2,Protein FAM171A2,39934,0.00150792235460351,0.0161407170237748,-0.0301278830119951,0.0331437277212021,0.925568769336945
NMR metabolomics,X23424.Total Lipids in VLDL,SCIN,Adseverin,39586,-0.000686522819560681,0.00763185307480255,-0.0156449548461737,0.0142719092070523,0.928324668973099
NMR metabolomics,X23424.Total Lipids in VLDL,BRME1,Break repair meiotic recombinase recruitment factor 1,39586,0.000365830791766949,0.00427717219799684,-0.00801742671630686,0.00874908829984075,0.931840814298997
NMR metabolomics,X23424.Total Lipids in VLDL,PYDC1,Pyrin domain-containing protein 1,39638,-0.00036301566677469,0.00426699338154071,-0.00872632269459449,0.00800029136104511,0.932203083804611
NMR metabolomics,X23424.Total Lipids in VLDL,KRT17,"Keratin, type I cytoskeletal 17",39575,0.000344438151561144,0.00417566000054886,-0.00783985544951462,0.00852873175263691,0.934260867489021
NMR metabolomics,X23424.Total Lipids in VLDL,HLA_A,,39934,0.000278206765294958,0.00339175302291786,-0.00636962915962405,0.00692604269021397,0.934628698190803
NMR metabolomics,X23424.Total Lipids in VLDL,TPSD1,Tryptase delta,39934,-0.000303287920118157,0.00377892050734895,-0.0077099721145221,0.00710339627428578,0.936033622080357
NMR metabolomics,X23424.Total Lipids in VLDL,SCN3B,Sodium channel subunit beta-3,39586,-0.000372142212025935,0.00481842973830113,-0.00981626449909614,0.00907198007504427,0.938439525624064
NMR metabolomics,X23424.Total Lipids in VLDL,ZNF830,Zinc finger protein 830,39919,-0.000613434649943349,0.00802052099137696,-0.0163336557930422,0.0151067864931555,0.939036076769132
NMR metabolomics,X23424.Total Lipids in VLDL,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,39919,-0.000593374900840219,0.00781199452771443,-0.0159048841751605,0.0147181343734801,0.939454728907688
NMR metabolomics,X23424.Total Lipids in VLDL,TOP1MT,"DNA topoisomerase I, mitochondrial",39560,0.000369025817240402,0.00499026221820832,-0.0094118881304479,0.0101499397649287,0.941052169575383
NMR metabolomics,X23424.Total Lipids in VLDL,WFDC12,WAP four-disulfide core domain protein 12,42223,-0.000481091005831979,0.00657454913094186,-0.013367207302478,0.0124050252908141,0.941668131344463
NMR metabolomics,X23424.Total Lipids in VLDL,PADI2,Protein-arginine deiminase type-2,41913,0.000429155242792362,0.0058881382545095,-0.0111115957360463,0.011969906221631,0.941898957011907
NMR metabolomics,X23424.Total Lipids in VLDL,DCLRE1C,Protein artemis,39560,-0.000228984073743212,0.0031514154346151,-0.0064057583255888,0.00594779017810238,0.942077442959848
NMR metabolomics,X23424.Total Lipids in VLDL,VCAN,Versican core protein,42249,-0.000215878568897474,0.00310452505724517,-0.00630074768109801,0.00586899054330307,0.944563403396481
NMR metabolomics,X23424.Total Lipids in VLDL,TSLP,Thymic stromal lymphopoietin,41900,0.000429543382063592,0.00621695339453269,-0.0117556852712205,0.0126147720353477,0.944917217839863
NMR metabolomics,X23424.Total Lipids in VLDL,EPGN,Epigen,39919,-0.000320094850756688,0.00478555546030513,-0.00969978355295474,0.00905959385144136,0.946672277660191
NMR metabolomics,X23424.Total Lipids in VLDL,WFDC2,WAP four-disulfide core domain protein 2,41430,-0.000279053006402381,0.00434131660488351,-0.00878803355197406,0.0082299275391693,0.948749531365527
NMR metabolomics,X23424.Total Lipids in VLDL,ANXA5,Annexin A5,41780,0.000193471839484282,0.00313755832972604,-0.00595614248677876,0.00634308616574732,0.950831993323476
NMR metabolomics,X23424.Total Lipids in VLDL,IL11,Interleukin-11,41913,0.000378140136606421,0.00629106031494361,-0.0119523380806831,0.0127086183538959,0.952070889889341
NMR metabolomics,X23424.Total Lipids in VLDL,RANGAP1,Ran GTPase-activating protein 1,41843,0.000293901507470514,0.00497096594139148,-0.00944919173765678,0.0100369947525978,0.952854536613545
NMR metabolomics,X23424.Total Lipids in VLDL,IL6,Interleukin-6,42070,-0.000442821581200438,0.00770737353214779,-0.0155492737042101,0.0146636305418092,0.954184179023405
NMR metabolomics,X23424.Total Lipids in VLDL,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,39560,-0.000259607120067129,0.00455431105716385,-0.00918605679210827,0.00866684255197402,0.954544242074737
NMR metabolomics,X23424.Total Lipids in VLDL,CADPS,Calcium-dependent secretion activator 1,39649,0.000235920052907936,0.00421704607593523,-0.00802949025592511,0.00850133036174098,0.955387122910555
NMR metabolomics,X23424.Total Lipids in VLDL,CTLA4,Cytotoxic T-lymphocyte protein 4,39966,-0.000175036679741081,0.00312884898963447,-0.00630758069942465,0.00595750733994248,0.955388330922873
NMR metabolomics,X23424.Total Lipids in VLDL,CD58,Lymphocyte function-associated antigen 3,42100,0.000100098596080243,0.0017979506549468,-0.00342388468761549,0.00362408187977597,0.955602561632265
NMR metabolomics,X23424.Total Lipids in VLDL,NPTN,Neuroplastin,41843,0.000444948612945636,0.00808401325408444,-0.0153997173650599,0.0162896145909511,0.956106981185942
NMR metabolomics,X23424.Total Lipids in VLDL,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,39575,0.000378882198405109,0.00705687448666719,-0.0134525917954626,0.0142103561922728,0.957183284610353
NMR metabolomics,X23424.Total Lipids in VLDL,SLK,STE20-like serine/threonine-protein kinase,39757,-0.000434820515434435,0.0081678488201726,-0.0164438042029727,0.0155741631721039,0.957545126402637
NMR metabolomics,X23424.Total Lipids in VLDL,VWA5A,von Willebrand factor A domain-containing protein 5A,39560,-0.000406091947741724,0.00798718484560646,-0.0160609742451304,0.0152487903496469,0.959451601663374
NMR metabolomics,X23424.Total Lipids in VLDL,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,39575,0.000128417523277028,0.00271879853292607,-0.00520042760125808,0.00545726264781213,0.96232823593952
NMR metabolomics,X23424.Total Lipids in VLDL,LTA4H,Leukotriene A-4 hydrolase,42262,0.000257772507163476,0.0061458340149734,-0.0117880621621844,0.0123036071765113,0.966545036933099
NMR metabolomics,X23424.Total Lipids in VLDL,TCP11,T-complex protein 11 homolog,39757,-0.000239397884211164,0.00598087582677516,-0.0119619145046905,0.0114831187362682,0.968072134558546
NMR metabolomics,X23424.Total Lipids in VLDL,NAAA,N-acylethanolamine-hydrolyzing acid amidase,41954,-0.000247127547378066,0.00619095750160869,-0.0123814042505311,0.011887149155775,0.968159495795224
NMR metabolomics,X23424.Total Lipids in VLDL,LHB,Lutropin subunit beta,41843,0.000358743369014893,0.00913358016244938,-0.0175430737493859,0.0182605604874157,0.968669809316972
NMR metabolomics,X23424.Total Lipids in VLDL,KIAA2013,Uncharacterized protein KIAA2013,39919,0.000178431229068409,0.00555088779555824,-0.0107013088502257,0.0110581713083626,0.974357279711513
NMR metabolomics,X23424.Total Lipids in VLDL,OBP2B,Odorant-binding protein 2b,41979,0.000189672163071377,0.00591479563150004,-0.0114033272746687,0.0117826716008114,0.974418773253849
NMR metabolomics,X23424.Total Lipids in VLDL,TGFBR1,TGF-beta receptor type-1,39657,-7.20456141581458e-05,0.00227427677606687,-0.0045296280952492,0.00438553686693291,0.974729034546085
NMR metabolomics,X23424.Total Lipids in VLDL,DAND5,DAN domain family member 5,39657,-0.000178942450643621,0.00565766353130513,-0.0112679629720017,0.0109100780707144,0.974769021272584
NMR metabolomics,X23424.Total Lipids in VLDL,NGFR,Tumor necrosis factor receptor superfamily member 16,39958,8.37032309058718e-05,0.00311229432720784,-0.00601639365042148,0.00618380011223323,0.978544447318836
NMR metabolomics,X23424.Total Lipids in VLDL,SPRR1B,Cornifin-B,39757,0.000202566046427816,0.00893439434620876,-0.0173088468721414,0.017713978964997,0.981911829025838
NMR metabolomics,X23424.Total Lipids in VLDL,CGN,Cingulin,39649,8.57520602763505e-05,0.00386913891262326,-0.00749776020846524,0.00766926432901794,0.98231826329516
NMR metabolomics,X23424.Total Lipids in VLDL,RBFOX3,RNA binding protein fox-1 homolog 3,39934,8.63891617268557e-05,0.00411040576115221,-0.00797000613013147,0.00814278445358518,0.983232316358819
NMR metabolomics,X23424.Total Lipids in VLDL,ARHGAP30,Rho GTPase-activating protein 30,39757,-8.31545657410833e-05,0.00415931522401536,-0.00823541240481118,0.00806910327332902,0.984049817317513
NMR metabolomics,X23424.Total Lipids in VLDL,MSLNL,Mesothelin-like protein,39649,-6.79632762462124e-05,0.00391994099197522,-0.00775104762051764,0.00761512106802522,0.9861674180428
NMR metabolomics,X23424.Total Lipids in VLDL,ATF4,Cyclic AMP-dependent transcription factor ATF-4,39560,-5.19805186071018e-05,0.00347317465548032,-0.00685940284334854,0.00675544180613433,0.988059351175703
NMR metabolomics,X23424.Total Lipids in VLDL,CASP4,Caspase-4,39757,-0.000197658556555789,0.0171627451789779,-0.0338366391073526,0.033441321994241,0.990811394757298
NMR metabolomics,X23424.Total Lipids in VLDL,MEGF11,Multiple epidermal growth factor-like domains protein 11,39575,3.89792468311779e-05,0.00339235800991779,-0.0066100424526077,0.00668800094627005,0.990832469240928
NMR metabolomics,X23424.Total Lipids in VLDL,DDX4,Probable ATP-dependent RNA helicase DDX4,39657,-6.1832237438231e-05,0.00560482264011185,-0.0110472846120575,0.010923620137181,0.991198138717483
NMR metabolomics,X23424.Total Lipids in VLDL,ZPR1,Zinc finger protein ZPR1,39586,9.36597523103084e-05,0.00996693181102928,-0.0194415265973071,0.0196288461019277,0.992502520201953
NMR metabolomics,X23424.Total Lipids in VLDL,THSD1,Thrombospondin type-1 domain-containing protein 1,39585,3.03524450173987e-05,0.00357299564726417,-0.00697271902362038,0.00703342391365518,0.993222240603892
NMR metabolomics,X23424.Total Lipids in VLDL,TAGLN3,Transgelin-3,39560,-4.05563746915512e-05,0.00621243174945205,-0.0122169226036176,0.0121358098542345,0.994791357308105
NMR metabolomics,X23424.Total Lipids in VLDL,SLC4A1,Band 3 anion transport protein,39966,-2.41679465347459e-05,0.00492449677867849,-0.0096761816327446,0.0096278457396751,0.99608432481079
